DrugA,DrugB,Interaction,Mechanism,risk_level
Certolizumab pegol,Brigatinib,The metabolism of Brigatinib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Brodalumab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Brodalumab.,increase,risk
Certolizumab pegol,Brolucizumab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Brolucizumab.,increase,risk
Certolizumab pegol,Bromazepam,The metabolism of Bromazepam can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Bumadizone,Bumadizone may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Bumetanide,Bumetanide may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Certolizumab pegol,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bupropion,The metabolism of Bupropion can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Burosumab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Burosumab.,increase,risk
Certolizumab pegol,Buspirone,The metabolism of Buspirone can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Busulfan,The metabolism of Busulfan can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Butabarbital,Butabarbital may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Gadodiamide,Gadodiamide may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Gadoteric acid,Certolizumab pegol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Gadoteridol,Gadoteridol may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Galantamine,The metabolism of Galantamine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Galcanezumab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Galcanezumab.,increase,risk
Certolizumab pegol,Ganciclovir,Ganciclovir may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Gefitinib,The metabolism of Gefitinib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Gentamicin,Certolizumab pegol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Gimeracil,Certolizumab pegol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Givosiran,Givosiran may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Glasdegib,The metabolism of Glasdegib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Gliclazide,The metabolism of Gliclazide can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Glimepiride,The metabolism of Glimepiride can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Glipizide,The metabolism of Glipizide can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Gliquidone,The metabolism of Gliquidone can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Glofitamab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Glofitamab.,increase,risk
Certolizumab pegol,Glyburide,The metabolism of Glyburide can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Glycerol phenylbutyrate,Certolizumab pegol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Golimumab,The risk or severity of infection can be increased when Golimumab is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Golodirsen,Certolizumab pegol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Goserelin,Goserelin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Guanabenz,The metabolism of Guanabenz can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Guanethidine,Guanethidine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Guanfacine,Guanfacine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Guselkumab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Guselkumab.,increase,risk
Certolizumab pegol,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Certolizumab pegol.,decrease,no risk
Certolizumab pegol,Halofantrine,The metabolism of Halofantrine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Haloperidol,The metabolism of Haloperidol can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Halothane,The metabolism of Halothane can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Certolizumab pegol.,decrease,no risk
Certolizumab pegol,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Certolizumab pegol.,decrease,no risk
Certolizumab pegol,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Human cytomegalovirus immune globulin.,increase,risk
Certolizumab pegol,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Human Rho(D) immune globulin.,increase,risk
Certolizumab pegol,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Human varicella-zoster immune globulin.,increase,risk
Certolizumab pegol,Hydralazine,Hydralazine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Certolizumab pegol,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Hydrocortisone succinate.,increase,risk
Certolizumab pegol,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Certolizumab pegol,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Hydroxyethyl Starch,Certolizumab pegol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Certolizumab pegol.,decrease,no risk
Certolizumab pegol,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Certolizumab pegol.,decrease,no risk
Certolizumab pegol,Kanamycin,Certolizumab pegol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Ketamine,The metabolism of Ketamine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Ketazolam,Ketazolam may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Ketoprofen,Ketoprofen may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Ketorolac,The metabolism of Ketorolac can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Obinutuzumab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Obinutuzumab.,increase,risk
Certolizumab pegol,Ocrelizumab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Ocrelizumab.,increase,risk
Certolizumab pegol,Octinoxate,Certolizumab pegol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Odesivimab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Odesivimab.,increase,risk
Certolizumab pegol,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Olanzapine,The metabolism of Olanzapine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Olaparib,The metabolism of Olaparib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Oliceridine,The metabolism of Oliceridine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Olodaterol,The metabolism of Olodaterol can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Olsalazine,Olsalazine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Omeprazole,The metabolism of Omeprazole can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Ondansetron,The metabolism of Ondansetron can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Opium,The metabolism of Opium can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Oseltamivir,Oseltamivir may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Osimertinib,The metabolism of Osimertinib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Ospemifene,The metabolism of Ospemifene can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Oxacillin,Oxacillin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Oxaprozin,Oxaprozin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Oxazepam,Oxazepam may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Oxybenzone,Oxybenzone may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Oxycodone,The metabolism of Oxycodone can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Oxyquinoline,Certolizumab pegol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Ozanimod,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Ozanimod.,increase,risk
Certolizumab pegol,Quetiapine,The metabolism of Quetiapine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Quinestrol,Quinestrol may increase the thrombogenic activities of Certolizumab pegol.,increase,no risk
Certolizumab pegol,Quinethazone,Quinethazone may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Certolizumab pegol,Quinidine,The metabolism of Quinidine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Quinine,The metabolism of Quinine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Quizartinib,The metabolism of Quizartinib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Udenafil,The metabolism of Udenafil can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Upadacitinib,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Upadacitinib.,increase,risk
Certolizumab pegol,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Vaborbactam,Certolizumab pegol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Valaciclovir,Valaciclovir may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Valbenazine,The metabolism of Valbenazine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Valganciclovir,Valganciclovir may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Valproic acid,The metabolism of Valproic acid can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Valsartan,The metabolism of Valsartan can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vancomycin,Certolizumab pegol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Vandetanib,The metabolism of Vandetanib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vardenafil,The metabolism of Vardenafil can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Varenicline,Varenicline may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Certolizumab pegol.,decrease,no risk
Certolizumab pegol,Vedolizumab,The risk or severity of infection can be increased when Certolizumab pegol is combined with Vedolizumab.,increase,risk
Certolizumab pegol,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Venetoclax,The metabolism of Venetoclax can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Verapamil,The metabolism of Verapamil can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vernakalant,The metabolism of Vernakalant can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Certolizumab pegol.,decrease,no risk
Certolizumab pegol,Vilanterol,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Vilanterol.,increase,risk
Certolizumab pegol,Vilazodone,The metabolism of Vilazodone can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Viloxazine,Certolizumab pegol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Vinblastine,The metabolism of Vinblastine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vincristine,The metabolism of Vincristine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vindesine,The metabolism of Vindesine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vinflunine,The metabolism of Vinflunine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Voclosporin,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Voclosporin.,increase,risk
Certolizumab pegol,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Voriconazole,The metabolism of Voriconazole can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Voxelotor,The metabolism of Voxelotor can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Warfarin,The metabolism of Warfarin can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Yohimbine,The metabolism of Yohimbine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zaleplon,The metabolism of Zaleplon can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zanamivir,Zanamivir may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zidovudine,The metabolism of Zidovudine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zileuton,The metabolism of Zileuton can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zolpidem,The metabolism of Zolpidem can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zonisamide,The metabolism of Zonisamide can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zopiclone,The metabolism of Zopiclone can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zotepine,The metabolism of Zotepine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Certolizumab pegol.,increase,no risk
Formestane,Butabarbital,Butabarbital may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Butacaine,The risk or severity of methemoglobinemia can be increased when Formestane is combined with Butacaine.,increase,risk
Formestane,Butamben,The risk or severity of methemoglobinemia can be increased when Formestane is combined with Butamben.,increase,risk
Formestane,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Gadodiamide,Gadodiamide may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Gadoteric acid,Formestane may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Formestane,Gadoteridol,Gadoteridol may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Ganciclovir,Ganciclovir may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Gemcitabine,Gemcitabine may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Gentamicin,Formestane may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Formestane,Gestrinone,The metabolism of Gestrinone can be increased when combined with Formestane.,increase,no risk
Formestane,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Formestane.,increase,no risk
Formestane,Gimeracil,Formestane may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Formestane,Givosiran,Givosiran may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Glipizide,Glipizide may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Glycerol phenylbutyrate,Formestane may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Formestane,Golodirsen,Formestane may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Formestane,Goserelin,Goserelin may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Guanethidine,Guanethidine may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Guanfacine,Guanfacine may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Haloperidol,Haloperidol may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Hydralazine,Hydralazine may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Formestane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Formestane,Hydrocortisone,The risk or severity of edema formation can be increased when Formestane is combined with Hydrocortisone.,increase,risk
Formestane,Hydrocortisone acetate,The risk or severity of edema formation can be increased when Formestane is combined with Hydrocortisone acetate.,increase,risk
Formestane,Hydrocortisone butyrate,The risk or severity of edema formation can be increased when Formestane is combined with Hydrocortisone butyrate.,increase,risk
Formestane,Hydrocortisone cypionate,The risk or severity of edema formation can be increased when Formestane is combined with Hydrocortisone cypionate.,increase,risk
Formestane,Hydrocortisone succinate,The risk or severity of edema formation can be increased when Formestane is combined with Hydrocortisone succinate.,increase,risk
Formestane,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Formestane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Formestane,Hydromorphone,Hydromorphone may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Hydroxyethyl Starch,Formestane may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Formestane,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Formestane.,increase,no risk
Formestane,Kanamycin,Formestane may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Formestane,Ketamine,Ketamine may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Ketazolam,Ketazolam may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Ketoprofen,Ketoprofen may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Ketorolac,Ketorolac may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Octinoxate,Formestane may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Formestane,Olaparib,The metabolism of Olaparib can be increased when combined with Formestane.,increase,no risk
Formestane,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Formestane.,decrease,no risk
Formestane,Olsalazine,Olsalazine may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Opium,Formestane may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Formestane,Oseltamivir,Oseltamivir may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Osimertinib,The metabolism of Osimertinib can be increased when combined with Formestane.,increase,no risk
Formestane,Oxacillin,Oxacillin may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Oxaprozin,Oxaprozin may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Oxazepam,Oxazepam may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Formestane is combined with Oxetacaine.,increase,risk
Formestane,Oxybenzone,Oxybenzone may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Formestane is combined with Oxybuprocaine.,increase,risk
Formestane,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Oxyquinoline,Formestane may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Formestane,Quetiapine,Quetiapine may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Quinethazone,Quinethazone may increase the excretion rate of Formestane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Formestane,Quinidine,The metabolism of Quinidine can be increased when combined with Formestane.,increase,no risk
Formestane,Ulipristal,The metabolism of Ulipristal can be increased when combined with Formestane.,increase,no risk
Formestane,Vaborbactam,Formestane may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Formestane,Valaciclovir,Valaciclovir may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Valbenazine,Formestane may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Formestane,Valdecoxib,Valdecoxib may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Valganciclovir,Valganciclovir may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Vamorolone,The risk or severity of edema formation can be increased when Formestane is combined with Vamorolone.,increase,risk
Formestane,Vancomycin,Formestane may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Formestane,Vandetanib,The metabolism of Vandetanib can be increased when combined with Formestane.,increase,no risk
Formestane,Varenicline,Varenicline may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Formestane.,increase,no risk
Formestane,Venetoclax,The metabolism of Venetoclax can be increased when combined with Formestane.,increase,no risk
Formestane,Venlafaxine,Venlafaxine may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Verapamil,Verapamil may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Vilanterol,Formestane may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Formestane,Viloxazine,Formestane may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Formestane,Vinblastine,The metabolism of Vinblastine can be increased when combined with Formestane.,increase,no risk
Formestane,Vincristine,The metabolism of Vincristine can be increased when combined with Formestane.,increase,no risk
Formestane,Vindesine,The metabolism of Vindesine can be increased when combined with Formestane.,increase,no risk
Formestane,Vinflunine,The metabolism of Vinflunine can be increased when combined with Formestane.,increase,no risk
Formestane,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Formestane.,increase,no risk
Formestane,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Formestane.,increase,no risk
Formestane,Vortioxetine,Formestane may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Formestane,Warfarin,The metabolism of Warfarin can be increased when combined with Formestane.,increase,no risk
Formestane,Zaleplon,Zaleplon may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Zanamivir,Zanamivir may decrease the excretion rate of Formestane which could result in a higher serum level.,decrease,no risk
Formestane,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Formestane.,increase,no risk
Formestane,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Formestane.,increase,no risk
Formestane,Zolpidem,The metabolism of Zolpidem can be increased when combined with Formestane.,increase,no risk
Formestane,Zonisamide,Zonisamide may increase the excretion rate of Formestane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Formestane,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Formestane.,increase,no risk
Fluticasone furoate,Bifonazole,The serum concentration of Fluticasone furoate can be increased when it is combined with Bifonazole.,increase,no risk
Fluticasone furoate,Bimekizumab,The metabolism of Fluticasone furoate can be increased when combined with Bimekizumab.,increase,no risk
Fluticasone furoate,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Blinatumomab,The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Blinatumomab.,increase,risk
Fluticasone furoate,Boceprevir,The serum concentration of Fluticasone furoate can be increased when it is combined with Boceprevir.,increase,no risk
Fluticasone furoate,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Fluticasone furoate.",decrease,no risk
Fluticasone furoate,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Bosutinib,The serum concentration of Fluticasone furoate can be increased when it is combined with Bosutinib.,increase,no risk
Fluticasone furoate,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Brentuximab vedotin,The serum concentration of Fluticasone furoate can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Fluticasone furoate,Brodalumab,The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Brodalumab.,increase,risk
Fluticasone furoate,Bromocriptine,The serum concentration of Fluticasone furoate can be increased when it is combined with Bromocriptine.,increase,no risk
Fluticasone furoate,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Bumadizone.,increase,risk
Fluticasone furoate,Bumetanide,The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Bumetanide.,increase,risk
Fluticasone furoate,Buprenorphine,The serum concentration of Fluticasone furoate can be increased when it is combined with Buprenorphine.,increase,no risk
Fluticasone furoate,Buspirone,The metabolism of Fluticasone furoate can be decreased when combined with Buspirone.,decrease,no risk
Fluticasone furoate,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Gatifloxacin,The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Gatifloxacin.,increase,risk
Fluticasone furoate,Gefitinib,The metabolism of Fluticasone furoate can be decreased when combined with Gefitinib.,decrease,no risk
Fluticasone furoate,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Gemifloxacin,The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Gemifloxacin.,increase,risk
Fluticasone furoate,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Gestrinone,The serum concentration of Fluticasone furoate can be increased when it is combined with Gestrinone.,increase,no risk
Fluticasone furoate,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Gliclazide,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Gliclazide.,increase,risk
Fluticasone furoate,Glimepiride,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Glimepiride.,increase,risk
Fluticasone furoate,Glipizide,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Glipizide.,increase,risk
Fluticasone furoate,Gliquidone,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Gliquidone.,increase,risk
Fluticasone furoate,Glofitamab,The serum concentration of Fluticasone furoate can be increased when it is combined with Glofitamab.,increase,no risk
Fluticasone furoate,Glyburide,The serum concentration of Fluticasone furoate can be increased when it is combined with Glyburide.,increase,no risk
Fluticasone furoate,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Glycol salicylate.,increase,risk
Fluticasone furoate,Glymidine,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Glymidine.,increase,risk
Fluticasone furoate,Golimumab,The metabolism of Fluticasone furoate can be increased when combined with Golimumab.,increase,no risk
Fluticasone furoate,Grepafloxacin,The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Grepafloxacin.,increase,risk
Fluticasone furoate,Guselkumab,The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Guselkumab.,increase,risk
Fluticasone furoate,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Halofantrine,The metabolism of Fluticasone furoate can be decreased when combined with Halofantrine.,decrease,no risk
Fluticasone furoate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Fluticasone furoate.,increase,no risk
Fluticasone furoate,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Fluticasone furoate.,increase,no risk
Fluticasone furoate,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Hydralazine,The serum concentration of Fluticasone furoate can be increased when it is combined with Hydralazine.,increase,no risk
Fluticasone furoate,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Hydrochlorothiazide.,increase,risk
Fluticasone furoate,Hydrocortisone,The metabolism of Fluticasone furoate can be decreased when combined with Hydrocortisone.,decrease,no risk
Fluticasone furoate,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Hydrocortisone acetate.,increase,risk
Fluticasone furoate,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Hydrocortisone butyrate.,increase,risk
Fluticasone furoate,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Hydrocortisone succinate.,increase,risk
Fluticasone furoate,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Hydroflumethiazide.,increase,risk
Fluticasone furoate,Hydrotalcite,The bioavailability of Fluticasone furoate can be decreased when combined with Hydrotalcite.,decrease,no risk
Fluticasone furoate,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Hydroxyprogesterone caproate,The serum concentration of Fluticasone furoate can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Fluticasone furoate,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Hydroxyzine,The metabolism of Fluticasone furoate can be decreased when combined with Hydroxyzine.,decrease,no risk
Fluticasone furoate,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Fluticasone furoate.,decrease,no risk
Fluticasone furoate,Ketazolam,The serum concentration of Fluticasone furoate can be increased when it is combined with Ketazolam.,increase,no risk
Fluticasone furoate,Ketoconazole,The serum concentration of Fluticasone furoate can be increased when it is combined with Ketoconazole.,increase,no risk
Fluticasone furoate,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Ketoprofen.,increase,risk
Fluticasone furoate,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Ketorolac.,increase,risk
Fluticasone furoate,Obinutuzumab,The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Obinutuzumab.,increase,risk
Fluticasone furoate,Ocrelizumab,The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Ocrelizumab.,increase,risk
Fluticasone furoate,Octreotide,The serum concentration of Fluticasone furoate can be increased when it is combined with Octreotide.,increase,no risk
Fluticasone furoate,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Ofloxacin,The risk or severity of tendinopathy can be increased when Fluticasone furoate is combined with Ofloxacin.,increase,risk
Fluticasone furoate,Olaparib,The serum concentration of Fluticasone furoate can be increased when it is combined with Olaparib.,increase,no risk
Fluticasone furoate,Olodaterol,The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Olodaterol.,increase,risk
Fluticasone furoate,Omaveloxolone,The serum concentration of Fluticasone furoate can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Fluticasone furoate,Ondansetron,The metabolism of Fluticasone furoate can be decreased when combined with Ondansetron.,decrease,no risk
Fluticasone furoate,Orciprenaline,The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Orciprenaline.,increase,risk
Fluticasone furoate,Orphenadrine,The serum concentration of Fluticasone furoate can be increased when it is combined with Orphenadrine.,increase,no risk
Fluticasone furoate,Osilodrostat,The serum concentration of Fluticasone furoate can be increased when it is combined with Osilodrostat.,increase,no risk
Fluticasone furoate,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Fluticasone furoate.,increase,risk
Fluticasone furoate,Oxandrolone,The risk or severity of fluid retention can be increased when Fluticasone furoate is combined with Oxandrolone.,increase,risk
Fluticasone furoate,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Oxaprozin.,increase,risk
Fluticasone furoate,Oxcarbazepine,The metabolism of Fluticasone furoate can be increased when combined with Oxcarbazepine.,increase,no risk
Fluticasone furoate,Oxetacaine,The serum concentration of Fluticasone furoate can be increased when it is combined with Oxetacaine.,increase,no risk
Fluticasone furoate,Oxybutynin,The serum concentration of Fluticasone furoate can be increased when it is combined with Oxybutynin.,increase,no risk
Fluticasone furoate,Oxycodone,The metabolism of Fluticasone furoate can be decreased when combined with Oxycodone.,decrease,no risk
Fluticasone furoate,Oxymetazoline,The absorption of Fluticasone furoate can be decreased when combined with Oxymetazoline.,decrease,no risk
Fluticasone furoate,Oxymetholone,The serum concentration of Fluticasone furoate can be increased when it is combined with Oxymetholone.,increase,no risk
Fluticasone furoate,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Fluticasone furoate is combined with Oxyphenbutazone.,increase,risk
Fluticasone furoate,Ozanimod,The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Ozanimod.,increase,risk
Canagliflozin,Benzatropine,Benzatropine may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Benznidazole,Canagliflozin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Canagliflozin,Benzthiazide,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Benzthiazide.,decrease,no risk
Canagliflozin,Benzydamine,The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Benzydamine.,increase,risk
Canagliflozin,Bepotastine,Bepotastine may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Bepridil,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Canagliflozin.,increase,risk
Canagliflozin,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Canagliflozin.,increase,risk
Canagliflozin,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Canagliflozin.,increase,risk
Canagliflozin,Betaxolol,The therapeutic efficacy of Canagliflozin can be increased when used in combination with Betaxolol.,increase,no risk
Canagliflozin,Bethanidine,Canagliflozin may increase the hypotensive activities of Bethanidine.,increase,no risk
Canagliflozin,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Bexagliflozin,Canagliflozin may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Canagliflozin,Bicisate,Canagliflozin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Canagliflozin,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Bismuth subgallate,Canagliflozin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Canagliflozin,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Canagliflozin.,increase,no risk
Canagliflozin,Bisoprolol,The therapeutic efficacy of Canagliflozin can be increased when used in combination with Bisoprolol.,increase,no risk
Canagliflozin,Bisoxatin,Canagliflozin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Bleomycin,Bleomycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Boceprevir,The metabolism of Canagliflozin can be decreased when combined with Boceprevir.,decrease,no risk
Canagliflozin,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Bosentan,The therapeutic efficacy of Canagliflozin can be increased when used in combination with Bosentan.,increase,no risk
Canagliflozin,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Bretylium,The risk or severity of adverse effects can be increased when Bretylium is combined with Canagliflozin.,increase,risk
Canagliflozin,Brexpiprazole,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Canagliflozin,Brivaracetam,Brivaracetam may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Bromazepam,Bromazepam may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Bromocriptine,Canagliflozin may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Canagliflozin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canagliflozin,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Canagliflozin.,increase,risk
Canagliflozin,Bumadizone,The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Bumadizone.,increase,risk
Canagliflozin,Bumetanide,The risk or severity of hypotension can be increased when Canagliflozin is combined with Bumetanide.,increase,risk
Canagliflozin,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Canagliflozin.,increase,risk
Canagliflozin,Bupropion,Bupropion may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Buserelin,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Buserelin.,decrease,no risk
Canagliflozin,Buspirone,Buspirone may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Butabarbital,The serum concentration of Canagliflozin can be decreased when it is combined with Butabarbital.,decrease,no risk
Canagliflozin,Butalbital,The serum concentration of Canagliflozin can be decreased when it is combined with Butalbital.,decrease,no risk
Canagliflozin,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Canagliflozin.,decrease,no risk
Canagliflozin,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Gadodiamide,Gadodiamide may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Gadoteric acid,Canagliflozin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Canagliflozin,Gadoteridol,Gadoteridol may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Ganciclovir,Ganciclovir may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Gatifloxacin,The therapeutic efficacy of Canagliflozin can be increased when used in combination with Gatifloxacin.,increase,no risk
Canagliflozin,Gefapixant,The therapeutic efficacy of Canagliflozin can be increased when used in combination with Gefapixant.,increase,no risk
Canagliflozin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Gemifloxacin,The therapeutic efficacy of Canagliflozin can be increased when used in combination with Gemifloxacin.,increase,no risk
Canagliflozin,Gentamicin,Canagliflozin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Gimeracil,Canagliflozin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Canagliflozin,Givosiran,Givosiran may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Gliclazide,Canagliflozin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Canagliflozin,Glimepiride,Canagliflozin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Canagliflozin,Glipizide,Canagliflozin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Canagliflozin,Gliquidone,Canagliflozin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Canagliflozin,Glofitamab,The serum concentration of Canagliflozin can be increased when it is combined with Glofitamab.,increase,no risk
Canagliflozin,Glyburide,Canagliflozin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Canagliflozin,Glycerol phenylbutyrate,Canagliflozin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Canagliflozin,Glymidine,Canagliflozin may increase the hypoglycemic activities of Glymidine.,increase,no risk
Canagliflozin,Golodirsen,Canagliflozin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Canagliflozin,Goserelin,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Goserelin.,decrease,no risk
Canagliflozin,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Grepafloxacin,The therapeutic efficacy of Canagliflozin can be increased when used in combination with Grepafloxacin.,increase,no risk
Canagliflozin,Guanabenz,Canagliflozin may increase the hypotensive activities of Guanabenz.,increase,no risk
Canagliflozin,Guanadrel,Canagliflozin may increase the hypotensive activities of Guanadrel.,increase,no risk
Canagliflozin,Guanethidine,Guanethidine may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Canagliflozin.,increase,risk
Canagliflozin,Guanoxan,Canagliflozin may increase the hypotensive activities of Guanoxan.,increase,no risk
Canagliflozin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Canagliflozin.,increase,risk
Canagliflozin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Canagliflozin.,increase,risk
Canagliflozin,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Canagliflozin.,increase,risk
Canagliflozin,Histrelin,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Histrelin.,decrease,no risk
Canagliflozin,Hydralazine,The risk or severity of adverse effects can be increased when Hydralazine is combined with Canagliflozin.,increase,risk
Canagliflozin,Hydrochlorothiazide,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Canagliflozin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Canagliflozin.,increase,risk
Canagliflozin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Canagliflozin.,increase,risk
Canagliflozin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Canagliflozin.,increase,risk
Canagliflozin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Canagliflozin.,increase,risk
Canagliflozin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Canagliflozin.,increase,risk
Canagliflozin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Canagliflozin.,increase,risk
Canagliflozin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Canagliflozin.,increase,risk
Canagliflozin,Hydroflumethiazide,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Canagliflozin,Hydromorphone,Hydromorphone may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Hydroxychloroquine,The therapeutic efficacy of Canagliflozin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Canagliflozin,Hydroxyethyl Starch,Canagliflozin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Canagliflozin,Hydroxyprogesterone caproate,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Canagliflozin,Kanamycin,Canagliflozin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Ketamine,Ketamine may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Ketazolam,Ketazolam may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Ketoconazole,The metabolism of Canagliflozin can be decreased when combined with Ketoconazole.,decrease,no risk
Canagliflozin,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Canagliflozin.,increase,risk
Canagliflozin,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Canagliflozin.,increase,risk
Canagliflozin,Ketotifen,The risk or severity of thrombocytopenia can be increased when Canagliflozin is combined with Ketotifen.,increase,risk
Canagliflozin,Obinutuzumab,The risk or severity of adverse effects can be increased when Canagliflozin is combined with Obinutuzumab.,increase,risk
Canagliflozin,Octinoxate,Canagliflozin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Canagliflozin,Octreotide,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Octreotide.,decrease,no risk
Canagliflozin,Ofloxacin,The therapeutic efficacy of Canagliflozin can be increased when used in combination with Ofloxacin.,increase,no risk
Canagliflozin,Olanzapine,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Olanzapine.,decrease,no risk
Canagliflozin,Olmesartan,"The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Olmesartan.",increase,risk
Canagliflozin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Canagliflozin.,increase,no risk
Canagliflozin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Omaveloxolone,The serum concentration of Canagliflozin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Canagliflozin,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Opicapone,The risk or severity of adverse effects can be increased when Canagliflozin is combined with Opicapone.,increase,risk
Canagliflozin,Opium,Canagliflozin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Canagliflozin,Oseltamivir,Oseltamivir may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Canagliflozin.,increase,no risk
Canagliflozin,Oxacillin,Oxacillin may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Canagliflozin.,increase,no risk
Canagliflozin,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Canagliflozin.,increase,risk
Canagliflozin,Oxazepam,Oxazepam may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Oxprenolol,The therapeutic efficacy of Canagliflozin can be increased when used in combination with Oxprenolol.,increase,no risk
Canagliflozin,Oxybenzone,Oxybenzone may decrease the excretion rate of Canagliflozin which could result in a higher serum level.,decrease,no risk
Canagliflozin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Canagliflozin.,increase,no risk
Canagliflozin,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Oxyphenbutazone is combined with Canagliflozin.,increase,risk
Canagliflozin,Oxyquinoline,Canagliflozin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Dimethyl fumarate,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Guselkumab,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Guselkumab.,increase,risk
Dimethyl fumarate,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Dimethyl fumarate.,decrease,no risk
Dimethyl fumarate,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Dimethyl fumarate.,decrease,no risk
Dimethyl fumarate,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Dimethyl fumarate.,decrease,no risk
Dimethyl fumarate,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Hydrocortisone acetate.,increase,risk
Dimethyl fumarate,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Hydrocortisone butyrate.,increase,risk
Dimethyl fumarate,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Hydrocortisone succinate.,increase,risk
Dimethyl fumarate,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dimethyl fumarate.,decrease,no risk
Dimethyl fumarate,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Dimethyl fumarate.,decrease,no risk
Dimethyl fumarate,Obinutuzumab,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Obinutuzumab.,increase,risk
Dimethyl fumarate,Ocrelizumab,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Ocrelizumab.,increase,risk
Dimethyl fumarate,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Olaparib,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Olaparib.,increase,risk
Dimethyl fumarate,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Ozanimod,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Ozanimod.,increase,risk
Dimethyl fumarate,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Upadacitinib,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Upadacitinib.,increase,risk
Dimethyl fumarate,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Dimethyl fumarate.,decrease,no risk
Dimethyl fumarate,Vedolizumab,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Vedolizumab.,increase,risk
Dimethyl fumarate,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dimethyl fumarate.,decrease,no risk
Dimethyl fumarate,Vilanterol,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Vilanterol.,increase,risk
Dimethyl fumarate,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Voclosporin,The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Voclosporin.,increase,risk
Dimethyl fumarate,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Dimethyl fumarate.,increase,risk
Dimethyl fumarate,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Dimethyl fumarate.,increase,risk
Pomalidomide,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Pomalidomide.,increase,risk
Pomalidomide,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Pomalidomide.,decrease,no risk
Pomalidomide,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Pomalidomide.,increase,risk
Pomalidomide,Bacitracin,Bacitracin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,decrease,no risk
Pomalidomide,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.,increase,no risk
Pomalidomide,Balsalazide,Balsalazide may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,decrease,no risk
Pomalidomide,Baricitinib,The risk or severity of adverse effects can be increased when Pomalidomide is combined with Baricitinib.,increase,risk
Pomalidomide,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Pomalidomide.,increase,risk
Pomalidomide,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Pomalidomide.,increase,risk
Pomalidomide,Beclomethasone dipropionate,The metabolism of Pomalidomide can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Pomalidomide,Belantamab mafodotin,The serum concentration of Pomalidomide can be increased when it is combined with Belantamab mafodotin.,increase,no risk
Pomalidomide,Belatacept,The risk or severity of adverse effects can be increased when Belatacept is combined with Pomalidomide.,increase,risk
Pomalidomide,Belimumab,The risk or severity of adverse effects can be increased when Belimumab is combined with Pomalidomide.,increase,risk
Pomalidomide,Belinostat,The risk or severity of adverse effects can be increased when Belinostat is combined with Pomalidomide.,increase,risk
Pomalidomide,Belumosudil,The serum concentration of Pomalidomide can be increased when it is combined with Belumosudil.,increase,no risk
Pomalidomide,Belzutifan,The serum concentration of Pomalidomide can be decreased when it is combined with Belzutifan.,decrease,no risk
Pomalidomide,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Pomalidomide.,increase,risk
Pomalidomide,Bendamustine,The risk or severity of adverse effects can be increased when Bendamustine is combined with Pomalidomide.,increase,risk
Pomalidomide,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pomalidomide,Benorilate,Benorilate may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,decrease,no risk
Pomalidomide,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,decrease,no risk
Pomalidomide,Benperidol,The risk or severity of CNS depression can be increased when Pomalidomide is combined with Benperidol.,increase,risk
Pomalidomide,Benserazide,Pomalidomide may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Pomalidomide,Benzatropine,Benzatropine may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,decrease,no risk
Pomalidomide,Benznidazole,Pomalidomide may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Pomalidomide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Pomalidomide is combined with Benzocaine.,increase,risk
Pomalidomide,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Pomalidomide.,increase,risk
Pomalidomide,Benzthiazide,Benzthiazide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pomalidomide,Benzydamine,Benzydamine may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,decrease,no risk
Pomalidomide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Pomalidomide is combined with Benzyl alcohol.,increase,risk
Pomalidomide,Bepotastine,Bepotastine may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,decrease,no risk
Pomalidomide,Berotralstat,The serum concentration of Pomalidomide can be increased when it is combined with Berotralstat.,increase,no risk
Pomalidomide,Betamethasone,The metabolism of Pomalidomide can be increased when combined with Betamethasone.,increase,no risk
Pomalidomide,Betamethasone phosphate,The metabolism of Pomalidomide can be increased when combined with Betamethasone phosphate.,increase,no risk
Pomalidomide,Betaxolol,The metabolism of Pomalidomide can be decreased when combined with Betaxolol.,decrease,no risk
Pomalidomide,Betrixaban,The serum concentration of Pomalidomide can be increased when it is combined with Betrixaban.,increase,no risk
Pomalidomide,Bexarotene,The metabolism of Pomalidomide can be increased when combined with Bexarotene.,increase,no risk
Pomalidomide,Bicalutamide,The metabolism of Pomalidomide can be decreased when combined with Bicalutamide.,decrease,no risk
Pomalidomide,Bicisate,Pomalidomide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Pomalidomide,Bifonazole,The metabolism of Pomalidomide can be decreased when combined with Bifonazole.,decrease,no risk
Pomalidomide,Bimekizumab,The metabolism of Pomalidomide can be increased when combined with Bimekizumab.,increase,no risk
Pomalidomide,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Pomalidomide.,decrease,no risk
Pomalidomide,Bismuth subgallate,Pomalidomide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Pomalidomide,Bisoprolol,The serum concentration of Pomalidomide can be increased when it is combined with Bisoprolol.,increase,no risk
Pomalidomide,Bisoxatin,Pomalidomide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Pomalidomide,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Pomalidomide.,increase,risk
Pomalidomide,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Pomalidomide.,increase,risk
Pomalidomide,Blinatumomab,The risk or severity of adverse effects can be increased when Pomalidomide is combined with Blinatumomab.,increase,risk
Pomalidomide,Boceprevir,The metabolism of Pomalidomide can be decreased when combined with Boceprevir.,decrease,no risk
Pomalidomide,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Pomalidomide.",decrease,no risk
Pomalidomide,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Pomalidomide.,increase,risk
Pomalidomide,Bosentan,The metabolism of Pomalidomide can be increased when combined with Bosentan.,increase,no risk
Pomalidomide,Bosutinib,The metabolism of Pomalidomide can be decreased when combined with Bosutinib.,decrease,no risk
Pomalidomide,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Pomalidomide.,increase,risk
Pomalidomide,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Pomalidomide.,increase,risk
Pomalidomide,Brentuximab vedotin,The serum concentration of Pomalidomide can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Pomalidomide,Brexanolone,The risk or severity of CNS depression can be increased when Pomalidomide is combined with Brexanolone.,increase,risk
Pomalidomide,Brexpiprazole,The risk or severity of CNS depression can be increased when Pomalidomide is combined with Brexpiprazole.,increase,risk
Pomalidomide,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.,increase,no risk
Pomalidomide,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Pomalidomide.,increase,risk
Pomalidomide,Brodalumab,The risk or severity of adverse effects can be increased when Pomalidomide is combined with Brodalumab.,increase,risk
Pomalidomide,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Pomalidomide.,increase,risk
Pomalidomide,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Pomalidomide.,increase,risk
Pomalidomide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pomalidomide,Bromperidol,The risk or severity of CNS depression can be increased when Pomalidomide is combined with Bromperidol.,increase,risk
Pomalidomide,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Pomalidomide.,increase,risk
Pomalidomide,Budesonide,The metabolism of Pomalidomide can be increased when combined with Budesonide.,increase,no risk
Pomalidomide,Bumadizone,Bumadizone may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,decrease,no risk
Pomalidomide,Bumetanide,Bumetanide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pomalidomide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Pomalidomide is combined with Bupivacaine.,increase,risk
Pomalidomide,Buprenorphine,Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Pomalidomide,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Pomalidomide.,increase,risk
Pomalidomide,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Pomalidomide.,increase,risk
Pomalidomide,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Pomalidomide.,increase,risk
Pomalidomide,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Pomalidomide.,increase,risk
Pomalidomide,Butacaine,The risk or severity of methemoglobinemia can be increased when Pomalidomide is combined with Butacaine.,increase,risk
Pomalidomide,Butalbital,The metabolism of Pomalidomide can be increased when combined with Butalbital.,increase,no risk
Pomalidomide,Butamben,The risk or severity of methemoglobinemia can be increased when Pomalidomide is combined with Butamben.,increase,risk
Pomalidomide,Butaperazine,The risk or severity of CNS depression can be increased when Pomalidomide is combined with Butaperazine.,increase,risk
Pomalidomide,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Pomalidomide.,increase,risk
Pomalidomide,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Pomalidomide.,increase,risk
Pomalidomide,Butriptyline,The risk or severity of CNS depression can be increased when Pomalidomide is combined with Butriptyline.,increase,risk
Trametinib,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Gadodiamide,Gadodiamide may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Gadoteric acid,Trametinib may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Trametinib,Gadoteridol,Gadoteridol may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Ganciclovir,Ganciclovir may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Gemcitabine,Gemcitabine may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Gentamicin,Trametinib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Trametinib,Gimeracil,Trametinib may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Trametinib,Givosiran,Givosiran may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Glipizide,Glipizide may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Golodirsen,Trametinib may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Trametinib,Goserelin,Goserelin may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Guanethidine,Guanethidine may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Guanfacine,Guanfacine may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Haloperidol,Haloperidol may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Hydralazine,Hydralazine may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trametinib,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trametinib,Hydromorphone,Hydromorphone may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Hydroxyethyl Starch,Trametinib may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Trametinib,Kanamycin,Trametinib may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Trametinib,Ketamine,Ketamine may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Ketazolam,Ketazolam may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Ketoprofen,Ketoprofen may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Ketorolac,Ketorolac may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Octinoxate,Trametinib may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Trametinib,Olsalazine,Olsalazine may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Opium,Trametinib may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Trametinib,Oseltamivir,Oseltamivir may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Oxacillin,Oxacillin may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Oxaprozin,Oxaprozin may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Oxazepam,Oxazepam may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Trametinib is combined with Oxetacaine.,increase,risk
Trametinib,Oxybenzone,Oxybenzone may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Trametinib is combined with Oxybuprocaine.,increase,risk
Trametinib,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Oxyquinoline,Trametinib may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Trametinib,Quetiapine,Quetiapine may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Quinethazone,Quinethazone may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trametinib,Quinidine,Trametinib may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Trametinib,Vaborbactam,Trametinib may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Trametinib,Valaciclovir,Valaciclovir may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Valbenazine,Trametinib may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Trametinib,Valdecoxib,Valdecoxib may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Valganciclovir,Valganciclovir may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Vancomycin,Trametinib may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Trametinib,Varenicline,Varenicline may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Venlafaxine,Venlafaxine may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Verapamil,Verapamil may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Vilanterol,Trametinib may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Trametinib,Viloxazine,Trametinib may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Trametinib,Vortioxetine,Trametinib may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Trametinib,Warfarin,Trametinib may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Trametinib,Zaleplon,Zaleplon may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Zanamivir,Zanamivir may decrease the excretion rate of Trametinib which could result in a higher serum level.,decrease,no risk
Trametinib,Zonisamide,Zonisamide may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dabrafenib,Belantamab mafodotin,The serum concentration of Dabrafenib can be increased when it is combined with Belantamab mafodotin.,increase,no risk
Dabrafenib,Belinostat,The metabolism of Belinostat can be decreased when combined with Dabrafenib.,decrease,no risk
Dabrafenib,Belumosudil,The serum concentration of Belumosudil can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Belzutifan,The serum concentration of Dabrafenib can be decreased when it is combined with Belzutifan.,decrease,no risk
Dabrafenib,Bempedoic acid,The excretion of Bempedoic acid can be decreased when combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Dabrafenib.,increase,no risk
Dabrafenib,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dabrafenib.,increase,risk
Dabrafenib,Benzocaine,The serum concentration of Benzocaine can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Benzphetamine,The serum concentration of Benzphetamine can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Benzyl alcohol,The serum concentration of Benzyl alcohol can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bepridil,The serum concentration of Bepridil can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Dabrafenib.,increase,no risk
Dabrafenib,Betamethasone,The serum concentration of Betamethasone can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Betamethasone phosphate,The serum concentration of Betamethasone phosphate can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Betrixaban,The serum concentration of Dabrafenib can be increased when it is combined with Betrixaban.,increase,no risk
Dabrafenib,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Dabrafenib.,decrease,no risk
Dabrafenib,Bexarotene,The serum concentration of Bexarotene can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bezafibrate,The serum concentration of Bezafibrate can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bicalutamide,The serum concentration of Bicalutamide can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bictegravir,The serum concentration of Bictegravir can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bifonazole,The metabolism of Dabrafenib can be decreased when combined with Bifonazole.,decrease,no risk
Dabrafenib,Bilastine,The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Bilastine.,increase,risk
Dabrafenib,Bimekizumab,The metabolism of Dabrafenib can be increased when combined with Bimekizumab.,increase,no risk
Dabrafenib,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bioallethrin,The serum concentration of Bioallethrin can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dabrafenib,Bisoprolol,The serum concentration of Bisoprolol can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Boceprevir,The serum concentration of Dabrafenib can be increased when it is combined with Boceprevir.,increase,no risk
Dabrafenib,Bortezomib,The serum concentration of Bortezomib can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bosentan,The serum concentration of Bosentan can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bosutinib,The serum concentration of Bosutinib can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dabrafenib.,increase,risk
Dabrafenib,Brexpiprazole,The serum concentration of Brexpiprazole can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Brigatinib,The serum concentration of Brigatinib can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Dabrafenib.,increase,no risk
Dabrafenib,Brinzolamide,The serum concentration of Brinzolamide can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Brivaracetam,The serum concentration of Brivaracetam can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bromocriptine,The serum concentration of Bromocriptine can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Brompheniramine,The serum concentration of Brompheniramine can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Dabrafenib.,increase,risk
Dabrafenib,Budesonide,The serum concentration of Budesonide can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bumetanide,The excretion of Bumetanide can be decreased when combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bupivacaine,The serum concentration of Bupivacaine can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Buprenorphine,The serum concentration of Buprenorphine can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Bupropion,The serum concentration of Bupropion can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Dabrafenib.,increase,risk
Dabrafenib,Buspirone,The serum concentration of Buspirone can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Busulfan,The serum concentration of Busulfan can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Butacaine,The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Butacaine.,increase,risk
Dabrafenib,Butalbital,The metabolism of Dabrafenib can be increased when combined with Butalbital.,increase,no risk
Dabrafenib,Butamben,The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Butamben.,increase,risk
Dabrafenib,Butriptyline,The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Butriptyline.,increase,risk
Dabrafenib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Gadobenic acid.,increase,risk
Dabrafenib,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Dabrafenib.,decrease,no risk
Dabrafenib,Galantamine,The serum concentration of Galantamine can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Dabrafenib.,increase,risk
Dabrafenib,Gefitinib,The serum concentration of Gefitinib can be decreased when it is combined with Dabrafenib.,decrease,no risk
Dabrafenib,Gemcitabine,The serum concentration of Dabrafenib can be increased when it is combined with Gemcitabine.,increase,no risk
Dabrafenib,Gemfibrozil,The serum concentration of Dabrafenib can be increased when it is combined with Gemfibrozil.,increase,no risk
Dabrafenib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Gemifloxacin.,increase,risk
Dabrafenib,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Dabrafenib.,increase,no risk
Dabrafenib,Gepirone,The serum concentration of Gepirone can be decreased when it is combined with Dabrafenib.,decrease,no risk
Afatinib,Gefitinib,Gefitinib may decrease the excretion rate of Afatinib which could result in a higher serum level.,decrease,no risk
Afatinib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Afatinib.,increase,no risk
Afatinib,Gilteritinib,Gilteritinib may decrease the excretion rate of Afatinib which could result in a higher serum level.,decrease,no risk
Afatinib,Glasdegib,The serum concentration of Afatinib can be increased when it is combined with Glasdegib.,increase,no risk
Afatinib,Glecaprevir,The serum concentration of Afatinib can be increased when it is combined with Glecaprevir.,increase,no risk
Afatinib,Glyburide,Afatinib may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Afatinib,Grazoprevir,Grazoprevir may decrease the excretion rate of Afatinib which could result in a higher serum level.,decrease,no risk
Afatinib,Ketoconazole,The serum concentration of Afatinib can be increased when it is combined with Ketoconazole.,increase,no risk
Afatinib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Afatinib.,increase,no risk
Afatinib,Ombitasvir,Afatinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Afatinib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Afatinib.,increase,no risk
Afatinib,Oteseconazole,The serum concentration of Afatinib can be increased when it is combined with Oteseconazole.,increase,no risk
Afatinib,Oxaliplatin,Afatinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Afatinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Oxetacaine.,increase,risk
Afatinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Oxybuprocaine.,increase,risk
Afatinib,Ozanimod,Afatinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Afatinib,Quinidine,The serum concentration of Afatinib can be increased when it is combined with Quinidine.,increase,no risk
Afatinib,Quinine,The serum concentration of Afatinib can be increased when it is combined with Quinine.,increase,no risk
Afatinib,Quizartinib,The serum concentration of Afatinib can be increased when it is combined with Quizartinib.,increase,no risk
Afatinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Afatinib.,increase,no risk
Afatinib,Umbralisib,The serum concentration of Afatinib can be increased when it is combined with Umbralisib.,increase,no risk
Afatinib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Afatinib.,increase,no risk
Afatinib,Vadadustat,Vadadustat may decrease the excretion rate of Afatinib which could result in a higher serum level.,decrease,no risk
Afatinib,Vandetanib,The serum concentration of Afatinib can be increased when it is combined with Vandetanib.,increase,no risk
Afatinib,Vardenafil,The serum concentration of Afatinib can be increased when it is combined with Vardenafil.,increase,no risk
Afatinib,Velpatasvir,The serum concentration of Afatinib can be increased when it is combined with Velpatasvir.,increase,no risk
Afatinib,Vemurafenib,The serum concentration of Afatinib can be increased when it is combined with Vemurafenib.,increase,no risk
Afatinib,Venetoclax,The serum concentration of Afatinib can be increased when it is combined with Venetoclax.,increase,no risk
Afatinib,Venlafaxine,Venlafaxine may increase the excretion rate of Afatinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Afatinib,Verapamil,The serum concentration of Afatinib can be increased when it is combined with Verapamil.,increase,no risk
Afatinib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Afatinib.,increase,no risk
Afatinib,Vincristine,The excretion of Vincristine can be decreased when combined with Afatinib.,decrease,no risk
Afatinib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Afatinib.,increase,no risk
Afatinib,Vismodegib,Vismodegib may decrease the excretion rate of Afatinib which could result in a higher serum level.,decrease,no risk
Afatinib,Voclosporin,The serum concentration of Afatinib can be increased when it is combined with Voclosporin.,increase,no risk
Afatinib,Vorapaxar,The serum concentration of Afatinib can be increased when it is combined with Vorapaxar.,increase,no risk
Afatinib,Voriconazole,The serum concentration of Afatinib can be increased when it is combined with Voriconazole.,increase,no risk
Afatinib,Voxilaprevir,The serum concentration of Afatinib can be increased when it is combined with Voxilaprevir.,increase,no risk
Afatinib,Zidovudine,Afatinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Afatinib,Zonisamide,The serum concentration of Afatinib can be increased when it is combined with Zonisamide.,increase,no risk
Ferric carboxymaltose,Gatifloxacin,Ferric carboxymaltose can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferric carboxymaltose,Gemifloxacin,Ferric carboxymaltose can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferric carboxymaltose,Grepafloxacin,Ferric carboxymaltose can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferric carboxymaltose,Ofloxacin,Ferric carboxymaltose can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferric carboxymaltose,Omeprazole,The absorption of Ferric carboxymaltose can be decreased when combined with Omeprazole.,decrease,no risk
Levomilnacipran,Bepotastine,Bepotastine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Berotralstat,The metabolism of Levomilnacipran can be decreased when combined with Berotralstat.,decrease,no risk
Levomilnacipran,Betamethasone,The metabolism of Levomilnacipran can be increased when combined with Betamethasone.,increase,no risk
Levomilnacipran,Bethanidine,Levomilnacipran may increase the tachycardic activities of Bethanidine.,increase,no risk
Levomilnacipran,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Bexagliflozin.,increase,risk
Levomilnacipran,Bexarotene,The metabolism of Levomilnacipran can be increased when combined with Bexarotene.,increase,no risk
Levomilnacipran,Bicisate,Levomilnacipran may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Biperiden,The risk or severity of Tachycardia can be increased when Biperiden is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Bismuth subgallate,Levomilnacipran may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Bisoprolol,Bisoprolol may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Bisoxatin,Levomilnacipran may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Bleomycin,Bleomycin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Boceprevir,The metabolism of Levomilnacipran can be decreased when combined with Boceprevir.,decrease,no risk
Levomilnacipran,Bosentan,The metabolism of Levomilnacipran can be increased when combined with Bosentan.,increase,no risk
Levomilnacipran,Brexpiprazole,The risk or severity of serotonin syndrome can be increased when Brexpiprazole is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Brigatinib,The metabolism of Levomilnacipran can be increased when combined with Brigatinib.,increase,no risk
Levomilnacipran,Brivaracetam,Brivaracetam may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Bromocriptine,Levomilnacipran may increase the tachycardic activities of Bromocriptine.,increase,no risk
Levomilnacipran,Bromotheophylline,Bromotheophylline may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levomilnacipran,Bromperidol,The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Bromperidol.,increase,risk
Levomilnacipran,Brompheniramine,The risk or severity of Tachycardia can be increased when Brompheniramine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Buclizine,The risk or severity of Tachycardia can be increased when Buclizine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Budesonide,The metabolism of Levomilnacipran can be increased when combined with Budesonide.,increase,no risk
Levomilnacipran,Bumadizone,Bumadizone may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Bumetanide,Bumetanide may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levomilnacipran,Buprenorphine,The risk or severity of serotonin syndrome can be increased when Buprenorphine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Buspirone,The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Butabarbital,Butabarbital may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Butalbital,The metabolism of Levomilnacipran can be increased when combined with Butalbital.,increase,no risk
Levomilnacipran,Butaperazine,The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Butaperazine.,increase,risk
Levomilnacipran,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Butriptyline,The risk or severity of serotonin syndrome can be increased when Butriptyline is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Butylscopolamine,The risk or severity of Tachycardia can be increased when Levomilnacipran is combined with Butylscopolamine.,increase,risk
Levomilnacipran,Gabapentin,The risk or severity of adverse effects can be increased when Gabapentin is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gadodiamide,Gadodiamide may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gadoteric acid,Levomilnacipran may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gadoteridol,Gadoteridol may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Ganciclovir,Ganciclovir may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Gatifloxacin is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Gemcitabine,Gemcitabine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gentamicin,Levomilnacipran may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Gilteritinib,The therapeutic efficacy of Levomilnacipran can be decreased when used in combination with Gilteritinib.,decrease,no risk
Levomilnacipran,Gimeracil,Levomilnacipran may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Givosiran,Givosiran may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Gliclazide,The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Gliclazide.,increase,risk
Levomilnacipran,Glimepiride,The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Glimepiride.,increase,risk
Levomilnacipran,Glipizide,The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Glipizide.,increase,risk
Levomilnacipran,Gliquidone,The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Gliquidone.,increase,risk
Levomilnacipran,Glofitamab,The serum concentration of Levomilnacipran can be increased when it is combined with Glofitamab.,increase,no risk
Levomilnacipran,Glyburide,The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Glyburide.,increase,risk
Levomilnacipran,Glycerol phenylbutyrate,The metabolism of Levomilnacipran can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Levomilnacipran,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Glymidine,The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Glymidine.,increase,risk
Levomilnacipran,Golodirsen,Levomilnacipran may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Goserelin,Goserelin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Griseofulvin,The metabolism of Levomilnacipran can be increased when combined with Griseofulvin.,increase,no risk
Levomilnacipran,Guanabenz,Levomilnacipran may increase the tachycardic activities of Guanabenz.,increase,no risk
Levomilnacipran,Guanethidine,Guanethidine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Guanfacine,Levomilnacipran may increase the tachycardic activities of Guanfacine.,increase,no risk
Levomilnacipran,Halazepam,The risk or severity of adverse effects can be increased when Halazepam is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Levomilnacipran.,increase,no risk
Levomilnacipran,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Hexocyclium,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Hydralazine,Hydralazine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levomilnacipran,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Hydrocortamate,The metabolism of Levomilnacipran can be increased when combined with Hydrocortamate.,increase,no risk
Levomilnacipran,Hydrocortisone,The metabolism of Levomilnacipran can be increased when combined with Hydrocortisone.,increase,no risk
Levomilnacipran,Hydrocortisone acetate,The metabolism of Levomilnacipran can be increased when combined with Hydrocortisone acetate.,increase,no risk
Levomilnacipran,Hydrocortisone butyrate,The metabolism of Levomilnacipran can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Levomilnacipran,Hydrocortisone succinate,The metabolism of Levomilnacipran can be increased when combined with Hydrocortisone succinate.,increase,no risk
Levomilnacipran,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levomilnacipran,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Hydroxyamphetamine,The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Hydroxyethyl Starch,Levomilnacipran may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Kanamycin,Levomilnacipran may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Ketamine,The metabolism of Levomilnacipran can be increased when combined with Ketamine.,increase,no risk
Levomilnacipran,Ketazolam,The risk or severity of adverse effects can be increased when Ketazolam is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Ketoconazole,The metabolism of Levomilnacipran can be decreased when combined with Ketoconazole.,decrease,no risk
Levomilnacipran,Ketoprofen,Levomilnacipran may increase the antiplatelet activities of Ketoprofen.,increase,no risk
Levomilnacipran,Ketorolac,Levomilnacipran may increase the antiplatelet activities of Ketorolac.,increase,no risk
Levomilnacipran,Octinoxate,Levomilnacipran may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Octreotide,The risk or severity of hypoglycemia can be increased when Octreotide is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Olanzapine,The risk or severity of serotonin syndrome can be increased when Olanzapine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Oliceridine,The risk or severity of serotonin syndrome can be increased when Levomilnacipran is combined with Oliceridine.,increase,risk
Levomilnacipran,Olodaterol,Levomilnacipran may increase the tachycardic activities of Olodaterol.,increase,no risk
Levomilnacipran,Olsalazine,Olsalazine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Olutasidenib,The metabolism of Levomilnacipran can be increased when combined with Olutasidenib.,increase,no risk
Levomilnacipran,Omaveloxolone,The serum concentration of Levomilnacipran can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Levomilnacipran,Ondansetron,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Orciprenaline,Levomilnacipran may increase the tachycardic activities of Orciprenaline.,increase,no risk
Levomilnacipran,Oritavancin,The metabolism of Levomilnacipran can be increased when combined with Oritavancin.,increase,no risk
Levomilnacipran,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Oseltamivir,Oseltamivir may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Oxacillin,Oxacillin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Oxaprozin,Levomilnacipran may increase the antiplatelet activities of Oxaprozin.,increase,no risk
Levomilnacipran,Oxazepam,The risk or severity of adverse effects can be increased when Oxazepam is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Oxcarbazepine,The metabolism of Levomilnacipran can be increased when combined with Oxcarbazepine.,increase,no risk
Levomilnacipran,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Oxybenzone,Oxybenzone may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Oxymetazoline,Levomilnacipran may increase the tachycardic activities of Oxymetazoline.,increase,no risk
Levomilnacipran,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Oxyquinoline,Levomilnacipran may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Quetiapine,The risk or severity of serotonin syndrome can be increased when Quetiapine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Quinethazone,Quinethazone may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levomilnacipran,Quinidine,Levomilnacipran may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Quinine,The metabolism of Levomilnacipran can be increased when combined with Quinine.,increase,no risk
Levomilnacipran,Quinupramine,The risk or severity of serotonin syndrome can be increased when Quinupramine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Ubidecarenone.,increase,risk
Levomilnacipran,Umeclidinium,The risk or severity of Tachycardia can be increased when Levomilnacipran is combined with Umeclidinium.,increase,risk
Levomilnacipran,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Vaborbactam,Levomilnacipran may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Vadadustat,The serum concentration of Levomilnacipran can be increased when it is combined with Vadadustat.,increase,no risk
Levomilnacipran,Valaciclovir,Valaciclovir may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Valbenazine,Levomilnacipran may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Valdecoxib,Valdecoxib may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Valganciclovir,Valganciclovir may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Valproate bismuth is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Valproic acid,The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Vancomycin,Levomilnacipran may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Varenicline,Varenicline may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Vemurafenib,The metabolism of Levomilnacipran can be increased when combined with Vemurafenib.,increase,no risk
Levomilnacipran,Venetoclax,The metabolism of Levomilnacipran can be decreased when combined with Venetoclax.,decrease,no risk
Levomilnacipran,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Verapamil,The metabolism of Levomilnacipran can be decreased when combined with Verapamil.,decrease,no risk
Levomilnacipran,Vibegron,Levomilnacipran may increase the tachycardic activities of Vibegron.,increase,no risk
Levomilnacipran,Vilanterol,Levomilnacipran may increase the tachycardic activities of Vilanterol.,increase,no risk
Levomilnacipran,Vilazodone,The risk or severity of serotonin syndrome can be increased when Vilazodone is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Vildagliptin,The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Vildagliptin.,increase,risk
Levomilnacipran,Viloxazine,The metabolism of Levomilnacipran can be decreased when combined with Viloxazine.,decrease,no risk
Levomilnacipran,Vinblastine,The metabolism of Levomilnacipran can be increased when combined with Vinblastine.,increase,no risk
Levomilnacipran,Vitamin E,The metabolism of Levomilnacipran can be increased when combined with Vitamin E.,increase,no risk
Levomilnacipran,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Voriconazole,The metabolism of Levomilnacipran can be decreased when combined with Voriconazole.,decrease,no risk
Levomilnacipran,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Vortioxetine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Xamoterol,Levomilnacipran may increase the tachycardic activities of Xamoterol.,increase,no risk
Levomilnacipran,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Xylometazoline,Levomilnacipran may increase the tachycardic activities of Xylometazoline.,increase,no risk
Levomilnacipran,Yohimbine,The risk or severity of serotonin syndrome can be increased when Yohimbine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Zaleplon,Zaleplon may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Zanamivir,Zanamivir may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,decrease,no risk
Levomilnacipran,Zimelidine,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Ziprasidone,The risk or severity of serotonin syndrome can be increased when Ziprasidone is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Levomilnacipran is combined with Zolmitriptan.,increase,risk
Levomilnacipran,Zonisamide,Zonisamide may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levomilnacipran,Zotepine,The risk or severity of serotonin syndrome can be increased when Zotepine is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Zuclopenthixol,The risk or severity of serotonin syndrome can be increased when Zuclopenthixol is combined with Levomilnacipran.,increase,risk
Levomilnacipran,Zuranolone,The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Zuranolone.,increase,risk
Perospirone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Perospirone.,increase,risk
Perospirone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Perospirone.,increase,risk
Perospirone,Galantamine,The metabolism of Perospirone can be decreased when combined with Galantamine.,decrease,no risk
Perospirone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Perospirone.,increase,risk
Perospirone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Perospirone is combined with Ganaxolone.",increase,risk
Perospirone,Gefitinib,The metabolism of Perospirone can be decreased when combined with Gefitinib.,decrease,no risk
Perospirone,Gemfibrozil,The metabolism of Perospirone can be decreased when combined with Gemfibrozil.,decrease,no risk
Perospirone,Gepirone,The risk or severity of CNS depression can be increased when Perospirone is combined with Gepirone.,increase,risk
Perospirone,Givosiran,The serum concentration of Perospirone can be increased when it is combined with Givosiran.,increase,no risk
Perospirone,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Perospirone.,decrease,no risk
Perospirone,Glofitamab,The serum concentration of Perospirone can be increased when it is combined with Glofitamab.,increase,no risk
Perospirone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Perospirone.,increase,risk
Perospirone,Glycerol phenylbutyrate,The metabolism of Perospirone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Perospirone,Golimumab,The metabolism of Perospirone can be increased when combined with Golimumab.,increase,no risk
Perospirone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Perospirone.,increase,risk
Perospirone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Perospirone.,increase,risk
Perospirone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Perospirone.,increase,risk
Perospirone,Halofantrine,The metabolism of Perospirone can be decreased when combined with Halofantrine.,decrease,no risk
Perospirone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Perospirone.,increase,risk
Perospirone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Perospirone.,increase,risk
Perospirone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Perospirone.,increase,risk
Perospirone,Hydrocodone,Perospirone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Perospirone,Hydrocortisone,The metabolism of Perospirone can be increased when combined with Hydrocortisone.,increase,no risk
Perospirone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Perospirone.,increase,risk
Perospirone,Hydroxychloroquine,The metabolism of Perospirone can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Perospirone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Perospirone.,increase,no risk
Perospirone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Perospirone.,increase,risk
Perospirone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Perospirone.,increase,risk
Perospirone,Ketoconazole,The metabolism of Perospirone can be decreased when combined with Ketoconazole.,decrease,no risk
Perospirone,Ketoprofen,The metabolism of Perospirone can be decreased when combined with Ketoprofen.,decrease,no risk
Perospirone,Ketorolac,The metabolism of Perospirone can be decreased when combined with Ketorolac.,decrease,no risk
Adrafinil,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Adrafinil.,increase,risk
Adrafinil,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Adrafinil.,increase,risk
Adrafinil,Guanabenz,Adrafinil may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Adrafinil,Guanadrel,Adrafinil may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Adrafinil,Guanethidine,Adrafinil may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Adrafinil,Guanfacine,Adrafinil may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Adrafinil,Guanoxan,Adrafinil may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Adrafinil,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Adrafinil.,increase,risk
Adrafinil,Hexocyclium,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Adrafinil.,increase,risk
Adrafinil,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Adrafinil.,increase,risk
Adrafinil,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Adrafinil.,increase,risk
Adrafinil,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Adrafinil.,increase,risk
Adrafinil,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Adrafinil.,increase,risk
Adrafinil,Hydralazine,Adrafinil may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Adrafinil,Hydrochlorothiazide,Adrafinil may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Adrafinil,Hydroflumethiazide,Adrafinil may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Adrafinil,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Adrafinil.,increase,risk
Adrafinil,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Adrafinil.,increase,risk
Adrafinil,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Adrafinil.,increase,risk
Adrafinil,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Adrafinil.,increase,risk
Adrafinil,Olanzapine,The therapeutic efficacy of Adrafinil can be decreased when used in combination with Olanzapine.,decrease,no risk
Adrafinil,Olmesartan,Adrafinil may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Adrafinil,Olodaterol,The risk or severity of hypertension can be increased when Adrafinil is combined with Olodaterol.,increase,risk
Adrafinil,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Adrafinil.,increase,risk
Adrafinil,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Adrafinil.,increase,risk
Adrafinil,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Adrafinil.,increase,risk
Adrafinil,Oxprenolol,The therapeutic efficacy of Adrafinil can be decreased when used in combination with Oxprenolol.,decrease,no risk
Adrafinil,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Adrafinil.,increase,risk
Adrafinil,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Adrafinil.,increase,risk
Adrafinil,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Adrafinil.,increase,risk
Adrafinil,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Adrafinil.,increase,risk
Adrafinil,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Adrafinil.,increase,risk
Adrafinil,Quetiapine,The therapeutic efficacy of Adrafinil can be decreased when used in combination with Quetiapine.,decrease,no risk
Adrafinil,Quinapril,Adrafinil may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Adrafinil,Quinidine,The therapeutic efficacy of Adrafinil can be decreased when used in combination with Quinidine.,decrease,no risk
Adrafinil,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Adrafinil.,increase,risk
Adrafinil,Umeclidinium,The risk or severity of Tachycardia can be increased when Adrafinil is combined with Umeclidinium.,increase,risk
Adrafinil,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Adrafinil.,increase,risk
Adrafinil,Valsartan,Adrafinil may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Adrafinil,Venlafaxine,Venlafaxine may increase the tachycardic activities of Adrafinil.,increase,no risk
Adrafinil,Verapamil,The therapeutic efficacy of Adrafinil can be decreased when used in combination with Verapamil.,decrease,no risk
Adrafinil,Vilanterol,The risk or severity of hypertension can be increased when Adrafinil is combined with Vilanterol.,increase,risk
Adrafinil,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Adrafinil.,increase,risk
Adrafinil,Vortioxetine,The risk or severity of hypertension can be increased when Adrafinil is combined with Vortioxetine.,increase,risk
Adrafinil,Xamoterol,The risk or severity of hypertension can be increased when Adrafinil is combined with Xamoterol.,increase,risk
Adrafinil,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Adrafinil.,increase,risk
Adrafinil,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Adrafinil.,increase,risk
Adrafinil,Ziprasidone,The therapeutic efficacy of Adrafinil can be decreased when used in combination with Ziprasidone.,decrease,no risk
Adrafinil,Zofenopril,Adrafinil may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Adrafinil,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Adrafinil.,increase,risk
Adrafinil,Zuclopenthixol,The therapeutic efficacy of Adrafinil can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Amperozide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Amperozide.,increase,risk
Amperozide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Amperozide.,increase,risk
Amperozide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Amperozide.,increase,risk
Amperozide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Amperozide is combined with Ganaxolone.",increase,risk
Amperozide,Gepirone,The risk or severity of CNS depression can be increased when Amperozide is combined with Gepirone.,increase,risk
Amperozide,Gilteritinib,The therapeutic efficacy of Amperozide can be decreased when used in combination with Gilteritinib.,decrease,no risk
Amperozide,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Amperozide.,increase,risk
Amperozide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Amperozide.,increase,risk
Amperozide,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Amperozide.,increase,risk
Amperozide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Amperozide.,increase,risk
Amperozide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Amperozide.,increase,risk
Amperozide,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Amperozide.,increase,risk
Amperozide,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Amperozide.,increase,risk
Amperozide,Hydrocodone,Amperozide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Amperozide,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Amperozide.,increase,risk
Amperozide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Amperozide.,increase,no risk
Amperozide,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Amperozide.,increase,risk
Amperozide,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Amperozide.,increase,risk
Amperozide,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Amperozide.,increase,risk
Amperozide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Amperozide is combined with Oliceridine.",increase,risk
Amperozide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Amperozide.,increase,risk
Amperozide,Opium,The risk or severity of CNS depression can be increased when Amperozide is combined with Opium.,increase,risk
Amperozide,Orphenadrine,Amperozide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Amperozide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Amperozide.,increase,risk
Amperozide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Amperozide.,increase,risk
Amperozide,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Amperozide.,increase,risk
Amperozide,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Amperozide.,increase,risk
Amperozide,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Amperozide.,increase,risk
Amperozide,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Amperozide.,increase,risk
Amperozide,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Amperozide.,increase,risk
Amperozide,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Amperozide.,increase,risk
Amperozide,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Amperozide.,increase,risk
Amperozide,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Amperozide.,decrease,no risk
Amperozide,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Amperozide.,increase,risk
Amperozide,Quinupramine,The risk or severity of CNS depression can be increased when Amperozide is combined with Quinupramine.,increase,risk
Amperozide,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Amperozide.,increase,risk
Amperozide,Valproate bismuth,Amperozide may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Amperozide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Amperozide.,increase,risk
Amperozide,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Amperozide.,increase,risk
Amperozide,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Amperozide.,increase,risk
Amperozide,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Amperozide.,increase,risk
Amperozide,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Amperozide.,increase,risk
Amperozide,Viloxazine,The risk or severity of CNS depression can be increased when Amperozide is combined with Viloxazine.,increase,risk
Amperozide,Vincristine,Vincristine may increase the neurotoxic activities of Amperozide.,increase,no risk
Amperozide,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Amperozide.,increase,no risk
Amperozide,Viomycin,Viomycin may increase the neurotoxic activities of Amperozide.,increase,no risk
Amperozide,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Amperozide.,increase,risk
Amperozide,Warfarin,The risk or severity of adverse effects can be increased when Amperozide is combined with Warfarin.,increase,risk
Amperozide,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Amperozide.,increase,risk
Amperozide,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Amperozide.,increase,risk
Amperozide,Ziconotide,The risk or severity of CNS depression can be increased when Amperozide is combined with Ziconotide.,increase,risk
Amperozide,Zimelidine,The risk or severity of adverse effects can be increased when Amperozide is combined with Zimelidine.,increase,risk
Amperozide,Ziprasidone,The risk or severity of adverse effects can be increased when Amperozide is combined with Ziprasidone.,increase,risk
Amperozide,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amperozide.,increase,risk
Amperozide,Zolpidem,Amperozide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Amperozide,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Amperozide.,increase,risk
Amperozide,Zopiclone,The risk or severity of adverse effects can be increased when Amperozide is combined with Zopiclone.,increase,risk
Amperozide,Zotepine,The risk or severity of CNS depression can be increased when Amperozide is combined with Zotepine.,increase,risk
Amperozide,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Amperozide.,increase,risk
Amperozide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Amperozide.,increase,risk
Dolutegravir,Gefitinib,Gefitinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Gemfibrozil,The metabolism of Dolutegravir can be decreased when combined with Gemfibrozil.,decrease,no risk
Dolutegravir,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Gilteritinib,Gilteritinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Glasdegib,Glasdegib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Glecaprevir,Glecaprevir may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Grazoprevir,Grazoprevir may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Histamine,The serum concentration of Histamine can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Dolutegravir.,decrease,no risk
Dolutegravir,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Hydrotalcite,The serum concentration of Dolutegravir can be decreased when it is combined with Hydrotalcite.,decrease,no risk
Dolutegravir,Kaolin,The serum concentration of Dolutegravir can be decreased when it is combined with Kaolin.,decrease,no risk
Dolutegravir,Ketoconazole,The serum concentration of Dolutegravir can be increased when it is combined with Ketoconazole.,increase,no risk
Dolutegravir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Ombitasvir,The metabolism of Dolutegravir can be decreased when combined with Ombitasvir.,decrease,no risk
Dolutegravir,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Osimertinib,Osimertinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Oteseconazole,The serum concentration of Dolutegravir can be increased when it is combined with Oteseconazole.,increase,no risk
Dolutegravir,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Oxcarbazepine,The serum concentration of Dolutegravir can be decreased when it is combined with Oxcarbazepine.,decrease,no risk
Dolutegravir,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Quinapril,The excretion of Quinapril can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Quinidine,The serum concentration of Dolutegravir can be increased when it is combined with Quinidine.,increase,no risk
Dolutegravir,Quinine,The serum concentration of Dolutegravir can be increased when it is combined with Quinine.,increase,no risk
Dolutegravir,Quizartinib,The serum concentration of Dolutegravir can be increased when it is combined with Quizartinib.,increase,no risk
Dolutegravir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Umbralisib,The serum concentration of Dolutegravir can be increased when it is combined with Umbralisib.,increase,no risk
Dolutegravir,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Valproic acid,The excretion of Valproic acid can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Vandetanib,Vandetanib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Vardenafil,The serum concentration of Dolutegravir can be increased when it is combined with Vardenafil.,increase,no risk
Dolutegravir,Varenicline,The excretion of Varenicline can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Dolutegravir.,decrease,no risk
Dolutegravir,Velpatasvir,Velpatasvir may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Vemurafenib,The serum concentration of Dolutegravir can be increased when it is combined with Vemurafenib.,increase,no risk
Dolutegravir,Venetoclax,Venetoclax may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Venlafaxine,Venlafaxine may increase the excretion rate of Dolutegravir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dolutegravir,Verapamil,The serum concentration of Dolutegravir can be increased when it is combined with Verapamil.,increase,no risk
Dolutegravir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dolutegravir.,decrease,no risk
Dolutegravir,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Dolutegravir.,increase,no risk
Dolutegravir,Vismodegib,Vismodegib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Voclosporin,The serum concentration of Dolutegravir can be increased when it is combined with Voclosporin.,increase,no risk
Dolutegravir,Vorapaxar,The serum concentration of Dolutegravir can be increased when it is combined with Vorapaxar.,increase,no risk
Dolutegravir,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Dolutegravir which could result in a higher serum level.,decrease,no risk
Dolutegravir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Dolutegravir.,decrease,no risk
Dolutegravir,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Zidovudine,The excretion of Zidovudine can be decreased when combined with Dolutegravir.,decrease,no risk
Dolutegravir,Zinc,Zinc can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dolutegravir,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dolutegravir,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dolutegravir,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dolutegravir,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dolutegravir,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dolutegravir,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dolutegravir,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Dolutegravir,Zonisamide,The serum concentration of Dolutegravir can be increased when it is combined with Zonisamide.,increase,no risk
Riociguat,Bosutinib,The metabolism of Riociguat can be decreased when combined with Bosutinib.,decrease,no risk
Riociguat,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Riociguat.,increase,no risk
Riociguat,Bretylium,Bretylium may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Riociguat.,decrease,no risk
Riociguat,Brimonidine,Brimonidine may increase the antihypertensive activities of Riociguat.,increase,no risk
Riociguat,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Bromotheophylline,Bromotheophylline may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Bumadizone,The therapeutic efficacy of Riociguat can be decreased when used in combination with Bumadizone.,decrease,no risk
Riociguat,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Riociguat.,increase,risk
Riociguat,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Riociguat.,increase,risk
Riociguat,Buprenorphine,Buprenorphine may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Buspirone,Buspirone may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Butabarbital,Butabarbital may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Butalbital,Butalbital may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Butriptyline,Butriptyline may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Gefitinib,Gefitinib may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Riociguat.,increase,no risk
Riociguat,Gemfibrozil,The metabolism of Riociguat can be decreased when combined with Gemfibrozil.,decrease,no risk
Riociguat,Gilteritinib,Gilteritinib may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Glasdegib,Glasdegib may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Glecaprevir,Glecaprevir may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Glofitamab,The serum concentration of Riociguat can be increased when it is combined with Glofitamab.,increase,no risk
Riociguat,Glycol salicylate,The therapeutic efficacy of Riociguat can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Riociguat,Golimumab,The metabolism of Riociguat can be increased when combined with Golimumab.,increase,no risk
Riociguat,Grazoprevir,Grazoprevir may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Guanabenz,Guanabenz may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Guanadrel,Guanadrel may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Guanethidine,Guanethidine may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Guanfacine,Guanfacine may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Guanoxan,Riociguat may increase the hypotensive activities of Guanoxan.,increase,no risk
Riociguat,Halofantrine,The metabolism of Riociguat can be decreased when combined with Halofantrine.,decrease,no risk
Riociguat,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Riociguat.,increase,no risk
Riociguat,Halothane,Halothane may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Hydralazine,Hydralazine may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Hydrochlorothiazide,The therapeutic efficacy of Riociguat can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Riociguat,Hydrocortisone,The metabolism of Riociguat can be increased when combined with Hydrocortisone.,increase,no risk
Riociguat,Hydroflumethiazide,The therapeutic efficacy of Riociguat can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Riociguat,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Riociguat,Hydroxychloroquine,The metabolism of Riociguat can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Riociguat,Ketamine,The metabolism of Riociguat can be decreased when combined with Ketamine.,decrease,no risk
Riociguat,Ketoconazole,The serum concentration of Riociguat can be increased when it is combined with Ketoconazole.,increase,no risk
Riociguat,Ketoprofen,The therapeutic efficacy of Riociguat can be decreased when used in combination with Ketoprofen.,decrease,no risk
Riociguat,Ketorolac,The therapeutic efficacy of Riociguat can be decreased when used in combination with Ketorolac.,decrease,no risk
Riociguat,Obinutuzumab,Riociguat may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Riociguat,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Riociguat.,increase,risk
Riociguat,Olmesartan,Olmesartan may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Riociguat.,decrease,no risk
Riociguat,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Riociguat.,increase,no risk
Riociguat,Omaveloxolone,The serum concentration of Riociguat can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Riociguat,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Riociguat.,decrease,no risk
Riociguat,Omeprazole,Omeprazole can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Riociguat,Opicapone,The risk or severity of adverse effects can be increased when Riociguat is combined with Opicapone.,increase,risk
Riociguat,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Osimertinib,Osimertinib may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Oteseconazole,The serum concentration of Riociguat can be increased when it is combined with Oteseconazole.,increase,no risk
Riociguat,Oxaprozin,The therapeutic efficacy of Riociguat can be decreased when used in combination with Oxaprozin.,decrease,no risk
Riociguat,Oxprenolol,Oxprenolol may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Oxtriphylline,Oxtriphylline may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Oxybutynin,The metabolism of Riociguat can be decreased when combined with Oxybutynin.,decrease,no risk
Riociguat,Oxymetazoline,The therapeutic efficacy of Riociguat can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Riociguat,Oxyphenbutazone,The therapeutic efficacy of Riociguat can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Riociguat,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Riociguat.,decrease,no risk
Riociguat,Quetiapine,Quetiapine may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Quinapril,Quinapril may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Quinidine,The serum concentration of Riociguat can be increased when it is combined with Quinidine.,increase,no risk
Riociguat,Quinine,The metabolism of Riociguat can be decreased when combined with Quinine.,decrease,no risk
Riociguat,Quinupramine,Quinupramine may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Quizartinib,The serum concentration of Riociguat can be increased when it is combined with Quizartinib.,increase,no risk
Riociguat,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Riociguat.,increase,no risk
Riociguat,Udenafil,Udenafil may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Umbralisib,The serum concentration of Riociguat can be increased when it is combined with Umbralisib.,increase,no risk
Riociguat,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Riociguat.,increase,no risk
Riociguat,Unoprostone,Unoprostone may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Vadadustat,The serum concentration of Riociguat can be increased when it is combined with Vadadustat.,increase,no risk
Riociguat,Valdecoxib,The therapeutic efficacy of Riociguat can be decreased when used in combination with Valdecoxib.,decrease,no risk
Riociguat,Valsartan,Valsartan may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Vandetanib,Vandetanib may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Vardenafil,Vardenafil may increase the hypotensive activities of Riociguat.,increase,no risk
Riociguat,Velpatasvir,Velpatasvir may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Vemurafenib,The serum concentration of Riociguat can be increased when it is combined with Vemurafenib.,increase,no risk
Riociguat,Venetoclax,The metabolism of Riociguat can be decreased when combined with Venetoclax.,decrease,no risk
Riociguat,Venlafaxine,Venlafaxine may increase the excretion rate of Riociguat which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Riociguat,Verapamil,The metabolism of Riociguat can be decreased when combined with Verapamil.,decrease,no risk
Riociguat,Vericiguat,The therapeutic efficacy of Vericiguat can be increased when used in combination with Riociguat.,increase,no risk
Riociguat,Vilanterol,Vilanterol may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Vilazodone,Vilazodone may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Viloxazine,The metabolism of Riociguat can be decreased when combined with Viloxazine.,decrease,no risk
Riociguat,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Riociguat.,increase,no risk
Riociguat,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Riociguat.,increase,no risk
Riociguat,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Riociguat.,increase,no risk
Riociguat,Vismodegib,Vismodegib may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Voclosporin,The serum concentration of Riociguat can be increased when it is combined with Voclosporin.,increase,no risk
Riociguat,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Riociguat,Vorapaxar,The serum concentration of Riociguat can be increased when it is combined with Vorapaxar.,increase,no risk
Riociguat,Voriconazole,The serum concentration of Riociguat can be increased when it is combined with Voriconazole.,increase,no risk
Riociguat,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Riociguat.,decrease,no risk
Riociguat,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Riociguat which could result in a higher serum level.,decrease,no risk
Riociguat,Xamoterol,Xamoterol may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Yohimbine,Yohimbine may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Zidovudine,The metabolism of Riociguat can be decreased when combined with Zidovudine.,decrease,no risk
Riociguat,Zimelidine,The metabolism of Riociguat can be decreased when combined with Zimelidine.,decrease,no risk
Riociguat,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Riociguat.,increase,no risk
Riociguat,Zofenopril,Riociguat may increase the hypotensive activities of Zofenopril.,increase,no risk
Riociguat,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Riociguat,Zonisamide,The serum concentration of Riociguat can be increased when it is combined with Zonisamide.,increase,no risk
Riociguat,Zopiclone,The metabolism of Riociguat can be decreased when combined with Zopiclone.,decrease,no risk
Riociguat,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Riociguat.,decrease,no risk
Macitentan,Brivaracetam,Brivaracetam may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Bromazepam,Bromazepam may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Macitentan.,decrease,no risk
Macitentan,Bromotheophylline,Bromotheophylline may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Macitentan,Budesonide,Budesonide may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Bumadizone,The therapeutic efficacy of Macitentan can be decreased when used in combination with Bumadizone.,decrease,no risk
Macitentan,Bumetanide,Bumetanide may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Macitentan,Bupivacaine,Bupivacaine may increase the hypotensive activities of Macitentan.,increase,no risk
Macitentan,Bupropion,Bupropion may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Buspirone,Buspirone may decrease the antihypertensive activities of Macitentan.,decrease,no risk
Macitentan,Butabarbital,Butabarbital may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Butriptyline,Butriptyline may decrease the antihypertensive activities of Macitentan.,decrease,no risk
Macitentan,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Gadodiamide,Gadodiamide may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Gadoteric acid,Macitentan may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Macitentan,Gadoteridol,Gadoteridol may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Ganciclovir,Ganciclovir may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Gemcitabine,Gemcitabine may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Gentamicin,Macitentan may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Macitentan,Gimeracil,Macitentan may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Macitentan,Givosiran,Givosiran may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Glipizide,Glipizide may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Glofitamab,The serum concentration of Macitentan can be increased when it is combined with Glofitamab.,increase,no risk
Macitentan,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Glycol salicylate,The therapeutic efficacy of Macitentan can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Macitentan,Golodirsen,Macitentan may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Macitentan,Goserelin,Goserelin may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Guanabenz,Guanabenz may decrease the antihypertensive activities of Macitentan.,decrease,no risk
Macitentan,Guanadrel,Guanadrel may increase the hypotensive activities of Macitentan.,increase,no risk
Macitentan,Guanethidine,Guanethidine may increase the hypotensive activities of Macitentan.,increase,no risk
Macitentan,Guanfacine,Guanfacine may decrease the antihypertensive activities of Macitentan.,decrease,no risk
Macitentan,Guanoxan,Macitentan may increase the hypotensive activities of Guanoxan.,increase,no risk
Macitentan,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Macitentan.,increase,no risk
Macitentan,Halothane,Halothane may decrease the antihypertensive activities of Macitentan.,decrease,no risk
Macitentan,Hydralazine,Hydralazine may increase the hypotensive activities of Macitentan.,increase,no risk
Macitentan,Hydrochlorothiazide,The therapeutic efficacy of Macitentan can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Macitentan,Hydroflumethiazide,The therapeutic efficacy of Macitentan can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Macitentan,Hydromorphone,Hydromorphone may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Hydroxyethyl Starch,Macitentan may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Macitentan,Kanamycin,Macitentan may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Macitentan,Ketamine,Ketamine may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Ketazolam,Ketazolam may decrease the excretion rate of Macitentan which could result in a higher serum level.,decrease,no risk
Macitentan,Ketoconazole,The metabolism of Macitentan can be decreased when combined with Ketoconazole.,decrease,no risk
Macitentan,Ketoprofen,The therapeutic efficacy of Macitentan can be decreased when used in combination with Ketoprofen.,decrease,no risk
Macitentan,Ketorolac,The therapeutic efficacy of Macitentan can be decreased when used in combination with Ketorolac.,decrease,no risk
Luliconazole,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Luliconazole.,increase,no risk
Luliconazole,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Luliconazole.,increase,no risk
Luliconazole,Vilazodone,The serum concentration of Vilazodone can be increased when it is combined with Luliconazole.,increase,no risk
Luliconazole,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Luliconazole.,decrease,no risk
Luliconazole,Voriconazole,The serum concentration of Voriconazole can be increased when it is combined with Luliconazole.,increase,no risk
Luliconazole,Vortioxetine,The serum concentration of Vortioxetine can be increased when it is combined with Luliconazole.,increase,no risk
Luliconazole,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Luliconazole.,increase,no risk
Luliconazole,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Luliconazole.,increase,no risk
Luliconazole,Zonisamide,The serum concentration of Zonisamide can be increased when it is combined with Luliconazole.,increase,no risk
Sofosbuvir,Bumetanide,Bumetanide may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sofosbuvir,Buprenorphine,Buprenorphine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Bupropion,Bupropion may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Buspirone,Buspirone may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Butabarbital,Butabarbital may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gadodiamide,Gadodiamide may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gadoteric acid,Sofosbuvir may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gadoteridol,Gadoteridol may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Ganciclovir,Ganciclovir may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gefitinib,Gefitinib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Sofosbuvir.,increase,no risk
Sofosbuvir,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gentamicin,Sofosbuvir may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gilteritinib,Gilteritinib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Gimeracil,Sofosbuvir may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Givosiran,Givosiran may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Glasdegib,Glasdegib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Glecaprevir,Glecaprevir may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Glipizide,Glipizide may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Golodirsen,Sofosbuvir may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Goserelin,Goserelin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Grazoprevir,Grazoprevir may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Guanethidine,Guanethidine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Guanfacine,Guanfacine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Haloperidol,Haloperidol may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Sofosbuvir.,decrease,no risk
Sofosbuvir,Hydralazine,Hydralazine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sofosbuvir,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sofosbuvir,Hydromorphone,Hydromorphone may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Hydroxyethyl Starch,Sofosbuvir may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Kanamycin,Sofosbuvir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Ketamine,Ketamine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Ketazolam,Ketazolam may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Ketoconazole,The serum concentration of Sofosbuvir can be increased when it is combined with Ketoconazole.,increase,no risk
Sofosbuvir,Ketoprofen,Ketoprofen may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Ketorolac,Ketorolac may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Octinoxate,Sofosbuvir may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Olsalazine,Olsalazine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Sofosbuvir.,increase,no risk
Sofosbuvir,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Sofosbuvir.,increase,no risk
Sofosbuvir,Opium,Sofosbuvir may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Oseltamivir,Oseltamivir may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Osimertinib,Osimertinib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Oteseconazole,The serum concentration of Sofosbuvir can be increased when it is combined with Oteseconazole.,increase,no risk
Sofosbuvir,Oxacillin,Oxacillin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Oxaprozin,Oxaprozin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Oxazepam,Oxazepam may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Oxybenzone,Oxybenzone may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Oxyquinoline,Sofosbuvir may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Quetiapine,Quetiapine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Quinethazone,Quinethazone may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sofosbuvir,Quinidine,Sofosbuvir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Quinine,The serum concentration of Sofosbuvir can be increased when it is combined with Quinine.,increase,no risk
Sofosbuvir,Quizartinib,The serum concentration of Sofosbuvir can be increased when it is combined with Quizartinib.,increase,no risk
Sofosbuvir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Sofosbuvir.,increase,no risk
Sofosbuvir,Umbralisib,The serum concentration of Sofosbuvir can be increased when it is combined with Umbralisib.,increase,no risk
Sofosbuvir,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Sofosbuvir.,increase,no risk
Sofosbuvir,Vaborbactam,Sofosbuvir may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Vadadustat,Vadadustat may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Valaciclovir,Valaciclovir may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Valbenazine,Sofosbuvir may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Valdecoxib,Valdecoxib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Valganciclovir,Valganciclovir may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Vancomycin,Sofosbuvir may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Vandetanib,Vandetanib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Vardenafil,The serum concentration of Sofosbuvir can be increased when it is combined with Vardenafil.,increase,no risk
Sofosbuvir,Varenicline,Varenicline may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Sofosbuvir.,decrease,no risk
Sofosbuvir,Vemurafenib,The serum concentration of Sofosbuvir can be increased when it is combined with Vemurafenib.,increase,no risk
Sofosbuvir,Venetoclax,Venetoclax may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Venlafaxine,Venlafaxine may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sofosbuvir,Verapamil,The serum concentration of Sofosbuvir can be increased when it is combined with Verapamil.,increase,no risk
Sofosbuvir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sofosbuvir.,decrease,no risk
Sofosbuvir,Vilanterol,Sofosbuvir may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Viloxazine,Sofosbuvir may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Sofosbuvir.,increase,no risk
Sofosbuvir,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Sofosbuvir.,increase,no risk
Sofosbuvir,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Sofosbuvir.,increase,no risk
Sofosbuvir,Vismodegib,Vismodegib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Voclosporin,The serum concentration of Sofosbuvir can be increased when it is combined with Voclosporin.,increase,no risk
Sofosbuvir,Vorapaxar,The serum concentration of Sofosbuvir can be increased when it is combined with Vorapaxar.,increase,no risk
Sofosbuvir,Vortioxetine,Sofosbuvir may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Warfarin,Sofosbuvir may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Sofosbuvir.,decrease,no risk
Sofosbuvir,Zaleplon,Zaleplon may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Zanamivir,Zanamivir may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,decrease,no risk
Sofosbuvir,Zonisamide,The serum concentration of Sofosbuvir can be increased when it is combined with Zonisamide.,increase,no risk
Obinutuzumab,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Bretylium,Bretylium may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Brodalumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Brodalumab.,increase,risk
Obinutuzumab,Brolucizumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Brolucizumab.,increase,risk
Obinutuzumab,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Bupivacaine.,increase,risk
Obinutuzumab,Burosumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Burosumab.,increase,risk
Obinutuzumab,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Butabarbital,Butabarbital may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Butacaine,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Butacaine.,increase,risk
Obinutuzumab,Butalbital,Butalbital may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Butamben,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Butamben.,increase,risk
Obinutuzumab,Galcanezumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Galcanezumab.,increase,risk
Obinutuzumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Glofitamab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Glofitamab.,increase,risk
Obinutuzumab,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Guanabenz,Guanabenz may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Guanadrel,Guanadrel may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Guanethidine,Guanethidine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Guanfacine,Guanfacine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Guanoxan,Guanoxan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Guselkumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Guselkumab.,increase,risk
Obinutuzumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Obinutuzumab,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Heparin is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Obinutuzumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Obinutuzumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Obinutuzumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Human Rho(D) immune globulin.,increase,risk
Obinutuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Obinutuzumab,Hydralazine,Hydralazine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Hydrochlorothiazide,Hydrochlorothiazide may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Hydrocortisone acetate.,increase,risk
Obinutuzumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Hydrocortisone butyrate.,increase,risk
Obinutuzumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Hydrocortisone succinate.,increase,risk
Obinutuzumab,Hydroflumethiazide,Hydroflumethiazide may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Obinutuzumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Obinutuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Odesivimab.,increase,risk
Obinutuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Olaparib,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Olaparib.,increase,risk
Obinutuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Olmesartan,Olmesartan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Opicapone,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Opicapone.,increase,risk
Obinutuzumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Oxetacaine.,increase,risk
Obinutuzumab,Oxprenolol,Oxprenolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Oxybuprocaine.,increase,risk
Obinutuzumab,Ozanimod,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Ozanimod.,increase,risk
Obinutuzumab,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Quinapril,Quinapril may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Upadacitinib,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Upadacitinib.,increase,risk
Obinutuzumab,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Valsartan,Valsartan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Obinutuzumab,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Obinutuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Vedolizumab.,increase,risk
Obinutuzumab,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Vericiguat,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Vericiguat.,increase,risk
Obinutuzumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Obinutuzumab,Vilanterol,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Vilanterol.,increase,risk
Obinutuzumab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Voclosporin,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Voclosporin.,increase,risk
Obinutuzumab,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Warfarin is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Ximelagatran is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Obinutuzumab.,increase,risk
Obinutuzumab,Zofenopril,Zofenopril may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Chlorcyclizine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Gadobenic acid.,increase,risk
Chlorcyclizine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Gemifloxacin.,increase,risk
Chlorcyclizine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Gilteritinib.,increase,risk
Chlorcyclizine,Glasdegib,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Glasdegib.,increase,risk
Chlorcyclizine,Goserelin,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Goserelin.,increase,risk
Chlorcyclizine,Granisetron,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Granisetron.,increase,risk
Chlorcyclizine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Grepafloxacin.,increase,risk
Chlorcyclizine,Halofantrine,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Halofantrine.,increase,risk
Chlorcyclizine,Haloperidol,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Haloperidol.,increase,risk
Chlorcyclizine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Hydroxyzine.,increase,risk
Chlorcyclizine,Hyoscyamine,Chlorcyclizine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Chlorcyclizine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Ofloxacin.,increase,risk
Chlorcyclizine,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Olodaterol,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Olodaterol.,increase,risk
Chlorcyclizine,Ondansetron,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Ondansetron.,increase,risk
Chlorcyclizine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Oxatomide,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Oxatomide.,increase,risk
Chlorcyclizine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Quetiapine,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Quetiapine.,increase,risk
Chlorcyclizine,Quinidine,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Quinidine.,increase,risk
Chlorcyclizine,Quinine,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Quinine.,increase,risk
Chlorcyclizine,Quizartinib,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Quizartinib.,increase,risk
Chlorcyclizine,Valproic acid,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Valproic acid.,increase,risk
Chlorcyclizine,Vandetanib,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Vandetanib.,increase,risk
Chlorcyclizine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Ziprasidone.,increase,risk
Chlorcyclizine,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Chlorcyclizine.,increase,risk
Chlorcyclizine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Zuclopenthixol.,increase,risk
Magaldrate,Gabapentin,The bioavailability of Gabapentin can be decreased when combined with Magaldrate.,decrease,no risk
Magaldrate,Gabapentin enacarbil,The serum concentration of Gabapentin enacarbil can be decreased when it is combined with Magaldrate.,decrease,no risk
Magaldrate,Gatifloxacin,Magaldrate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Gefitinib,Magaldrate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Gemifloxacin,The absorption of Gemifloxacin can be decreased when combined with Magaldrate.,decrease,no risk
Magaldrate,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Magaldrate.,decrease,no risk
Magaldrate,Grepafloxacin,Magaldrate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Halofantrine,Magaldrate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Hydrocortisone,The bioavailability of Hydrocortisone can be decreased when combined with Magaldrate.,decrease,no risk
Magaldrate,Hydrocortisone butyrate,The bioavailability of Hydrocortisone butyrate can be decreased when combined with Magaldrate.,decrease,no risk
Magaldrate,Hydrocortisone cypionate,The bioavailability of Hydrocortisone cypionate can be decreased when combined with Magaldrate.,decrease,no risk
Magaldrate,Hydroxychloroquine,Magaldrate can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Hyoscyamine,Magaldrate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Ketoconazole,Magaldrate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Obeticholic acid,Magaldrate can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Octreotide,Magaldrate can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Ofloxacin,Magaldrate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Omadacycline,Magaldrate can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Oteseconazole,Magaldrate can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Ox bile extract,The serum concentration of Ox bile extract can be decreased when it is combined with Magaldrate.,decrease,no risk
Magaldrate,Oxytetracycline,Magaldrate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Quinidine,Magaldrate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Magaldrate,Ursodeoxycholic acid,Magaldrate can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Magaldrate.,decrease,no risk
Magaldrate,Vamorolone,The bioavailability of Vamorolone can be decreased when combined with Magaldrate.,decrease,no risk
Magaldrate,Verapamil,The risk or severity of hypotension can be increased when Magaldrate is combined with Verapamil.,increase,risk
Magaldrate,Vitamin D,The serum concentration of Magaldrate can be increased when it is combined with Vitamin D.,increase,no risk
Magaldrate,Voriconazole,Magaldrate can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Magaldrate,Ziconotide,The risk or severity of hypotension can be increased when Magaldrate is combined with Ziconotide.,increase,risk
Magaldrate,Zoledronic acid,The serum concentration of Zoledronic acid can be decreased when it is combined with Magaldrate.,decrease,no risk
Magaldrate,Zonisamide,The risk or severity of hypotension can be increased when Magaldrate is combined with Zonisamide.,increase,risk
Kebuzone,Bismuth subgallate,Kebuzone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Kebuzone,Bisoprolol,Kebuzone may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Kebuzone,Bisoxatin,Kebuzone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Kebuzone,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Bivalirudin.,increase,risk
Kebuzone,Bleomycin,Kebuzone may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Kebuzone,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Brexpiprazole,The risk or severity of hypertension can be increased when Kebuzone is combined with Brexpiprazole.,increase,risk
Kebuzone,Brivaracetam,Kebuzone may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Kebuzone,Bromazepam,Kebuzone may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Kebuzone,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Kebuzone.,increase,risk
Kebuzone,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Kebuzone.,increase,risk
Kebuzone,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Kebuzone.,increase,risk
Kebuzone,Bufexamac,The risk or severity of adverse effects can be increased when Kebuzone is combined with Bufexamac.,increase,risk
Kebuzone,Bumadizone,The risk or severity of adverse effects can be increased when Kebuzone is combined with Bumadizone.,increase,risk
Kebuzone,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Bupropion,Kebuzone may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Kebuzone,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Kebuzone.,increase,risk
Kebuzone,Butabarbital,Kebuzone may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Kebuzone,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Kebuzone.,increase,risk
Kebuzone,Gabapentin enacarbil,Kebuzone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Kebuzone,Gadobenic acid,Kebuzone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Kebuzone,Gadodiamide,Kebuzone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Kebuzone,Gadofosveset trisodium,Kebuzone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Kebuzone,Gadopentetic acid,Kebuzone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Kebuzone,Gadoteric acid,Kebuzone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Kebuzone,Gadoteridol,Kebuzone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Kebuzone,Ganciclovir,Kebuzone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Kebuzone,Gatifloxacin,Kebuzone may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Kebuzone,Gemcitabine,Kebuzone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Kebuzone,Gemfibrozil,Kebuzone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Kebuzone,Gemifloxacin,Kebuzone may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Kebuzone,Gentamicin,Kebuzone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Kebuzone,Gimeracil,Kebuzone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Kebuzone,Givosiran,The risk or severity of nephrotoxicity can be increased when Kebuzone is combined with Givosiran.,increase,risk
Kebuzone,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Kebuzone.,decrease,no risk
Kebuzone,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Kebuzone.,decrease,no risk
Kebuzone,Glipizide,The protein binding of Glipizide can be decreased when combined with Kebuzone.,decrease,no risk
Kebuzone,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Kebuzone.,decrease,no risk
Kebuzone,Glyburide,The protein binding of Glyburide can be decreased when combined with Kebuzone.,decrease,no risk
Kebuzone,Glycerol phenylbutyrate,Kebuzone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Kebuzone,Glycol salicylate,The risk or severity of adverse effects can be increased when Kebuzone is combined with Glycol salicylate.,increase,risk
Kebuzone,Golodirsen,Kebuzone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Kebuzone,Goserelin,Kebuzone may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Kebuzone,Grepafloxacin,Kebuzone may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Kebuzone,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Kebuzone.,increase,no risk
Kebuzone,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Kebuzone.,increase,risk
Kebuzone,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Heparin.,increase,risk
Kebuzone,Hydralazine,Kebuzone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Kebuzone,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Kebuzone.,increase,risk
Kebuzone,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Kebuzone.,increase,risk
Kebuzone,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Kebuzone.,increase,risk
Kebuzone,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Kebuzone.,increase,risk
Kebuzone,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Kebuzone.,increase,risk
Kebuzone,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Hydromorphone,Kebuzone may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Kebuzone,Hydroxocobalamin,Kebuzone may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Kebuzone,Hydroxyethyl Starch,Kebuzone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Kebuzone,Kanamycin,Kebuzone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kebuzone,Ketamine,Kebuzone may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Kebuzone,Ketazolam,Kebuzone may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Kebuzone,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Kebuzone.,increase,risk
Kebuzone,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Kebuzone.,increase,risk
Kebuzone,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Kebuzone.,increase,risk
Kebuzone,Octinoxate,Kebuzone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Kebuzone,Ofloxacin,Kebuzone may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Kebuzone,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Kebuzone.",increase,risk
Kebuzone,Olodaterol,The risk or severity of hypertension can be increased when Kebuzone is combined with Olodaterol.,increase,risk
Kebuzone,Olsalazine,The risk or severity of nephrotoxicity can be increased when Kebuzone is combined with Olsalazine.,increase,risk
Kebuzone,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Kebuzone is combined with Omacetaxine mepesuccinate.,increase,risk
Kebuzone,Opium,Kebuzone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Kebuzone,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Kebuzone.,increase,risk
Kebuzone,Oseltamivir,Kebuzone may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Kebuzone,Oxacillin,Kebuzone may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Kebuzone,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Kebuzone.,increase,risk
Kebuzone,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Kebuzone.,increase,risk
Kebuzone,Oxazepam,Kebuzone may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Kebuzone,Oxprenolol,Kebuzone may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Kebuzone,Oxybenzone,Kebuzone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Kebuzone,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Kebuzone.,increase,risk
Kebuzone,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Kebuzone.,increase,risk
Kebuzone,Oxyquinoline,Kebuzone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Kebuzone,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Kebuzone.,increase,risk
Kebuzone,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Kebuzone is combined with Quinapril.",increase,risk
Kebuzone,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Quinidine,Kebuzone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Kebuzone,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Kebuzone.,increase,risk
Kebuzone,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Kebuzone.,decrease,no risk
Kebuzone,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Urokinase.,increase,risk
Kebuzone,Vaborbactam,Kebuzone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Kebuzone,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Kebuzone.,increase,risk
Kebuzone,Valbenazine,Kebuzone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Kebuzone,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Kebuzone.,increase,risk
Kebuzone,Valganciclovir,Kebuzone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Kebuzone,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Kebuzone.,decrease,no risk
Kebuzone,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Kebuzone.",increase,risk
Kebuzone,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Kebuzone.,increase,risk
Kebuzone,Vancomycin,Kebuzone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Kebuzone,Varenicline,Kebuzone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Kebuzone,Venlafaxine,Kebuzone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Kebuzone,Verapamil,Kebuzone may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Kebuzone,Vilanterol,The risk or severity of hypertension can be increased when Kebuzone is combined with Vilanterol.,increase,risk
Kebuzone,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Kebuzone.,increase,risk
Kebuzone,Viloxazine,Kebuzone may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Kebuzone,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Vorapaxar.,increase,risk
Kebuzone,Voriconazole,The serum concentration of Kebuzone can be increased when it is combined with Voriconazole.,increase,no risk
Kebuzone,Vortioxetine,The risk or severity of hypertension can be increased when Kebuzone is combined with Vortioxetine.,increase,risk
Kebuzone,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Warfarin.,increase,risk
Kebuzone,Xamoterol,The risk or severity of hypertension can be increased when Kebuzone is combined with Xamoterol.,increase,risk
Kebuzone,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Ximelagatran.,increase,risk
Kebuzone,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Kebuzone.,increase,risk
Kebuzone,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Kebuzone.,increase,risk
Kebuzone,Zaleplon,Kebuzone may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Kebuzone,Zanamivir,Kebuzone may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Kebuzone,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Kebuzone.,increase,risk
Kebuzone,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Kebuzone.,increase,risk
Kebuzone,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Kebuzone.,increase,risk
Kebuzone,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Kebuzone is combined with Zofenopril.",increase,risk
Kebuzone,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Kebuzone is combined with Zoledronic acid.,increase,risk
Kebuzone,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Kebuzone.,increase,risk
Kebuzone,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Kebuzone.,increase,risk
Isoxsuprine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Isoxsuprine.,decrease,no risk
Isoxsuprine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Guanabenz,Isoxsuprine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Isoxsuprine,Guanadrel,Isoxsuprine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Isoxsuprine,Guanethidine,Isoxsuprine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Isoxsuprine,Guanfacine,Isoxsuprine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Isoxsuprine,Guanoxan,Isoxsuprine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Isoxsuprine,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Hexocyclium,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Hydralazine,Isoxsuprine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Isoxsuprine,Hydrochlorothiazide,Isoxsuprine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Isoxsuprine,Hydroflumethiazide,Isoxsuprine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Isoxsuprine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Olanzapine,The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Olanzapine.,decrease,no risk
Isoxsuprine,Olmesartan,Isoxsuprine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Isoxsuprine,Olodaterol,The risk or severity of hypertension can be increased when Isoxsuprine is combined with Olodaterol.,increase,risk
Isoxsuprine,Opicapone,The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Opicapone.,increase,risk
Isoxsuprine,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Oxprenolol,The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Isoxsuprine,Oxtriphylline,The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Oxtriphylline.,increase,risk
Isoxsuprine,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Quetiapine,The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Quetiapine.,decrease,no risk
Isoxsuprine,Quinapril,Isoxsuprine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Isoxsuprine,Quinidine,The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Quinidine.,decrease,no risk
Isoxsuprine,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Umeclidinium,The risk or severity of Tachycardia can be increased when Isoxsuprine is combined with Umeclidinium.,increase,risk
Isoxsuprine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Valsartan,Isoxsuprine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Isoxsuprine,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Isoxsuprine.,increase,no risk
Isoxsuprine,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Vericiguat,The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Vericiguat.,increase,risk
Isoxsuprine,Vilanterol,The risk or severity of hypertension can be increased when Isoxsuprine is combined with Vilanterol.,increase,risk
Isoxsuprine,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Vortioxetine,The risk or severity of hypertension can be increased when Isoxsuprine is combined with Vortioxetine.,increase,risk
Isoxsuprine,Xamoterol,The risk or severity of hypertension can be increased when Isoxsuprine is combined with Xamoterol.,increase,risk
Isoxsuprine,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Ziprasidone,The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Isoxsuprine,Zofenopril,Isoxsuprine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Isoxsuprine,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Isoxsuprine.,increase,risk
Isoxsuprine,Zuclopenthixol,The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Isoxicam,Bismuth subgallate,Isoxicam may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Isoxicam,Bisoprolol,Isoxicam may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Isoxicam,Bisoxatin,Isoxicam may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Isoxicam,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Bivalirudin.,increase,risk
Isoxicam,Bleomycin,Isoxicam may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Isoxicam,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Brexpiprazole,The risk or severity of hypertension can be increased when Isoxicam is combined with Brexpiprazole.,increase,risk
Isoxicam,Brivaracetam,Isoxicam may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Isoxicam,Bromazepam,Isoxicam may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Isoxicam,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Isoxicam.,increase,risk
Isoxicam,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Isoxicam.,increase,risk
Isoxicam,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Isoxicam.,increase,risk
Isoxicam,Bufexamac,The risk or severity of adverse effects can be increased when Isoxicam is combined with Bufexamac.,increase,risk
Isoxicam,Bumadizone,The risk or severity of adverse effects can be increased when Isoxicam is combined with Bumadizone.,increase,risk
Isoxicam,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Bupropion,Isoxicam may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Isoxicam,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Isoxicam.,increase,risk
Isoxicam,Butabarbital,Isoxicam may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Isoxicam,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Isoxicam.,increase,risk
Isoxicam,Gabapentin enacarbil,Isoxicam may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Isoxicam,Gadobenic acid,Isoxicam may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Isoxicam,Gadodiamide,Isoxicam may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Isoxicam,Gadofosveset trisodium,Isoxicam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Isoxicam,Gadopentetic acid,Isoxicam may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Isoxicam,Gadoteric acid,Isoxicam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Isoxicam,Gadoteridol,Isoxicam may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Isoxicam,Ganciclovir,Isoxicam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Isoxicam,Gatifloxacin,Isoxicam may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Isoxicam,Gemcitabine,Isoxicam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Isoxicam,Gemfibrozil,Isoxicam may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Isoxicam,Gemifloxacin,Isoxicam may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Isoxicam,Gentamicin,Isoxicam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Isoxicam,Gimeracil,Isoxicam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Isoxicam,Givosiran,The risk or severity of nephrotoxicity can be increased when Isoxicam is combined with Givosiran.,increase,risk
Isoxicam,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Isoxicam.,decrease,no risk
Isoxicam,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Isoxicam.,decrease,no risk
Isoxicam,Glipizide,The protein binding of Glipizide can be decreased when combined with Isoxicam.,decrease,no risk
Isoxicam,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Isoxicam.,decrease,no risk
Isoxicam,Glyburide,The protein binding of Glyburide can be decreased when combined with Isoxicam.,decrease,no risk
Isoxicam,Glycerol phenylbutyrate,Isoxicam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Isoxicam,Glycol salicylate,The risk or severity of adverse effects can be increased when Isoxicam is combined with Glycol salicylate.,increase,risk
Isoxicam,Golodirsen,Isoxicam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Isoxicam,Goserelin,Isoxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Isoxicam,Grepafloxacin,Isoxicam may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Isoxicam,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Isoxicam.,increase,no risk
Isoxicam,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Isoxicam.,increase,risk
Isoxicam,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Heparin.,increase,risk
Isoxicam,Hydralazine,Isoxicam may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Isoxicam,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Isoxicam.,increase,risk
Isoxicam,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Isoxicam.,increase,risk
Isoxicam,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Isoxicam.,increase,risk
Isoxicam,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Isoxicam.,increase,risk
Isoxicam,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Isoxicam.,increase,risk
Isoxicam,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Hydromorphone,Isoxicam may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Isoxicam,Hydroxocobalamin,Isoxicam may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Isoxicam,Hydroxyethyl Starch,Isoxicam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Isoxicam,Kanamycin,Isoxicam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Isoxicam,Ketamine,Isoxicam may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Isoxicam,Ketazolam,Isoxicam may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Isoxicam,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Isoxicam.,increase,risk
Isoxicam,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Isoxicam.,increase,risk
Isoxicam,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Isoxicam.,increase,risk
Isoxicam,Octinoxate,Isoxicam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Isoxicam,Ofloxacin,Isoxicam may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Isoxicam,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Isoxicam.",increase,risk
Isoxicam,Olodaterol,The risk or severity of hypertension can be increased when Isoxicam is combined with Olodaterol.,increase,risk
Isoxicam,Olsalazine,The risk or severity of nephrotoxicity can be increased when Isoxicam is combined with Olsalazine.,increase,risk
Isoxicam,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Isoxicam is combined with Omacetaxine mepesuccinate.,increase,risk
Isoxicam,Opium,Isoxicam may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Isoxicam,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Isoxicam.,increase,risk
Isoxicam,Oseltamivir,Isoxicam may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Isoxicam,Oxacillin,Isoxicam may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Isoxicam,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Isoxicam.,increase,risk
Isoxicam,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Isoxicam.,increase,risk
Isoxicam,Oxazepam,Isoxicam may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Isoxicam,Oxprenolol,Isoxicam may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Isoxicam,Oxybenzone,Isoxicam may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Isoxicam,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Isoxicam.,increase,risk
Isoxicam,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Isoxicam.,increase,risk
Isoxicam,Oxyquinoline,Isoxicam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Isoxicam,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Isoxicam.,increase,risk
Isoxicam,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Isoxicam is combined with Quinapril.",increase,risk
Isoxicam,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Quinidine,Isoxicam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Isoxicam,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Isoxicam.,increase,risk
Isoxicam,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Isoxicam.,decrease,no risk
Isoxicam,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Urokinase.,increase,risk
Isoxicam,Vaborbactam,Isoxicam may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Isoxicam,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Isoxicam.,increase,risk
Isoxicam,Valbenazine,Isoxicam may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Isoxicam,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Isoxicam.,increase,risk
Isoxicam,Valganciclovir,Isoxicam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Isoxicam,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Isoxicam.,decrease,no risk
Isoxicam,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Isoxicam.",increase,risk
Isoxicam,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Isoxicam.,increase,risk
Isoxicam,Vancomycin,Isoxicam may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Isoxicam,Varenicline,Isoxicam may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Isoxicam,Venlafaxine,Isoxicam may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Isoxicam,Verapamil,Isoxicam may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Isoxicam,Vilanterol,The risk or severity of hypertension can be increased when Isoxicam is combined with Vilanterol.,increase,risk
Isoxicam,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Isoxicam.,increase,risk
Isoxicam,Viloxazine,Isoxicam may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Isoxicam,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Vorapaxar.,increase,risk
Isoxicam,Voriconazole,The serum concentration of Isoxicam can be increased when it is combined with Voriconazole.,increase,no risk
Isoxicam,Vortioxetine,The risk or severity of hypertension can be increased when Isoxicam is combined with Vortioxetine.,increase,risk
Isoxicam,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Warfarin.,increase,risk
Isoxicam,Xamoterol,The risk or severity of hypertension can be increased when Isoxicam is combined with Xamoterol.,increase,risk
Isoxicam,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Ximelagatran.,increase,risk
Isoxicam,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Isoxicam.,increase,risk
Isoxicam,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Isoxicam.,increase,risk
Isoxicam,Zaleplon,Isoxicam may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Isoxicam,Zanamivir,Isoxicam may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Isoxicam,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Isoxicam.,increase,risk
Isoxicam,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Isoxicam.,increase,risk
Isoxicam,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Isoxicam.,increase,risk
Indoramin,Glycol salicylate,The therapeutic efficacy of Indoramin can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Indoramin,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Indoramin.,decrease,no risk
Indoramin,Guanadrel,Indoramin may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Indoramin,Guanethidine,Indoramin may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Indoramin,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Indoramin.,decrease,no risk
Indoramin,Guanoxan,Indoramin may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Indoramin,Halothane,Halothane may decrease the antihypertensive activities of Indoramin.,decrease,no risk
Indoramin,Hydralazine,Indoramin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Indoramin,Hydrochlorothiazide,The therapeutic efficacy of Indoramin can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Indoramin,Hydroflumethiazide,The therapeutic efficacy of Indoramin can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Indoramin,Ketoprofen,The therapeutic efficacy of Indoramin can be decreased when used in combination with Ketoprofen.,decrease,no risk
Indoramin,Ketorolac,The therapeutic efficacy of Indoramin can be decreased when used in combination with Ketorolac.,decrease,no risk
Indoramin,Obinutuzumab,Indoramin may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Indoramin,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Indoramin.",increase,no risk
Indoramin,Olmesartan,Indoramin may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Indoramin,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Indoramin.,decrease,no risk
Indoramin,Opicapone,The risk or severity of adverse effects can be increased when Indoramin is combined with Opicapone.,increase,risk
Indoramin,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Indoramin.,decrease,no risk
Indoramin,Oxaprozin,The therapeutic efficacy of Indoramin can be decreased when used in combination with Oxaprozin.,decrease,no risk
Indoramin,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Indoramin.,increase,no risk
Indoramin,Oxymetazoline,The therapeutic efficacy of Indoramin can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Indoramin,Oxyphenbutazone,The therapeutic efficacy of Indoramin can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Indoramin,Quetiapine,Quetiapine may increase the hypotensive activities of Indoramin.,increase,no risk
Indoramin,Quinapril,Indoramin may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Indoramin,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Indoramin.",increase,no risk
Indoramin,Quinine,Quinine may increase the hypotensive activities of Indoramin.,increase,no risk
Indoramin,Quinupramine,Quinupramine may decrease the antihypertensive activities of Indoramin.,decrease,no risk
Indoramin,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Indoramin.,increase,risk
Indoramin,Unoprostone,Unoprostone may increase the hypotensive activities of Indoramin.,increase,no risk
Indoramin,Valdecoxib,The therapeutic efficacy of Indoramin can be decreased when used in combination with Valdecoxib.,decrease,no risk
Indoramin,Valsartan,Indoramin may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Indoramin,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Indoramin.,increase,risk
Indoramin,Verapamil,The risk or severity of hypotension can be increased when Indoramin is combined with Verapamil.,increase,risk
Indoramin,Vericiguat,The risk or severity of adverse effects can be increased when Indoramin is combined with Vericiguat.,increase,risk
Indoramin,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Indoramin.,decrease,no risk
Indoramin,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Indoramin.,decrease,no risk
Indoramin,Vilazodone,Vilazodone may decrease the antihypertensive activities of Indoramin.,decrease,no risk
Indoramin,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Indoramin.,decrease,no risk
Indoramin,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Indoramin.,decrease,no risk
Indoramin,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Indoramin.,decrease,no risk
Indoramin,Yohimbine,Yohimbine may decrease the antihypertensive activities of Indoramin.,decrease,no risk
Indoramin,Ziconotide,The risk or severity of hypotension can be increased when Indoramin is combined with Ziconotide.,increase,risk
Indoramin,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Indoramin.,increase,no risk
Indoramin,Zofenopril,Indoramin may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Indoramin,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Indoramin.,decrease,no risk
Indoramin,Zonisamide,The risk or severity of hypotension can be increased when Indoramin is combined with Zonisamide.,increase,risk
Indoramin,Zuclopenthixol,"Zuclopenthixol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Indoramin.",increase,no risk
Indoprofen,Bismuth subgallate,Indoprofen may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Indoprofen,Bisoprolol,Indoprofen may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Indoprofen,Bisoxatin,Indoprofen may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Indoprofen,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Bivalirudin.,increase,risk
Indoprofen,Bleomycin,Indoprofen may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Indoprofen,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Brexpiprazole,The risk or severity of hypertension can be increased when Indoprofen is combined with Brexpiprazole.,increase,risk
Indoprofen,Brivaracetam,Indoprofen may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Indoprofen,Bromazepam,Indoprofen may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Indoprofen,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Indoprofen.,increase,risk
Indoprofen,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Indoprofen.,increase,risk
Indoprofen,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Indoprofen.,increase,risk
Indoprofen,Bufexamac,The risk or severity of adverse effects can be increased when Indoprofen is combined with Bufexamac.,increase,risk
Indoprofen,Bumadizone,The risk or severity of adverse effects can be increased when Indoprofen is combined with Bumadizone.,increase,risk
Indoprofen,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Bupropion,Indoprofen may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Indoprofen,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Indoprofen.,increase,risk
Indoprofen,Butabarbital,Indoprofen may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Indoprofen,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Indoprofen.,increase,risk
Indoprofen,Gabapentin enacarbil,Indoprofen may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Indoprofen,Gadobenic acid,Indoprofen may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Indoprofen,Gadodiamide,Indoprofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Indoprofen,Gadofosveset trisodium,Indoprofen may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Indoprofen,Gadopentetic acid,Indoprofen may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Indoprofen,Gadoteric acid,Indoprofen may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Indoprofen,Gadoteridol,Indoprofen may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Indoprofen,Ganciclovir,Indoprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Indoprofen,Gatifloxacin,Indoprofen may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Indoprofen,Gemcitabine,Indoprofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Indoprofen,Gemfibrozil,Indoprofen may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Indoprofen,Gemifloxacin,Indoprofen may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Indoprofen,Gentamicin,Indoprofen may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Indoprofen,Gimeracil,Indoprofen may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Indoprofen,Givosiran,The risk or severity of nephrotoxicity can be increased when Indoprofen is combined with Givosiran.,increase,risk
Indoprofen,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Indoprofen.,decrease,no risk
Indoprofen,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Indoprofen.,decrease,no risk
Indoprofen,Glipizide,The protein binding of Glipizide can be decreased when combined with Indoprofen.,decrease,no risk
Indoprofen,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Indoprofen.,decrease,no risk
Indoprofen,Glyburide,The protein binding of Glyburide can be decreased when combined with Indoprofen.,decrease,no risk
Indoprofen,Glycerol phenylbutyrate,Indoprofen may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Indoprofen,Glycol salicylate,The risk or severity of adverse effects can be increased when Indoprofen is combined with Glycol salicylate.,increase,risk
Indoprofen,Golodirsen,Indoprofen may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Indoprofen,Goserelin,Indoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Indoprofen,Grepafloxacin,Indoprofen may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Indoprofen,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Indoprofen.,increase,no risk
Indoprofen,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Indoprofen.,increase,risk
Indoprofen,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Heparin.,increase,risk
Indoprofen,Hydralazine,Indoprofen may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Indoprofen,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Indoprofen.,increase,risk
Indoprofen,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Indoprofen.,increase,risk
Indoprofen,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Indoprofen.,increase,risk
Indoprofen,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Indoprofen.,increase,risk
Indoprofen,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Indoprofen.,increase,risk
Indoprofen,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Hydromorphone,Indoprofen may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Indoprofen,Hydroxocobalamin,Indoprofen may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Indoprofen,Hydroxyethyl Starch,Indoprofen may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Indoprofen,Kanamycin,Indoprofen may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Indoprofen,Ketamine,Indoprofen may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Indoprofen,Ketazolam,Indoprofen may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Indoprofen,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Indoprofen.,increase,risk
Indoprofen,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Indoprofen.,increase,risk
Indoprofen,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Indoprofen.,increase,risk
Indoprofen,Octinoxate,Indoprofen may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Indoprofen,Ofloxacin,Indoprofen may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Indoprofen,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Indoprofen.",increase,risk
Indoprofen,Olodaterol,The risk or severity of hypertension can be increased when Indoprofen is combined with Olodaterol.,increase,risk
Indoprofen,Olsalazine,The risk or severity of nephrotoxicity can be increased when Indoprofen is combined with Olsalazine.,increase,risk
Indoprofen,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Indoprofen is combined with Omacetaxine mepesuccinate.,increase,risk
Indoprofen,Opium,Indoprofen may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Indoprofen,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Indoprofen.,increase,risk
Indoprofen,Oseltamivir,Indoprofen may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Indoprofen,Oxacillin,Indoprofen may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Indoprofen,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Indoprofen.,increase,risk
Indoprofen,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Indoprofen.,increase,risk
Indoprofen,Oxazepam,Indoprofen may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Indoprofen,Oxprenolol,Indoprofen may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Indoprofen,Oxybenzone,Indoprofen may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Indoprofen,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Indoprofen.,increase,risk
Indoprofen,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Indoprofen.,increase,risk
Indoprofen,Oxyquinoline,Indoprofen may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Indoprofen,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Indoprofen.,increase,risk
Indoprofen,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indoprofen is combined with Quinapril.",increase,risk
Indoprofen,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Quinidine,Indoprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Indoprofen,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Indoprofen.,increase,risk
Indoprofen,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Indoprofen.,decrease,no risk
Indoprofen,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Urokinase.,increase,risk
Indoprofen,Vaborbactam,Indoprofen may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Indoprofen,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Indoprofen.,increase,risk
Indoprofen,Valbenazine,Indoprofen may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Indoprofen,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Indoprofen.,increase,risk
Indoprofen,Valganciclovir,Indoprofen may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Indoprofen,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Indoprofen.,decrease,no risk
Indoprofen,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Indoprofen.",increase,risk
Indoprofen,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Indoprofen.,increase,risk
Indoprofen,Vancomycin,Indoprofen may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Indoprofen,Varenicline,Indoprofen may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Indoprofen,Venlafaxine,Indoprofen may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Indoprofen,Verapamil,Indoprofen may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Indoprofen,Vilanterol,The risk or severity of hypertension can be increased when Indoprofen is combined with Vilanterol.,increase,risk
Indoprofen,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Indoprofen.,increase,risk
Indoprofen,Viloxazine,Indoprofen may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Indoprofen,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Vorapaxar.,increase,risk
Indoprofen,Voriconazole,The serum concentration of Indoprofen can be increased when it is combined with Voriconazole.,increase,no risk
Indoprofen,Vortioxetine,The risk or severity of hypertension can be increased when Indoprofen is combined with Vortioxetine.,increase,risk
Indoprofen,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Warfarin.,increase,risk
Indoprofen,Xamoterol,The risk or severity of hypertension can be increased when Indoprofen is combined with Xamoterol.,increase,risk
Indoprofen,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Ximelagatran.,increase,risk
Indoprofen,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Indoprofen.,increase,risk
Indoprofen,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Indoprofen.,increase,risk
Indoprofen,Zaleplon,Indoprofen may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Indoprofen,Zanamivir,Indoprofen may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Indoprofen,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Indoprofen.,increase,risk
Indoprofen,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Indoprofen.,increase,risk
Indenolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Indenolol.,decrease,no risk
Indenolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Indenolol.,increase,no risk
Indenolol,Bilastine,The risk or severity of QTc prolongation can be increased when Indenolol is combined with Bilastine.,increase,risk
Indenolol,Bimatoprost,Bimatoprost may increase the hypotensive activities of Indenolol.,increase,no risk
Indenolol,Bimekizumab,The metabolism of Indenolol can be increased when combined with Bimekizumab.,increase,no risk
Indenolol,Bioallethrin,Indenolol may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Indenolol,Biperiden,The metabolism of Indenolol can be decreased when combined with Biperiden.,decrease,no risk
Indenolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Indenolol.,increase,risk
Indenolol,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Indenolol.,increase,risk
Indenolol,Bosentan,Bosentan may increase the hypotensive activities of Indenolol.,increase,no risk
Indenolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Indenolol.,increase,risk
Indenolol,Bretylium,Bretylium may increase the arrhythmogenic activities of Indenolol.,increase,no risk
Indenolol,Brexpiprazole,Indenolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Indenolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Indenolol.,increase,no risk
Indenolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Indenolol.,increase,no risk
Indenolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Indenolol is combined with Bromotheophylline.,increase,risk
Indenolol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Indenolol.,increase,risk
Indenolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Indenolol.,increase,risk
Indenolol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Indenolol.,increase,risk
Indenolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Indenolol.,decrease,no risk
Indenolol,Bumetanide,Bumetanide may increase the hypotensive activities of Indenolol.,increase,no risk
Indenolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Indenolol.,increase,no risk
Indenolol,Buprenorphine,The metabolism of Indenolol can be decreased when combined with Buprenorphine.,decrease,no risk
Indenolol,Bupropion,The metabolism of Indenolol can be decreased when combined with Bupropion.,decrease,no risk
Indenolol,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Indenolol.,increase,risk
Indenolol,Buspirone,Buspirone may decrease the antihypertensive activities of Indenolol.,decrease,no risk
Indenolol,Butabarbital,The serum concentration of Indenolol can be decreased when it is combined with Butabarbital.,decrease,no risk
Indenolol,Butalbital,The serum concentration of Indenolol can be decreased when it is combined with Butalbital.,decrease,no risk
Indenolol,Butaperazine,The serum concentration of Indenolol can be increased when it is combined with Butaperazine.,increase,no risk
Indenolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Indenolol.,decrease,no risk
Indenolol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Indenolol is combined with Gadobenic acid.,increase,risk
Indenolol,Galantamine,Galantamine may increase the bradycardic activities of Indenolol.,increase,no risk
Indenolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Indenolol.,increase,no risk
Indenolol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Indenolol.,increase,risk
Indenolol,Gefitinib,The metabolism of Indenolol can be decreased when combined with Gefitinib.,decrease,no risk
Indenolol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Indenolol is combined with Gemifloxacin.,increase,risk
Indenolol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Indenolol.,increase,risk
Indenolol,Gilteritinib,The risk or severity of QTc prolongation can be increased when Indenolol is combined with Gilteritinib.,increase,risk
Indenolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Indenolol.,increase,no risk
Indenolol,Givosiran,The serum concentration of Indenolol can be increased when it is combined with Givosiran.,increase,no risk
Indenolol,Glasdegib,The risk or severity of QTc prolongation can be increased when Indenolol is combined with Glasdegib.,increase,risk
Indenolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Indenolol.,increase,no risk
Indenolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Indenolol.,increase,no risk
Indalpine,Bepridil,The metabolism of Bepridil can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Berotralstat,The metabolism of Indalpine can be decreased when combined with Berotralstat.,decrease,no risk
Indalpine,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Indalpine.,increase,no risk
Indalpine,Betrixaban,The risk or severity of hemorrhage can be increased when Indalpine is combined with Betrixaban.,increase,risk
Indalpine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Indalpine is combined with Bexagliflozin.,increase,risk
Indalpine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Indalpine.,increase,no risk
Indalpine,Bivalirudin,The risk or severity of hemorrhage can be increased when Indalpine is combined with Bivalirudin.,increase,risk
Indalpine,Boceprevir,The metabolism of Indalpine can be decreased when combined with Boceprevir.,decrease,no risk
Indalpine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Bosentan,The metabolism of Bosentan can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Indalpine.,increase,risk
Indalpine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Indalpine.,increase,risk
Indalpine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Indalpine.,increase,risk
Indalpine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Indalpine.,increase,no risk
Indalpine,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Indalpine.,increase,risk
Indalpine,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Indalpine.,increase,risk
Indalpine,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Indalpine.,increase,risk
Indalpine,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Indalpine.,increase,risk
Indalpine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Indalpine.,increase,risk
Indalpine,Budesonide,The metabolism of Budesonide can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Bumadizone.,increase,risk
Indalpine,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Indalpine.,increase,risk
Indalpine,Buprenorphine,Indalpine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Indalpine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Indalpine.,increase,risk
Indalpine,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Indalpine.,increase,risk
Indalpine,Busulfan,The metabolism of Busulfan can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Indalpine.,increase,risk
Indalpine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Indalpine.,increase,risk
Indalpine,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Indalpine.,increase,risk
Indalpine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Indalpine.,increase,risk
Indalpine,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Indalpine.,increase,risk
Indalpine,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Indalpine.,increase,risk
Indalpine,Gabapentin,The risk or severity of adverse effects can be increased when Gabapentin is combined with Indalpine.,increase,risk
Indalpine,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Indalpine.,increase,risk
Indalpine,Galantamine,The metabolism of Galantamine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Indalpine.,increase,risk
Indalpine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Indalpine is combined with Ganaxolone.",increase,risk
Indalpine,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Gatifloxacin is combined with Indalpine.,increase,risk
Indalpine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Indalpine.,increase,no risk
Indalpine,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Gilteritinib,The therapeutic efficacy of Indalpine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Indalpine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Gliclazide,The risk or severity of hypoglycemia can be increased when Indalpine is combined with Gliclazide.,increase,risk
Indalpine,Glimepiride,The risk or severity of hypoglycemia can be increased when Indalpine is combined with Glimepiride.,increase,risk
Indalpine,Glipizide,The risk or severity of hypoglycemia can be increased when Indalpine is combined with Glipizide.,increase,risk
Indalpine,Gliquidone,The risk or severity of hypoglycemia can be increased when Indalpine is combined with Gliquidone.,increase,risk
Indalpine,Glofitamab,The serum concentration of Indalpine can be increased when it is combined with Glofitamab.,increase,no risk
Indalpine,Glutethimide,The risk or severity of adverse effects can be increased when Glutethimide is combined with Indalpine.,increase,risk
Indalpine,Glyburide,The risk or severity of hypoglycemia can be increased when Indalpine is combined with Glyburide.,increase,risk
Indalpine,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Glycol salicylate.,increase,risk
Indalpine,Glymidine,The risk or severity of hypoglycemia can be increased when Indalpine is combined with Glymidine.,increase,risk
Indalpine,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with Indalpine.,increase,risk
Indalpine,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Indalpine.,increase,risk
Indalpine,Halazepam,The risk or severity of adverse effects can be increased when Halazepam is combined with Indalpine.,increase,risk
Indalpine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Indalpine.,increase,risk
Indalpine,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Indalpine.,increase,risk
Indalpine,Heparin,The risk or severity of hemorrhage can be increased when Indalpine is combined with Heparin.,increase,risk
Indalpine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Indalpine.,increase,risk
Indalpine,Hydrochlorothiazide,The risk or severity of hyponatremia can be increased when Indalpine is combined with Hydrochlorothiazide.,increase,risk
Indalpine,Hydrocodone,Indalpine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Indalpine,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Hydroflumethiazide,The risk or severity of hyponatremia can be increased when Indalpine is combined with Hydroflumethiazide.,increase,risk
Indalpine,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Indalpine.,increase,risk
Indalpine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Indalpine.,increase,no risk
Indalpine,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Indalpine.,increase,risk
Indalpine,Ketazolam,The risk or severity of adverse effects can be increased when Ketazolam is combined with Indalpine.,increase,risk
Indalpine,Ketoconazole,The metabolism of Indalpine can be decreased when combined with Ketoconazole.,decrease,no risk
Indalpine,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Ketoprofen.,increase,risk
Indalpine,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Ketorolac.,increase,risk
Indalpine,Octreotide,The risk or severity of hypoglycemia can be increased when Octreotide is combined with Indalpine.,increase,risk
Indalpine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Indalpine.,increase,risk
Indalpine,Olaparib,The metabolism of Olaparib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Indalpine is combined with Oliceridine.",increase,risk
Indalpine,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Indalpine.,increase,no risk
Indalpine,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Indalpine.,increase,risk
Indalpine,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Indalpine.,increase,risk
Indalpine,Orphenadrine,Indalpine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Indalpine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Oxaprozin.,increase,risk
Indalpine,Oxazepam,The risk or severity of adverse effects can be increased when Oxazepam is combined with Indalpine.,increase,risk
Indalpine,Oxcarbazepine,The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Indalpine.,increase,risk
Indalpine,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Indalpine.,increase,risk
Indalpine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Indalpine.,increase,risk
Indalpine,Oxybuprocaine,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Indalpine.,increase,risk
Indalpine,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Indalpine.,increase,risk
Indalpine,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Indalpine.,increase,risk
Indalpine,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Oxyphenbutazone.,increase,risk
Indalpine,Quazepam,The risk or severity of adverse effects can be increased when Quazepam is combined with Indalpine.,increase,risk
Indalpine,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Indalpine.,increase,risk
Indalpine,Quinethazone,The risk or severity of hyponatremia can be increased when Indalpine is combined with Quinethazone.,increase,risk
Indalpine,Quinidine,The metabolism of Quinidine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Indalpine.,increase,risk
Indalpine,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Indalpine.,increase,risk
Indalpine,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Indalpine is combined with Ubidecarenone.,increase,risk
Indalpine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Indalpine.,increase,no risk
Indalpine,Udenafil,The metabolism of Udenafil can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Urethane,The risk or severity of adverse effects can be increased when Urethane is combined with Indalpine.,increase,risk
Indalpine,Urokinase,The risk or severity of hemorrhage can be increased when Indalpine is combined with Urokinase.,increase,risk
Indalpine,Vadadustat,The serum concentration of Indalpine can be increased when it is combined with Vadadustat.,increase,no risk
Indalpine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Valdecoxib.,increase,risk
Indalpine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Valproate bismuth.,increase,risk
Indalpine,Valproic acid,The risk or severity of adverse effects can be increased when Valproic acid is combined with Indalpine.,increase,risk
Indalpine,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vasopressin,Indalpine may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Indalpine,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Indalpine.,increase,risk
Indalpine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Venlafaxine.,increase,risk
Indalpine,Verapamil,The metabolism of Indalpine can be decreased when combined with Verapamil.,decrease,no risk
Indalpine,Vigabatrin,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Indalpine.,increase,risk
Indalpine,Vilanterol,The metabolism of Vilanterol can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Indalpine.,increase,risk
Indalpine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Indalpine is combined with Vildagliptin.,increase,risk
Indalpine,Viloxazine,The metabolism of Indalpine can be decreased when combined with Viloxazine.,decrease,no risk
Indalpine,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vincristine,The metabolism of Vincristine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vindesine,The metabolism of Vindesine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Vorapaxar,The risk or severity of hemorrhage can be increased when Indalpine is combined with Vorapaxar.,increase,risk
Indalpine,Voriconazole,The metabolism of Indalpine can be decreased when combined with Voriconazole.,decrease,no risk
Indalpine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Indalpine.,increase,risk
Indalpine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Indalpine.,increase,no risk
Indalpine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Indalpine.,increase,no risk
Indalpine,Ximelagatran,The risk or severity of hemorrhage can be increased when Indalpine is combined with Ximelagatran.,increase,risk
Indalpine,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Indalpine.,increase,risk
Indalpine,Zaleplon,The risk or severity of adverse effects can be increased when Zaleplon is combined with Indalpine.,increase,risk
Indalpine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Ziconotide,The risk or severity of adverse effects can be increased when Ziconotide is combined with Indalpine.,increase,risk
Indalpine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Zileuton,The metabolism of Zileuton can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Zimelidine,The risk or severity of adverse effects can be increased when Zimelidine is combined with Indalpine.,increase,risk
Indalpine,Ziprasidone,The risk or severity of adverse effects can be increased when Indalpine is combined with Ziprasidone.,increase,risk
Indalpine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Zolmitriptan.,increase,risk
Indalpine,Zolpidem,Indalpine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Indalpine,Zonisamide,The risk or severity of adverse effects can be increased when Zonisamide is combined with Indalpine.,increase,risk
Indalpine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Indalpine.,decrease,no risk
Indalpine,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Indalpine.,increase,risk
Indalpine,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Indalpine.,increase,risk
Indalpine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Indalpine.,increase,risk
Ifenprodil,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Ifenprodil.,increase,risk
Ifenprodil,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Ifenprodil.,increase,risk
Ifenprodil,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Ifenprodil.,increase,risk
Ifenprodil,Gamolenic acid,The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Ifenprodil,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ifenprodil is combined with Ganaxolone.",increase,risk
Ifenprodil,Ganciclovir,The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ifenprodil,Gepirone,The risk or severity of CNS depression can be increased when Ifenprodil is combined with Gepirone.,increase,risk
Ifenprodil,Gestrinone,The metabolism of Gestrinone can be increased when combined with Ifenprodil.,increase,no risk
Ifenprodil,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Ifenprodil.,increase,risk
Ifenprodil,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Ifenprodil.,increase,risk
Ifenprodil,Guanabenz,Ifenprodil may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Ifenprodil,Guanadrel,Ifenprodil may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Ifenprodil,Guanethidine,Ifenprodil may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Ifenprodil,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Ifenprodil.,increase,risk
Ifenprodil,Guanoxan,Ifenprodil may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Ifenprodil,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Ifenprodil.,increase,risk
Ifenprodil,Halofantrine,The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Halofantrine.,decrease,no risk
Ifenprodil,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Ifenprodil.,increase,risk
Ifenprodil,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Ifenprodil.,increase,risk
Ifenprodil,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Ifenprodil.,increase,risk
Ifenprodil,Hydralazine,Ifenprodil may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ifenprodil,Hydrochlorothiazide,Ifenprodil may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Ifenprodil,Hydrocodone,Ifenprodil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ifenprodil,Hydroflumethiazide,Ifenprodil may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Ifenprodil,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Ifenprodil.,increase,risk
Ifenprodil,Hydroxychloroquine,The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Ifenprodil,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Ifenprodil.,increase,no risk
Ifenprodil,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ifenprodil.,increase,no risk
Ifenprodil,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Ifenprodil.,increase,risk
Ifenprodil,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Ifenprodil.,increase,risk
Ifenprodil,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Ifenprodil.,increase,risk
Ifenprodil,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Ifenprodil.,increase,risk
Ifenprodil,Olanzapine,The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Olanzapine.,decrease,no risk
Ifenprodil,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ifenprodil is combined with Oliceridine.",increase,risk
Ifenprodil,Olmesartan,Ifenprodil may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Ifenprodil,Olodaterol,The risk or severity of hypertension can be increased when Ifenprodil is combined with Olodaterol.,increase,risk
Ifenprodil,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ifenprodil.,increase,risk
Ifenprodil,Opium,The risk or severity of CNS depression can be increased when Ifenprodil is combined with Opium.,increase,risk
Ifenprodil,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Ifenprodil.,increase,risk
Ifenprodil,Orlistat,Orlistat can cause a decrease in the absorption of Ifenprodil resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ifenprodil,Orphenadrine,Ifenprodil may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Ifenprodil,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Ifenprodil.,increase,risk
Ifenprodil,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ifenprodil.,increase,risk
Ifenprodil,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Ifenprodil.,increase,risk
Ifenprodil,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ifenprodil is combined with Oxetacaine.,increase,risk
Ifenprodil,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Ifenprodil.,increase,risk
Ifenprodil,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Ifenprodil.,increase,risk
Ifenprodil,Oxtriphylline,Ifenprodil may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ifenprodil,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ifenprodil is combined with Oxybuprocaine.,increase,risk
Ibuproxam,Bismuth subgallate,Ibuproxam may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ibuproxam,Bisoprolol,Ibuproxam may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Ibuproxam,Bisoxatin,Ibuproxam may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ibuproxam,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Bivalirudin.,increase,risk
Ibuproxam,Bleomycin,Ibuproxam may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Ibuproxam,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Ibuproxam.,decrease,no risk
Ibuproxam,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Ibuproxam.,decrease,no risk
Ibuproxam,Brexpiprazole,The risk or severity of hypertension can be increased when Ibuproxam is combined with Brexpiprazole.,increase,risk
Ibuproxam,Brivaracetam,Ibuproxam may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Ibuproxam,Bromazepam,Ibuproxam may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Ibuproxam,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Ibuproxam.,increase,risk
Ibuproxam,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Ibuproxam.,increase,risk
Ibuproxam,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Ibuproxam.,increase,risk
Ibuproxam,Bufexamac,The risk or severity of adverse effects can be increased when Ibuproxam is combined with Bufexamac.,increase,risk
Ibuproxam,Bumadizone,The risk or severity of adverse effects can be increased when Ibuproxam is combined with Bumadizone.,increase,risk
Ibuproxam,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuproxam.,decrease,no risk
Ibuproxam,Bupropion,Ibuproxam may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Ibuproxam,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Ibuproxam.,increase,risk
Ibuproxam,Butabarbital,Ibuproxam may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Ibuproxam,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Ibuproxam.,increase,risk
Ibuproxam,Gabapentin enacarbil,Ibuproxam may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ibuproxam,Gadobenic acid,Ibuproxam may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ibuproxam,Gadodiamide,Ibuproxam may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ibuproxam,Gadofosveset trisodium,Ibuproxam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ibuproxam,Gadopentetic acid,Ibuproxam may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ibuproxam,Gadoteric acid,Ibuproxam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ibuproxam,Gadoteridol,Ibuproxam may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ibuproxam,Ganciclovir,Ibuproxam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ibuproxam,Gatifloxacin,Ibuproxam may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Ibuproxam,Gemcitabine,Ibuproxam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ibuproxam,Gemfibrozil,Ibuproxam may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ibuproxam,Gemifloxacin,Ibuproxam may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Ibuproxam,Gentamicin,Ibuproxam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ibuproxam,Gimeracil,Ibuproxam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ibuproxam,Givosiran,The risk or severity of nephrotoxicity can be increased when Ibuproxam is combined with Givosiran.,increase,risk
Ibuproxam,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Ibuproxam.,decrease,no risk
Ibuproxam,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Ibuproxam.,decrease,no risk
Ibuproxam,Glipizide,The protein binding of Glipizide can be decreased when combined with Ibuproxam.,decrease,no risk
Ibuproxam,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Ibuproxam.,decrease,no risk
Ibuproxam,Glyburide,The protein binding of Glyburide can be decreased when combined with Ibuproxam.,decrease,no risk
Ibuproxam,Glycerol phenylbutyrate,Ibuproxam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ibuproxam,Glycol salicylate,The risk or severity of adverse effects can be increased when Ibuproxam is combined with Glycol salicylate.,increase,risk
Ibuproxam,Golodirsen,Ibuproxam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ibuproxam,Goserelin,Ibuproxam may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Ibuproxam,Grepafloxacin,Ibuproxam may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Ibuproxam,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Ibuproxam.,decrease,no risk
Ibuproxam,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Ibuproxam.,decrease,no risk
Ibuproxam,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Ibuproxam.,decrease,no risk
Ibuproxam,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Ibuproxam.,decrease,no risk
Ibuproxam,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Ibuproxam.,decrease,no risk
Ibuproxam,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Ibuproxam.,increase,no risk
Ibuproxam,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Ibuproxam.,increase,risk
Ibuproxam,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Heparin.,increase,risk
Ibuproxam,Hydralazine,Ibuproxam may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ibuproxam,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ibuproxam.,decrease,no risk
Ibuproxam,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Ibuproxam.,increase,risk
Ibuproxam,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Ibuproxam.,increase,risk
Ibuproxam,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Ibuproxam.,increase,risk
Ibuproxam,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Ibuproxam.,increase,risk
Ibuproxam,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Ibuproxam.,increase,risk
Ibuproxam,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Ibuproxam.,decrease,no risk
Ibuproxam,Hydromorphone,Ibuproxam may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ibuproxam,Hydroxocobalamin,Ibuproxam may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Ibuproxam,Hydroxyethyl Starch,Ibuproxam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ibuproxam,Kanamycin,Ibuproxam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ibuproxam,Ketamine,Ibuproxam may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Hexoprenaline,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Guanabenz,Hexoprenaline may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Hexoprenaline,Guanadrel,Hexoprenaline may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Hexoprenaline,Guanethidine,Hexoprenaline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Hexoprenaline,Guanfacine,Hexoprenaline may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Hexoprenaline,Guanoxan,Hexoprenaline may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Hexoprenaline,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Hexocyclium,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Hydralazine,Hexoprenaline may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hexoprenaline,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Hexoprenaline is combined with Hydrochlorothiazide.,increase,risk
Hexoprenaline,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Hexoprenaline is combined with Hydroflumethiazide.,increase,risk
Hexoprenaline,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Olanzapine,The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Olanzapine.,decrease,no risk
Hexoprenaline,Olmesartan,Hexoprenaline may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Hexoprenaline,Olodaterol,The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Olodaterol.,increase,risk
Hexoprenaline,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Hexoprenaline.,decrease,no risk
Hexoprenaline,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Quetiapine,The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Quetiapine.,decrease,no risk
Hexoprenaline,Quinapril,Hexoprenaline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Hexoprenaline,Quinethazone,Hexoprenaline may increase the hypokalemic activities of Quinethazone.,increase,no risk
Hexoprenaline,Quinidine,The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Quinidine.,decrease,no risk
Hexoprenaline,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Umeclidinium,The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Umeclidinium.,increase,risk
Hexoprenaline,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Valsartan,Hexoprenaline may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Hexoprenaline,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Venlafaxine,Venlafaxine may increase the tachycardic activities of Hexoprenaline.,increase,no risk
Hexoprenaline,Verapamil,The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Verapamil.,decrease,no risk
Hexoprenaline,Vilanterol,The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Vilanterol.,increase,risk
Hexoprenaline,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Vortioxetine,The risk or severity of hypertension can be increased when Hexoprenaline is combined with Vortioxetine.,increase,risk
Hexoprenaline,Xamoterol,The risk or severity of hypertension can be increased when Hexoprenaline is combined with Xamoterol.,increase,risk
Hexoprenaline,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Ziprasidone,The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Ziprasidone.,decrease,no risk
Hexoprenaline,Zofenopril,Hexoprenaline may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Hexoprenaline,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Hexoprenaline.,increase,risk
Hexoprenaline,Zuclopenthixol,The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Hexetidine,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Hexetidine.,increase,no risk
Hexamethonium,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Hexamethonium.,increase,risk
Hexamethonium,Buprenorphine,Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Hexamethonium,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Hexamethonium.,increase,risk
Hexamethonium,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Hexamethonium.,increase,risk
Hexamethonium,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Hexamethonium.,increase,risk
Hexamethonium,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Hexamethonium.,increase,risk
Hexamethonium,Butaperazine,The risk or severity of CNS depression can be increased when Hexamethonium is combined with Butaperazine.,increase,risk
Hexamethonium,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Hexamethonium.,increase,risk
Hexamethonium,Butorphanol,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Butorphanol.,increase,risk
Hexamethonium,Butriptyline,The risk or severity of CNS depression can be increased when Hexamethonium is combined with Butriptyline.,increase,risk
Hexamethonium,Butylscopolamine,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Butylscopolamine.,increase,risk
Hexamethonium,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Hexamethonium.,increase,risk
Hexamethonium,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Hexamethonium.,increase,risk
Hexamethonium,Galantamine,The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Galantamine.,decrease,no risk
Hexamethonium,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Hexamethonium.,increase,risk
Hexamethonium,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Hexamethonium is combined with Ganaxolone.",increase,risk
Hexamethonium,Gefapixant,The risk or severity of adverse effects can be increased when Gefapixant is combined with Hexamethonium.,increase,risk
Hexamethonium,Gentamicin,The risk or severity of adverse effects can be increased when Gentamicin is combined with Hexamethonium.,increase,risk
Hexamethonium,Gepirone,The risk or severity of CNS depression can be increased when Hexamethonium is combined with Gepirone.,increase,risk
Hexamethonium,Ginkgo biloba,The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Hexamethonium,Gliclazide,The risk or severity of adverse effects can be increased when Gliclazide is combined with Hexamethonium.,increase,risk
Hexamethonium,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Hexamethonium.,increase,risk
Hexamethonium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hexamethonium.,decrease,no risk
Hexamethonium,Glycol salicylate,The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Hexamethonium,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Hexamethonium.,increase,risk
Hexamethonium,Glymidine,The risk or severity of adverse effects can be increased when Glymidine is combined with Hexamethonium.,increase,risk
Hexamethonium,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Hexamethonium.,increase,risk
Hexamethonium,Guanabenz,Guanabenz may decrease the antihypertensive activities of Hexamethonium.,decrease,no risk
Hexamethonium,Guanadrel,Guanadrel may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Guanethidine,Guanethidine may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Hexamethonium.,increase,risk
Hexamethonium,Guanoxan,Hexamethonium may increase the hypotensive activities of Guanoxan.,increase,no risk
Hexamethonium,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Hexamethonium.,increase,risk
Hexamethonium,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Hexamethonium.,increase,risk
Hexamethonium,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Hexamethonium.,increase,risk
Hexamethonium,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Hexamethonium.,increase,risk
Hexamethonium,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Hexamethonium.,increase,risk
Hexamethonium,Homatropine,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Homatropine.,increase,risk
Hexamethonium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Hexamethonium.,increase,risk
Hexamethonium,Huperzine A,The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Huperzine A.,decrease,no risk
Hexamethonium,Hydralazine,Hydralazine may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Hydrochlorothiazide,The therapeutic efficacy of Hexamethonium can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hexamethonium,Hydrocodone,Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hexamethonium,Hydroflumethiazide,The therapeutic efficacy of Hexamethonium can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Hexamethonium,Hydromorphone,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Hydromorphone.,increase,risk
Hexamethonium,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hexamethonium.,increase,no risk
Hexamethonium,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Hexamethonium.,increase,risk
Hexamethonium,Kanamycin,The risk or severity of adverse effects can be increased when Kanamycin is combined with Hexamethonium.,increase,risk
Hexamethonium,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Hexamethonium.,increase,risk
Hexamethonium,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Hexamethonium.,increase,risk
Hexamethonium,Ketoprofen,The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ketoprofen.,decrease,no risk
Hexamethonium,Ketorolac,The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Ketorolac.,decrease,no risk
Hexamethonium,Obinutuzumab,Hexamethonium may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Hexamethonium,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Hexamethonium.,increase,risk
Hexamethonium,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Hexamethonium is combined with Oliceridine.",increase,risk
Hexamethonium,Olmesartan,Olmesartan may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Olodaterol,Olodaterol may decrease the antihypertensive activities of Hexamethonium.,decrease,no risk
Hexamethonium,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Hexamethonium.,increase,risk
Hexamethonium,Opicapone,Opicapone may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Opium,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Opium.,increase,risk
Hexamethonium,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Hexamethonium.,decrease,no risk
Hexamethonium,Orphenadrine,Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Hexamethonium,Oxaprozin,The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Oxaprozin.,decrease,no risk
Hexamethonium,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Hexamethonium.,increase,risk
Hexamethonium,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Hexamethonium.,increase,risk
Hexamethonium,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Hexamethonium.,increase,risk
Hexamethonium,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Hexamethonium.,increase,risk
Hexamethonium,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Hexamethonium.,increase,risk
Hexamethonium,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Hexamethonium.,increase,risk
Hexamethonium,Oxycodone,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Oxycodone.,increase,risk
Hexamethonium,Oxymetazoline,The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Hexamethonium,Oxymorphone,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Oxymorphone.,increase,risk
Hexamethonium,Oxyphenbutazone,The therapeutic efficacy of Hexamethonium can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Hexamethonium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hexamethonium.,increase,risk
Hexamethonium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Hexamethonium.,decrease,no risk
Hexamethonium,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hexamethonium.,increase,risk
Hexamethonium,Oxytetracycline,The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Hexamethonium.,increase,risk
Hexamethonium,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Hexamethonium.,increase,risk
Hexamethonium,Quetiapine,Quetiapine may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Quinapril,Quinapril may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Quinethazone,The risk or severity of adverse effects can be increased when Quinethazone is combined with Hexamethonium.,increase,risk
Hexamethonium,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Hexamethonium.,increase,risk
Hexamethonium,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Hexamethonium.,increase,risk
Hexamethonium,Quinupramine,The risk or severity of CNS depression can be increased when Hexamethonium is combined with Quinupramine.,increase,risk
Hexamethonium,Udenafil,The risk or severity of adverse effects can be increased when Udenafil is combined with Hexamethonium.,increase,risk
Hexamethonium,Umeclidinium,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Umeclidinium.,increase,risk
Hexamethonium,Unoprostone,Unoprostone may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Hexamethonium.,increase,risk
Hexamethonium,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Hexamethonium.,increase,risk
Hexamethonium,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Hexamethonium.,increase,risk
Hexamethonium,Valsartan,Valsartan may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Vancomycin,The risk or severity of adverse effects can be increased when Vancomycin is combined with Hexamethonium.,increase,risk
Hexamethonium,Vardenafil,Vardenafil may increase the antihypertensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Vasopressin,Hexamethonium may increase the hypertensive activities of Vasopressin.,increase,no risk
Hexamethonium,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Hexamethonium.,increase,risk
Hexamethonium,Vemurafenib,The risk or severity of adverse effects can be increased when Vemurafenib is combined with Hexamethonium.,increase,risk
Hexamethonium,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Hexamethonium.,increase,risk
Hexamethonium,Verapamil,Verapamil may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Vericiguat,Vericiguat may increase the hypotensive activities of Hexamethonium.,increase,no risk
Hexamethonium,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Hexamethonium.,increase,risk
Hexamethonium,Vilanterol,Vilanterol may decrease the antihypertensive activities of Hexamethonium.,decrease,no risk
Hexamethonium,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Hexamethonium.,increase,risk
Hexamethonium,Viloxazine,The risk or severity of CNS depression can be increased when Hexamethonium is combined with Viloxazine.,increase,risk
Hexamethonium,Viomycin,The risk or severity of adverse effects can be increased when Viomycin is combined with Hexamethonium.,increase,risk
Hexamethonium,Vortioxetine,The risk or severity of CNS depression can be increased when Hexamethonium is combined with Vortioxetine.,increase,risk
Hexamethonium,Xamoterol,Xamoterol may decrease the antihypertensive activities of Hexamethonium.,decrease,no risk
Hexamethonium,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Hexamethonium.,decrease,no risk
Hexamethonium,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Hexamethonium.,increase,risk
Hexamethonium,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Hexamethonium.,increase,risk
Hexamethonium,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Hexamethonium.,increase,risk
Hexamethonium,Zimelidine,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Zimelidine.,increase,risk
Hexamethonium,Ziprasidone,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Ziprasidone.,increase,risk
Hexamethonium,Zofenopril,Hexamethonium may increase the hypotensive activities of Zofenopril.,increase,no risk
Hexamethonium,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Hexamethonium.,increase,risk
Hexamethonium,Zolpidem,Hexamethonium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Hexamethonium,Zonisamide,The risk or severity of adverse effects can be increased when Zonisamide is combined with Hexamethonium.,increase,risk
Hexamethonium,Zopiclone,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Zopiclone.,increase,risk
Hexamethonium,Zotepine,The risk or severity of CNS depression can be increased when Hexamethonium is combined with Zotepine.,increase,risk
Hexamethonium,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Hexamethonium.,increase,risk
Hexamethonium,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Hexamethonium.,increase,risk
Azosemide,Gabapentin enacarbil,Azosemide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gadobenic acid,Azosemide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gadodiamide,Azosemide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gadofosveset trisodium,Azosemide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gadopentetic acid,Azosemide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gadoteric acid,Azosemide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gadoteridol,Azosemide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gallamine triethiodide,Azosemide may decrease the neuromuscular blocking activities of Gallamine triethiodide.,decrease,no risk
Azosemide,Ganciclovir,Azosemide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gemcitabine,Azosemide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gemfibrozil,Azosemide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Azosemide.,increase,no risk
Azosemide,Gimeracil,Azosemide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Azosemide.,increase,no risk
Azosemide,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Azosemide.,increase,no risk
Azosemide,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Azosemide.,increase,no risk
Azosemide,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Azosemide.,increase,no risk
Azosemide,Gluconic Acid,The risk or severity of dehydration can be increased when Azosemide is combined with Gluconic Acid.,increase,risk
Azosemide,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Azosemide.,increase,no risk
Azosemide,Glycerin,The risk or severity of dehydration can be increased when Azosemide is combined with Glycerin.,increase,risk
Azosemide,Glycerol phenylbutyrate,Azosemide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Glycol salicylate,The therapeutic efficacy of Azosemide can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Azosemide,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Azosemide.,increase,no risk
Azosemide,Golodirsen,Azosemide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Goserelin,Azosemide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Guanethidine,Azosemide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Guanfacine,Azosemide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Haloperidol,Azosemide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Hydralazine,Azosemide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Hydrocodone,The therapeutic efficacy of Azosemide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Azosemide,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Azosemide.,increase,risk
Azosemide,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Azosemide.,increase,risk
Azosemide,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Azosemide.,increase,risk
Azosemide,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Azosemide.,increase,risk
Azosemide,Hydromorphone,Azosemide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Hydroxocobalamin,Azosemide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Hydroxyethyl Starch,Azosemide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Kanamycin,The serum concentration of Kanamycin can be increased when it is combined with Azosemide.,increase,no risk
Azosemide,Ketamine,Azosemide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Ketazolam,Azosemide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azosemide,Ketoprofen,The therapeutic efficacy of Azosemide can be decreased when used in combination with Ketoprofen.,decrease,no risk
Azosemide,Ketorolac,The therapeutic efficacy of Azosemide can be decreased when used in combination with Ketorolac.,decrease,no risk
Glibornuride,Gatifloxacin,The therapeutic efficacy of Glibornuride can be increased when used in combination with Gatifloxacin.,increase,no risk
Glibornuride,Gefapixant,The therapeutic efficacy of Glibornuride can be increased when used in combination with Gefapixant.,increase,no risk
Glibornuride,Gemfibrozil,The metabolism of Glibornuride can be decreased when combined with Gemfibrozil.,decrease,no risk
Glibornuride,Gemifloxacin,The therapeutic efficacy of Glibornuride can be increased when used in combination with Gemifloxacin.,increase,no risk
Glibornuride,Gestrinone,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Gestrinone.,decrease,no risk
Glibornuride,Ginkgo biloba,The metabolism of Glibornuride can be decreased when combined with Ginkgo biloba.,decrease,no risk
Glibornuride,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Glibornuride.,increase,risk
Glibornuride,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Glibornuride.,increase,risk
Glibornuride,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Glibornuride.,increase,risk
Glibornuride,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Glibornuride.,increase,risk
Glibornuride,Glofitamab,The serum concentration of Glibornuride can be increased when it is combined with Glofitamab.,increase,no risk
Glibornuride,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Glibornuride.,increase,risk
Glibornuride,Glycol salicylate,The protein binding of Glibornuride can be decreased when combined with Glycol salicylate.,decrease,no risk
Glibornuride,Glymidine,The therapeutic efficacy of Glibornuride can be increased when used in combination with Glymidine.,increase,no risk
Glibornuride,Golimumab,The metabolism of Glibornuride can be increased when combined with Golimumab.,increase,no risk
Glibornuride,Goserelin,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Goserelin.,decrease,no risk
Glibornuride,Grepafloxacin,The therapeutic efficacy of Glibornuride can be increased when used in combination with Grepafloxacin.,increase,no risk
Glibornuride,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Glibornuride.,increase,risk
Glibornuride,Haloperidol,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Haloperidol.,decrease,no risk
Glibornuride,Halothane,The metabolism of Glibornuride can be decreased when combined with Halothane.,decrease,no risk
Glibornuride,Histrelin,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Histrelin.,decrease,no risk
Glibornuride,Hydrochlorothiazide,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Glibornuride,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Glibornuride.,increase,risk
Glibornuride,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Glibornuride.,increase,risk
Glibornuride,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Glibornuride.,increase,risk
Glibornuride,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Glibornuride.,increase,risk
Glibornuride,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Glibornuride.,increase,risk
Glibornuride,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Glibornuride.,increase,risk
Glibornuride,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Glibornuride.,increase,risk
Glibornuride,Hydroflumethiazide,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Glibornuride,Hydromorphone,The metabolism of Glibornuride can be decreased when combined with Hydromorphone.,decrease,no risk
Glibornuride,Hydroxychloroquine,The therapeutic efficacy of Glibornuride can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Glibornuride,Hydroxyprogesterone caproate,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Glibornuride,Ketamine,The metabolism of Glibornuride can be decreased when combined with Ketamine.,decrease,no risk
Glibornuride,Ketoprofen,The protein binding of Glibornuride can be decreased when combined with Ketoprofen.,decrease,no risk
Glibornuride,Ketorolac,The protein binding of Glibornuride can be decreased when combined with Ketorolac.,decrease,no risk
Glibornuride,Ketotifen,The risk or severity of thrombocytopenia can be increased when Glibornuride is combined with Ketotifen.,increase,risk
Glibornuride,Octreotide,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Octreotide.,decrease,no risk
Glibornuride,Ofloxacin,The therapeutic efficacy of Glibornuride can be increased when used in combination with Ofloxacin.,increase,no risk
Glibornuride,Olanzapine,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Olanzapine.,decrease,no risk
Glibornuride,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Glibornuride.,decrease,no risk
Glibornuride,Olsalazine,Olsalazine may increase the hypoglycemic activities of Glibornuride.,increase,no risk
Glibornuride,Ondansetron,The metabolism of Glibornuride can be decreased when combined with Ondansetron.,decrease,no risk
Glibornuride,Oritavancin,The metabolism of Glibornuride can be decreased when combined with Oritavancin.,decrease,no risk
Glibornuride,Ospemifene,The metabolism of Glibornuride can be decreased when combined with Ospemifene.,decrease,no risk
Glibornuride,Oxandrolone,The metabolism of Glibornuride can be decreased when combined with Oxandrolone.,decrease,no risk
Glibornuride,Oxaprozin,The protein binding of Glibornuride can be decreased when combined with Oxaprozin.,decrease,no risk
Glibornuride,Oxprenolol,The therapeutic efficacy of Glibornuride can be increased when used in combination with Oxprenolol.,increase,no risk
Glibornuride,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Glibornuride.,increase,no risk
Glibornuride,Oxyphenbutazone,The protein binding of Glibornuride can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Fusafungine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Fusafungine.,decrease,no risk
Fusafungine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Fusafungine is combined with Benzocaine.,increase,risk
Fusafungine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Fusafungine is combined with Benzyl alcohol.,increase,risk
Fusafungine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Fusafungine is combined with Bupivacaine.,increase,risk
Fusafungine,Butacaine,The risk or severity of methemoglobinemia can be increased when Fusafungine is combined with Butacaine.,increase,risk
Fusafungine,Butamben,The risk or severity of methemoglobinemia can be increased when Fusafungine is combined with Butamben.,increase,risk
Fusafungine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fusafungine is combined with Oxetacaine.,increase,risk
Fusafungine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fusafungine is combined with Oxybuprocaine.,increase,risk
Fusafungine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Fusafungine.,decrease,no risk
Fusafungine,Warfarin,The risk or severity of bleeding can be increased when Fusafungine is combined with Warfarin.,increase,risk
Dimetotiazine,Benzphetamine,Benzphetamine may decrease the sedative activities of Dimetotiazine.,decrease,no risk
Dimetotiazine,Benzylpenicilloyl polylysine,Dimetotiazine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Dimetotiazine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Dimetotiazine.,decrease,no risk
Dimetotiazine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dimetotiazine.,decrease,no risk
Dimetotiazine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Dimetotiazine.,decrease,no risk
Dimetotiazine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Dimetotiazine.,decrease,no risk
Dimetotiazine,Hyoscyamine,Dimetotiazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Fluprednidene,Bimekizumab,The risk or severity of adverse effects can be increased when Fluprednidene is combined with Bimekizumab.,increase,risk
Fluprednidene,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluprednidene.,increase,risk
Fluprednidene,Blinatumomab,The risk or severity of adverse effects can be increased when Fluprednidene is combined with Blinatumomab.,increase,risk
Fluprednidene,Boceprevir,The metabolism of Fluprednidene can be decreased when combined with Boceprevir.,decrease,no risk
Fluprednidene,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Fluprednidene.",decrease,no risk
Fluprednidene,Bortezomib,The metabolism of Bortezomib can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Bosutinib,The metabolism of Bosutinib can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Fluprednidene.,increase,risk
Fluprednidene,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Brigatinib,The metabolism of Brigatinib can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Brodalumab,The risk or severity of adverse effects can be increased when Fluprednidene is combined with Brodalumab.,increase,risk
Fluprednidene,Bromocriptine,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Bromocriptine.,increase,risk
Fluprednidene,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Fluprednidene.,increase,risk
Fluprednidene,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Bumadizone.,increase,risk
Fluprednidene,Bumetanide,The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Bumetanide.,increase,risk
Fluprednidene,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Buspirone,The metabolism of Buspirone can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Busulfan,The metabolism of Busulfan can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Gatifloxacin,The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Gatifloxacin.,increase,risk
Fluprednidene,Gefitinib,The metabolism of Gefitinib can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Fluprednidene.,increase,risk
Fluprednidene,Gemifloxacin,The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Gemifloxacin.,increase,risk
Fluprednidene,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluprednidene.,increase,risk
Fluprednidene,Gestrinone,The serum concentration of Fluprednidene can be increased when it is combined with Gestrinone.,increase,no risk
Fluprednidene,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluprednidene.,increase,risk
Fluprednidene,Gliclazide,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Gliclazide.,increase,risk
Fluprednidene,Glimepiride,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glimepiride.,increase,risk
Fluprednidene,Glipizide,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glipizide.,increase,risk
Fluprednidene,Gliquidone,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Gliquidone.,increase,risk
Fluprednidene,Glofitamab,The serum concentration of Fluprednidene can be increased when it is combined with Glofitamab.,increase,no risk
Fluprednidene,Glyburide,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glyburide.,increase,risk
Fluprednidene,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Glycol salicylate.,increase,risk
Fluprednidene,Glymidine,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Glymidine.,increase,risk
Fluprednidene,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Fluprednidene.,increase,risk
Fluprednidene,Grepafloxacin,The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Grepafloxacin.,increase,risk
Fluprednidene,Guselkumab,The risk or severity of adverse effects can be increased when Fluprednidene is combined with Guselkumab.,increase,risk
Fluprednidene,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Halofantrine,The metabolism of Halofantrine can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Fluprednidene.,increase,no risk
Fluprednidene,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Fluprednidene.,increase,risk
Fluprednidene,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Hydrochlorothiazide.,increase,risk
Fluprednidene,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Fluprednidene is combined with Hydrocortisone acetate.,increase,risk
Fluprednidene,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Fluprednidene is combined with Hydrocortisone butyrate.,increase,risk
Fluprednidene,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Fluprednidene is combined with Hydrocortisone succinate.,increase,risk
Fluprednidene,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Fluprednidene is combined with Hydroflumethiazide.,increase,risk
Fluprednidene,Hydrotalcite,The bioavailability of Fluprednidene can be decreased when combined with Hydrotalcite.,decrease,no risk
Fluprednidene,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Fluprednidene.,increase,risk
Fluprednidene,Hydroxyprogesterone caproate,The serum concentration of Fluprednidene can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Fluprednidene,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Fluprednidene.,increase,risk
Fluprednidene,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Fluprednidene.,decrease,no risk
Fluprednidene,Ketoconazole,The metabolism of Fluprednidene can be decreased when combined with Ketoconazole.,decrease,no risk
Fluprednidene,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Ketoprofen.,increase,risk
Fluprednidene,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Ketorolac.,increase,risk
Fluprednidene,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Fluprednidene.,increase,risk
Fluprednidene,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Fluprednidene.,increase,no risk
Fluprednidene,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Fluprednidene.,increase,risk
Fluprednidene,Ofloxacin,The risk or severity of tendinopathy can be increased when Fluprednidene is combined with Ofloxacin.,increase,risk
Fluprednidene,Olaparib,The metabolism of Olaparib can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Olodaterol,The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Olodaterol.,increase,risk
Fluprednidene,Omaveloxolone,The serum concentration of Fluprednidene can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Fluprednidene,Ondansetron,The metabolism of Ondansetron can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Orciprenaline,The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Orciprenaline.,increase,risk
Fluprednidene,Osimertinib,The metabolism of Osimertinib can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Fluprednidene.,increase,risk
Fluprednidene,Oxandrolone,The risk or severity of fluid retention can be increased when Fluprednidene is combined with Oxandrolone.,increase,risk
Fluprednidene,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Oxaprozin.,increase,risk
Fluprednidene,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Oxycodone,The metabolism of Oxycodone can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Oxymetholone,The risk or severity of fluid retention can be increased when Fluprednidene is combined with Oxymetholone.,increase,risk
Fluprednidene,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Fluprednidene is combined with Oxyphenbutazone.,increase,risk
Fluprednidene,Ozanimod,The risk or severity of adverse effects can be increased when Fluprednidene is combined with Ozanimod.,increase,risk
Fluprednidene,Quetiapine,The metabolism of Quetiapine can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Quinethazone,Fluprednidene may increase the hypokalemic activities of Quinethazone.,increase,no risk
Fluprednidene,Quinidine,The metabolism of Quinidine can be increased when combined with Fluprednidene.,increase,no risk
Fluprednidene,Quinine,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Quinine.,increase,risk
Fluprednidene,Quizartinib,The metabolism of Quizartinib can be increased when combined with Fluprednidene.,increase,no risk
Fluocortolone,Bimekizumab,The risk or severity of adverse effects can be increased when Fluocortolone is combined with Bimekizumab.,increase,risk
Fluocortolone,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluocortolone.,increase,risk
Fluocortolone,Blinatumomab,The risk or severity of adverse effects can be increased when Fluocortolone is combined with Blinatumomab.,increase,risk
Fluocortolone,Boceprevir,The metabolism of Fluocortolone can be decreased when combined with Boceprevir.,decrease,no risk
Fluocortolone,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Fluocortolone.",decrease,no risk
Fluocortolone,Bortezomib,The metabolism of Bortezomib can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Bosutinib,The metabolism of Bosutinib can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Fluocortolone.,increase,risk
Fluocortolone,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Brigatinib,The metabolism of Brigatinib can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Brodalumab,The risk or severity of adverse effects can be increased when Fluocortolone is combined with Brodalumab.,increase,risk
Fluocortolone,Bromocriptine,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Bromocriptine.,increase,risk
Fluocortolone,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Fluocortolone.,increase,risk
Fluocortolone,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Bumadizone.,increase,risk
Fluocortolone,Bumetanide,The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Bumetanide.,increase,risk
Fluocortolone,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Buspirone,The metabolism of Buspirone can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Busulfan,The metabolism of Busulfan can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Gatifloxacin,The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Gatifloxacin.,increase,risk
Fluocortolone,Gefitinib,The metabolism of Gefitinib can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Fluocortolone.,increase,risk
Fluocortolone,Gemifloxacin,The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Gemifloxacin.,increase,risk
Fluocortolone,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluocortolone.,increase,risk
Fluocortolone,Gestrinone,The serum concentration of Fluocortolone can be increased when it is combined with Gestrinone.,increase,no risk
Fluocortolone,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluocortolone.,increase,risk
Fluocortolone,Gliclazide,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Gliclazide.,increase,risk
Fluocortolone,Glimepiride,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glimepiride.,increase,risk
Fluocortolone,Glipizide,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glipizide.,increase,risk
Fluocortolone,Gliquidone,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Gliquidone.,increase,risk
Fluocortolone,Glofitamab,The serum concentration of Fluocortolone can be increased when it is combined with Glofitamab.,increase,no risk
Fluocortolone,Glyburide,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glyburide.,increase,risk
Fluocortolone,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Glycol salicylate.,increase,risk
Fluocortolone,Glymidine,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Glymidine.,increase,risk
Fluocortolone,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Fluocortolone.,increase,risk
Fluocortolone,Grepafloxacin,The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Grepafloxacin.,increase,risk
Fluocortolone,Guselkumab,The risk or severity of adverse effects can be increased when Fluocortolone is combined with Guselkumab.,increase,risk
Fluocortolone,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Halofantrine,The metabolism of Halofantrine can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Fluocortolone.,increase,no risk
Fluocortolone,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Fluocortolone.,increase,risk
Fluocortolone,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Hydrochlorothiazide.,increase,risk
Fluocortolone,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Fluocortolone is combined with Hydrocortisone acetate.,increase,risk
Fluocortolone,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Fluocortolone is combined with Hydrocortisone butyrate.,increase,risk
Fluocortolone,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Fluocortolone is combined with Hydrocortisone succinate.,increase,risk
Fluocortolone,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Fluocortolone is combined with Hydroflumethiazide.,increase,risk
Fluocortolone,Hydrotalcite,The bioavailability of Fluocortolone can be decreased when combined with Hydrotalcite.,decrease,no risk
Fluocortolone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Fluocortolone.,increase,risk
Fluocortolone,Hydroxyprogesterone caproate,The serum concentration of Fluocortolone can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Fluocortolone,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Fluocortolone.,increase,risk
Fluocortolone,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Fluocortolone.,decrease,no risk
Fluocortolone,Ketoconazole,The metabolism of Fluocortolone can be decreased when combined with Ketoconazole.,decrease,no risk
Fluocortolone,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Ketoprofen.,increase,risk
Fluocortolone,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Ketorolac.,increase,risk
Fluocortolone,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Fluocortolone.,increase,risk
Fluocortolone,Ocrelizumab,The risk or severity of adverse effects can be increased when Fluocortolone is combined with Ocrelizumab.,increase,risk
Fluocortolone,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Fluocortolone.,increase,risk
Fluocortolone,Ofloxacin,The risk or severity of tendinopathy can be increased when Fluocortolone is combined with Ofloxacin.,increase,risk
Fluocortolone,Olaparib,The metabolism of Olaparib can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Olodaterol,The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Olodaterol.,increase,risk
Fluocortolone,Omaveloxolone,The serum concentration of Fluocortolone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Fluocortolone,Ondansetron,The metabolism of Ondansetron can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Orciprenaline,The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Orciprenaline.,increase,risk
Fluocortolone,Osimertinib,The metabolism of Osimertinib can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Fluocortolone.,increase,risk
Fluocortolone,Oxandrolone,The risk or severity of fluid retention can be increased when Fluocortolone is combined with Oxandrolone.,increase,risk
Fluocortolone,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Oxaprozin.,increase,risk
Fluocortolone,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Oxycodone,The metabolism of Oxycodone can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Oxymetholone,The risk or severity of fluid retention can be increased when Fluocortolone is combined with Oxymetholone.,increase,risk
Fluocortolone,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Fluocortolone is combined with Oxyphenbutazone.,increase,risk
Fluocortolone,Ozanimod,The risk or severity of adverse effects can be increased when Fluocortolone is combined with Ozanimod.,increase,risk
Fluocortolone,Quetiapine,The metabolism of Quetiapine can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Quinethazone,Fluocortolone may increase the hypokalemic activities of Quinethazone.,increase,no risk
Fluocortolone,Quinidine,The metabolism of Quinidine can be increased when combined with Fluocortolone.,increase,no risk
Fluocortolone,Quinine,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Quinine.,increase,risk
Fluocortolone,Quizartinib,The metabolism of Quizartinib can be increased when combined with Fluocortolone.,increase,no risk
Flumequine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Gadobenic acid.,increase,risk
Flumequine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Flumequine.,increase,risk
Flumequine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Flumequine.,increase,risk
Flumequine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Gemifloxacin.,increase,risk
Flumequine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Flumequine.,increase,risk
Flumequine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Gilteritinib.,increase,risk
Flumequine,Glasdegib,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Glasdegib.,increase,risk
Flumequine,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Flumequine.,increase,no risk
Flumequine,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Flumequine.,increase,no risk
Flumequine,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Flumequine.,increase,no risk
Flumequine,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Flumequine.,increase,no risk
Flumequine,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Flumequine.,increase,no risk
Flumequine,Glycol salicylate,Glycol salicylate may increase the neuroexcitatory activities of Flumequine.,increase,no risk
Flumequine,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Flumequine.,increase,no risk
Flumequine,Goserelin,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Goserelin.,increase,risk
Flumequine,Granisetron,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Granisetron.,increase,risk
Flumequine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Grepafloxacin.,increase,risk
Flumequine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Flumequine.,decrease,no risk
Flumequine,Halofantrine,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Halofantrine.,increase,risk
Flumequine,Haloperidol,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Haloperidol.,increase,risk
Flumequine,Hetacillin,The serum concentration of Flumequine can be increased when it is combined with Hetacillin.,increase,no risk
Flumequine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Flumequine.,increase,risk
Flumequine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Flumequine.,increase,risk
Flumequine,Hydrocortisone,The risk or severity of tendinopathy can be increased when Hydrocortisone is combined with Flumequine.,increase,risk
Flumequine,Hydrocortisone acetate,The risk or severity of tendinopathy can be increased when Hydrocortisone acetate is combined with Flumequine.,increase,risk
Flumequine,Hydrocortisone butyrate,The risk or severity of tendinopathy can be increased when Hydrocortisone butyrate is combined with Flumequine.,increase,risk
Flumequine,Hydrocortisone cypionate,The risk or severity of tendinopathy can be increased when Hydrocortisone cypionate is combined with Flumequine.,increase,risk
Flumequine,Hydrocortisone succinate,The risk or severity of tendinopathy can be increased when Hydrocortisone succinate is combined with Flumequine.,increase,risk
Flumequine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Flumequine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Flumequine.,increase,risk
Flumequine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Hydroxyzine.,increase,risk
Flumequine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Flumequine.,increase,risk
Flumequine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Flumequine.,increase,risk
Flumequine,Ketoprofen,Ketoprofen may increase the neuroexcitatory activities of Flumequine.,increase,no risk
Flumequine,Ketorolac,Ketorolac may increase the neuroexcitatory activities of Flumequine.,increase,no risk
Flumequine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Flumequine.,increase,risk
Flumequine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Ofloxacin.,increase,risk
Flumequine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Flumequine.,decrease,no risk
Flumequine,Olodaterol,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Olodaterol.,increase,risk
Flumequine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Flumequine.,decrease,no risk
Flumequine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Flumequine.,increase,risk
Flumequine,Oxacillin,The serum concentration of Flumequine can be increased when it is combined with Oxacillin.,increase,no risk
Flumequine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Flumequine.,increase,risk
Flumequine,Oxaprozin,Oxaprozin may increase the neuroexcitatory activities of Flumequine.,increase,no risk
Flumequine,Oxatomide,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Oxatomide.,increase,risk
Flumequine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Flumequine is combined with Oxetacaine.,increase,risk
Flumequine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Flumequine.,decrease,no risk
Flumequine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Flumequine is combined with Oxybuprocaine.,increase,risk
Flumequine,Oxyphenbutazone,Oxyphenbutazone may increase the neuroexcitatory activities of Flumequine.,increase,no risk
Flumequine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Flumequine.,increase,risk
Flumequine,Quetiapine,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Quetiapine.,increase,risk
Flumequine,Quinapril,Quinapril can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Flumequine,Quinidine,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Quinidine.,increase,risk
Flumequine,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Flumequine.,increase,no risk
Flumequine,Quizartinib,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Quizartinib.,increase,risk
Flumequine,Valdecoxib,Valdecoxib may increase the neuroexcitatory activities of Flumequine.,increase,no risk
Flumequine,Valproic acid,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Valproic acid.,increase,risk
Flumequine,Vamorolone,The risk or severity of tendinopathy can be increased when Vamorolone is combined with Flumequine.,increase,risk
Flumequine,Vandetanib,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Vandetanib.,increase,risk
Flumequine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Flumequine.,increase,risk
Flumequine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Flumequine.,increase,risk
Flumequine,Verapamil,The metabolism of Verapamil can be decreased when combined with Flumequine.,decrease,no risk
Flumequine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Flumequine.,increase,risk
Flumequine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Flumequine.,decrease,no risk
Flumequine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Flumequine.,increase,risk
Flumequine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Flumequine.,increase,no risk
Flumequine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Flumequine.,increase,risk
Flumequine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Flumequine.,increase,risk
Flumequine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Flumequine.,decrease,no risk
Flumequine,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Flumequine.,increase,no risk
Flumequine,Zileuton,The metabolism of Zileuton can be decreased when combined with Flumequine.,decrease,no risk
Flumequine,Zinc,Zinc can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Flumequine,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Flumequine,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Flumequine,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Flumequine,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Flumequine,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Flumequine,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Flumequine,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Flumequine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Flumequine is combined with Ziprasidone.,increase,risk
Flumequine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Flumequine.,decrease,no risk
Flumequine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Flumequine.,decrease,no risk
Flumequine,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Flumequine.,increase,risk
Flumequine,Zotepine,The metabolism of Zotepine can be decreased when combined with Flumequine.,decrease,no risk
Floctafenine,Bismuth subgallate,Floctafenine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Floctafenine,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Floctafenine.,increase,risk
Floctafenine,Bisoxatin,Floctafenine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Floctafenine,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Bivalirudin.,increase,risk
Floctafenine,Bleomycin,Floctafenine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Floctafenine,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Brexpiprazole,The risk or severity of hypertension can be increased when Floctafenine is combined with Brexpiprazole.,increase,risk
Floctafenine,Brivaracetam,Floctafenine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Floctafenine,Bromazepam,Floctafenine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Floctafenine,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Floctafenine.,increase,risk
Floctafenine,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Floctafenine.,increase,risk
Floctafenine,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Floctafenine.,increase,risk
Floctafenine,Bufexamac,The risk or severity of adverse effects can be increased when Floctafenine is combined with Bufexamac.,increase,risk
Floctafenine,Bumadizone,The risk or severity of adverse effects can be increased when Floctafenine is combined with Bumadizone.,increase,risk
Floctafenine,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Bupropion,Floctafenine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Floctafenine,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Floctafenine.,increase,risk
Floctafenine,Butabarbital,Floctafenine may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Floctafenine,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Floctafenine.,increase,risk
Floctafenine,Gabapentin enacarbil,Floctafenine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Floctafenine,Gadobenic acid,Floctafenine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Floctafenine,Gadodiamide,Floctafenine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Floctafenine,Gadofosveset trisodium,Floctafenine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Floctafenine,Gadopentetic acid,Floctafenine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Floctafenine,Gadoteric acid,Floctafenine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Floctafenine,Gadoteridol,Floctafenine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Floctafenine,Ganciclovir,Floctafenine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Floctafenine,Gatifloxacin,Floctafenine may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Floctafenine,Gemcitabine,Floctafenine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Floctafenine,Gemfibrozil,Floctafenine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Floctafenine,Gemifloxacin,Floctafenine may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Floctafenine,Gentamicin,Floctafenine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Floctafenine,Gimeracil,Floctafenine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Floctafenine,Givosiran,The risk or severity of nephrotoxicity can be increased when Floctafenine is combined with Givosiran.,increase,risk
Floctafenine,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Floctafenine.,decrease,no risk
Floctafenine,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Floctafenine.,decrease,no risk
Floctafenine,Glipizide,The protein binding of Glipizide can be decreased when combined with Floctafenine.,decrease,no risk
Floctafenine,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Floctafenine.,decrease,no risk
Floctafenine,Glyburide,The protein binding of Glyburide can be decreased when combined with Floctafenine.,decrease,no risk
Floctafenine,Glycerol phenylbutyrate,Floctafenine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Floctafenine,Glycol salicylate,The risk or severity of adverse effects can be increased when Floctafenine is combined with Glycol salicylate.,increase,risk
Floctafenine,Golodirsen,Floctafenine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Floctafenine,Goserelin,Floctafenine may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Floctafenine,Grepafloxacin,Floctafenine may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Floctafenine,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Floctafenine.,increase,no risk
Floctafenine,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Floctafenine.,increase,risk
Floctafenine,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Heparin.,increase,risk
Floctafenine,Hydralazine,Floctafenine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Floctafenine,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Floctafenine.,increase,risk
Floctafenine,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Floctafenine.,increase,risk
Floctafenine,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Floctafenine.,increase,risk
Floctafenine,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Floctafenine.,increase,risk
Floctafenine,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Floctafenine.,increase,risk
Floctafenine,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Hydromorphone,Floctafenine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Floctafenine,Hydroxocobalamin,Floctafenine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Floctafenine,Hydroxyethyl Starch,Floctafenine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Floctafenine,Kanamycin,Floctafenine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Floctafenine,Ketamine,Floctafenine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Floctafenine,Ketazolam,Floctafenine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Floctafenine,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Floctafenine.,increase,risk
Floctafenine,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Floctafenine.,increase,risk
Floctafenine,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Floctafenine.,increase,risk
Floctafenine,Octinoxate,Floctafenine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Floctafenine,Ofloxacin,Floctafenine may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Floctafenine,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Floctafenine.",increase,risk
Floctafenine,Olodaterol,The risk or severity of hypertension can be increased when Floctafenine is combined with Olodaterol.,increase,risk
Floctafenine,Olsalazine,The risk or severity of nephrotoxicity can be increased when Floctafenine is combined with Olsalazine.,increase,risk
Floctafenine,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Floctafenine is combined with Omacetaxine mepesuccinate.,increase,risk
Floctafenine,Opium,Floctafenine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Floctafenine,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Floctafenine.,increase,risk
Floctafenine,Oseltamivir,Floctafenine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Floctafenine,Oxacillin,Floctafenine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Floctafenine,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Floctafenine.,increase,risk
Floctafenine,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Floctafenine.,increase,risk
Floctafenine,Oxazepam,Floctafenine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Floctafenine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Floctafenine.,increase,risk
Floctafenine,Oxybenzone,Floctafenine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Floctafenine,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Floctafenine.,increase,risk
Floctafenine,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Floctafenine.,increase,risk
Floctafenine,Oxyquinoline,Floctafenine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Floctafenine,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Floctafenine.,increase,risk
Floctafenine,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Floctafenine is combined with Quinapril.",increase,risk
Floctafenine,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Quinidine,Floctafenine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Floctafenine,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Floctafenine.,increase,risk
Floctafenine,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Floctafenine.,decrease,no risk
Floctafenine,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Urokinase.,increase,risk
Floctafenine,Vaborbactam,Floctafenine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Floctafenine,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Floctafenine.,increase,risk
Floctafenine,Valbenazine,Floctafenine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Floctafenine,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Floctafenine.,increase,risk
Floctafenine,Valganciclovir,Floctafenine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Floctafenine,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Floctafenine.,decrease,no risk
Floctafenine,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Floctafenine.",increase,risk
Floctafenine,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Floctafenine.,increase,risk
Floctafenine,Vancomycin,Floctafenine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Floctafenine,Varenicline,Floctafenine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Floctafenine,Venlafaxine,Floctafenine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Floctafenine,Verapamil,Floctafenine may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Floctafenine,Vilanterol,The risk or severity of hypertension can be increased when Floctafenine is combined with Vilanterol.,increase,risk
Floctafenine,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Floctafenine.,increase,risk
Floctafenine,Viloxazine,Floctafenine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Floctafenine,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Vorapaxar.,increase,risk
Floctafenine,Voriconazole,The serum concentration of Floctafenine can be increased when it is combined with Voriconazole.,increase,no risk
Floctafenine,Vortioxetine,The risk or severity of hypertension can be increased when Floctafenine is combined with Vortioxetine.,increase,risk
Floctafenine,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Warfarin.,increase,risk
Floctafenine,Xamoterol,The risk or severity of hypertension can be increased when Floctafenine is combined with Xamoterol.,increase,risk
Floctafenine,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Ximelagatran.,increase,risk
Floctafenine,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Floctafenine.,increase,risk
Floctafenine,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Floctafenine.,increase,risk
Floctafenine,Zaleplon,Floctafenine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Floctafenine,Zanamivir,Floctafenine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Floctafenine,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Floctafenine.,increase,risk
Floctafenine,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Floctafenine.,increase,risk
Floctafenine,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Floctafenine.,increase,risk
Fendiline,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Fendiline.,increase,risk
Fendiline,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Fendiline.,increase,risk
Fendiline,Gallamine triethiodide,Fendiline may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Fendiline,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Fendiline.,increase,risk
Fendiline,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Fendiline.,increase,risk
Fendiline,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Fendiline.,increase,risk
Fendiline,Gilteritinib,The risk or severity of QTc prolongation can be increased when Fendiline is combined with Gilteritinib.,increase,risk
Fendiline,Glasdegib,The risk or severity of QTc prolongation can be increased when Fendiline is combined with Glasdegib.,increase,risk
Fendiline,Gliclazide,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Gliclazide.,increase,risk
Fendiline,Glimepiride,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Glimepiride.,increase,risk
Fendiline,Glipizide,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Glipizide.,increase,risk
Fendiline,Gliquidone,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Gliquidone.,increase,risk
Fendiline,Glofitamab,The serum concentration of Fendiline can be increased when it is combined with Glofitamab.,increase,no risk
Fendiline,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Fendiline.,decrease,no risk
Fendiline,Glyburide,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Glyburide.,increase,risk
Fendiline,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Fendiline.,decrease,no risk
Fendiline,Glymidine,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Glymidine.,increase,risk
Fendiline,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Fendiline.,increase,risk
Fendiline,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Fendiline.,increase,risk
Fendiline,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Fendiline is combined with Grepafloxacin.,increase,risk
Fendiline,Guanfacine,Guanfacine may increase the bradycardic activities of Fendiline.,increase,no risk
Fendiline,Halofantrine,The risk or severity of QTc prolongation can be increased when Fendiline is combined with Halofantrine.,increase,risk
Fendiline,Haloperidol,The risk or severity of QTc prolongation can be increased when Fendiline is combined with Haloperidol.,increase,risk
Fendiline,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Fendiline.,increase,risk
Fendiline,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Fendiline.,increase,risk
Fendiline,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Fendiline.,increase,risk
Fendiline,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Fendiline.,increase,risk
Fendiline,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Fendiline.,increase,risk
Fendiline,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Fendiline is combined with Hydroxyzine.,increase,risk
Fendiline,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Fendiline.,increase,no risk
Fendiline,Ketoconazole,The metabolism of Fendiline can be decreased when combined with Ketoconazole.,decrease,no risk
Fendiline,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Fendiline.,increase,risk
Fendiline,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Fendiline.,increase,risk
Fenbufen,Bismuth subgallate,Fenbufen may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Fenbufen,Bisoprolol,Fenbufen may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Fenbufen,Bisoxatin,Fenbufen may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Fenbufen,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Bivalirudin.,increase,risk
Fenbufen,Bleomycin,Fenbufen may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Fenbufen,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Brexpiprazole,The risk or severity of hypertension can be increased when Fenbufen is combined with Brexpiprazole.,increase,risk
Fenbufen,Brivaracetam,Fenbufen may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Fenbufen,Bromazepam,Fenbufen may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Fenbufen,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Fenbufen.,increase,risk
Fenbufen,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Fenbufen.,increase,risk
Fenbufen,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Fenbufen.,increase,risk
Fenbufen,Bufexamac,The risk or severity of adverse effects can be increased when Fenbufen is combined with Bufexamac.,increase,risk
Fenbufen,Bumadizone,The risk or severity of adverse effects can be increased when Fenbufen is combined with Bumadizone.,increase,risk
Fenbufen,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Bupropion,Fenbufen may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Fenbufen,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Fenbufen.,increase,risk
Fenbufen,Butabarbital,Fenbufen may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Fenbufen,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Fenbufen.,increase,risk
Fenbufen,Gabapentin enacarbil,Fenbufen may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Fenbufen,Gadobenic acid,Fenbufen may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Fenbufen,Gadodiamide,Fenbufen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Fenbufen,Gadofosveset trisodium,Fenbufen may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Fenbufen,Gadopentetic acid,Fenbufen may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Fenbufen,Gadoteric acid,Fenbufen may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Fenbufen,Gadoteridol,Fenbufen may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Fenbufen,Ganciclovir,Fenbufen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Fenbufen,Gatifloxacin,Fenbufen may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Fenbufen,Gemcitabine,Fenbufen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Fenbufen,Gemfibrozil,Fenbufen may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Fenbufen,Gemifloxacin,Fenbufen may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Fenbufen,Gentamicin,Fenbufen may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Fenbufen,Gimeracil,Fenbufen may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Fenbufen,Givosiran,The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Givosiran.,increase,risk
Fenbufen,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Fenbufen.,decrease,no risk
Fenbufen,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Fenbufen.,decrease,no risk
Fenbufen,Glipizide,The protein binding of Glipizide can be decreased when combined with Fenbufen.,decrease,no risk
Fenbufen,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Fenbufen.,decrease,no risk
Fenbufen,Glyburide,The protein binding of Glyburide can be decreased when combined with Fenbufen.,decrease,no risk
Fenbufen,Glycerol phenylbutyrate,Fenbufen may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Fenbufen,Glycol salicylate,The risk or severity of adverse effects can be increased when Fenbufen is combined with Glycol salicylate.,increase,risk
Fenbufen,Golodirsen,Fenbufen may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Fenbufen,Goserelin,Fenbufen may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Fenbufen,Grepafloxacin,Fenbufen may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Fenbufen,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Fenbufen.,increase,no risk
Fenbufen,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Fenbufen.,increase,risk
Fenbufen,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Heparin.,increase,risk
Fenbufen,Hydralazine,Fenbufen may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Fenbufen,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Fenbufen.,increase,risk
Fenbufen,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Fenbufen.,increase,risk
Fenbufen,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Fenbufen.,increase,risk
Fenbufen,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Fenbufen.,increase,risk
Fenbufen,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Fenbufen.,increase,risk
Fenbufen,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Hydromorphone,Fenbufen may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Fenbufen,Hydroxocobalamin,Fenbufen may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Fenbufen,Hydroxyethyl Starch,Fenbufen may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Fenbufen,Kanamycin,Fenbufen may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Fenbufen,Ketamine,Fenbufen may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Fenbufen,Ketazolam,Fenbufen may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Fenbufen,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Fenbufen.,increase,risk
Fenbufen,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fenbufen.,increase,risk
Fenbufen,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Fenbufen.,increase,risk
Fenbufen,Octinoxate,Fenbufen may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Fenbufen,Ofloxacin,Fenbufen may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Fenbufen,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Fenbufen.",increase,risk
Fenbufen,Olodaterol,The risk or severity of hypertension can be increased when Fenbufen is combined with Olodaterol.,increase,risk
Fenbufen,Olsalazine,The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Olsalazine.,increase,risk
Fenbufen,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Fenbufen is combined with Omacetaxine mepesuccinate.,increase,risk
Fenbufen,Opium,Fenbufen may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Fenbufen,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Fenbufen.,increase,risk
Fenbufen,Oseltamivir,Fenbufen may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Fenbufen,Oxacillin,Fenbufen may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Fenbufen,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Fenbufen.,increase,risk
Fenbufen,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Fenbufen.,increase,risk
Fenbufen,Oxazepam,Fenbufen may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Fenbufen,Oxprenolol,Fenbufen may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Fenbufen,Oxybenzone,Fenbufen may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Fenbufen,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Fenbufen.,increase,risk
Fenbufen,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Fenbufen.,increase,risk
Fenbufen,Oxyquinoline,Fenbufen may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Fenbufen,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Fenbufen.,increase,risk
Fenbufen,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Quinapril.",increase,risk
Fenbufen,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Quinidine,Fenbufen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Fenbufen,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Fenbufen.,increase,risk
Fenbufen,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Fenbufen.,decrease,no risk
Fenbufen,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Urokinase.,increase,risk
Fenbufen,Vaborbactam,Fenbufen may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Fenbufen,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Fenbufen.,increase,risk
Fenbufen,Valbenazine,Fenbufen may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Fenbufen,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Fenbufen.,increase,risk
Fenbufen,Valganciclovir,Fenbufen may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Fenbufen,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Fenbufen.,decrease,no risk
Fenbufen,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Fenbufen.",increase,risk
Fenbufen,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Fenbufen.,increase,risk
Fenbufen,Vancomycin,Fenbufen may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Fenbufen,Varenicline,Fenbufen may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Fenbufen,Venlafaxine,Fenbufen may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Fenbufen,Verapamil,Fenbufen may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Fenbufen,Vilanterol,The risk or severity of hypertension can be increased when Fenbufen is combined with Vilanterol.,increase,risk
Fenbufen,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Fenbufen.,increase,risk
Fenbufen,Viloxazine,Fenbufen may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Fenbufen,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Vorapaxar.,increase,risk
Fenbufen,Voriconazole,The serum concentration of Fenbufen can be increased when it is combined with Voriconazole.,increase,no risk
Fenbufen,Vortioxetine,The risk or severity of hypertension can be increased when Fenbufen is combined with Vortioxetine.,increase,risk
Fenbufen,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Warfarin.,increase,risk
Fenbufen,Xamoterol,The risk or severity of hypertension can be increased when Fenbufen is combined with Xamoterol.,increase,risk
Fenbufen,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Ximelagatran.,increase,risk
Fenbufen,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Fenbufen.,increase,risk
Fenbufen,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Fenbufen.,increase,risk
Fenbufen,Zaleplon,Fenbufen may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Fenbufen,Zanamivir,Fenbufen may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Fenbufen,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Fenbufen.,increase,risk
Fenbufen,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Fenbufen.,increase,risk
Fenbufen,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Fenbufen.,increase,risk
Etofibrate,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Etofibrate is combined with Ubidecarenone.",increase,risk
Etofibrate,Ursodeoxycholic acid,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Etofibrate.,decrease,no risk
Etofibrate,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Etofibrate.",increase,risk
Etofibrate,Warfarin,The risk or severity of bleeding can be increased when Etofibrate is combined with Warfarin.,increase,risk
Etofibrate,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Etofibrate.",increase,risk
Etofenamate,Betulinic Acid,The risk or severity of adverse effects can be increased when Etofenamate is combined with Betulinic Acid.,increase,risk
Etofenamate,Bicisate,Etofenamate may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Etofenamate,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Etofenamate.,decrease,no risk
Etofenamate,Bismuth subgallate,Etofenamate may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Etofenamate,Bisoprolol,Etofenamate may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Etofenamate,Bisoxatin,Etofenamate may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Etofenamate,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Bivalirudin.,increase,risk
Etofenamate,Bleomycin,Etofenamate may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Etofenamate,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Etofenamate.,decrease,no risk
Etofenamate,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Etofenamate.,decrease,no risk
Etofenamate,Brexpiprazole,The risk or severity of hypertension can be increased when Etofenamate is combined with Brexpiprazole.,increase,risk
Etofenamate,Brivaracetam,Etofenamate may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Etofenamate,Bromazepam,Etofenamate may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Etofenamate,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Etofenamate.,increase,risk
Etofenamate,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Etofenamate.,increase,risk
Etofenamate,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Etofenamate.,increase,risk
Etofenamate,Bufexamac,The risk or severity of adverse effects can be increased when Etofenamate is combined with Bufexamac.,increase,risk
Etofenamate,Bumadizone,The risk or severity of adverse effects can be increased when Etofenamate is combined with Bumadizone.,increase,risk
Etofenamate,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Etofenamate.,decrease,no risk
Etofenamate,Bupropion,Etofenamate may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Etofenamate,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Etofenamate.,increase,risk
Etofenamate,Butabarbital,Etofenamate may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Etofenamate,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Etofenamate.,increase,risk
Etilefrine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Etilefrine.,increase,risk
Etilefrine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Etilefrine.,decrease,no risk
Etilefrine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Etilefrine.,increase,risk
Etilefrine,Guanabenz,Etilefrine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Etilefrine,Guanadrel,Etilefrine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Etilefrine,Guanethidine,Etilefrine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Etilefrine,Guanfacine,Etilefrine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Etilefrine,Guanoxan,Etilefrine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Etilefrine,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Etilefrine.,increase,risk
Etilefrine,Hexocyclium,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Etilefrine.,increase,risk
Etilefrine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Etilefrine.,increase,risk
Etilefrine,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Etilefrine.,increase,risk
Etilefrine,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Etilefrine.,increase,risk
Etilefrine,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Etilefrine.,increase,risk
Etilefrine,Hydralazine,Etilefrine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Etilefrine,Hydrochlorothiazide,Etilefrine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Etilefrine,Hydroflumethiazide,Etilefrine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Etilefrine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Etilefrine.,increase,risk
Etilefrine,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Etilefrine.,increase,risk
Etilefrine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Etilefrine.,increase,risk
Etilefrine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Etilefrine.,increase,risk
Etilefrine,Olanzapine,The therapeutic efficacy of Etilefrine can be decreased when used in combination with Olanzapine.,decrease,no risk
Etilefrine,Olmesartan,Etilefrine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Etilefrine,Olodaterol,The risk or severity of hypertension can be increased when Etilefrine is combined with Olodaterol.,increase,risk
Etilefrine,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Etilefrine.,increase,risk
Etilefrine,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Etilefrine.,increase,risk
Etilefrine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Etilefrine.,increase,risk
Etilefrine,Oxprenolol,The therapeutic efficacy of Etilefrine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Etilefrine,Oxtriphylline,The risk or severity of adverse effects can be increased when Etilefrine is combined with Oxtriphylline.,increase,risk
Etilefrine,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Etilefrine.,increase,risk
Etilefrine,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Etilefrine.,increase,risk
Etilefrine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Etilefrine.,increase,risk
Etilefrine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Etilefrine.,increase,risk
Etilefrine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Etilefrine.,increase,risk
Etilefrine,Oxytocin,The risk or severity of hypertension can be increased when Etilefrine is combined with Oxytocin.,increase,risk
Etilefrine,Quetiapine,The therapeutic efficacy of Etilefrine can be decreased when used in combination with Quetiapine.,decrease,no risk
Etilefrine,Quinapril,Etilefrine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Etilefrine,Quinidine,The therapeutic efficacy of Etilefrine can be decreased when used in combination with Quinidine.,decrease,no risk
Etilefrine,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Etilefrine.,increase,risk
Etilefrine,Umeclidinium,The risk or severity of Tachycardia can be increased when Etilefrine is combined with Umeclidinium.,increase,risk
Etilefrine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Etilefrine.,increase,risk
Etilefrine,Valsartan,Etilefrine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Etilefrine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Etilefrine.,increase,no risk
Etilefrine,Verapamil,The therapeutic efficacy of Etilefrine can be decreased when used in combination with Verapamil.,decrease,no risk
Etilefrine,Vilanterol,The risk or severity of hypertension can be increased when Etilefrine is combined with Vilanterol.,increase,risk
Etilefrine,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Etilefrine.,increase,risk
Etilefrine,Vortioxetine,The risk or severity of hypertension can be increased when Etilefrine is combined with Vortioxetine.,increase,risk
Etilefrine,Xamoterol,The risk or severity of hypertension can be increased when Etilefrine is combined with Xamoterol.,increase,risk
Etilefrine,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Etilefrine.,increase,risk
Etilefrine,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Etilefrine.,increase,risk
Etilefrine,Ziprasidone,The therapeutic efficacy of Etilefrine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Etilefrine,Zofenopril,Etilefrine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Etilefrine,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Etilefrine.,increase,risk
Etilefrine,Zuclopenthixol,The therapeutic efficacy of Etilefrine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Etifoxine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Etifoxine.,increase,risk
Etifoxine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Etifoxine.,increase,risk
Etifoxine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Etifoxine.,increase,risk
Etifoxine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Etifoxine is combined with Ganaxolone.",increase,risk
Etifoxine,Gepirone,The risk or severity of CNS depression can be increased when Etifoxine is combined with Gepirone.,increase,risk
Etifoxine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Etifoxine.,increase,risk
Etifoxine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Etifoxine.,increase,risk
Etifoxine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Etifoxine.,increase,risk
Etifoxine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Etifoxine.,increase,risk
Etifoxine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Etifoxine.,increase,risk
Etifoxine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Etifoxine.,increase,risk
Etifoxine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Etifoxine.,increase,risk
Etifoxine,Hydrocodone,Etifoxine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Etifoxine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Etifoxine.,increase,risk
Etifoxine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Etifoxine.,increase,no risk
Etifoxine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Etifoxine.,increase,risk
Etifoxine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Etifoxine.,increase,risk
Etifoxine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Etifoxine.,increase,risk
Etifoxine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Etifoxine is combined with Oliceridine.",increase,risk
Etifoxine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Etifoxine.,increase,risk
Etifoxine,Opium,The risk or severity of CNS depression can be increased when Etifoxine is combined with Opium.,increase,risk
Etifoxine,Orphenadrine,Etifoxine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Etifoxine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Etifoxine.,increase,risk
Etifoxine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Etifoxine.,increase,risk
Etifoxine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Etifoxine.,increase,risk
Etifoxine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Etifoxine.,increase,risk
Etifoxine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Etifoxine.,increase,risk
Etifoxine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Etifoxine.,increase,risk
Etifoxine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Etifoxine.,increase,risk
Etifoxine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Etifoxine.,increase,risk
Etifoxine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Etifoxine.,increase,risk
Etifoxine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Etifoxine.,increase,risk
Etifoxine,Quinupramine,The risk or severity of CNS depression can be increased when Etifoxine is combined with Quinupramine.,increase,risk
Etifoxine,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Etifoxine.,increase,risk
Etifoxine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Etifoxine.,increase,risk
Etifoxine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Etifoxine.,increase,risk
Etifoxine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Etifoxine.,increase,risk
Etifoxine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Etifoxine.,increase,risk
Etifoxine,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Etifoxine.,increase,risk
Etifoxine,Viloxazine,The risk or severity of CNS depression can be increased when Etifoxine is combined with Viloxazine.,increase,risk
Etifoxine,Vortioxetine,The risk or severity of CNS depression can be increased when Etifoxine is combined with Vortioxetine.,increase,risk
Etifoxine,Yohimbine,The therapeutic efficacy of Etifoxine can be increased when used in combination with Yohimbine.,increase,no risk
Etifoxine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Etifoxine.,increase,risk
Etifoxine,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Etifoxine.,increase,risk
Etifoxine,Zimelidine,The risk or severity of adverse effects can be increased when Etifoxine is combined with Zimelidine.,increase,risk
Etifoxine,Ziprasidone,The risk or severity of adverse effects can be increased when Etifoxine is combined with Ziprasidone.,increase,risk
Etifoxine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Etifoxine.,increase,risk
Etifoxine,Zolpidem,Etifoxine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Etifoxine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Etifoxine.,increase,risk
Etifoxine,Zopiclone,The risk or severity of adverse effects can be increased when Etifoxine is combined with Zopiclone.,increase,risk
Etifoxine,Zotepine,The risk or severity of CNS depression can be increased when Etifoxine is combined with Zotepine.,increase,risk
Etifoxine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Etifoxine.,increase,risk
Etifoxine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Etifoxine.,increase,risk
Etidocaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Etidocaine.,increase,risk
Etidocaine,Ganaxolone,The risk or severity of methemoglobinemia can be increased when Ganaxolone is combined with Etidocaine.,increase,risk
Etidocaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Etidocaine.,increase,risk
Etidocaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Etidocaine.,increase,risk
Etidocaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Etidocaine.,increase,risk
Etidocaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Etidocaine.,increase,risk
Etidocaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Etidocaine.,increase,risk
Etidocaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Etidocaine.,increase,risk
Etidocaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Etidocaine.,increase,risk
Etidocaine,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Etidocaine.,increase,risk
Etidocaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Etidocaine.,increase,risk
Etidocaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Etidocaine.,increase,risk
Etidocaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Etidocaine.,increase,risk
Etidocaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Etidocaine.,increase,risk
Etidocaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Etidocaine.,increase,risk
Etidocaine,Hyaluronidase,Hyaluronidase can cause an increase in the absorption of Etidocaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Etidocaine,Hyaluronidase (human recombinant),Hyaluronidase (human recombinant) can cause an increase in the absorption of Etidocaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Etidocaine,Hyaluronidase (ovine),Hyaluronidase (ovine) can cause an increase in the absorption of Etidocaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Etidocaine,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Etidocaine.,increase,risk
Etidocaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Etidocaine.,increase,risk
Etidocaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Etidocaine.,increase,risk
Etidocaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Etidocaine.,increase,risk
Etidocaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Etidocaine.,increase,risk
Etidocaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Etidocaine.,increase,risk
Etidocaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Etidocaine.,increase,risk
Etidocaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Etidocaine.,increase,risk
Etidocaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Etidocaine.,increase,risk
Etidocaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Etidocaine.,increase,risk
Etidocaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Etidocaine.,increase,risk
Etidocaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Etidocaine.,increase,risk
Etidocaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Etidocaine.,increase,risk
Etidocaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Etidocaine.,increase,risk
Etidocaine,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Etidocaine.,increase,risk
Etidocaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Etidocaine.,increase,risk
Etidocaine,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Etidocaine.,increase,risk
Etidocaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Etidocaine.,increase,risk
Etidocaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Etidocaine is combined with Oxetacaine.,increase,risk
Etidocaine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Etidocaine.,increase,risk
Etidocaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Etidocaine.,increase,risk
Etidocaine,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Etidocaine.,increase,risk
Etidocaine,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Etidocaine.,increase,risk
Etidocaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Etidocaine.,increase,risk
Etidocaine,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Etidocaine.,increase,risk
Etidocaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Etidocaine.,increase,risk
Etidocaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Etidocaine.,increase,risk
Etidocaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Etidocaine.,increase,risk
Etidocaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Etidocaine.,increase,risk
Etidocaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Etidocaine.,increase,risk
Etidocaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Etidocaine.,increase,risk
Etidocaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Etidocaine.,increase,risk
Etidocaine,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Etidocaine.,increase,risk
Etidocaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Etidocaine.,increase,risk
Etidocaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Etidocaine.,increase,risk
Etidocaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Etidocaine.,increase,risk
Etidocaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Etidocaine.,increase,risk
Etidocaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Etidocaine.,increase,risk
Etidocaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Etidocaine.,increase,risk
Etidocaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Etidocaine.,increase,risk
Etidocaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Etidocaine.,increase,risk
Etidocaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Etidocaine.,increase,risk
Etidocaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Etidocaine.,increase,risk
Etidocaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Etidocaine.,increase,risk
Etidocaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Etidocaine.,increase,risk
Etidocaine,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Etidocaine.,increase,risk
Epirizole,Bismuth subgallate,Epirizole may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Epirizole,Bisoprolol,Epirizole may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Epirizole,Bisoxatin,Epirizole may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Epirizole,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Bivalirudin.,increase,risk
Epirizole,Bleomycin,Epirizole may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Epirizole,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Brexpiprazole,The risk or severity of hypertension can be increased when Epirizole is combined with Brexpiprazole.,increase,risk
Epirizole,Brivaracetam,Epirizole may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Epirizole,Bromazepam,Epirizole may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Epirizole,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Epirizole.,increase,risk
Epirizole,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Epirizole.,increase,risk
Epirizole,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Epirizole.,increase,risk
Epirizole,Bufexamac,The risk or severity of adverse effects can be increased when Epirizole is combined with Bufexamac.,increase,risk
Epirizole,Bumadizone,The risk or severity of adverse effects can be increased when Epirizole is combined with Bumadizone.,increase,risk
Epirizole,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Bupropion,Epirizole may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Epirizole,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Epirizole.,increase,risk
Epirizole,Butabarbital,Epirizole may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Epirizole,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Epirizole.,increase,risk
Epirizole,Gabapentin enacarbil,Epirizole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Epirizole,Gadobenic acid,Epirizole may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Epirizole,Gadodiamide,Epirizole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Epirizole,Gadofosveset trisodium,Epirizole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Epirizole,Gadopentetic acid,Epirizole may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Epirizole,Gadoteric acid,Epirizole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Epirizole,Gadoteridol,Epirizole may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Epirizole,Ganciclovir,Epirizole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Epirizole,Gatifloxacin,Epirizole may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Epirizole,Gemcitabine,Epirizole may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Epirizole,Gemfibrozil,Epirizole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Epirizole,Gemifloxacin,Epirizole may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Epirizole,Gentamicin,Epirizole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Epirizole,Gimeracil,Epirizole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Epirizole,Givosiran,The risk or severity of nephrotoxicity can be increased when Epirizole is combined with Givosiran.,increase,risk
Epirizole,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Epirizole.,decrease,no risk
Epirizole,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Epirizole.,decrease,no risk
Epirizole,Glipizide,The protein binding of Glipizide can be decreased when combined with Epirizole.,decrease,no risk
Epirizole,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Epirizole.,decrease,no risk
Epirizole,Glyburide,The protein binding of Glyburide can be decreased when combined with Epirizole.,decrease,no risk
Epirizole,Glycerol phenylbutyrate,Epirizole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Epirizole,Glycol salicylate,The risk or severity of adverse effects can be increased when Epirizole is combined with Glycol salicylate.,increase,risk
Epirizole,Golodirsen,Epirizole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Epirizole,Goserelin,Epirizole may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Epirizole,Grepafloxacin,Epirizole may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Epirizole,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Epirizole.,increase,no risk
Epirizole,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Epirizole.,increase,risk
Epirizole,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Heparin.,increase,risk
Epirizole,Hydralazine,Epirizole may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Epirizole,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Epirizole.,increase,risk
Epirizole,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Epirizole.,increase,risk
Epirizole,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Epirizole.,increase,risk
Epirizole,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Epirizole.,increase,risk
Epirizole,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Epirizole.,increase,risk
Epirizole,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Hydromorphone,Epirizole may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Epirizole,Hydroxocobalamin,Epirizole may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Epirizole,Hydroxyethyl Starch,Epirizole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Epirizole,Kanamycin,Epirizole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Epirizole,Ketamine,Epirizole may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Epirizole,Ketazolam,Epirizole may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Epirizole,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Epirizole.,increase,risk
Epirizole,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Epirizole.,increase,risk
Epirizole,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Epirizole.,increase,risk
Epirizole,Octinoxate,Epirizole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Epirizole,Ofloxacin,Epirizole may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Epirizole,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Epirizole.",increase,risk
Epirizole,Olodaterol,The risk or severity of hypertension can be increased when Epirizole is combined with Olodaterol.,increase,risk
Epirizole,Olsalazine,The risk or severity of nephrotoxicity can be increased when Epirizole is combined with Olsalazine.,increase,risk
Epirizole,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Epirizole is combined with Omacetaxine mepesuccinate.,increase,risk
Epirizole,Opium,Epirizole may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Epirizole,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Epirizole.,increase,risk
Epirizole,Oseltamivir,Epirizole may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Epirizole,Oxacillin,Epirizole may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Epirizole,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Epirizole.,increase,risk
Epirizole,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Epirizole.,increase,risk
Epirizole,Oxazepam,Epirizole may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Epirizole,Oxprenolol,Epirizole may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Epirizole,Oxybenzone,Epirizole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Epirizole,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Epirizole.,increase,risk
Epirizole,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Epirizole.,increase,risk
Epirizole,Oxyquinoline,Epirizole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Epirizole,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Epirizole.,increase,risk
Epirizole,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Epirizole is combined with Quinapril.",increase,risk
Epirizole,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Quinidine,Epirizole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Epirizole,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Epirizole.,increase,risk
Epirizole,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Epirizole.,decrease,no risk
Epirizole,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Urokinase.,increase,risk
Epirizole,Vaborbactam,Epirizole may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Epirizole,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Epirizole.,increase,risk
Epirizole,Valbenazine,Epirizole may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Epirizole,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Epirizole.,increase,risk
Epirizole,Valganciclovir,Epirizole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Epirizole,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Epirizole.,decrease,no risk
Epirizole,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Epirizole.",increase,risk
Epirizole,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Epirizole.,increase,risk
Epirizole,Vancomycin,Epirizole may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Epirizole,Varenicline,Epirizole may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Epirizole,Venlafaxine,Epirizole may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Epirizole,Verapamil,Epirizole may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Epirizole,Vilanterol,The risk or severity of hypertension can be increased when Epirizole is combined with Vilanterol.,increase,risk
Epirizole,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Epirizole.,increase,risk
Epirizole,Viloxazine,Epirizole may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Epirizole,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Vorapaxar.,increase,risk
Epirizole,Voriconazole,The serum concentration of Epirizole can be increased when it is combined with Voriconazole.,increase,no risk
Epirizole,Vortioxetine,The risk or severity of hypertension can be increased when Epirizole is combined with Vortioxetine.,increase,risk
Epirizole,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Warfarin.,increase,risk
Epirizole,Xamoterol,The risk or severity of hypertension can be increased when Epirizole is combined with Xamoterol.,increase,risk
Epirizole,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Ximelagatran.,increase,risk
Epirizole,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Epirizole.,increase,risk
Epirizole,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Epirizole.,increase,risk
Epirizole,Zaleplon,Epirizole may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Epirizole,Zanamivir,Epirizole may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Epirizole,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Epirizole.,increase,risk
Epirizole,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Epirizole.,increase,risk
Eperisone,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Eperisone.,increase,risk
Eperisone,Bretylium,Bretylium may increase the arrhythmogenic activities of Eperisone.,increase,no risk
Eperisone,Brexanolone,The risk or severity of CNS depression can be increased when Eperisone is combined with Brexanolone.,increase,risk
Eperisone,Brexpiprazole,The risk or severity of CNS depression can be increased when Eperisone is combined with Brexpiprazole.,increase,risk
Eperisone,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Eperisone.,increase,no risk
Eperisone,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Eperisone.,increase,risk
Eperisone,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Eperisone.,increase,risk
Eperisone,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Eperisone.,increase,risk
Eperisone,Bromperidol,The risk or severity of CNS depression can be increased when Eperisone is combined with Bromperidol.,increase,risk
Eperisone,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Eperisone.,increase,risk
Eperisone,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Eperisone.,increase,risk
Eperisone,Bumadizone,The risk or severity of hyperkalemia can be increased when Eperisone is combined with Bumadizone.,increase,risk
Eperisone,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Eperisone.,increase,risk
Eperisone,Buprenorphine,Eperisone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Eperisone,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Eperisone.,increase,risk
Eperisone,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Eperisone.,increase,risk
Eperisone,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Eperisone.,increase,risk
Eperisone,Butabarbital,The metabolism of Eperisone can be increased when combined with Butabarbital.,increase,no risk
Eperisone,Butalbital,The metabolism of Eperisone can be increased when combined with Butalbital.,increase,no risk
Eperisone,Butaperazine,The risk or severity of CNS depression can be increased when Eperisone is combined with Butaperazine.,increase,risk
Eperisone,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Eperisone.,increase,risk
Eperisone,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Eperisone.,increase,risk
Eperisone,Butriptyline,The risk or severity of QTc prolongation can be increased when Eperisone is combined with Butriptyline.,increase,risk
Eperisone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Eperisone.,increase,risk
Eperisone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Eperisone.,increase,risk
Eperisone,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Eperisone.,increase,risk
Eperisone,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Eperisone.,increase,risk
Eperisone,Gallamine triethiodide,Eperisone may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Eperisone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Eperisone is combined with Ganaxolone.",increase,risk
Eperisone,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Eperisone.,increase,risk
Eperisone,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Eperisone.,increase,risk
Eperisone,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Eperisone.,increase,risk
Eperisone,Gilteritinib,The risk or severity of QTc prolongation can be increased when Eperisone is combined with Gilteritinib.,increase,risk
Eperisone,Glasdegib,The risk or severity of QTc prolongation can be increased when Eperisone is combined with Glasdegib.,increase,risk
Eperisone,Gliclazide,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Gliclazide.,increase,risk
Eperisone,Glimepiride,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Glimepiride.,increase,risk
Eperisone,Glipizide,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Glipizide.,increase,risk
Eperisone,Gliquidone,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Gliquidone.,increase,risk
Eperisone,Glofitamab,The serum concentration of Eperisone can be increased when it is combined with Glofitamab.,increase,no risk
Eperisone,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Eperisone.,decrease,no risk
Eperisone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Eperisone.,increase,risk
Eperisone,Glyburide,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Glyburide.,increase,risk
Eperisone,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Eperisone.,decrease,no risk
Eperisone,Glymidine,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Glymidine.,increase,risk
Eperisone,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Eperisone.,increase,risk
Eperisone,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Eperisone.,increase,risk
Eperisone,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Eperisone is combined with Grepafloxacin.,increase,risk
Eperisone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Eperisone.,increase,risk
Eperisone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Eperisone.,increase,risk
Eperisone,Halofantrine,The risk or severity of QTc prolongation can be increased when Eperisone is combined with Halofantrine.,increase,risk
Eperisone,Haloperidol,The risk or severity of QTc prolongation can be increased when Eperisone is combined with Haloperidol.,increase,risk
Eperisone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Eperisone.,increase,risk
Eperisone,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Eperisone.,increase,risk
Eperisone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Eperisone.,increase,risk
Eperisone,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Eperisone.,increase,risk
Eperisone,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Eperisone.,increase,risk
Eperisone,Hydrocodone,Eperisone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Eperisone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Eperisone.,increase,risk
Eperisone,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Eperisone.,increase,risk
Eperisone,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Eperisone.,increase,risk
Eperisone,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Eperisone is combined with Hydroxyzine.,increase,risk
Eperisone,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Eperisone.,increase,no risk
Eperisone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Eperisone.,increase,risk
Eperisone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Eperisone.,increase,risk
Eperisone,Ketoconazole,The metabolism of Eperisone can be decreased when combined with Ketoconazole.,decrease,no risk
Eperisone,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Eperisone.,increase,risk
Eperisone,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Eperisone.,increase,risk
Eperisone,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Eperisone.,increase,no risk
Eperisone,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Eperisone.,increase,risk
Eperisone,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Eperisone.,increase,risk
Eperisone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Eperisone is combined with Oliceridine.",increase,risk
Eperisone,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Eperisone.,increase,risk
Eperisone,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Eperisone.,increase,risk
Eperisone,Omaveloxolone,The serum concentration of Eperisone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Eperisone,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Eperisone.,increase,risk
Eperisone,Opium,The risk or severity of CNS depression can be increased when Eperisone is combined with Opium.,increase,risk
Eperisone,Orphenadrine,Eperisone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Eperisone,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Eperisone.,increase,no risk
Eperisone,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Eperisone.,increase,no risk
Eperisone,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Eperisone.,increase,risk
Eperisone,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Eperisone.,increase,risk
Eperisone,Oxatomide,The risk or severity of QTc prolongation can be increased when Eperisone is combined with Oxatomide.,increase,risk
Eperisone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Eperisone.,increase,risk
Eperisone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Eperisone.,increase,risk
Eperisone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Eperisone.,increase,risk
Eperisone,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Eperisone.,increase,no risk
Eperisone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Eperisone.,increase,risk
Eperisone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Eperisone.,increase,risk
Eperisone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Eperisone.,increase,risk
Eperisone,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Oxyphenbutazone is combined with Eperisone.,increase,risk
Eperisone,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Eperisone.,decrease,no risk
Eperisone,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Eperisone.,increase,risk
Eperisone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Eperisone.,increase,risk
Eperisone,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Eperisone.,increase,risk
Eperisone,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Eperisone.,increase,risk
Eperisone,Quinidine,Quinidine may increase the arrhythmogenic activities of Eperisone.,increase,no risk
Eperisone,Quinine,The risk or severity of QTc prolongation can be increased when Eperisone is combined with Quinine.,increase,risk
Eperisone,Quinupramine,The risk or severity of CNS depression can be increased when Eperisone is combined with Quinupramine.,increase,risk
Eperisone,Quizartinib,The risk or severity of QTc prolongation can be increased when Eperisone is combined with Quizartinib.,increase,risk
Enviomycin,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Enviomycin.,decrease,no risk
Enviomycin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Enviomycin.,decrease,no risk
Enviomycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Enviomycin is combined with Benzocaine.,increase,risk
Enviomycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Enviomycin is combined with Benzyl alcohol.,increase,risk
Enviomycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Enviomycin is combined with Bupivacaine.,increase,risk
Enviomycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Enviomycin is combined with Butacaine.,increase,risk
Enviomycin,Butamben,The risk or severity of methemoglobinemia can be increased when Enviomycin is combined with Butamben.,increase,risk
Enviomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Enviomycin is combined with Oxetacaine.,increase,risk
Enviomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Enviomycin is combined with Oxybuprocaine.,increase,risk
Enviomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Enviomycin.,decrease,no risk
Enviomycin,Warfarin,The risk or severity of bleeding can be increased when Enviomycin is combined with Warfarin.,increase,risk
Ditazole,Gemcitabine,The risk or severity of bleeding can be increased when Ditazole is combined with Gemcitabine.,increase,risk
Ditazole,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Ditazole is combined with Gemtuzumab ozogamicin.,increase,risk
Ditazole,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Ditazole.,increase,risk
Ditazole,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Ditazole.,increase,no risk
Ditazole,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Ditazole.,increase,risk
Ditazole,Hemin,Hemin may increase the anticoagulant activities of Ditazole.,increase,no risk
Ditazole,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Ditazole.,increase,risk
Ditazole,Hydrochlorothiazide,The therapeutic efficacy of Ditazole can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Ditazole,Hydroflumethiazide,The therapeutic efficacy of Ditazole can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Ditazole,Hydroxyprogesterone caproate,The therapeutic efficacy of Ditazole can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Ditazole,Hydroxyurea,The risk or severity of bleeding can be increased when Ditazole is combined with Hydroxyurea.,increase,risk
Ditazole,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Ditazole.,increase,risk
Ditazole,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Ditazole.,increase,risk
Ditazole,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Ditazole is combined with Obeticholic acid.,increase,risk
Ditazole,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Ditazole is combined with Obinutuzumab.,increase,risk
Ditazole,Olaparib,The risk or severity of bleeding can be increased when Ditazole is combined with Olaparib.,increase,risk
Ditazole,Olive oil,The therapeutic efficacy of Ditazole can be decreased when used in combination with Olive oil.,decrease,no risk
Ditazole,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Ditazole.,increase,risk
Ditazole,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Ditazole is combined with Omacetaxine mepesuccinate.,increase,risk
Ditazole,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Ditazole.,increase,no risk
Ditazole,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Ditazole.,increase,risk
Ditazole,Omega-3-carboxylic acids,The therapeutic efficacy of Ditazole can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Ditazole,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Ditazole.,increase,risk
Ditazole,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Ditazole.,increase,risk
Ditazole,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Ditazole.,increase,risk
Ditazole,Quinestrol,Quinestrol may decrease the anticoagulant activities of Ditazole.,decrease,no risk
Ditazole,Quinidine,The therapeutic efficacy of Ditazole can be increased when used in combination with Quinidine.,increase,no risk
Ditazole,Quinine,The therapeutic efficacy of Ditazole can be increased when used in combination with Quinine.,increase,no risk
Ditazole,Ulipristal,The therapeutic efficacy of Ditazole can be decreased when used in combination with Ulipristal.,decrease,no risk
Ditazole,Urokinase,Urokinase may increase the anticoagulant activities of Ditazole.,increase,no risk
Ditazole,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Ditazole is combined with Ursodeoxycholic acid.,increase,risk
Ditazole,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Ditazole.,increase,risk
Ditazole,Venlafaxine,The risk or severity of bleeding can be increased when Ditazole is combined with Venlafaxine.,increase,risk
Ditazole,Vinblastine,The risk or severity of bleeding can be increased when Ditazole is combined with Vinblastine.,increase,risk
Ditazole,Vindesine,The risk or severity of bleeding can be increased when Ditazole is combined with Vindesine.,increase,risk
Ditazole,Vinorelbine,The risk or severity of bleeding can be increased when Ditazole is combined with Vinorelbine.,increase,risk
Ditazole,Vitamin E,Vitamin E may increase the anticoagulant activities of Ditazole.,increase,no risk
Ditazole,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Ditazole.,decrease,no risk
Ditazole,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ditazole.,increase,risk
Ditazole,Vorinostat,The risk or severity of bleeding can be increased when Ditazole is combined with Vorinostat.,increase,risk
Ditazole,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Ditazole.,increase,risk
Ditazole,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Ditazole.,increase,risk
Ditazole,Zidovudine,The risk or severity of bleeding can be increased when Ditazole is combined with Zidovudine.,increase,risk
Ditazole,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ditazole.,increase,risk
Diosmin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Glipizide,The metabolism of Glipizide can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Glyburide,The metabolism of Glyburide can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Halothane,The metabolism of Halothane can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Ketamine,The metabolism of Ketamine can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Quinine,The serum concentration of Quinine can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Valsartan,The metabolism of Valsartan can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Vincristine,The excretion of Vincristine can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Diosmin.,increase,no risk
Diosmin,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Zileuton,The metabolism of Zileuton can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Diosmin.,decrease,no risk
Diosmin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Diosmin.,decrease,no risk
Dimetacrine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Dimetacrine.,increase,risk
Dimetacrine,Bepotastine,Bepotastine may decrease the excretion rate of Dimetacrine which could result in a higher serum level.,decrease,no risk
Dimetacrine,Bepridil,Dimetacrine may decrease the antihypertensive activities of Bepridil.,decrease,no risk
Dimetacrine,Betaxolol,Dimetacrine may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Dimetacrine,Bethanidine,The risk or severity of hypertension can be increased when Dimetacrine is combined with Bethanidine.,increase,risk
Dimetacrine,Betulinic Acid,The risk or severity of gastrointestinal bleeding can be increased when Dimetacrine is combined with Betulinic Acid.,increase,risk
Dimetacrine,Bexagliflozin,Dimetacrine may decrease the hypoglycemic activities of Bexagliflozin.,decrease,no risk
Dimetacrine,Bicisate,Dimetacrine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Dimetacrine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Dimetacrine.,increase,risk
Dimetacrine,Bismuth subcitrate potassium,Dimetacrine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Dimetacrine,Bismuth subgallate,Dimetacrine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Dimetacrine,Bismuth subnitrate,Dimetacrine may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Dimetacrine,Bisoprolol,Dimetacrine may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Dimetacrine,Bisoxatin,Dimetacrine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Dimetacrine,Bleomycin,Bleomycin may decrease the excretion rate of Dimetacrine which could result in a higher serum level.,decrease,no risk
Dimetacrine,Bosentan,Dimetacrine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Dimetacrine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Dimetacrine.,increase,risk
Dimetacrine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Dimetacrine.,increase,risk
Dimetacrine,Bretylium,Dimetacrine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Dimetacrine,Brexanolone,The risk or severity of CNS depression can be increased when Dimetacrine is combined with Brexanolone.,increase,risk
Dimetacrine,Brexpiprazole,The risk or severity of CNS depression can be increased when Dimetacrine is combined with Brexpiprazole.,increase,risk
Dimetacrine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Dimetacrine.,increase,no risk
Dimetacrine,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Dimetacrine.,increase,risk
Dimetacrine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Dimetacrine.,increase,risk
Dimetacrine,Bromfenac,The risk or severity of gastrointestinal bleeding can be increased when Dimetacrine is combined with Bromfenac.,increase,risk
Dimetacrine,Bromocriptine,Dimetacrine may increase the vasopressor activities of Bromocriptine.,increase,no risk
Dimetacrine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Dimetacrine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dimetacrine,Bromperidol,The risk or severity of CNS depression can be increased when Dimetacrine is combined with Bromperidol.,increase,risk
Dimetacrine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Dimetacrine.,increase,risk
Dimetacrine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Dimetacrine.,increase,risk
Dimetacrine,Budesonide,Budesonide may decrease the excretion rate of Dimetacrine which could result in a higher serum level.,decrease,no risk
Dimetacrine,Bufexamac,The risk or severity of gastrointestinal bleeding can be increased when Dimetacrine is combined with Bufexamac.,increase,risk
Dimetacrine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Dimetacrine is combined with Bumadizone.,increase,risk
Dimetacrine,Bumetanide,Bumetanide may increase the excretion rate of Dimetacrine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dimetacrine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Dimetacrine.,increase,risk
Dimetacrine,Buprenorphine,Dimetacrine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Dimetacrine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Dimetacrine.,increase,risk
Dimetacrine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Dimetacrine.,increase,risk
Dimetacrine,Butabarbital,The metabolism of Dimetacrine can be increased when combined with Butabarbital.,increase,no risk
Dimetacrine,Butalbital,The metabolism of Dimetacrine can be increased when combined with Butalbital.,increase,no risk
Dimetacrine,Butaperazine,The serum concentration of Dimetacrine can be increased when it is combined with Butaperazine.,increase,no risk
Dimetacrine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Dimetacrine.,increase,risk
Dimetacrine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Dimetacrine.,increase,risk
Dimetacrine,Butriptyline,The risk or severity of CNS depression can be increased when Dimetacrine is combined with Butriptyline.,increase,risk
Dimetacrine,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Dimetacrine.,increase,risk
Dexetimide,Galantamine,The therapeutic efficacy of Dexetimide can be decreased when used in combination with Galantamine.,decrease,no risk
Dexetimide,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Dexetimide.,increase,risk
Dexetimide,Ginkgo biloba,The therapeutic efficacy of Dexetimide can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Dexetimide,Glucagon,Dexetimide may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Dexetimide,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Dexetimide.,decrease,no risk
Dexetimide,Glycopyrronium,The risk or severity of adverse effects can be increased when Dexetimide is combined with Glycopyrronium.,increase,risk
Dexetimide,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Dexetimide.,increase,risk
Dexetimide,Guanfacine,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Dexetimide.,increase,risk
Dexetimide,Haloperidol,The therapeutic efficacy of Dexetimide can be decreased when used in combination with Haloperidol.,decrease,no risk
Dexetimide,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Dexetimide.,increase,risk
Dexetimide,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Dexetimide.,increase,risk
Dexetimide,Homatropine,The risk or severity of adverse effects can be increased when Dexetimide is combined with Homatropine.,increase,risk
Dexetimide,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Dexetimide.,increase,risk
Dexetimide,Huperzine A,The therapeutic efficacy of Dexetimide can be decreased when used in combination with Huperzine A.,decrease,no risk
Dexetimide,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Dexetimide.,increase,no risk
Dexetimide,Hydrocodone,The risk or severity of adverse effects can be increased when Dexetimide is combined with Hydrocodone.,increase,risk
Dexetimide,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Dexetimide.,increase,no risk
Dexetimide,Hydromorphone,The risk or severity of adverse effects can be increased when Dexetimide is combined with Hydromorphone.,increase,risk
Dexetimide,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Dexetimide.,increase,risk
Dexetimide,Ketamine,The therapeutic efficacy of Dexetimide can be decreased when used in combination with Ketamine.,decrease,no risk
Dexetimide,Olanzapine,The therapeutic efficacy of Dexetimide can be decreased when used in combination with Olanzapine.,decrease,no risk
Dexetimide,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Dexetimide is combined with Oliceridine.",increase,risk
Dexetimide,Olodaterol,The risk or severity of Tachycardia can be increased when Dexetimide is combined with Olodaterol.,increase,risk
Dexetimide,Opium,The risk or severity of adverse effects can be increased when Dexetimide is combined with Opium.,increase,risk
Dexetimide,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Dexetimide.,increase,risk
Dexetimide,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Dexetimide.,increase,risk
Dexetimide,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Dexetimide.,increase,risk
Dexetimide,Oxycodone,The risk or severity of adverse effects can be increased when Dexetimide is combined with Oxycodone.,increase,risk
Dexetimide,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Dexetimide.,increase,risk
Dexetimide,Oxymorphone,The risk or severity of adverse effects can be increased when Dexetimide is combined with Oxymorphone.,increase,risk
Dexetimide,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Dexetimide.,increase,risk
Dexetimide,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Dexetimide.,decrease,no risk
Dexetimide,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Dexetimide.,increase,risk
Dexetimide,Quetiapine,The therapeutic efficacy of Dexetimide can be decreased when used in combination with Quetiapine.,decrease,no risk
Dexetimide,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Dexetimide.,increase,no risk
Dexetimide,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Dexetimide.,increase,risk
Dexetimide,Quinupramine,The risk or severity of adverse effects can be increased when Dexetimide is combined with Quinupramine.,increase,risk
Dexetimide,Umeclidinium,The risk or severity of adverse effects can be increased when Dexetimide is combined with Umeclidinium.,increase,risk
Dexetimide,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Dexetimide.,increase,risk
Dexetimide,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Dexetimide.,increase,risk
Dexetimide,Vilanterol,The risk or severity of Tachycardia can be increased when Dexetimide is combined with Vilanterol.,increase,risk
Dexetimide,Xamoterol,The risk or severity of Tachycardia can be increased when Dexetimide is combined with Xamoterol.,increase,risk
Dexetimide,Xylometazoline,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Dexetimide.,increase,risk
Dexetimide,Ziprasidone,The therapeutic efficacy of Dexetimide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Dexetimide,Zotepine,The therapeutic efficacy of Dexetimide can be decreased when used in combination with Zotepine.,decrease,no risk
Dexetimide,Zuclopenthixol,The therapeutic efficacy of Dexetimide can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Cyclopentamine,Udenafil,The risk or severity of adverse effects can be increased when Udenafil is combined with Cyclopentamine.,increase,risk
Cyclopentamine,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Cyclopentamine.,increase,risk
Cyclopentamine,Vancomycin,The risk or severity of adverse effects can be increased when Vancomycin is combined with Cyclopentamine.,increase,risk
Cyclopentamine,Vasopressin,Cyclopentamine may increase the hypertensive activities of Vasopressin.,increase,no risk
Cyclopentamine,Vemurafenib,The risk or severity of adverse effects can be increased when Vemurafenib is combined with Cyclopentamine.,increase,risk
Cyclopentamine,Viomycin,The risk or severity of adverse effects can be increased when Viomycin is combined with Cyclopentamine.,increase,risk
Cyclopentamine,Zonisamide,The risk or severity of adverse effects can be increased when Zonisamide is combined with Cyclopentamine.,increase,risk
Cyamemazine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Cyamemazine.,increase,risk
Cyamemazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Cyamemazine.,increase,risk
Cyamemazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Cyamemazine.,increase,risk
Cyamemazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Cyamemazine is combined with Ganaxolone.",increase,risk
Cyamemazine,Gepirone,The risk or severity of CNS depression can be increased when Cyamemazine is combined with Gepirone.,increase,risk
Cyamemazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Cyamemazine.,decrease,no risk
Cyamemazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Cyamemazine.,decrease,no risk
Cyamemazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Cyamemazine.,decrease,no risk
Cyamemazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Cyamemazine.,decrease,no risk
Cyamemazine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Cyamemazine.,increase,risk
Cyamemazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyamemazine.,decrease,no risk
Cyamemazine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Cyamemazine.,increase,risk
Cyamemazine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Cyamemazine.,increase,risk
Cyamemazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Cyamemazine.,increase,risk
Cyamemazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Cyamemazine.,increase,risk
Cyamemazine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Cyamemazine.,increase,risk
Cyamemazine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Cyamemazine.,increase,risk
Cyamemazine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Cyamemazine.,increase,risk
Cyamemazine,Hydrocodone,Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cyamemazine,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Hydromorphone.,increase,risk
Cyamemazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Cyamemazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Cyamemazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Cyamemazine.,increase,risk
Cyamemazine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.,increase,no risk
Cyamemazine,Hyoscyamine,Cyamemazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Cyamemazine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Cyamemazine.,increase,risk
Cyamemazine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Cyamemazine.,increase,risk
Cyamemazine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Cyamemazine.,increase,risk
Cyamemazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cyamemazine is combined with Oliceridine.",increase,risk
Cyamemazine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Cyamemazine.,increase,risk
Cyamemazine,Opium,The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Opium.,increase,risk
Cyamemazine,Orphenadrine,Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Cyamemazine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Cyamemazine.,increase,risk
Cyamemazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Cyamemazine.,increase,risk
Cyamemazine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Cyamemazine.,increase,risk
Cyamemazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Cyamemazine.,increase,no risk
Cyamemazine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Cyamemazine.,increase,risk
Cyamemazine,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Oxycodone.,increase,risk
Cyamemazine,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when Cyamemazine is combined with Oxymorphone.,increase,risk
Cyamemazine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Cyamemazine.,increase,risk
Cyamemazine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Cyamemazine.,increase,risk
Barbexaclone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Barbexaclone.,increase,risk
Barbexaclone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Barbexaclone.,increase,risk
Barbexaclone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Barbexaclone.,increase,risk
Barbexaclone,Gamolenic acid,The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Barbexaclone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Barbexaclone is combined with Ganaxolone.",increase,risk
Barbexaclone,Ganciclovir,The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Ganciclovir.,decrease,no risk
Barbexaclone,Gepirone,The risk or severity of CNS depression can be increased when Barbexaclone is combined with Gepirone.,increase,risk
Barbexaclone,Gestrinone,The metabolism of Gestrinone can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Barbexaclone.,increase,risk
Barbexaclone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Barbexaclone.,increase,risk
Barbexaclone,Griseofulvin,The serum concentration of Griseofulvin can be decreased when it is combined with Barbexaclone.,decrease,no risk
Barbexaclone,Guanfacine,Barbexaclone may increase the hypotensive activities of Guanfacine.,increase,no risk
Barbexaclone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Barbexaclone.,increase,risk
Barbexaclone,Halofantrine,The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Halofantrine.,decrease,no risk
Barbexaclone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Barbexaclone.,increase,risk
Barbexaclone,Halothane,Barbexaclone may increase the hypotensive activities of Halothane.,increase,no risk
Barbexaclone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Barbexaclone.,increase,risk
Barbexaclone,Hydralazine,Barbexaclone may increase the hypotensive activities of Hydralazine.,increase,no risk
Barbexaclone,Hydrochlorothiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Barbexaclone is combined with Hydrochlorothiazide.,increase,risk
Barbexaclone,Hydrocodone,Barbexaclone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Barbexaclone,Hydroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Barbexaclone is combined with Hydroflumethiazide.,increase,risk
Barbexaclone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Barbexaclone.,increase,risk
Barbexaclone,Hydroxychloroquine,The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Barbexaclone,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Barbexaclone.,increase,no risk
Barbexaclone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Barbexaclone.,increase,risk
Barbexaclone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Barbexaclone.,increase,risk
Barbexaclone,Obinutuzumab,Barbexaclone may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Barbexaclone,Olanzapine,Barbexaclone may increase the hypotensive activities of Olanzapine.,increase,no risk
Barbexaclone,Olaparib,The metabolism of Olaparib can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Barbexaclone is combined with Oliceridine.",increase,risk
Barbexaclone,Olmesartan,Barbexaclone may increase the hypotensive activities of Olmesartan.,increase,no risk
Barbexaclone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Barbexaclone.,increase,risk
Barbexaclone,Opicapone,Barbexaclone may increase the hypotensive activities of Opicapone.,increase,no risk
Barbexaclone,Opium,The risk or severity of CNS depression can be increased when Barbexaclone is combined with Opium.,increase,risk
Barbexaclone,Orlistat,Orlistat can cause a decrease in the absorption of Barbexaclone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Barbexaclone,Orphenadrine,Barbexaclone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Barbexaclone,Osimertinib,The metabolism of Osimertinib can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Barbexaclone.,increase,risk
Barbexaclone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Barbexaclone.,increase,risk
Barbexaclone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Barbexaclone is combined with Oxetacaine.,increase,risk
Barbexaclone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Barbexaclone.,increase,risk
Barbexaclone,Oxprenolol,Barbexaclone may increase the hypotensive activities of Oxprenolol.,increase,no risk
Barbexaclone,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Barbexaclone.,decrease,no risk
Barbexaclone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Barbexaclone is combined with Oxybuprocaine.,increase,risk
Barbexaclone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Barbexaclone.,increase,risk
Barbexaclone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Barbexaclone.,increase,risk
Barbexaclone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Barbexaclone.,increase,risk
Barbexaclone,Quetiapine,Barbexaclone may increase the hypotensive activities of Quetiapine.,increase,no risk
Barbexaclone,Quinapril,Barbexaclone may increase the hypotensive activities of Quinapril.,increase,no risk
Barbexaclone,Quinethazone,The risk or severity of hypotension and orthostatic hypotension can be increased when Barbexaclone is combined with Quinethazone.,increase,risk
Barbexaclone,Quinidine,The metabolism of Quinidine can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Barbexaclone.,increase,risk
Barbexaclone,Quinupramine,The metabolism of Quinupramine can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Barbexaclone.,decrease,no risk
Barbexaclone,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Barbexaclone.,increase,risk
Barbexaclone,Valganciclovir,The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Valganciclovir.,decrease,no risk
Barbexaclone,Valproic acid,The serum concentration of Barbexaclone can be increased when it is combined with Valproic acid.,increase,no risk
Barbexaclone,Valsartan,Barbexaclone may increase the hypotensive activities of Valsartan.,increase,no risk
Barbexaclone,Vandetanib,The metabolism of Vandetanib can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Barbexaclone.,increase,risk
Barbexaclone,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Venetoclax,The metabolism of Venetoclax can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Barbexaclone.,increase,risk
Barbexaclone,Verapamil,Barbexaclone may increase the hypotensive activities of Verapamil.,increase,no risk
Barbexaclone,Vericiguat,Barbexaclone may increase the hypotensive activities of Vericiguat.,increase,no risk
Barbexaclone,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Barbexaclone.,increase,risk
Barbexaclone,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Barbexaclone.,increase,risk
Barbexaclone,Viloxazine,The risk or severity of CNS depression can be increased when Barbexaclone is combined with Viloxazine.,increase,risk
Barbexaclone,Vinblastine,The metabolism of Vinblastine can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Vincristine,The metabolism of Vincristine can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Vindesine,The metabolism of Vindesine can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Vinflunine,The metabolism of Vinflunine can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with Barbexaclone.,decrease,no risk
Barbexaclone,Vortioxetine,The risk or severity of CNS depression can be increased when Barbexaclone is combined with Vortioxetine.,increase,risk
Barbexaclone,Warfarin,The metabolism of Warfarin can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Xylometazoline,The metabolism of Xylometazoline can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Barbexaclone.,increase,risk
Barbexaclone,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Barbexaclone.,increase,risk
Barbexaclone,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Ziconotide,The risk or severity of CNS depression can be increased when Barbexaclone is combined with Ziconotide.,increase,risk
Barbexaclone,Zimelidine,The risk or severity of adverse effects can be increased when Barbexaclone is combined with Zimelidine.,increase,risk
Barbexaclone,Ziprasidone,The risk or severity of adverse effects can be increased when Barbexaclone is combined with Ziprasidone.,increase,risk
Barbexaclone,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Barbexaclone.,increase,risk
Barbexaclone,Zolpidem,Barbexaclone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Barbexaclone,Zonisamide,The metabolism of Zonisamide can be increased when combined with Barbexaclone.,increase,no risk
Barbexaclone,Zopiclone,The risk or severity of adverse effects can be increased when Barbexaclone is combined with Zopiclone.,increase,risk
Barbexaclone,Zotepine,The risk or severity of CNS depression can be increased when Barbexaclone is combined with Zotepine.,increase,risk
Barbexaclone,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Barbexaclone.,increase,risk
Barbexaclone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Barbexaclone.,increase,risk
Chlorphenoxamine,Galantamine,The therapeutic efficacy of Chlorphenoxamine can be decreased when used in combination with Galantamine.,decrease,no risk
Chlorphenoxamine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Ginkgo biloba,The therapeutic efficacy of Chlorphenoxamine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Chlorphenoxamine,Glucagon,Chlorphenoxamine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Chlorphenoxamine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Chlorphenoxamine.,decrease,no risk
Chlorphenoxamine,Glycopyrronium,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Glycopyrronium.,increase,risk
Chlorphenoxamine,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Guanfacine,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Homatropine,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Homatropine.,increase,risk
Chlorphenoxamine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Huperzine A,The therapeutic efficacy of Chlorphenoxamine can be decreased when used in combination with Huperzine A.,decrease,no risk
Chlorphenoxamine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorphenoxamine.,decrease,no risk
Chlorphenoxamine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Chlorphenoxamine.,decrease,no risk
Chlorphenoxamine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Chlorphenoxamine.,decrease,no risk
Chlorphenoxamine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Chlorphenoxamine.,increase,no risk
Chlorphenoxamine,Hydrocodone,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Hydrocodone.,increase,risk
Chlorphenoxamine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Chlorphenoxamine.,increase,no risk
Chlorphenoxamine,Hydromorphone,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Hydromorphone.,increase,risk
Chlorphenoxamine,Hyoscyamine,Chlorphenoxamine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Chlorphenoxamine,Ketamine,The therapeutic efficacy of Chlorphenoxamine can be decreased when used in combination with Ketamine.,decrease,no risk
Chlorphenoxamine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Chlorphenoxamine is combined with Oliceridine.",increase,risk
Chlorphenoxamine,Olodaterol,The risk or severity of Tachycardia can be increased when Chlorphenoxamine is combined with Olodaterol.,increase,risk
Chlorphenoxamine,Opium,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Opium.,increase,risk
Chlorphenoxamine,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Oxycodone,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Oxycodone.,increase,risk
Chlorphenoxamine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Oxymorphone,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Oxymorphone.,increase,risk
Chlorphenoxamine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Chlorphenoxamine.,decrease,no risk
Chlorphenoxamine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Chlorphenoxamine.,increase,no risk
Chlorphenoxamine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Quinupramine,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Quinupramine.,increase,risk
Chlorphenoxamine,Umeclidinium,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Umeclidinium.,increase,risk
Chlorphenoxamine,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Vilanterol,The risk or severity of Tachycardia can be increased when Chlorphenoxamine is combined with Vilanterol.,increase,risk
Chlorphenoxamine,Xamoterol,The risk or severity of Tachycardia can be increased when Chlorphenoxamine is combined with Xamoterol.,increase,risk
Chlorphenoxamine,Xylometazoline,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Chlorphenoxamine.,increase,risk
Chlorphenoxamine,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Chlorphenoxamine.,increase,risk
Cefaloridine,Gabapentin enacarbil,Cefaloridine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefaloridine,Gadobenic acid,Cefaloridine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefaloridine,Gadodiamide,Cefaloridine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefaloridine,Gadofosveset trisodium,Cefaloridine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefaloridine,Gadopentetic acid,Cefaloridine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefaloridine,Gadoteric acid,Cefaloridine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefaloridine,Gadoteridol,Cefaloridine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefaloridine,Ganciclovir,The excretion of Cefaloridine can be decreased when combined with Ganciclovir.,decrease,no risk
Cefaloridine,Gemcitabine,Cefaloridine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefaloridine,Gemfibrozil,The excretion of Cefaloridine can be decreased when combined with Gemfibrozil.,decrease,no risk
Cefaloridine,Gentamicin,Cefaloridine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefaloridine,Gimeracil,Cefaloridine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefaloridine,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefaloridine is combined with Givosiran.,increase,risk
Cefaloridine,Glipizide,Cefaloridine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefaloridine,Glyburide,The excretion of Cefaloridine can be decreased when combined with Glyburide.,decrease,no risk
Cefaloridine,Glycerol phenylbutyrate,Cefaloridine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefaloridine,Golodirsen,Cefaloridine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefaloridine,Goserelin,Cefaloridine may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefaloridine,Guanethidine,Cefaloridine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefaloridine,Guanfacine,Cefaloridine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefaloridine,Guanidine,The excretion of Cefaloridine can be decreased when combined with Guanidine.,decrease,no risk
Cefaloridine,Haloperidol,Cefaloridine may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefaloridine,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefaloridine.,decrease,no risk
Cefaloridine,Hydralazine,Cefaloridine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefaloridine,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Cefaloridine.,decrease,no risk
Cefaloridine,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Cefaloridine.,decrease,no risk
Cefaloridine,Hydromorphone,Cefaloridine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefaloridine,Hydroxocobalamin,Cefaloridine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefaloridine,Hydroxyethyl Starch,Cefaloridine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefaloridine,Kanamycin,Cefaloridine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefaloridine,Ketamine,Cefaloridine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefaloridine,Ketazolam,Cefaloridine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefaloridine,Ketoprofen,The excretion of Cefaloridine can be decreased when combined with Ketoprofen.,decrease,no risk
Cefaloridine,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefaloridine.,increase,risk
Cefaloridine,Octinoxate,Cefaloridine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefaloridine,Ofloxacin,The excretion of Cefaloridine can be decreased when combined with Ofloxacin.,decrease,no risk
Cefaloridine,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefaloridine is combined with Olsalazine.,increase,risk
Cefaloridine,Opium,Cefaloridine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefaloridine,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Cefaloridine.,decrease,no risk
Cefaloridine,Ouabain,The excretion of Cefaloridine can be decreased when combined with Ouabain.,decrease,no risk
Cefaloridine,Oxacillin,Cefaloridine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefaloridine,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefaloridine.,increase,risk
Cefaloridine,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cefaloridine.,increase,risk
Cefaloridine,Oxazepam,Cefaloridine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefaloridine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefaloridine is combined with Oxetacaine.,increase,risk
Cefaloridine,Oxybenzone,Cefaloridine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefaloridine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefaloridine is combined with Oxybuprocaine.,increase,risk
Cefaloridine,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Cefaloridine.,increase,risk
Cefaloridine,Oxyquinoline,Cefaloridine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefaloridine,Oxytetracycline,The excretion of Cefaloridine can be decreased when combined with Oxytetracycline.,decrease,no risk
Cefaloridine,Quetiapine,Cefaloridine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefaloridine,Quinapril,The excretion of Quinapril can be decreased when combined with Cefaloridine.,decrease,no risk
Cefaloridine,Quinidine,Cefaloridine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Articaine,Brexpiprazole,The risk or severity of CNS depression can be increased when Articaine is combined with Brexpiprazole.,increase,risk
Articaine,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Articaine.,increase,risk
Articaine,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Articaine.,increase,risk
Articaine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Articaine.,increase,no risk
Articaine,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Articaine.,increase,risk
Articaine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Articaine.,increase,risk
Articaine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Articaine.,decrease,no risk
Articaine,Bromperidol,The risk or severity of CNS depression can be increased when Articaine is combined with Bromperidol.,increase,risk
Articaine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Articaine.,increase,risk
Articaine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Articaine.,increase,risk
Articaine,Buprenorphine,Articaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Articaine,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Articaine.,increase,risk
Articaine,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Articaine.,increase,risk
Articaine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Articaine.,increase,risk
Articaine,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Articaine.,increase,risk
Articaine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Articaine.,increase,risk
Articaine,Butacaine,The risk or severity of methemoglobinemia can be increased when Articaine is combined with Butacaine.,increase,risk
Articaine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Articaine.,increase,risk
Articaine,Butamben,The risk or severity of methemoglobinemia can be increased when Articaine is combined with Butamben.,increase,risk
Articaine,Butaperazine,The risk or severity of CNS depression can be increased when Articaine is combined with Butaperazine.,increase,risk
Articaine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Articaine.,increase,risk
Articaine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Articaine.,increase,risk
Articaine,Butriptyline,The risk or severity of CNS depression can be increased when Articaine is combined with Butriptyline.,increase,risk
Articaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Articaine.,increase,risk
Articaine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Articaine.,increase,risk
Articaine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Articaine.,increase,risk
Articaine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Articaine is combined with Ganaxolone.",increase,risk
Articaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Articaine.,increase,risk
Articaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Articaine.,increase,risk
Articaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Articaine.,increase,risk
Articaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Articaine.,increase,risk
Articaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Articaine.,increase,risk
Articaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Articaine.,increase,risk
Articaine,Gepirone,The risk or severity of CNS depression can be increased when Articaine is combined with Gepirone.,increase,risk
Articaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Articaine.,increase,risk
Articaine,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Articaine.,increase,risk
Articaine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Articaine.,decrease,no risk
Articaine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Articaine.,decrease,no risk
Articaine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Articaine.,decrease,no risk
Articaine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Articaine.,decrease,no risk
Articaine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Articaine.,increase,risk
Articaine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Articaine.,decrease,no risk
Articaine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Articaine.,decrease,no risk
Articaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Articaine.,increase,risk
Articaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Articaine.,increase,risk
Articaine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Articaine.,increase,risk
Articaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Articaine.,increase,risk
Articaine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Articaine.,increase,risk
Articaine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Articaine.,increase,risk
Articaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Articaine.,increase,risk
Articaine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Articaine.,increase,risk
Articaine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Articaine.,increase,risk
Articaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Articaine.,increase,risk
Articaine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Articaine.,increase,risk
Articaine,Hyaluronidase,Hyaluronidase can cause an increase in the absorption of Articaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Articaine,Hyaluronidase (human recombinant),Hyaluronidase (human recombinant) can cause an increase in the absorption of Articaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Articaine,Hyaluronidase (ovine),Hyaluronidase (ovine) can cause an increase in the absorption of Articaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Articaine,Hydrocodone,Articaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Articaine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Articaine.,increase,risk
Articaine,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Articaine.,increase,risk
Articaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Articaine.,increase,risk
Articaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Articaine.,increase,risk
Articaine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Articaine.,increase,no risk
Articaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Articaine.,increase,risk
Articaine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Articaine.,increase,risk
Articaine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Articaine.,increase,risk
Articaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Articaine.,increase,risk
Articaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Articaine.,increase,risk
Articaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Articaine.,increase,risk
Articaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Articaine.,increase,risk
Articaine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Articaine.,increase,risk
Articaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Articaine.,increase,risk
Articaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Articaine.,increase,risk
Articaine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Articaine is combined with Oliceridine.",increase,risk
Articaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Articaine.,increase,risk
Articaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Articaine.,increase,risk
Articaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Articaine.,increase,risk
Articaine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Articaine.,increase,risk
Articaine,Opium,The risk or severity of CNS depression can be increased when Articaine is combined with Opium.,increase,risk
Articaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Articaine.,increase,risk
Articaine,Orphenadrine,Articaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Articaine,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Articaine.,increase,risk
Articaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Articaine.,increase,risk
Articaine,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Articaine.,increase,risk
Articaine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Articaine.,increase,risk
Articaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Articaine.,increase,risk
Articaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Articaine is combined with Oxetacaine.,increase,risk
Articaine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Articaine.,increase,risk
Articaine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Articaine.,increase,risk
Articaine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Articaine.,increase,risk
Articaine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Articaine.,increase,risk
Articaine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Articaine.,increase,risk
Articaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Articaine.,increase,risk
Articaine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Articaine.,increase,risk
Articaine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Articaine.,increase,risk
Articaine,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Articaine.,increase,risk
Articaine,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Articaine.,increase,risk
Articaine,Quinupramine,The risk or severity of CNS depression can be increased when Articaine is combined with Quinupramine.,increase,risk
Articaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Articaine.,increase,risk
Articaine,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Articaine.,increase,risk
Articaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Articaine.,increase,risk
Articaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Articaine.,increase,risk
Articaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Articaine.,increase,risk
Articaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Articaine.,increase,risk
Articaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Articaine.,increase,risk
Articaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Articaine.,increase,risk
Articaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Articaine.,increase,risk
Articaine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Articaine.,increase,risk
Articaine,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Articaine.,increase,risk
Articaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Articaine.,increase,risk
Articaine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Articaine.,increase,risk
Articaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Articaine.,increase,risk
Articaine,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Articaine.,increase,risk
Articaine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Articaine.,decrease,no risk
Articaine,Viloxazine,The risk or severity of CNS depression can be increased when Articaine is combined with Viloxazine.,increase,risk
Articaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Articaine.,increase,risk
Articaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Articaine.,increase,risk
Articaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Articaine.,increase,risk
Articaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Articaine.,increase,risk
Articaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Articaine.,increase,risk
Articaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Articaine.,increase,risk
Articaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Articaine.,increase,risk
Articaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Articaine.,increase,risk
Articaine,Vortioxetine,The risk or severity of CNS depression can be increased when Articaine is combined with Vortioxetine.,increase,risk
Articaine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Articaine.,increase,risk
Articaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Articaine.,increase,risk
Articaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Articaine.,increase,risk
Articaine,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Articaine.,increase,risk
Articaine,Zimelidine,The risk or severity of adverse effects can be increased when Articaine is combined with Zimelidine.,increase,risk
Articaine,Ziprasidone,The risk or severity of adverse effects can be increased when Articaine is combined with Ziprasidone.,increase,risk
Articaine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Articaine.,increase,risk
Articaine,Zolpidem,Articaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Articaine,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Articaine.,increase,risk
Articaine,Zopiclone,The risk or severity of adverse effects can be increased when Articaine is combined with Zopiclone.,increase,risk
Articaine,Zotepine,The risk or severity of CNS depression can be increased when Articaine is combined with Zotepine.,increase,risk
Articaine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Articaine.,increase,risk
Articaine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Articaine.,increase,risk
Carmofur,Benzocaine,The risk or severity of methemoglobinemia can be increased when Carmofur is combined with Benzocaine.,increase,risk
Carmofur,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Carmofur is combined with Benzyl alcohol.,increase,risk
Carmofur,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Carmofur is combined with Bupivacaine.,increase,risk
Carmofur,Butacaine,The risk or severity of methemoglobinemia can be increased when Carmofur is combined with Butacaine.,increase,risk
Carmofur,Butamben,The risk or severity of methemoglobinemia can be increased when Carmofur is combined with Butamben.,increase,risk
Carmofur,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Carmofur is combined with Oxetacaine.,increase,risk
Carmofur,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Carmofur is combined with Oxybuprocaine.,increase,risk
Beclamide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Beclamide.,increase,risk
Beclamide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Beclamide.,increase,risk
Beclamide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Beclamide.,increase,risk
Beclamide,Gamolenic acid,The therapeutic efficacy of Beclamide can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Beclamide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Beclamide is combined with Ganaxolone.",increase,risk
Beclamide,Ganciclovir,The therapeutic efficacy of Beclamide can be decreased when used in combination with Ganciclovir.,decrease,no risk
Beclamide,Gepirone,The risk or severity of CNS depression can be increased when Beclamide is combined with Gepirone.,increase,risk
Beclamide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Beclamide.,increase,no risk
Beclamide,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Beclamide.,increase,risk
Beclamide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Beclamide.,increase,risk
Beclamide,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Beclamide.,increase,risk
Beclamide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Beclamide.,increase,risk
Beclamide,Halofantrine,The therapeutic efficacy of Beclamide can be decreased when used in combination with Halofantrine.,decrease,no risk
Beclamide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Beclamide.,increase,risk
Beclamide,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Beclamide.,increase,risk
Beclamide,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Beclamide.,increase,risk
Beclamide,Hydrocodone,Beclamide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Beclamide,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Beclamide.,increase,risk
Beclamide,Hydroxychloroquine,The therapeutic efficacy of Beclamide can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Beclamide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Beclamide.,increase,no risk
Beclamide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Beclamide.,increase,no risk
Beclamide,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Beclamide.,increase,risk
Beclamide,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Beclamide.,increase,risk
Beclamide,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Beclamide.,increase,risk
Beclamide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Beclamide is combined with Oliceridine.",increase,risk
Beclamide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Beclamide.,increase,risk
Beclamide,Opium,The risk or severity of CNS depression can be increased when Beclamide is combined with Opium.,increase,risk
Beclamide,Orlistat,Orlistat can cause a decrease in the absorption of Beclamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Beclamide,Orphenadrine,Beclamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Beclamide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Beclamide.,increase,risk
Beclamide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Beclamide.,increase,risk
Beclamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Beclamide is combined with Oxetacaine.,increase,risk
Beclamide,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Beclamide.,increase,risk
Beclamide,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Beclamide.,increase,risk
Beclamide,Oxtriphylline,Beclamide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Beclamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Beclamide is combined with Oxybuprocaine.,increase,risk
Beclamide,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Beclamide.,increase,risk
Beclamide,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Beclamide.,increase,risk
Beclamide,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Beclamide.,increase,risk
Beclamide,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Beclamide.,increase,risk
Beclamide,Quinidine,The therapeutic efficacy of Beclamide can be decreased when used in combination with Quinidine.,decrease,no risk
Beclamide,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Beclamide.,increase,risk
Beclamide,Quinupramine,The risk or severity of CNS depression can be increased when Beclamide is combined with Quinupramine.,increase,risk
Beclamide,Ulipristal,The metabolism of Ulipristal can be increased when combined with Beclamide.,increase,no risk
Beclamide,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Beclamide.,increase,risk
Beclamide,Valganciclovir,The therapeutic efficacy of Beclamide can be decreased when used in combination with Valganciclovir.,decrease,no risk
Beclamide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Beclamide.,increase,risk
Beclamide,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Beclamide.,increase,risk
Beclamide,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Beclamide.,increase,risk
Beclamide,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Beclamide.,increase,risk
Beclamide,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Beclamide.,increase,risk
Beclamide,Viloxazine,The risk or severity of CNS depression can be increased when Beclamide is combined with Viloxazine.,increase,risk
Beclamide,Vortioxetine,The risk or severity of CNS depression can be increased when Beclamide is combined with Vortioxetine.,increase,risk
Beclamide,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Beclamide.,increase,risk
Beclamide,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Beclamide.,increase,risk
Beclamide,Ziconotide,The risk or severity of CNS depression can be increased when Beclamide is combined with Ziconotide.,increase,risk
Beclamide,Zimelidine,The risk or severity of adverse effects can be increased when Beclamide is combined with Zimelidine.,increase,risk
Beclamide,Ziprasidone,The risk or severity of adverse effects can be increased when Beclamide is combined with Ziprasidone.,increase,risk
Beclamide,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Beclamide.,increase,risk
Beclamide,Zolpidem,Beclamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Beclamide,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Beclamide.,increase,risk
Beclamide,Zopiclone,The risk or severity of adverse effects can be increased when Beclamide is combined with Zopiclone.,increase,risk
Beclamide,Zotepine,The risk or severity of CNS depression can be increased when Beclamide is combined with Zotepine.,increase,risk
Beclamide,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Beclamide.,increase,risk
Beclamide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Beclamide.,increase,risk
Befunolol,Givosiran,The serum concentration of Befunolol can be increased when it is combined with Givosiran.,increase,no risk
Befunolol,Haloperidol,The serum concentration of Befunolol can be increased when it is combined with Haloperidol.,increase,no risk
Befunolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Befunolol.,increase,no risk
Befunolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Befunolol.,increase,risk
Befunolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Befunolol.,decrease,no risk
Befunolol,Viloxazine,The metabolism of Befunolol can be decreased when combined with Viloxazine.,decrease,no risk
Captodiame,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Captodiame.,increase,risk
Captodiame,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Captodiame.,increase,risk
Captodiame,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Captodiame.,increase,risk
Captodiame,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Captodiame is combined with Ganaxolone.",increase,risk
Captodiame,Gepirone,The risk or severity of CNS depression can be increased when Captodiame is combined with Gepirone.,increase,risk
Captodiame,Gilteritinib,The therapeutic efficacy of Captodiame can be decreased when used in combination with Gilteritinib.,decrease,no risk
Captodiame,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Captodiame.,increase,risk
Captodiame,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Captodiame.,increase,risk
Captodiame,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Captodiame.,increase,risk
Captodiame,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Captodiame.,increase,risk
Captodiame,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Captodiame.,increase,risk
Captodiame,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Captodiame.,increase,risk
Captodiame,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Captodiame.,increase,risk
Captodiame,Hydrocodone,Captodiame may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Captodiame,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Captodiame.,increase,risk
Captodiame,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Captodiame.,increase,no risk
Captodiame,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Captodiame.,increase,risk
Captodiame,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Captodiame.,increase,risk
Captodiame,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Captodiame.,increase,risk
Captodiame,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Captodiame is combined with Oliceridine.",increase,risk
Captodiame,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Captodiame.,increase,risk
Captodiame,Opium,The risk or severity of CNS depression can be increased when Captodiame is combined with Opium.,increase,risk
Captodiame,Orphenadrine,Captodiame may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Captodiame,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Captodiame.,increase,risk
Captodiame,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Captodiame.,increase,risk
Captodiame,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Captodiame.,increase,risk
Captodiame,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Captodiame.,increase,risk
Captodiame,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Captodiame.,increase,risk
Captodiame,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Captodiame.,increase,risk
Captodiame,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Captodiame.,increase,risk
Captodiame,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Captodiame.,increase,risk
Captodiame,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Captodiame.,increase,risk
Captodiame,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Captodiame.,increase,risk
Captodiame,Quinupramine,The risk or severity of CNS depression can be increased when Captodiame is combined with Quinupramine.,increase,risk
Captodiame,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Captodiame.,increase,risk
Captodiame,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Captodiame.,increase,risk
Captodiame,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Captodiame.,increase,risk
Captodiame,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Captodiame.,increase,risk
Captodiame,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Captodiame.,increase,risk
Captodiame,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Captodiame.,increase,risk
Captodiame,Viloxazine,The risk or severity of CNS depression can be increased when Captodiame is combined with Viloxazine.,increase,risk
Captodiame,Vortioxetine,The risk or severity of CNS depression can be increased when Captodiame is combined with Vortioxetine.,increase,risk
Captodiame,Warfarin,The risk or severity of adverse effects can be increased when Captodiame is combined with Warfarin.,increase,risk
Captodiame,Yohimbine,The therapeutic efficacy of Captodiame can be increased when used in combination with Yohimbine.,increase,no risk
Captodiame,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Captodiame.,increase,risk
Captodiame,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Captodiame.,increase,risk
Captodiame,Zimelidine,The risk or severity of adverse effects can be increased when Captodiame is combined with Zimelidine.,increase,risk
Captodiame,Ziprasidone,The risk or severity of adverse effects can be increased when Captodiame is combined with Ziprasidone.,increase,risk
Captodiame,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Captodiame.,increase,risk
Captodiame,Zolpidem,Captodiame may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Captodiame,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Captodiame.,increase,risk
Captodiame,Zopiclone,The risk or severity of adverse effects can be increased when Captodiame is combined with Zopiclone.,increase,risk
Captodiame,Zotepine,The risk or severity of CNS depression can be increased when Captodiame is combined with Zotepine.,increase,risk
Captodiame,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Captodiame.,increase,risk
Captodiame,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Captodiame.,increase,risk
Canrenoic acid,Gabapentin enacarbil,Canrenoic acid may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Gadobenic acid,Canrenoic acid may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Gadodiamide,Canrenoic acid may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Gadofosveset trisodium,Canrenoic acid may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Gadopentetic acid,Canrenoic acid may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Gadoteric acid,Canrenoic acid may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Gadoteridol,Canrenoic acid may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Ganciclovir,Canrenoic acid may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Gemcitabine,Canrenoic acid may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Gemfibrozil,Canrenoic acid may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Gimeracil,Canrenoic acid may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Glipizide,Canrenoic acid may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Gluconic Acid,The risk or severity of dehydration can be increased when Canrenoic acid is combined with Gluconic Acid.,increase,risk
Canrenoic acid,Glycerin,The risk or severity of dehydration can be increased when Canrenoic acid is combined with Glycerin.,increase,risk
Canrenoic acid,Glycerol phenylbutyrate,Canrenoic acid may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Glycol salicylate is combined with Canrenoic acid.",increase,risk
Canrenoic acid,Golodirsen,Canrenoic acid may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Goserelin,Canrenoic acid may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Guanethidine,Canrenoic acid may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Guanfacine,Canrenoic acid may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Haloperidol,Canrenoic acid may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Canrenoic acid.,increase,risk
Canrenoic acid,Hydralazine,Canrenoic acid may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Hydrocodone,The therapeutic efficacy of Canrenoic acid can be decreased when used in combination with Hydrocodone.,decrease,no risk
Canrenoic acid,Hydromorphone,Canrenoic acid may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Hydroxocobalamin,Canrenoic acid may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Hydroxyethyl Starch,Canrenoic acid may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Ketamine,Canrenoic acid may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Ketazolam,Canrenoic acid may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Canrenoic acid.,increase,risk
Canrenoic acid,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Canrenoic acid.",increase,risk
Canrenoic acid,Ketorolac,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Canrenoic acid.",increase,risk
Canrenoic acid,Octinoxate,Canrenoic acid may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Oliceridine,The therapeutic efficacy of Canrenoic acid can be decreased when used in combination with Oliceridine.,decrease,no risk
Canrenoic acid,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Canrenoic acid.,increase,risk
Canrenoic acid,Opium,Canrenoic acid may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Oseltamivir,Canrenoic acid may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Ouabain,Canrenoic acid may decrease the excretion rate of Ouabain which could result in a higher serum level.,decrease,no risk
Canrenoic acid,Oxacillin,Canrenoic acid may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Canrenoic acid.",increase,risk
Canrenoic acid,Oxazepam,Canrenoic acid may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Canrenoic acid.,increase,risk
Canrenoic acid,Oxybenzone,Canrenoic acid may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Oxycodone,The therapeutic efficacy of Canrenoic acid can be decreased when used in combination with Oxycodone.,decrease,no risk
Canrenoic acid,Oxymorphone,The therapeutic efficacy of Canrenoic acid can be decreased when used in combination with Oxymorphone.,decrease,no risk
Canrenoic acid,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Canrenoic acid.",increase,risk
Canrenoic acid,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Canrenoic acid is combined with Oxyphenisatin acetate.,increase,risk
Canrenoic acid,Oxyquinoline,Canrenoic acid may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Quetiapine,Canrenoic acid may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Quinapril,The risk or severity of hyperkalemia can be increased when Canrenoic acid is combined with Quinapril.,increase,risk
Canrenoic acid,Quinidine,Canrenoic acid may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Vaborbactam,Canrenoic acid may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Valaciclovir,Canrenoic acid may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Valbenazine,Canrenoic acid may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valdecoxib is combined with Canrenoic acid.",increase,risk
Canrenoic acid,Valganciclovir,Canrenoic acid may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Valsartan,The risk or severity of hyperkalemia can be increased when Valsartan is combined with Canrenoic acid.,increase,risk
Canrenoic acid,Vancomycin,Canrenoic acid may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Varenicline,Canrenoic acid may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Venlafaxine,Canrenoic acid may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Verapamil,Canrenoic acid may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Vilanterol,Canrenoic acid may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Viloxazine,Canrenoic acid may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Vortioxetine,Canrenoic acid may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Warfarin,Canrenoic acid may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Zaleplon,Canrenoic acid may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Zanamivir,Canrenoic acid may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Canrenoic acid,Ziconotide,The risk or severity of CNS depression can be increased when Canrenoic acid is combined with Ziconotide.,increase,risk
Canrenoic acid,Zofenopril,The risk or severity of hyperkalemia can be increased when Canrenoic acid is combined with Zofenopril.,increase,risk
Canrenoic acid,Zonisamide,Canrenoic acid may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Butriptyline,Brexanolone,The risk or severity of CNS depression can be increased when Butriptyline is combined with Brexanolone.,increase,risk
Butriptyline,Brexpiprazole,The risk or severity of CNS depression can be increased when Butriptyline is combined with Brexpiprazole.,increase,risk
Butriptyline,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Butriptyline.,increase,no risk
Butriptyline,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Butriptyline.,increase,risk
Butriptyline,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Butriptyline.,increase,risk
Butriptyline,Bromfenac,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Bromfenac.,increase,risk
Butriptyline,Bromocriptine,Butriptyline may increase the vasopressor activities of Bromocriptine.,increase,no risk
Butriptyline,Bromperidol,The risk or severity of CNS depression can be increased when Butriptyline is combined with Bromperidol.,increase,risk
Butriptyline,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Butriptyline.,increase,risk
Butriptyline,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Butriptyline.,increase,risk
Butriptyline,Bufexamac,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Bufexamac.,increase,risk
Butriptyline,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Bumadizone.,increase,risk
Butriptyline,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Butriptyline.,increase,risk
Butriptyline,Buprenorphine,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Butriptyline,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Butriptyline.,increase,risk
Butriptyline,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Butriptyline.,increase,risk
Butriptyline,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Butriptyline.,increase,risk
Butriptyline,Butabarbital,The metabolism of Butriptyline can be increased when combined with Butabarbital.,increase,no risk
Butriptyline,Butalbital,The metabolism of Butriptyline can be increased when combined with Butalbital.,increase,no risk
Butriptyline,Butaperazine,The serum concentration of Butriptyline can be increased when it is combined with Butaperazine.,increase,no risk
Butriptyline,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Butriptyline.,increase,risk
Butriptyline,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Butriptyline.,increase,risk
Butriptyline,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Butriptyline.,increase,risk
Butriptyline,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Butriptyline.,increase,risk
Butriptyline,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Butriptyline.,increase,risk
Butriptyline,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Butriptyline.,increase,risk
Butriptyline,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Butriptyline.,increase,risk
Butriptyline,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Butriptyline.,increase,risk
Butriptyline,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Butriptyline is combined with Ganaxolone.",increase,risk
Butriptyline,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Butriptyline.,increase,risk
Butriptyline,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Butriptyline.,increase,risk
Butriptyline,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Butriptyline.,increase,risk
Butriptyline,Gilteritinib,The therapeutic efficacy of Butriptyline can be decreased when used in combination with Gilteritinib.,decrease,no risk
Butriptyline,Glasdegib,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Glasdegib.,increase,risk
Butriptyline,Gliclazide,Butriptyline may decrease the hypoglycemic activities of Gliclazide.,decrease,no risk
Butriptyline,Glimepiride,Butriptyline may decrease the hypoglycemic activities of Glimepiride.,decrease,no risk
Butriptyline,Glipizide,Butriptyline may decrease the hypoglycemic activities of Glipizide.,decrease,no risk
Butriptyline,Gliquidone,Butriptyline may decrease the hypoglycemic activities of Gliquidone.,decrease,no risk
Butriptyline,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Butriptyline.,increase,risk
Butriptyline,Glyburide,Butriptyline may decrease the hypoglycemic activities of Glyburide.,decrease,no risk
Butriptyline,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Glycol salicylate.,increase,risk
Butriptyline,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Butriptyline.,increase,risk
Butriptyline,Glymidine,Butriptyline may decrease the hypoglycemic activities of Glymidine.,decrease,no risk
Butriptyline,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Butriptyline.,increase,risk
Butriptyline,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Butriptyline.,increase,risk
Butriptyline,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Grepafloxacin.,increase,risk
Butriptyline,Guanabenz,The risk or severity of hypertension can be increased when Butriptyline is combined with Guanabenz.,increase,risk
Butriptyline,Guanadrel,Butriptyline may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Butriptyline,Guanethidine,Butriptyline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Butriptyline,Guanfacine,The risk or severity of hypertension can be increased when Butriptyline is combined with Guanfacine.,increase,risk
Butriptyline,Guanoxan,Butriptyline may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Butriptyline,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Butriptyline.,increase,risk
Butriptyline,Halofantrine,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Halofantrine.,increase,risk
Butriptyline,Haloperidol,The serum concentration of Butriptyline can be increased when it is combined with Haloperidol.,increase,no risk
Butriptyline,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Butriptyline.,increase,risk
Butriptyline,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Butriptyline.,increase,risk
Butriptyline,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Butriptyline.,increase,risk
Butriptyline,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Butriptyline.,increase,risk
Butriptyline,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Butriptyline.,increase,risk
Butriptyline,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Butriptyline.,decrease,no risk
Butriptyline,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Butriptyline.,decrease,no risk
Butriptyline,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Butriptyline.,decrease,no risk
Butriptyline,Hydralazine,Butriptyline may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Butriptyline,Hydrochlorothiazide,Butriptyline may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Butriptyline,Hydrocodone,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Butriptyline,Hydroflumethiazide,Butriptyline may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Butriptyline,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Butriptyline.,increase,risk
Butriptyline,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Butriptyline.,increase,risk
Butriptyline,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Hydroxyzine.,increase,risk
Butriptyline,Hyoscyamine,Butriptyline may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Butriptyline,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Butriptyline.,increase,risk
Butriptyline,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Butriptyline.,increase,risk
Butriptyline,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Butriptyline.,increase,risk
Butriptyline,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Ketoprofen.,increase,risk
Butriptyline,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Ketorolac.,increase,risk
Butriptyline,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Butriptyline.,increase,risk
Butriptyline,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Butriptyline.,increase,risk
Butriptyline,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Butriptyline.,increase,risk
Butriptyline,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Butriptyline is combined with Oliceridine.",increase,risk
Butriptyline,Olmesartan,Butriptyline may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Butriptyline,Olodaterol,The risk or severity of hypertension can be increased when Butriptyline is combined with Olodaterol.,increase,risk
Butriptyline,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Butriptyline.,increase,risk
Butriptyline,Opium,The risk or severity of CNS depression can be increased when Butriptyline is combined with Opium.,increase,risk
Butriptyline,Orciprenaline,The risk or severity of hypertension can be increased when Butriptyline is combined with Orciprenaline.,increase,risk
Butriptyline,Orphenadrine,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Butriptyline,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Butriptyline.,increase,risk
Butriptyline,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Oxaprozin.,increase,risk
Butriptyline,Oxatomide,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Oxatomide.,increase,risk
Butriptyline,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Butriptyline.,increase,risk
Butriptyline,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Butriptyline.,increase,risk
Butriptyline,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Butriptyline.,increase,risk
Butriptyline,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Butriptyline.,increase,risk
Butriptyline,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Butriptyline.,increase,risk
Butriptyline,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Butriptyline.,increase,risk
Butriptyline,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Butriptyline.,increase,risk
Butriptyline,Oxymetazoline,Butriptyline may increase the vasopressor activities of Oxymetazoline.,increase,no risk
Butriptyline,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Butriptyline.,increase,risk
Butriptyline,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Oxyphenbutazone.,increase,risk
Butriptyline,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Butriptyline.,increase,risk
Butriptyline,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Butriptyline.,increase,risk
Butriptyline,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Butriptyline.,increase,risk
Butriptyline,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Butriptyline.,increase,risk
Butriptyline,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Butriptyline.,increase,risk
Butriptyline,Quinapril,Butriptyline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Butriptyline,Quinestrol,The serum concentration of Butriptyline can be increased when it is combined with Quinestrol.,increase,no risk
Butriptyline,Quinidine,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Quinidine.,increase,risk
Butriptyline,Quinine,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Quinine.,increase,risk
Butriptyline,Quinupramine,The risk or severity of CNS depression can be increased when Butriptyline is combined with Quinupramine.,increase,risk
Butriptyline,Quizartinib,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Quizartinib.,increase,risk
Butriptyline,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Butriptyline.,increase,risk
Butriptyline,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Butriptyline.,increase,risk
Butriptyline,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Valdecoxib.,increase,risk
Butriptyline,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Butriptyline is combined with Valproate bismuth.,increase,risk
Butriptyline,Valproic acid,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Valproic acid.,increase,risk
Butriptyline,Valsartan,Butriptyline may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Butriptyline,Vandetanib,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Vandetanib.,increase,risk
Butriptyline,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Butriptyline.,increase,risk
Butriptyline,Vasopressin,Butriptyline may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Butriptyline,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Butriptyline.,increase,risk
Butriptyline,Vemurafenib,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Vemurafenib.,increase,risk
Butriptyline,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Butriptyline is combined with Venlafaxine.,increase,risk
Butriptyline,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Butriptyline.,increase,risk
Butriptyline,Vibegron,The risk or severity of hypertension can be increased when Butriptyline is combined with Vibegron.,increase,risk
Butriptyline,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Butriptyline.,increase,risk
Butriptyline,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Butriptyline.,increase,risk
Butriptyline,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Butriptyline.,increase,risk
Butriptyline,Vildagliptin,Butriptyline may decrease the hypoglycemic activities of Vildagliptin.,decrease,no risk
Butriptyline,Viloxazine,The risk or severity of CNS depression can be increased when Butriptyline is combined with Viloxazine.,increase,risk
Butriptyline,Vincristine,Vincristine may increase the neurotoxic activities of Butriptyline.,increase,no risk
Butriptyline,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Butriptyline.,increase,no risk
Butriptyline,Viomycin,Viomycin may increase the neurotoxic activities of Butriptyline.,increase,no risk
Butriptyline,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Butriptyline.,increase,risk
Butriptyline,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Butriptyline.,increase,risk
Butriptyline,Vortioxetine,The risk or severity of CNS depression can be increased when Butriptyline is combined with Vortioxetine.,increase,risk
Butriptyline,Warfarin,The risk or severity of bleeding can be increased when Butriptyline is combined with Warfarin.,increase,risk
Butriptyline,Xamoterol,The risk or severity of hypertension can be increased when Butriptyline is combined with Xamoterol.,increase,risk
Butriptyline,Xylometazoline,Butriptyline may increase the vasopressor activities of Xylometazoline.,increase,no risk
Butriptyline,Yohimbine,The therapeutic efficacy of Butriptyline can be increased when used in combination with Yohimbine.,increase,no risk
Butriptyline,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Butriptyline.,increase,risk
Butriptyline,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Butriptyline.,increase,risk
Butriptyline,Zimelidine,The risk or severity of adverse effects can be increased when Butriptyline is combined with Zimelidine.,increase,risk
Butriptyline,Ziprasidone,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Ziprasidone.,increase,risk
Butriptyline,Zofenopril,Butriptyline may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Butriptyline,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Butriptyline.,increase,risk
Butriptyline,Zolpidem,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Butriptyline,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Butriptyline.,increase,risk
Butriptyline,Zopiclone,The risk or severity of adverse effects can be increased when Butriptyline is combined with Zopiclone.,increase,risk
Butriptyline,Zotepine,The risk or severity of CNS depression can be increased when Butriptyline is combined with Zotepine.,increase,risk
Butriptyline,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Zuclopenthixol.,increase,risk
Butriptyline,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Butriptyline.,increase,risk
Brotizolam,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Brotizolam.,increase,risk
Brotizolam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Brotizolam.,increase,risk
Brotizolam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Brotizolam.,increase,risk
Brotizolam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Brotizolam is combined with Ganaxolone.",increase,risk
Brotizolam,Gepirone,The risk or severity of CNS depression can be increased when Brotizolam is combined with Gepirone.,increase,risk
Brotizolam,Glofitamab,The serum concentration of Brotizolam can be increased when it is combined with Glofitamab.,increase,no risk
Brotizolam,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Brotizolam.,increase,risk
Brotizolam,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Brotizolam.,increase,risk
Brotizolam,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Brotizolam.,increase,risk
Brotizolam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Brotizolam.,increase,risk
Brotizolam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Brotizolam.,increase,risk
Brotizolam,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Brotizolam.,increase,risk
Brotizolam,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Brotizolam.,increase,risk
Brotizolam,Hydrocodone,Brotizolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Brotizolam,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Brotizolam.,increase,risk
Brotizolam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Brotizolam.,increase,no risk
Brotizolam,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Brotizolam.,increase,risk
Brotizolam,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Brotizolam.,increase,risk
Brotizolam,Ketoconazole,The metabolism of Brotizolam can be decreased when combined with Ketoconazole.,decrease,no risk
Brotizolam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Brotizolam.,increase,risk
Brotizolam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Brotizolam is combined with Oliceridine.",increase,risk
Brotizolam,Omaveloxolone,The serum concentration of Brotizolam can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Brotizolam,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Brotizolam.,increase,risk
Brotizolam,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Brotizolam.,increase,risk
Brotizolam,Orphenadrine,Brotizolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Brotizolam,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Brotizolam.,increase,risk
Brotizolam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Brotizolam.,increase,risk
Brotizolam,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Brotizolam.,increase,risk
Brotizolam,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Brotizolam.,increase,risk
Brotizolam,Oxtriphylline,The therapeutic efficacy of Brotizolam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Brotizolam,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Brotizolam.,increase,risk
Brotizolam,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Brotizolam.,increase,risk
Brotizolam,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Brotizolam.,increase,risk
Brotizolam,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Brotizolam.,increase,risk
Brotizolam,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Brotizolam.,increase,risk
Brotizolam,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Brotizolam.,increase,risk
Brotizolam,Quinupramine,The risk or severity of CNS depression can be increased when Brotizolam is combined with Quinupramine.,increase,risk
Bromopride,Benzatropine,The risk or severity of adverse effects can be increased when Bromopride is combined with Benzatropine.,increase,risk
Bromopride,Brexpiprazole,The therapeutic efficacy of Brexpiprazole can be decreased when used in combination with Bromopride.,decrease,no risk
Bromopride,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Bromopride.,decrease,no risk
Bromopride,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Bromopride.,decrease,no risk
Bisacodyl,Gallamine triethiodide,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Bisacodyl,Glycerin,The risk or severity of adverse effects can be increased when Bisacodyl is combined with Glycerin.,increase,risk
Bisacodyl,Glycopyrronium,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Bisacodyl,Hexafluronium,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Hexafluronium.,decrease,no risk
Bisacodyl,Hexocyclium,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Hexocyclium.,decrease,no risk
Bisacodyl,Homatropine,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Homatropine.,decrease,no risk
Bisacodyl,Homatropine methylbromide,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Bisacodyl,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Bisacodyl.,increase,risk
Bisacodyl,Hydrocodone,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Hydrocodone.,decrease,no risk
Bisacodyl,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Bisacodyl.,increase,risk
Bisacodyl,Hydromorphone,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Hydromorphone.,decrease,no risk
Bisacodyl,Hydrotalcite,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Hydrotalcite.,decrease,no risk
Bisacodyl,Hyoscyamine,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Bisacodyl,Olanzapine,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Olanzapine.,decrease,no risk
Bisacodyl,Oliceridine,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Oliceridine.,decrease,no risk
Bisacodyl,Omeprazole,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Omeprazole.,decrease,no risk
Bisacodyl,Opium,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Opium.,decrease,no risk
Bisacodyl,Orphenadrine,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Orphenadrine.,decrease,no risk
Bisacodyl,Oxybutynin,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Oxybutynin.,decrease,no risk
Bisacodyl,Oxycodone,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Oxycodone.,decrease,no risk
Bisacodyl,Oxymorphone,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Oxymorphone.,decrease,no risk
Bisacodyl,Oxyphencyclimine,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Bisacodyl,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Bisacodyl is combined with Oxyphenisatin acetate.,increase,risk
Bisacodyl,Oxyphenonium,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Bisacodyl,Quetiapine,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Quetiapine.,decrease,no risk
Bisacodyl,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Bisacodyl.,increase,risk
Bisacodyl,Quinidine,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Quinidine.,decrease,no risk
Bisacodyl,Umeclidinium,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Umeclidinium.,decrease,no risk
Bisacodyl,Vecuronium,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Vecuronium.,decrease,no risk
Bisacodyl,Verapamil,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Verapamil.,decrease,no risk
Bisacodyl,Vonoprazan,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Vonoprazan.,decrease,no risk
Bisacodyl,Xylometazoline,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Xylometazoline.,decrease,no risk
Bisacodyl,Ziconotide,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Ziconotide.,decrease,no risk
Bisacodyl,Ziprasidone,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Ziprasidone.,decrease,no risk
Bisacodyl,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Bisacodyl.,increase,risk
Benzoctamine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Benzoctamine.,increase,risk
Benzoctamine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Benzoctamine.,increase,risk
Benzoctamine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Benzoctamine.,increase,risk
Benzoctamine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Benzoctamine is combined with Ganaxolone.",increase,risk
Benzoctamine,Gepirone,The risk or severity of CNS depression can be increased when Benzoctamine is combined with Gepirone.,increase,risk
Benzoctamine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Benzoctamine.,increase,risk
Benzoctamine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Benzoctamine.,increase,risk
Benzoctamine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Benzoctamine.,increase,risk
Benzoctamine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Benzoctamine.,increase,risk
Benzoctamine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Benzoctamine.,increase,risk
Benzoctamine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Benzoctamine.,increase,risk
Benzoctamine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Benzoctamine.,increase,risk
Benzoctamine,Hydrocodone,Benzoctamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Benzoctamine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Benzoctamine.,increase,risk
Benzoctamine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benzoctamine.,increase,no risk
Benzoctamine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Benzoctamine.,increase,risk
Benzoctamine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Benzoctamine.,increase,risk
Benzoctamine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Benzoctamine.,increase,risk
Benzoctamine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Benzoctamine is combined with Oliceridine.",increase,risk
Benzoctamine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Benzoctamine.,increase,risk
Benzoctamine,Opium,The risk or severity of CNS depression can be increased when Benzoctamine is combined with Opium.,increase,risk
Benzoctamine,Orphenadrine,Benzoctamine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Benzoctamine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Benzoctamine.,increase,risk
Benzoctamine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Benzoctamine.,increase,risk
Benzoctamine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Benzoctamine.,increase,risk
Benzoctamine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Benzoctamine.,increase,risk
Benzoctamine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Benzoctamine.,increase,risk
Benzoctamine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Benzoctamine.,increase,risk
Benzoctamine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Benzoctamine.,increase,risk
Benzoctamine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Benzoctamine.,increase,risk
Benzoctamine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Benzoctamine.,increase,risk
Benzoctamine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Benzoctamine.,increase,risk
Benzoctamine,Quinupramine,The risk or severity of CNS depression can be increased when Benzoctamine is combined with Quinupramine.,increase,risk
Benzoctamine,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Benzoctamine.,increase,risk
Benzoctamine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Benzoctamine.,increase,risk
Benzoctamine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Benzoctamine.,increase,risk
Benzoctamine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Benzoctamine.,increase,risk
Benzoctamine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Benzoctamine.,increase,risk
Benzoctamine,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Benzoctamine.,increase,risk
Benzoctamine,Viloxazine,The risk or severity of CNS depression can be increased when Benzoctamine is combined with Viloxazine.,increase,risk
Benzoctamine,Vortioxetine,The risk or severity of CNS depression can be increased when Benzoctamine is combined with Vortioxetine.,increase,risk
Benzoctamine,Yohimbine,The therapeutic efficacy of Benzoctamine can be increased when used in combination with Yohimbine.,increase,no risk
Benzoctamine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Benzoctamine.,increase,risk
Benzoctamine,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Benzoctamine.,increase,risk
Benzoctamine,Zimelidine,The risk or severity of adverse effects can be increased when Benzoctamine is combined with Zimelidine.,increase,risk
Benzoctamine,Ziprasidone,The risk or severity of adverse effects can be increased when Benzoctamine is combined with Ziprasidone.,increase,risk
Benzoctamine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Benzoctamine.,increase,risk
Benzoctamine,Zolpidem,Benzoctamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Benzoctamine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Benzoctamine.,increase,risk
Benzoctamine,Zopiclone,The risk or severity of adverse effects can be increased when Benzoctamine is combined with Zopiclone.,increase,risk
Benzoctamine,Zotepine,The risk or severity of CNS depression can be increased when Benzoctamine is combined with Zotepine.,increase,risk
Benzoctamine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Benzoctamine.,increase,risk
Benzoctamine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Benzoctamine.,increase,risk
Benfluorex,Gatifloxacin,The therapeutic efficacy of Benfluorex can be increased when used in combination with Gatifloxacin.,increase,no risk
Benfluorex,Gefapixant,The therapeutic efficacy of Benfluorex can be increased when used in combination with Gefapixant.,increase,no risk
Benfluorex,Gemifloxacin,The therapeutic efficacy of Benfluorex can be increased when used in combination with Gemifloxacin.,increase,no risk
Benfluorex,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Benfluorex.,increase,risk
Benfluorex,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Benfluorex.,increase,risk
Benfluorex,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Benfluorex.,increase,risk
Benfluorex,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Benfluorex.,increase,risk
Benfluorex,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Benfluorex.,increase,risk
Benfluorex,Glymidine,The therapeutic efficacy of Benfluorex can be increased when used in combination with Glymidine.,increase,no risk
Benfluorex,Goserelin,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Goserelin.,decrease,no risk
Benfluorex,Grepafloxacin,The therapeutic efficacy of Benfluorex can be increased when used in combination with Grepafloxacin.,increase,no risk
Benfluorex,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Benfluorex.,increase,risk
Benfluorex,Haloperidol,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Haloperidol.,decrease,no risk
Benfluorex,Histrelin,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Histrelin.,decrease,no risk
Benfluorex,Hydrochlorothiazide,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Benfluorex,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Benfluorex.,increase,risk
Benfluorex,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Benfluorex.,increase,risk
Benfluorex,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Benfluorex.,increase,risk
Benfluorex,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Benfluorex.,increase,risk
Benfluorex,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Benfluorex.,increase,risk
Benfluorex,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Benfluorex.,increase,risk
Benfluorex,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Benfluorex.,increase,risk
Benfluorex,Hydroflumethiazide,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Benfluorex,Hydroxychloroquine,The therapeutic efficacy of Benfluorex can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Benfluorex,Hydroxyprogesterone caproate,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Benfluorex,Ketotifen,The risk or severity of thrombocytopenia can be increased when Benfluorex is combined with Ketotifen.,increase,risk
Benfluorex,Octreotide,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Octreotide.,decrease,no risk
Benfluorex,Ofloxacin,The therapeutic efficacy of Benfluorex can be increased when used in combination with Ofloxacin.,increase,no risk
Benfluorex,Olanzapine,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Olanzapine.,decrease,no risk
Benfluorex,Olsalazine,Olsalazine may increase the hypoglycemic activities of Benfluorex.,increase,no risk
Benfluorex,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Benfluorex.,increase,no risk
Benfluorex,Oxprenolol,The therapeutic efficacy of Benfluorex can be increased when used in combination with Oxprenolol.,increase,no risk
Benfluorex,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Benfluorex.,increase,no risk
Benfluorex,Quetiapine,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Quetiapine.,decrease,no risk
Benfluorex,Quinethazone,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Quinethazone.,decrease,no risk
Benfluorex,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Benfluorex.,increase,risk
Benfluorex,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Benfluorex.,decrease,no risk
Benfluorex,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Benfluorex.,increase,risk
Benfluorex,Udenafil,The therapeutic efficacy of Benfluorex can be increased when used in combination with Udenafil.,increase,no risk
Benfluorex,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Benfluorex.,increase,risk
Benfluorex,Valdecoxib,The therapeutic efficacy of Benfluorex can be increased when used in combination with Valdecoxib.,increase,no risk
Benfluorex,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Benfluorex.,increase,risk
Benfluorex,Vemurafenib,The therapeutic efficacy of Benfluorex can be increased when used in combination with Vemurafenib.,increase,no risk
Benfluorex,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Benfluorex.,increase,risk
Benfluorex,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Benfluorex.,increase,risk
Benfluorex,Vildagliptin,The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with Benfluorex.,increase,risk
Benfluorex,Vorinostat,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Vorinostat.,decrease,no risk
Benfluorex,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Benfluorex.,increase,risk
Benfluorex,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Benfluorex.,increase,risk
Benfluorex,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Benfluorex.,increase,risk
Benfluorex,Ziprasidone,The therapeutic efficacy of Benfluorex can be decreased when used in combination with Ziprasidone.,decrease,no risk
Benfluorex,Zonisamide,The therapeutic efficacy of Benfluorex can be increased when used in combination with Zonisamide.,increase,no risk
Benactyzine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Benactyzine.,increase,risk
Benactyzine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Benactyzine.,increase,risk
Benactyzine,Galantamine,The therapeutic efficacy of Benactyzine can be decreased when used in combination with Galantamine.,decrease,no risk
Benactyzine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Benactyzine.,increase,risk
Benactyzine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Benactyzine is combined with Ganaxolone.",increase,risk
Benactyzine,Gepirone,The risk or severity of CNS depression can be increased when Benactyzine is combined with Gepirone.,increase,risk
Benactyzine,Ginkgo biloba,The therapeutic efficacy of Benactyzine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Benactyzine,Glucagon,Benactyzine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Benactyzine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Benactyzine.,increase,risk
Benactyzine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Benactyzine.,decrease,no risk
Benactyzine,Glycopyrronium,The risk or severity of adverse effects can be increased when Benactyzine is combined with Glycopyrronium.,increase,risk
Benactyzine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Benactyzine.,increase,risk
Benactyzine,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Benactyzine.,increase,risk
Benactyzine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Benactyzine.,increase,risk
Benactyzine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Benactyzine.,increase,risk
Benactyzine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Benactyzine.,increase,risk
Benactyzine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Benactyzine.,increase,risk
Benactyzine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Benactyzine.,increase,risk
Benactyzine,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Benactyzine.,increase,risk
Benactyzine,Homatropine,The risk or severity of adverse effects can be increased when Benactyzine is combined with Homatropine.,increase,risk
Benactyzine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Benactyzine.,increase,risk
Benactyzine,Huperzine A,The therapeutic efficacy of Benactyzine can be decreased when used in combination with Huperzine A.,decrease,no risk
Benactyzine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Benactyzine.,increase,no risk
Benactyzine,Hydrocodone,Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Benactyzine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Benactyzine.,increase,no risk
Benactyzine,Hydromorphone,The risk or severity of adverse effects can be increased when Benactyzine is combined with Hydromorphone.,increase,risk
Benactyzine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benactyzine.,increase,no risk
Benactyzine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Benactyzine.,increase,risk
Benactyzine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Benactyzine.,increase,risk
Benactyzine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Benactyzine.,increase,risk
Benactyzine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Benactyzine.,increase,risk
Benactyzine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Benactyzine is combined with Oliceridine.",increase,risk
Benactyzine,Olodaterol,The risk or severity of Tachycardia can be increased when Benactyzine is combined with Olodaterol.,increase,risk
Benactyzine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Benactyzine.,increase,risk
Benactyzine,Opium,The risk or severity of adverse effects can be increased when Benactyzine is combined with Opium.,increase,risk
Benactyzine,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Benactyzine.,increase,risk
Benactyzine,Orphenadrine,Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Benactyzine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Benactyzine.,increase,risk
Benactyzine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Benactyzine.,increase,risk
Benactyzine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Benactyzine.,increase,risk
Benactyzine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Benactyzine.,increase,risk
Benactyzine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Benactyzine.,increase,risk
Benactyzine,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Benactyzine.,increase,risk
Benactyzine,Oxycodone,The risk or severity of adverse effects can be increased when Benactyzine is combined with Oxycodone.,increase,risk
Benactyzine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Benactyzine.,increase,risk
Benactyzine,Oxymorphone,The risk or severity of adverse effects can be increased when Benactyzine is combined with Oxymorphone.,increase,risk
Benactyzine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Benactyzine.,increase,risk
Benactyzine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Benactyzine.,decrease,no risk
Benactyzine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Benactyzine.,increase,risk
Benactyzine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Benactyzine.,increase,risk
Benactyzine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Benactyzine.,increase,risk
Benactyzine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Benactyzine.,increase,no risk
Benactyzine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Benactyzine.,increase,risk
Benactyzine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Benactyzine.,increase,risk
Benactyzine,Quinupramine,The risk or severity of CNS depression can be increased when Benactyzine is combined with Quinupramine.,increase,risk
Benactyzine,Umeclidinium,The risk or severity of adverse effects can be increased when Benactyzine is combined with Umeclidinium.,increase,risk
Benactyzine,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Benactyzine.,increase,risk
Benactyzine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Benactyzine.,increase,risk
Benactyzine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Benactyzine.,increase,risk
Benactyzine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Benactyzine.,increase,risk
Benactyzine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Benactyzine.,increase,risk
Benactyzine,Vilanterol,The risk or severity of Tachycardia can be increased when Benactyzine is combined with Vilanterol.,increase,risk
Benactyzine,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Benactyzine.,increase,risk
Benactyzine,Viloxazine,The risk or severity of CNS depression can be increased when Benactyzine is combined with Viloxazine.,increase,risk
Benactyzine,Vortioxetine,The risk or severity of CNS depression can be increased when Benactyzine is combined with Vortioxetine.,increase,risk
Benactyzine,Warfarin,The risk or severity of adverse effects can be increased when Benactyzine is combined with Warfarin.,increase,risk
Benactyzine,Xamoterol,The risk or severity of Tachycardia can be increased when Benactyzine is combined with Xamoterol.,increase,risk
Benactyzine,Xylometazoline,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Benactyzine.,increase,risk
Benactyzine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Benactyzine.,increase,risk
Benactyzine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Benactyzine.,increase,risk
Benactyzine,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Benactyzine.,increase,risk
Benactyzine,Zimelidine,The risk or severity of adverse effects can be increased when Benactyzine is combined with Zimelidine.,increase,risk
Benactyzine,Ziprasidone,The risk or severity of adverse effects can be increased when Benactyzine is combined with Ziprasidone.,increase,risk
Benactyzine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Benactyzine.,increase,risk
Benactyzine,Zolpidem,Benactyzine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Benactyzine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Benactyzine.,increase,risk
Benactyzine,Zopiclone,The risk or severity of adverse effects can be increased when Benactyzine is combined with Zopiclone.,increase,risk
Benactyzine,Zotepine,The risk or severity of CNS depression can be increased when Benactyzine is combined with Zotepine.,increase,risk
Benactyzine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Benactyzine.,increase,risk
Benactyzine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Benactyzine.,increase,risk
Ledipasvir,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ledipasvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ledipasvir,Budesonide,Budesonide may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Bumadizone,Bumadizone may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Bumetanide,Bumetanide may increase the excretion rate of Ledipasvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ledipasvir,Bupropion,Bupropion may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Buspirone,Buspirone may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Butabarbital,Butabarbital may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gadodiamide,Gadodiamide may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gadoteric acid,Ledipasvir may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gadoteridol,Gadoteridol may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Ganciclovir,Ganciclovir may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gefitinib,Ledipasvir may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Ledipasvir.,increase,no risk
Ledipasvir,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gentamicin,Ledipasvir may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ledipasvir,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Ledipasvir.,increase,no risk
Ledipasvir,Gimeracil,Ledipasvir may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ledipasvir,Givosiran,Givosiran may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Glasdegib,The serum concentration of Ledipasvir can be increased when it is combined with Glasdegib.,increase,no risk
Ledipasvir,Glecaprevir,The serum concentration of Ledipasvir can be increased when it is combined with Glecaprevir.,increase,no risk
Ledipasvir,Glipizide,Glipizide may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Glyburide,Ledipasvir may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Ledipasvir,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Golodirsen,Ledipasvir may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ledipasvir,Goserelin,Goserelin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Ledipasvir.,increase,no risk
Ledipasvir,Guanethidine,Guanethidine may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Guanfacine,Guanfacine may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Haloperidol,Haloperidol may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Ledipasvir.,decrease,no risk
Ledipasvir,Hydralazine,Hydralazine may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ledipasvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ledipasvir,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ledipasvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ledipasvir,Hydromorphone,Hydromorphone may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ledipasvir,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Hydroxyethyl Starch,Ledipasvir may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ledipasvir,Kanamycin,Ledipasvir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ledipasvir,Ketamine,Ketamine may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Ketazolam,Ketazolam may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Ketoconazole,The serum concentration of Ledipasvir can be increased when it is combined with Ketoconazole.,increase,no risk
Ledipasvir,Ketoprofen,Ketoprofen may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Ketorolac,Ketorolac may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Octinoxate,Ledipasvir may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ledipasvir,Olanzapine,Olanzapine can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ledipasvir,Olsalazine,Olsalazine may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Ledipasvir.,increase,no risk
Ledipasvir,Ombitasvir,Ledipasvir may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Omeprazole,Omeprazole can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ledipasvir,Opium,Ledipasvir may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ledipasvir,Oseltamivir,Oseltamivir may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Ledipasvir.,increase,no risk
Ledipasvir,Oxacillin,Oxacillin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Oxaliplatin,Ledipasvir may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Ledipasvir,Oxaprozin,Oxaprozin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Oxazepam,Oxazepam may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Oxybenzone,Oxybenzone may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Oxyquinoline,Ledipasvir may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ledipasvir,Ozanimod,Ledipasvir may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Ledipasvir,Quetiapine,Quetiapine may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Quinethazone,Quinethazone may increase the excretion rate of Ledipasvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ledipasvir,Quinidine,The serum concentration of Ledipasvir can be increased when it is combined with Quinidine.,increase,no risk
Ledipasvir,Quinine,The serum concentration of Ledipasvir can be increased when it is combined with Quinine.,increase,no risk
Ledipasvir,Quizartinib,The serum concentration of Ledipasvir can be increased when it is combined with Quizartinib.,increase,no risk
Ledipasvir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ledipasvir.,increase,no risk
Ledipasvir,Umbralisib,The serum concentration of Ledipasvir can be increased when it is combined with Umbralisib.,increase,no risk
Ledipasvir,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Ledipasvir.,increase,no risk
Ledipasvir,Vaborbactam,Ledipasvir may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ledipasvir,Valaciclovir,Valaciclovir may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Valbenazine,Ledipasvir may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ledipasvir,Valdecoxib,Valdecoxib may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Valganciclovir,Valganciclovir may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Vancomycin,Ledipasvir may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ledipasvir,Vandetanib,The serum concentration of Ledipasvir can be increased when it is combined with Vandetanib.,increase,no risk
Ledipasvir,Vardenafil,The serum concentration of Ledipasvir can be increased when it is combined with Vardenafil.,increase,no risk
Ledipasvir,Varenicline,Varenicline may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Ledipasvir.,decrease,no risk
Ledipasvir,Velpatasvir,The serum concentration of Ledipasvir can be increased when it is combined with Velpatasvir.,increase,no risk
Ledipasvir,Vemurafenib,The serum concentration of Ledipasvir can be increased when it is combined with Vemurafenib.,increase,no risk
Ledipasvir,Venetoclax,The serum concentration of Ledipasvir can be increased when it is combined with Venetoclax.,increase,no risk
Ledipasvir,Venlafaxine,Venlafaxine may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Verapamil,The serum concentration of Ledipasvir can be increased when it is combined with Verapamil.,increase,no risk
Ledipasvir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ledipasvir.,decrease,no risk
Ledipasvir,Vilanterol,Ledipasvir may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ledipasvir,Viloxazine,Ledipasvir may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ledipasvir,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Ledipasvir.,increase,no risk
Ledipasvir,Vincristine,The excretion of Vincristine can be decreased when combined with Ledipasvir.,decrease,no risk
Ledipasvir,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Ledipasvir.,increase,no risk
Ledipasvir,Voclosporin,The serum concentration of Ledipasvir can be increased when it is combined with Voclosporin.,increase,no risk
Ledipasvir,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ledipasvir,Vorapaxar,The serum concentration of Ledipasvir can be increased when it is combined with Vorapaxar.,increase,no risk
Ledipasvir,Vortioxetine,Ledipasvir may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ledipasvir,Voxilaprevir,The serum concentration of Ledipasvir can be increased when it is combined with Voxilaprevir.,increase,no risk
Ledipasvir,Warfarin,Ledipasvir may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ledipasvir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Ledipasvir.,decrease,no risk
Ledipasvir,Zaleplon,Zaleplon may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Zanamivir,Zanamivir may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,decrease,no risk
Ledipasvir,Zidovudine,Ledipasvir may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Ledipasvir,Zonisamide,The serum concentration of Ledipasvir can be increased when it is combined with Zonisamide.,increase,no risk
Secukinumab,Bepridil,The metabolism of Bepridil can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Besilesomab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Besilesomab.,increase,risk
Secukinumab,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Secukinumab.,increase,risk
Secukinumab,Betaxolol,The metabolism of Betaxolol can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Secukinumab.,increase,risk
Secukinumab,Bexarotene,The metabolism of Bexarotene can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Bezlotoxumab.,increase,risk
Secukinumab,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Bimekizumab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Bimekizumab.,increase,risk
Secukinumab,Binimetinib,The metabolism of Binimetinib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Secukinumab.,increase,risk
Secukinumab,Blinatumomab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Blinatumomab.,increase,risk
Secukinumab,Boceprevir,The metabolism of Boceprevir can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Secukinumab.",decrease,no risk
Secukinumab,Bortezomib,The metabolism of Bortezomib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Bosentan,The metabolism of Bosentan can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Bosutinib,The metabolism of Bosutinib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Brigatinib,The metabolism of Brigatinib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Brodalumab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Brodalumab.,increase,risk
Secukinumab,Brolucizumab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Brolucizumab.,increase,risk
Secukinumab,Bromazepam,The metabolism of Bromazepam can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Secukinumab.,increase,risk
Secukinumab,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Bupropion,The metabolism of Bupropion can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Burosumab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Burosumab.,increase,risk
Secukinumab,Buspirone,The metabolism of Buspirone can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Busulfan,The metabolism of Busulfan can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Galantamine,The metabolism of Galantamine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Galcanezumab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Galcanezumab.,increase,risk
Secukinumab,Gefitinib,The metabolism of Gefitinib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Secukinumab.,increase,risk
Secukinumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Secukinumab.,increase,risk
Secukinumab,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Glasdegib,The metabolism of Glasdegib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Secukinumab.,increase,risk
Secukinumab,Gliclazide,The metabolism of Gliclazide can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Glimepiride,The metabolism of Glimepiride can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Glipizide,The metabolism of Glipizide can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Gliquidone,The metabolism of Gliquidone can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Glofitamab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Glofitamab.,increase,risk
Secukinumab,Glyburide,The metabolism of Glyburide can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Secukinumab.,increase,risk
Secukinumab,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Guanabenz,The metabolism of Guanabenz can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Guselkumab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Guselkumab.,increase,risk
Secukinumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Secukinumab.,decrease,no risk
Secukinumab,Halofantrine,The metabolism of Halofantrine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Haloperidol,The metabolism of Haloperidol can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Halothane,The metabolism of Halothane can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Secukinumab.,decrease,no risk
Secukinumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Secukinumab.,increase,risk
Secukinumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Secukinumab.,decrease,no risk
Secukinumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Secukinumab.,increase,risk
Secukinumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Secukinumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Secukinumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Secukinumab.,increase,risk
Secukinumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Secukinumab is combined with Human Rho(D) immune globulin.,increase,risk
Secukinumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Secukinumab is combined with Human varicella-zoster immune globulin.,increase,risk
Secukinumab,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Secukinumab is combined with Hydrocortisone succinate.,increase,risk
Secukinumab,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Secukinumab.,increase,risk
Secukinumab,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Secukinumab.,decrease,no risk
Secukinumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Secukinumab.,decrease,no risk
Secukinumab,Ketamine,The metabolism of Ketamine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Ketorolac,The metabolism of Ketorolac can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Secukinumab.,increase,risk
Secukinumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Secukinumab.,increase,risk
Secukinumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Secukinumab.,increase,no risk
Secukinumab,Odesivimab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Odesivimab.,increase,risk
Secukinumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Secukinumab.,increase,risk
Secukinumab,Olanzapine,The metabolism of Olanzapine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Olaparib,The metabolism of Olaparib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Secukinumab.,increase,risk
Secukinumab,Oliceridine,The metabolism of Oliceridine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Olodaterol,The metabolism of Olodaterol can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Secukinumab.,increase,risk
Secukinumab,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Omeprazole,The metabolism of Omeprazole can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Ondansetron,The metabolism of Ondansetron can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Opium,The metabolism of Opium can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Osimertinib,The metabolism of Osimertinib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Ospemifene,The metabolism of Ospemifene can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Secukinumab.,increase,risk
Secukinumab,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Oxycodone,The metabolism of Oxycodone can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Ozanimod,The risk or severity of adverse effects can be increased when Secukinumab is combined with Ozanimod.,increase,risk
Secukinumab,Quetiapine,The metabolism of Quetiapine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Secukinumab.,increase,no risk
Secukinumab,Quinidine,The metabolism of Quinidine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Quinine,The metabolism of Quinine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Quizartinib,The metabolism of Quizartinib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Secukinumab.,increase,risk
Secukinumab,Udenafil,The metabolism of Udenafil can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Upadacitinib,The risk or severity of adverse effects can be increased when Secukinumab is combined with Upadacitinib.,increase,risk
Secukinumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Secukinumab.,increase,risk
Secukinumab,Valbenazine,The metabolism of Valbenazine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Valproic acid,The metabolism of Valproic acid can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Valsartan,The metabolism of Valsartan can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vandetanib,The metabolism of Vandetanib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vardenafil,The metabolism of Vardenafil can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Secukinumab.,increase,risk
Secukinumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Secukinumab.,decrease,no risk
Secukinumab,Vedolizumab,The risk or severity of adverse effects can be increased when Secukinumab is combined with Vedolizumab.,increase,risk
Secukinumab,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Venetoclax,The metabolism of Venetoclax can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Verapamil,The metabolism of Verapamil can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vernakalant,The metabolism of Vernakalant can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Secukinumab.,decrease,no risk
Secukinumab,Vilanterol,The risk or severity of adverse effects can be increased when Secukinumab is combined with Vilanterol.,increase,risk
Secukinumab,Vilazodone,The metabolism of Vilazodone can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vinblastine,The metabolism of Vinblastine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vincristine,The metabolism of Vincristine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vindesine,The metabolism of Vindesine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vinflunine,The metabolism of Vinflunine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Voclosporin,The risk or severity of adverse effects can be increased when Secukinumab is combined with Voclosporin.,increase,risk
Secukinumab,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Voriconazole,The metabolism of Voriconazole can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Secukinumab.,increase,risk
Secukinumab,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Voxelotor,The metabolism of Voxelotor can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Warfarin,The metabolism of Warfarin can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Secukinumab.,increase,risk
Secukinumab,Yohimbine,The metabolism of Yohimbine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zaleplon,The metabolism of Zaleplon can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zidovudine,The metabolism of Zidovudine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zileuton,The metabolism of Zileuton can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zolpidem,The metabolism of Zolpidem can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zonisamide,The metabolism of Zonisamide can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zopiclone,The metabolism of Zopiclone can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zotepine,The metabolism of Zotepine can be increased when combined with Secukinumab.,increase,no risk
Secukinumab,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Secukinumab.,increase,no risk
Miltefosine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Miltefosine is combined with Benzocaine.,increase,risk
Miltefosine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Miltefosine is combined with Benzyl alcohol.,increase,risk
Miltefosine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Miltefosine is combined with Bupivacaine.,increase,risk
Miltefosine,Butacaine,The risk or severity of methemoglobinemia can be increased when Miltefosine is combined with Butacaine.,increase,risk
Miltefosine,Butamben,The risk or severity of methemoglobinemia can be increased when Miltefosine is combined with Butamben.,increase,risk
Miltefosine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Miltefosine is combined with Oxetacaine.,increase,risk
Miltefosine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Miltefosine is combined with Oxybuprocaine.,increase,risk
Miltefosine,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Miltefosine.,increase,no risk
Suvorexant,Butaperazine,Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Butobarbital,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Butorphanol,Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Butriptyline,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Gabapentin,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Gallamine triethiodide,Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Ganaxolone,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Gepirone,Gepirone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Ginkgo biloba,The metabolism of Suvorexant can be decreased when combined with Ginkgo biloba.,decrease,no risk
Suvorexant,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Glofitamab,The serum concentration of Suvorexant can be increased when it is combined with Glofitamab.,increase,no risk
Suvorexant,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Glyburide,The metabolism of Suvorexant can be decreased when combined with Glyburide.,decrease,no risk
Suvorexant,Glycerol phenylbutyrate,The metabolism of Suvorexant can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Suvorexant,Golimumab,The metabolism of Suvorexant can be increased when combined with Golimumab.,increase,no risk
Suvorexant,Granisetron,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Grapefruit,The metabolism of Suvorexant can be decreased when combined with Grapefruit.,decrease,no risk
Suvorexant,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Griseofulvin,The metabolism of Suvorexant can be increased when combined with Griseofulvin.,increase,no risk
Suvorexant,Guanfacine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Haloperidol,Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Halothane,Halothane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Hydralazine,The metabolism of Suvorexant can be decreased when combined with Hydralazine.,decrease,no risk
Suvorexant,Hydrocodone,Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Suvorexant,Hydrocortamate,The metabolism of Suvorexant can be increased when combined with Hydrocortamate.,increase,no risk
Suvorexant,Hydrocortisone,The metabolism of Suvorexant can be increased when combined with Hydrocortisone.,increase,no risk
Suvorexant,Hydrocortisone acetate,The metabolism of Suvorexant can be increased when combined with Hydrocortisone acetate.,increase,no risk
Suvorexant,Hydrocortisone butyrate,The metabolism of Suvorexant can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Suvorexant,Hydrocortisone succinate,The metabolism of Suvorexant can be increased when combined with Hydrocortisone succinate.,increase,no risk
Suvorexant,Hydromorphone,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Ketamine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Ketoconazole,The metabolism of Suvorexant can be decreased when combined with Ketoconazole.,decrease,no risk
Suvorexant,Octreotide,The metabolism of Suvorexant can be decreased when combined with Octreotide.,decrease,no risk
Suvorexant,Olanzapine,Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Olaparib,The metabolism of Olaparib can be decreased when combined with Suvorexant.,decrease,no risk
Suvorexant,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Suvorexant is combined with Oliceridine.",increase,risk
Suvorexant,Olutasidenib,The metabolism of Suvorexant can be increased when combined with Olutasidenib.,increase,no risk
Suvorexant,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Omaveloxolone,The serum concentration of Suvorexant can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Suvorexant,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Ondansetron,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Opium,Opium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Oritavancin,The metabolism of Suvorexant can be increased when combined with Oritavancin.,increase,no risk
Suvorexant,Orphenadrine,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Osilodrostat,The metabolism of Suvorexant can be decreased when combined with Osilodrostat.,decrease,no risk
Suvorexant,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Oxazepam,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Oxcarbazepine,Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Oxitriptan,Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Oxprenolol,Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Oxybuprocaine,Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Oxybutynin,The metabolism of Suvorexant can be decreased when combined with Oxybutynin.,decrease,no risk
Suvorexant,Oxycodone,Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Oxymorphone,Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Quazepam,Quazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Quetiapine,Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Quinine,Quinine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Quinupramine,Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Quinupristin,The metabolism of Suvorexant can be decreased when combined with Quinupristin.,decrease,no risk
Suvorexant,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Urethane,Urethane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Vadadustat,The serum concentration of Suvorexant can be increased when it is combined with Vadadustat.,increase,no risk
Suvorexant,Valproic acid,Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Suvorexant.,decrease,no risk
Suvorexant,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Vecuronium,Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Venlafaxine,Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Verapamil,The metabolism of Suvorexant can be decreased when combined with Verapamil.,decrease,no risk
Suvorexant,Vigabatrin,Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Vilazodone,Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Viloxazine,Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Vincristine,The excretion of Vincristine can be decreased when combined with Suvorexant.,decrease,no risk
Suvorexant,Vindesine,The metabolism of Vindesine can be decreased when combined with Suvorexant.,decrease,no risk
Suvorexant,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Suvorexant.,decrease,no risk
Suvorexant,Vitamin E,The metabolism of Suvorexant can be increased when combined with Vitamin E.,increase,no risk
Suvorexant,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Vorapaxar,The metabolism of Suvorexant can be decreased when combined with Vorapaxar.,decrease,no risk
Suvorexant,Voriconazole,The metabolism of Suvorexant can be decreased when combined with Voriconazole.,decrease,no risk
Suvorexant,Vortioxetine,Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Suvorexant.,increase,no risk
Suvorexant,Warfarin,The metabolism of Warfarin can be decreased when combined with Suvorexant.,decrease,no risk
Suvorexant,Yohimbine,Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Zafirlukast,The metabolism of Suvorexant can be decreased when combined with Zafirlukast.,decrease,no risk
Suvorexant,Zaleplon,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Suvorexant.,decrease,no risk
Suvorexant,Ziconotide,Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Zimelidine,Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Ziprasidone,Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Zolmitriptan,Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Zolpidem,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Zonisamide,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Zopiclone,Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Zotepine,Zotepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Zuclopenthixol,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Suvorexant,Zuranolone,Zuranolone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,increase,no risk
Siltuximab,Benzocaine,The metabolism of Benzocaine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Benzphetamine,The metabolism of Benzphetamine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Benzyl alcohol,The metabolism of Benzyl alcohol can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Bepridil,The metabolism of Bepridil can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Besilesomab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Besilesomab.,increase,risk
Siltuximab,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Siltuximab.,increase,risk
Siltuximab,Betaxolol,The metabolism of Betaxolol can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Siltuximab.,increase,risk
Siltuximab,Bexarotene,The metabolism of Bexarotene can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Bezlotoxumab.,increase,risk
Siltuximab,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Bimekizumab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Bimekizumab.,increase,risk
Siltuximab,Binimetinib,The metabolism of Binimetinib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Siltuximab.,increase,risk
Siltuximab,Blinatumomab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Blinatumomab.,increase,risk
Siltuximab,Boceprevir,The metabolism of Boceprevir can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Siltuximab.",decrease,no risk
Siltuximab,Bortezomib,The metabolism of Bortezomib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Bosentan,The metabolism of Bosentan can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Bosutinib,The metabolism of Bosutinib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Brigatinib,The metabolism of Brigatinib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Brodalumab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Brodalumab.,increase,risk
Siltuximab,Brolucizumab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Brolucizumab.,increase,risk
Siltuximab,Bromazepam,The metabolism of Bromazepam can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Siltuximab.,increase,risk
Siltuximab,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Bupropion,The metabolism of Bupropion can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Burosumab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Burosumab.,increase,risk
Siltuximab,Buspirone,The metabolism of Buspirone can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Busulfan,The metabolism of Busulfan can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Butacaine,The risk or severity of methemoglobinemia can be increased when Siltuximab is combined with Butacaine.,increase,risk
Siltuximab,Butamben,The risk or severity of methemoglobinemia can be increased when Siltuximab is combined with Butamben.,increase,risk
Siltuximab,Galantamine,The metabolism of Galantamine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Galcanezumab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Galcanezumab.,increase,risk
Siltuximab,Gefitinib,The metabolism of Gefitinib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Siltuximab.,increase,risk
Siltuximab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Siltuximab.,increase,risk
Siltuximab,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Siltuximab.,increase,no risk
Siltuximab,Gestrinone,The metabolism of Gestrinone can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Glasdegib,The metabolism of Glasdegib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Siltuximab.,increase,risk
Siltuximab,Gliclazide,The metabolism of Gliclazide can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Glimepiride,The metabolism of Glimepiride can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Glipizide,The metabolism of Glipizide can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Gliquidone,The metabolism of Gliquidone can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Glofitamab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Glofitamab.,increase,risk
Siltuximab,Glyburide,The metabolism of Glyburide can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Siltuximab.,increase,risk
Siltuximab,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Guanabenz,The metabolism of Guanabenz can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Guselkumab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Guselkumab.,increase,risk
Siltuximab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Siltuximab.,decrease,no risk
Siltuximab,Halofantrine,The metabolism of Halofantrine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Siltuximab.,increase,no risk
Siltuximab,Halothane,The metabolism of Halothane can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Siltuximab.,decrease,no risk
Siltuximab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Siltuximab.,increase,risk
Siltuximab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Siltuximab.,decrease,no risk
Siltuximab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Siltuximab.,increase,risk
Siltuximab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Siltuximab is combined with Human cytomegalovirus immune globulin.,increase,risk
Siltuximab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Siltuximab.,increase,risk
Siltuximab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Siltuximab is combined with Human Rho(D) immune globulin.,increase,risk
Siltuximab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Siltuximab is combined with Human varicella-zoster immune globulin.,increase,risk
Siltuximab,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Siltuximab is combined with Hydrocortisone succinate.,increase,risk
Siltuximab,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Siltuximab.,increase,risk
Siltuximab,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Siltuximab.,decrease,no risk
Siltuximab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Siltuximab.,decrease,no risk
Siltuximab,Ketamine,The metabolism of Ketamine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Ketorolac,The metabolism of Ketorolac can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Siltuximab.,increase,risk
Siltuximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Siltuximab.,increase,risk
Siltuximab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Siltuximab.,increase,no risk
Siltuximab,Odesivimab,The risk or severity of adverse effects can be increased when Siltuximab is combined with Odesivimab.,increase,risk
Siltuximab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Siltuximab.,increase,risk
Siltuximab,Olanzapine,The metabolism of Olanzapine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Olaparib,The metabolism of Olaparib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Siltuximab.,increase,risk
Siltuximab,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Siltuximab.,decrease,no risk
Siltuximab,Olodaterol,The metabolism of Olodaterol can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Siltuximab.,increase,risk
Siltuximab,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Omeprazole,The metabolism of Omeprazole can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Ondansetron,The metabolism of Ondansetron can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Opium,The metabolism of Opium can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Osimertinib,The metabolism of Osimertinib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Ospemifene,The metabolism of Ospemifene can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Siltuximab.,increase,risk
Siltuximab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Siltuximab is combined with Oxetacaine.,increase,risk
Siltuximab,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Siltuximab is combined with Oxybuprocaine.,increase,risk
Siltuximab,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Oxycodone,The metabolism of Oxycodone can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Ozanimod,The risk or severity of adverse effects can be increased when Siltuximab is combined with Ozanimod.,increase,risk
Siltuximab,Quetiapine,The metabolism of Quetiapine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Siltuximab.,increase,no risk
Siltuximab,Quinidine,The metabolism of Quinidine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Quinine,The metabolism of Quinine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Quizartinib,The metabolism of Quizartinib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Siltuximab.,increase,risk
Siltuximab,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Siltuximab.,increase,no risk
Siltuximab,Udenafil,The metabolism of Udenafil can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Ulipristal,The metabolism of Ulipristal can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Upadacitinib,The risk or severity of adverse effects can be increased when Siltuximab is combined with Upadacitinib.,increase,risk
Siltuximab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Siltuximab.,increase,risk
Siltuximab,Valbenazine,The metabolism of Valbenazine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Valproic acid,The metabolism of Valproic acid can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Valsartan,The metabolism of Valsartan can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vandetanib,The metabolism of Vandetanib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Siltuximab.,decrease,no risk
Siltuximab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Siltuximab.,increase,risk
Siltuximab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Siltuximab.,decrease,no risk
Siltuximab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Siltuximab.,increase,risk
Siltuximab,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Venetoclax,The metabolism of Venetoclax can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Verapamil,The metabolism of Verapamil can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vernakalant,The metabolism of Vernakalant can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Siltuximab.,decrease,no risk
Siltuximab,Vilanterol,The risk or severity of adverse effects can be increased when Siltuximab is combined with Vilanterol.,increase,risk
Siltuximab,Vilazodone,The metabolism of Vilazodone can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vinblastine,The metabolism of Vinblastine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vincristine,The metabolism of Vincristine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vindesine,The metabolism of Vindesine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vinflunine,The metabolism of Vinflunine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Voclosporin,The risk or severity of adverse effects can be increased when Siltuximab is combined with Voclosporin.,increase,risk
Siltuximab,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Voriconazole,The metabolism of Voriconazole can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Siltuximab.,increase,risk
Siltuximab,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Siltuximab.,increase,no risk
Siltuximab,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Warfarin,The metabolism of Warfarin can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Siltuximab.,increase,risk
Siltuximab,Yohimbine,The metabolism of Yohimbine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zaleplon,The metabolism of Zaleplon can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zidovudine,The metabolism of Zidovudine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zileuton,The metabolism of Zileuton can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zolpidem,The metabolism of Zolpidem can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zonisamide,The metabolism of Zonisamide can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Siltuximab.,decrease,no risk
Siltuximab,Zotepine,The metabolism of Zotepine can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Siltuximab.,increase,no risk
Siltuximab,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Siltuximab.,decrease,no risk
Pembrolizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Pembrolizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Pembrolizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Pembrolizumab.,increase,risk
Pembrolizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Pembrolizumab.,increase,risk
Pembrolizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Pembrolizumab is combined with Ocrelizumab.,increase,risk
Pembrolizumab,Odesivimab,The risk or severity of adverse effects can be increased when Pembrolizumab is combined with Odesivimab.,increase,risk
Pembrolizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Pembrolizumab.,increase,risk
Pembrolizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Pembrolizumab.,increase,risk
Pembrolizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pembrolizumab.,increase,risk
Pembrolizumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pembrolizumab is combined with Oxetacaine.,increase,risk
Pembrolizumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pembrolizumab is combined with Oxybuprocaine.,increase,risk
Pembrolizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Pembrolizumab.,increase,no risk
Pembrolizumab,Ublituximab,The risk or severity of adverse effects can be increased when Pembrolizumab is combined with Ublituximab.,increase,risk
Pembrolizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Pembrolizumab.,increase,risk
Pembrolizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Pembrolizumab.,increase,risk
Empagliflozin,Gatifloxacin,The therapeutic efficacy of Empagliflozin can be increased when used in combination with Gatifloxacin.,increase,no risk
Empagliflozin,Gefapixant,The therapeutic efficacy of Empagliflozin can be increased when used in combination with Gefapixant.,increase,no risk
Empagliflozin,Gemifloxacin,The therapeutic efficacy of Empagliflozin can be increased when used in combination with Gemifloxacin.,increase,no risk
Empagliflozin,Gliclazide,Empagliflozin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Empagliflozin,Glimepiride,Empagliflozin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Empagliflozin,Glipizide,Empagliflozin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Empagliflozin,Gliquidone,Empagliflozin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Empagliflozin,Glyburide,Empagliflozin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Empagliflozin,Glymidine,Empagliflozin may increase the hypoglycemic activities of Glymidine.,increase,no risk
Empagliflozin,Goserelin,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Goserelin.,decrease,no risk
Empagliflozin,Grepafloxacin,The therapeutic efficacy of Empagliflozin can be increased when used in combination with Grepafloxacin.,increase,no risk
Empagliflozin,Guanabenz,Empagliflozin may increase the hypotensive activities of Guanabenz.,increase,no risk
Empagliflozin,Guanadrel,Empagliflozin may increase the hypotensive activities of Guanadrel.,increase,no risk
Empagliflozin,Guanethidine,Empagliflozin may increase the hypotensive activities of Guanethidine.,increase,no risk
Empagliflozin,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Empagliflozin.,increase,risk
Empagliflozin,Guanoxan,Empagliflozin may increase the hypotensive activities of Guanoxan.,increase,no risk
Empagliflozin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Empagliflozin.,increase,risk
Empagliflozin,Haloperidol,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Haloperidol.,decrease,no risk
Empagliflozin,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Empagliflozin.,increase,risk
Empagliflozin,Histrelin,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Histrelin.,decrease,no risk
Empagliflozin,Hydralazine,The risk or severity of adverse effects can be increased when Hydralazine is combined with Empagliflozin.,increase,risk
Empagliflozin,Hydrochlorothiazide,Empagliflozin may increase the diuretic activities of Hydrochlorothiazide.,increase,no risk
Empagliflozin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Empagliflozin.,increase,risk
Empagliflozin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Empagliflozin.,increase,risk
Empagliflozin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Empagliflozin.,increase,risk
Empagliflozin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Empagliflozin.,increase,risk
Empagliflozin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Empagliflozin.,increase,risk
Empagliflozin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Empagliflozin.,increase,risk
Empagliflozin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Empagliflozin.,increase,risk
Empagliflozin,Hydroflumethiazide,Empagliflozin may increase the diuretic activities of Hydroflumethiazide.,increase,no risk
Empagliflozin,Hydroxychloroquine,The therapeutic efficacy of Empagliflozin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Empagliflozin,Hydroxyprogesterone caproate,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Empagliflozin,Ketotifen,The risk or severity of thrombocytopenia can be increased when Empagliflozin is combined with Ketotifen.,increase,risk
Empagliflozin,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Empagliflozin.,increase,risk
Empagliflozin,Octreotide,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Octreotide.,decrease,no risk
Empagliflozin,Ofloxacin,The therapeutic efficacy of Empagliflozin can be increased when used in combination with Ofloxacin.,increase,no risk
Empagliflozin,Olanzapine,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Olanzapine.,decrease,no risk
Empagliflozin,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Empagliflozin.,increase,risk
Empagliflozin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Empagliflozin.,increase,no risk
Empagliflozin,Opicapone,The risk or severity of adverse effects can be increased when Empagliflozin is combined with Opicapone.,increase,risk
Empagliflozin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Empagliflozin.,increase,no risk
Empagliflozin,Oxprenolol,The therapeutic efficacy of Empagliflozin can be increased when used in combination with Oxprenolol.,increase,no risk
Empagliflozin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Empagliflozin.,increase,no risk
Empagliflozin,Quetiapine,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Quetiapine.,decrease,no risk
Empagliflozin,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Quinapril.",increase,risk
Empagliflozin,Quinethazone,Empagliflozin may increase the diuretic activities of Quinethazone.,increase,no risk
Empagliflozin,Quinine,Empagliflozin may increase the hypoglycemic activities of Quinine.,increase,no risk
Empagliflozin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Empagliflozin.,decrease,no risk
Empagliflozin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Empagliflozin.,increase,risk
Empagliflozin,Udenafil,The therapeutic efficacy of Empagliflozin can be increased when used in combination with Udenafil.,increase,no risk
Empagliflozin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Empagliflozin.,increase,risk
Empagliflozin,Valdecoxib,The therapeutic efficacy of Empagliflozin can be increased when used in combination with Valdecoxib.,increase,no risk
Empagliflozin,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Empagliflozin.,increase,risk
Empagliflozin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Empagliflozin.,increase,risk
Empagliflozin,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Empagliflozin.,increase,risk
Empagliflozin,Vemurafenib,The therapeutic efficacy of Empagliflozin can be increased when used in combination with Vemurafenib.,increase,no risk
Empagliflozin,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Empagliflozin.,increase,risk
Empagliflozin,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Empagliflozin.,increase,risk
Empagliflozin,Vericiguat,The risk or severity of adverse effects can be increased when Empagliflozin is combined with Vericiguat.,increase,risk
Empagliflozin,Vildagliptin,Empagliflozin may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Empagliflozin,Vorinostat,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Vorinostat.,decrease,no risk
Empagliflozin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Empagliflozin.,increase,risk
Empagliflozin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Empagliflozin.,increase,risk
Empagliflozin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Empagliflozin.,increase,risk
Empagliflozin,Ziprasidone,The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Empagliflozin,Zofenopril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Zofenopril.",increase,risk
Empagliflozin,Zonisamide,Empagliflozin may increase the diuretic activities of Zonisamide.,increase,no risk
Tedizolid phosphate,Gemcitabine,The risk or severity of myelosuppression can be increased when Gemcitabine is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Gemtuzumab ozogamicin,The risk or severity of myelosuppression can be increased when Gemtuzumab ozogamicin is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Hydroxyurea,The risk or severity of myelosuppression can be increased when Hydroxyurea is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Obinutuzumab,The risk or severity of myelosuppression can be increased when Obinutuzumab is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Olaparib,The risk or severity of myelosuppression can be increased when Tedizolid phosphate is combined with Olaparib.,increase,risk
Tedizolid phosphate,Orciprenaline,Tedizolid phosphate may increase the hypertensive activities of Orciprenaline.,increase,no risk
Tedizolid phosphate,Oxaliplatin,The risk or severity of myelosuppression can be increased when Oxaliplatin is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tedizolid phosphate is combined with Oxetacaine.,increase,risk
Tedizolid phosphate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tedizolid phosphate is combined with Oxybuprocaine.,increase,risk
Tedizolid phosphate,Oxymetazoline,Tedizolid phosphate may increase the hypertensive activities of Oxymetazoline.,increase,no risk
Tedizolid phosphate,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Venlafaxine.,increase,risk
Tedizolid phosphate,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tedizolid phosphate.,decrease,no risk
Tedizolid phosphate,Vilazodone,The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Vilazodone.,increase,risk
Tedizolid phosphate,Vinblastine,The risk or severity of myelosuppression can be increased when Vinblastine is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Vindesine,The risk or severity of myelosuppression can be increased when Vindesine is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Vinorelbine,The risk or severity of myelosuppression can be increased when Vinorelbine is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Vorinostat,The risk or severity of myelosuppression can be increased when Vorinostat is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Vortioxetine.,increase,risk
Tedizolid phosphate,Warfarin,The risk or severity of bleeding can be increased when Tedizolid phosphate is combined with Warfarin.,increase,risk
Tedizolid phosphate,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Zidovudine,The risk or severity of myelosuppression can be increased when Zidovudine is combined with Tedizolid phosphate.,increase,risk
Tedizolid phosphate,Zimelidine,The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Zimelidine.,increase,risk
Tedizolid phosphate,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Zolmitriptan.,increase,risk
Dulaglutide,Galcanezumab,The risk or severity of adverse effects can be increased when Dulaglutide is combined with Galcanezumab.,increase,risk
Dulaglutide,Gatifloxacin,The therapeutic efficacy of Dulaglutide can be increased when used in combination with Gatifloxacin.,increase,no risk
Dulaglutide,Gefapixant,The therapeutic efficacy of Dulaglutide can be increased when used in combination with Gefapixant.,increase,no risk
Dulaglutide,Gemifloxacin,The therapeutic efficacy of Dulaglutide can be increased when used in combination with Gemifloxacin.,increase,no risk
Dulaglutide,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dulaglutide.,increase,risk
Dulaglutide,Gliclazide,Dulaglutide may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Dulaglutide,Glimepiride,Dulaglutide may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Dulaglutide,Glipizide,Dulaglutide may increase the hypoglycemic activities of Glipizide.,increase,no risk
Dulaglutide,Gliquidone,Dulaglutide may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Dulaglutide,Glofitamab,The risk or severity of adverse effects can be increased when Dulaglutide is combined with Glofitamab.,increase,risk
Dulaglutide,Glyburide,Dulaglutide may increase the hypoglycemic activities of Glyburide.,increase,no risk
Dulaglutide,Glymidine,The therapeutic efficacy of Dulaglutide can be increased when used in combination with Glymidine.,increase,no risk
Dulaglutide,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Dulaglutide.,increase,risk
Dulaglutide,Goserelin,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Goserelin.,decrease,no risk
Dulaglutide,Grepafloxacin,The therapeutic efficacy of Dulaglutide can be increased when used in combination with Grepafloxacin.,increase,no risk
Dulaglutide,Guselkumab,The risk or severity of adverse effects can be increased when Dulaglutide is combined with Guselkumab.,increase,risk
Dulaglutide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Dulaglutide.,increase,risk
Dulaglutide,Haloperidol,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Haloperidol.,decrease,no risk
Dulaglutide,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Dulaglutide.,increase,risk
Dulaglutide,Histrelin,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Histrelin.,decrease,no risk
Dulaglutide,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Dulaglutide is combined with Human cytomegalovirus immune globulin.,increase,risk
Dulaglutide,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dulaglutide.,increase,risk
Dulaglutide,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Dulaglutide is combined with Human Rho(D) immune globulin.,increase,risk
Dulaglutide,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Dulaglutide is combined with Human varicella-zoster immune globulin.,increase,risk
Dulaglutide,Hydrochlorothiazide,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Dulaglutide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Dulaglutide.,increase,risk
Dulaglutide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Dulaglutide.,increase,risk
Dulaglutide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Dulaglutide.,increase,risk
Dulaglutide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Dulaglutide.,increase,risk
Dulaglutide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Dulaglutide.,increase,risk
Dulaglutide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Dulaglutide.,increase,risk
Dulaglutide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Dulaglutide.,increase,risk
Dulaglutide,Hydroflumethiazide,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Dulaglutide,Hydroxychloroquine,The therapeutic efficacy of Dulaglutide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Dulaglutide,Hydroxyprogesterone caproate,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Dulaglutide,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Dulaglutide.,increase,risk
Dulaglutide,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Dulaglutide.,increase,risk
Dulaglutide,Ocrelizumab,The risk or severity of adverse effects can be increased when Dulaglutide is combined with Ocrelizumab.,increase,risk
Dulaglutide,Octreotide,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Octreotide.,decrease,no risk
Dulaglutide,Odesivimab,The risk or severity of adverse effects can be increased when Dulaglutide is combined with Odesivimab.,increase,risk
Dulaglutide,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Dulaglutide.,increase,risk
Dulaglutide,Ofloxacin,The therapeutic efficacy of Dulaglutide can be increased when used in combination with Ofloxacin.,increase,no risk
Dulaglutide,Olanzapine,The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Olanzapine.,decrease,no risk
Dulaglutide,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Dulaglutide.,increase,risk
Dulaglutide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Dulaglutide.,increase,no risk
Dulaglutide,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dulaglutide.,increase,risk
Dulaglutide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Dulaglutide.,increase,no risk
Dulaglutide,Oxprenolol,The therapeutic efficacy of Dulaglutide can be increased when used in combination with Oxprenolol.,increase,no risk
Dulaglutide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Dulaglutide.,increase,no risk
Metreleptin,Galantamine,The metabolism of Galantamine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Gefitinib,The metabolism of Gefitinib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Gemfibrozil,The metabolism of Gemfibrozil can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Gepirone,The metabolism of Gepirone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Gestrinone,The metabolism of Gestrinone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Glasdegib,The metabolism of Glasdegib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Gliclazide,Metreleptin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Metreleptin,Glimepiride,Metreleptin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Metreleptin,Glipizide,Metreleptin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Metreleptin,Gliquidone,Metreleptin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Metreleptin,Glyburide,Metreleptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Metreleptin,Granisetron,The metabolism of Granisetron can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Grazoprevir,The metabolism of Grazoprevir can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Guanfacine,The metabolism of Guanfacine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Halofantrine,The metabolism of Halofantrine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Haloperidol,The metabolism of Haloperidol can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Halothane,The metabolism of Halothane can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Ketamine,The metabolism of Ketamine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Ketazolam,The metabolism of Ketazolam can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Ketoconazole,The metabolism of Ketoconazole can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Olaparib,The metabolism of Olaparib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Oliceridine,The metabolism of Oliceridine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Olutasidenib,The metabolism of Olutasidenib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Omaveloxolone,The metabolism of Omaveloxolone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Ondansetron,The metabolism of Ondansetron can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Opium,The metabolism of Opium can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Orphenadrine,The metabolism of Orphenadrine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Osimertinib,The metabolism of Osimertinib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Ospemifene,The metabolism of Ospemifene can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Oxycodone,The metabolism of Oxycodone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Quazepam,The metabolism of Quazepam can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Quetiapine,The metabolism of Quetiapine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Quinidine,The metabolism of Quinidine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Quinine,The metabolism of Quinine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Quizartinib,The metabolism of Quizartinib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Ubrogepant,The metabolism of Ubrogepant can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Udenafil,The metabolism of Udenafil can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Ulipristal,The metabolism of Ulipristal can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Upadacitinib,The metabolism of Upadacitinib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Valbenazine,The metabolism of Valbenazine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Valproic acid,The metabolism of Valproic acid can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vamorolone,The metabolism of Vamorolone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vandetanib,The metabolism of Vandetanib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vardenafil,The metabolism of Vardenafil can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Venetoclax,The metabolism of Venetoclax can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Verapamil,The metabolism of Verapamil can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vilanterol,The metabolism of Vilanterol can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vilazodone,The metabolism of Vilazodone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vinblastine,The metabolism of Vinblastine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vincristine,The metabolism of Vincristine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vindesine,The metabolism of Vindesine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vinflunine,The metabolism of Vinflunine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vitamin D,The metabolism of Vitamin D can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vitamin E,The metabolism of Vitamin E can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Voclosporin,The metabolism of Voclosporin can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Voriconazole,The metabolism of Voriconazole can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Voxelotor,The metabolism of Voxelotor can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Warfarin,The metabolism of Warfarin can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Yohimbine,The metabolism of Yohimbine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Zaleplon,The metabolism of Zaleplon can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Zidovudine,The metabolism of Zidovudine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Zileuton,The metabolism of Zileuton can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Zolpidem,The metabolism of Zolpidem can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Zonisamide,The metabolism of Zonisamide can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Zopiclone,The metabolism of Zopiclone can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Zotepine,The metabolism of Zotepine can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Metreleptin.,increase,no risk
Metreleptin,Zuranolone,The metabolism of Zuranolone can be increased when combined with Metreleptin.,increase,no risk
Finafloxacin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Finafloxacin is combined with Benzocaine.,increase,risk
Finafloxacin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Finafloxacin is combined with Benzyl alcohol.,increase,risk
Finafloxacin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Finafloxacin is combined with Bupivacaine.,increase,risk
Finafloxacin,Butacaine,The risk or severity of methemoglobinemia can be increased when Finafloxacin is combined with Butacaine.,increase,risk
Finafloxacin,Butamben,The risk or severity of methemoglobinemia can be increased when Finafloxacin is combined with Butamben.,increase,risk
Finafloxacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Finafloxacin is combined with Oxetacaine.,increase,risk
Finafloxacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Finafloxacin is combined with Oxybuprocaine.,increase,risk
Finafloxacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Finafloxacin.,decrease,no risk
Netupitant,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Bromocriptine,The metabolism of Bromocriptine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Budesonide,The metabolism of Budesonide can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Bupropion,The metabolism of Netupitant can be decreased when combined with Bupropion.,decrease,no risk
Netupitant,Buspirone,The metabolism of Buspirone can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Busulfan,The metabolism of Busulfan can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Butalbital,The metabolism of Netupitant can be increased when combined with Butalbital.,increase,no risk
Netupitant,Galantamine,The metabolism of Galantamine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Gemfibrozil,The metabolism of Netupitant can be decreased when combined with Gemfibrozil.,decrease,no risk
Netupitant,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Ginkgo biloba,The metabolism of Netupitant can be decreased when combined with Ginkgo biloba.,decrease,no risk
Netupitant,Givosiran,The serum concentration of Netupitant can be increased when it is combined with Givosiran.,increase,no risk
Netupitant,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Gliclazide,The metabolism of Netupitant can be decreased when combined with Gliclazide.,decrease,no risk
Netupitant,Glimepiride,The metabolism of Netupitant can be decreased when combined with Glimepiride.,decrease,no risk
Netupitant,Glipizide,The metabolism of Netupitant can be decreased when combined with Glipizide.,decrease,no risk
Netupitant,Gliquidone,The metabolism of Netupitant can be decreased when combined with Gliquidone.,decrease,no risk
Netupitant,Glofitamab,The serum concentration of Netupitant can be increased when it is combined with Glofitamab.,increase,no risk
Netupitant,Glyburide,The metabolism of Glyburide can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Glycerol phenylbutyrate,The metabolism of Netupitant can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Netupitant,Golimumab,The metabolism of Netupitant can be increased when combined with Golimumab.,increase,no risk
Netupitant,Granisetron,The metabolism of Granisetron can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Grapefruit,The metabolism of Netupitant can be decreased when combined with Grapefruit.,decrease,no risk
Netupitant,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Griseofulvin,The metabolism of Netupitant can be increased when combined with Griseofulvin.,increase,no risk
Netupitant,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Halofantrine,The metabolism of Netupitant can be decreased when combined with Halofantrine.,decrease,no risk
Netupitant,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Halothane,The metabolism of Netupitant can be decreased when combined with Halothane.,decrease,no risk
Netupitant,Hydralazine,The metabolism of Netupitant can be decreased when combined with Hydralazine.,decrease,no risk
Netupitant,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Hydrocortamate,The metabolism of Netupitant can be increased when combined with Hydrocortamate.,increase,no risk
Netupitant,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Hydromorphone,The metabolism of Netupitant can be decreased when combined with Hydromorphone.,decrease,no risk
Netupitant,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Ketamine,The metabolism of Ketamine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Ketoconazole,The metabolism of Netupitant can be decreased when combined with Ketoconazole.,decrease,no risk
Netupitant,Ketorolac,The metabolism of Netupitant can be decreased when combined with Ketorolac.,decrease,no risk
Netupitant,Octreotide,The metabolism of Netupitant can be decreased when combined with Octreotide.,decrease,no risk
Netupitant,Olanzapine,The metabolism of Netupitant can be decreased when combined with Olanzapine.,decrease,no risk
Netupitant,Olaparib,The metabolism of Olaparib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Opium,The metabolism of Opium can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Oritavancin,The metabolism of Netupitant can be increased when combined with Oritavancin.,increase,no risk
Netupitant,Orphenadrine,The metabolism of Netupitant can be decreased when combined with Orphenadrine.,decrease,no risk
Netupitant,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Oxamniquine,The metabolism of Netupitant can be decreased when combined with Oxamniquine.,decrease,no risk
Netupitant,Oxandrolone,The metabolism of Netupitant can be decreased when combined with Oxandrolone.,decrease,no risk
Netupitant,Oxcarbazepine,The metabolism of Netupitant can be increased when combined with Oxcarbazepine.,increase,no risk
Netupitant,Oxprenolol,The metabolism of Netupitant can be decreased when combined with Oxprenolol.,decrease,no risk
Netupitant,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Quazepam,The metabolism of Quazepam can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Quinine,The metabolism of Netupitant can be decreased when combined with Quinine.,decrease,no risk
Netupitant,Quinupristin,The metabolism of Netupitant can be decreased when combined with Quinupristin.,decrease,no risk
Netupitant,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Udenafil,The metabolism of Udenafil can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vadadustat,The serum concentration of Netupitant can be increased when it is combined with Vadadustat.,increase,no risk
Netupitant,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Valproic acid,The metabolism of Netupitant can be decreased when combined with Valproic acid.,decrease,no risk
Netupitant,Valsartan,The metabolism of Netupitant can be decreased when combined with Valsartan.,decrease,no risk
Netupitant,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Venlafaxine,The metabolism of Netupitant can be decreased when combined with Venlafaxine.,decrease,no risk
Netupitant,Verapamil,The metabolism of Netupitant can be decreased when combined with Verapamil.,decrease,no risk
Netupitant,Vernakalant,The metabolism of Netupitant can be decreased when combined with Vernakalant.,decrease,no risk
Netupitant,Vilanterol,The metabolism of Vilanterol can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vilazodone,The metabolism of Netupitant can be decreased when combined with Vilazodone.,decrease,no risk
Netupitant,Viloxazine,The metabolism of Netupitant can be decreased when combined with Viloxazine.,decrease,no risk
Netupitant,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Vincristine,The excretion of Vincristine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vindesine,The metabolism of Vindesine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Voriconazole,The metabolism of Netupitant can be decreased when combined with Voriconazole.,decrease,no risk
Netupitant,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Netupitant.,increase,no risk
Netupitant,Ximelagatran,The metabolism of Netupitant can be decreased when combined with Ximelagatran.,decrease,no risk
Netupitant,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Zafirlukast,The metabolism of Netupitant can be decreased when combined with Zafirlukast.,decrease,no risk
Netupitant,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Zileuton,The metabolism of Zileuton can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Zimelidine,The metabolism of Netupitant can be decreased when combined with Zimelidine.,decrease,no risk
Netupitant,Ziprasidone,The metabolism of Netupitant can be decreased when combined with Ziprasidone.,decrease,no risk
Netupitant,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Zotepine,The metabolism of Zotepine can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Netupitant.,decrease,no risk
Netupitant,Zuranolone,The metabolism of Zuranolone can be decreased when combined with Netupitant.,decrease,no risk
Naloxegol,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Naloxegol.,increase,risk
Naloxegol,Glasdegib,The serum concentration of Naloxegol can be increased when it is combined with Glasdegib.,increase,no risk
Naloxegol,Glecaprevir,The serum concentration of Naloxegol can be increased when it is combined with Glecaprevir.,increase,no risk
Naloxegol,Glofitamab,The serum concentration of Naloxegol can be increased when it is combined with Glofitamab.,increase,no risk
Naloxegol,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Naloxegol.,decrease,no risk
Naloxegol,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Naloxegol.,decrease,no risk
Naloxegol,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Naloxegol.,increase,risk
Naloxegol,Halazepam,The risk or severity of adverse effects can be increased when Naloxegol is combined with Halazepam.,increase,risk
Naloxegol,Haloperidol,The metabolism of Naloxegol can be decreased when combined with Haloperidol.,decrease,no risk
Naloxegol,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Naloxegol.,increase,risk
Naloxegol,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Naloxegol.,increase,risk
Naloxegol,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Naloxegol.,increase,risk
Naloxegol,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Naloxegol.,decrease,no risk
Naloxegol,Hydrocodone,The risk or severity of adverse effects can be increased when Hydrocodone is combined with Naloxegol.,increase,risk
Naloxegol,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Naloxegol.,decrease,no risk
Naloxegol,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Naloxegol.,increase,risk
Naloxegol,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Naloxegol.,increase,risk
Naloxegol,Ketazolam,The risk or severity of adverse effects can be increased when Naloxegol is combined with Ketazolam.,increase,risk
Naloxegol,Ketoconazole,The serum concentration of Naloxegol can be increased when it is combined with Ketoconazole.,increase,no risk
Naloxegol,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Naloxegol.,increase,risk
Naloxegol,Oliceridine,The risk or severity of adverse effects can be increased when Naloxegol is combined with Oliceridine.,increase,risk
Naloxegol,Olutasidenib,The therapeutic efficacy of Naloxegol can be decreased when used in combination with Olutasidenib.,decrease,no risk
Naloxegol,Omaveloxolone,The serum concentration of Naloxegol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Naloxegol,Opium,The risk or severity of adverse effects can be increased when Naloxegol is combined with Opium.,increase,risk
Naloxegol,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Naloxegol.,increase,risk
Naloxegol,Oxazepam,The risk or severity of adverse effects can be increased when Naloxegol is combined with Oxazepam.,increase,risk
Naloxegol,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Naloxegol.,increase,risk
Naloxegol,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Naloxegol.,increase,risk
Naloxegol,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Naloxegol.,increase,risk
Naloxegol,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Naloxegol.,increase,risk
Naloxegol,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Naloxegol.,decrease,no risk
Naloxegol,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Naloxegol.,increase,risk
Naloxegol,Quazepam,The risk or severity of adverse effects can be increased when Naloxegol is combined with Quazepam.,increase,risk
Naloxegol,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Naloxegol.,increase,risk
Naloxegol,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Naloxegol.,decrease,no risk
Naloxegol,Quinidine,The serum concentration of Naloxegol can be increased when it is combined with Quinidine.,increase,no risk
Naloxegol,Quinine,The serum concentration of Naloxegol can be increased when it is combined with Quinine.,increase,no risk
Naloxegol,Quizartinib,The serum concentration of Naloxegol can be increased when it is combined with Quizartinib.,increase,no risk
Naloxegol,Umbralisib,The serum concentration of Naloxegol can be increased when it is combined with Umbralisib.,increase,no risk
Naloxegol,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Naloxegol.,increase,risk
Naloxegol,Vadadustat,The serum concentration of Naloxegol can be increased when it is combined with Vadadustat.,increase,no risk
Naloxegol,Vandetanib,The serum concentration of Naloxegol can be increased when it is combined with Vandetanib.,increase,no risk
Naloxegol,Vardenafil,The serum concentration of Naloxegol can be increased when it is combined with Vardenafil.,increase,no risk
Naloxegol,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Naloxegol.,increase,risk
Naloxegol,Velpatasvir,The serum concentration of Naloxegol can be increased when it is combined with Velpatasvir.,increase,no risk
Naloxegol,Vemurafenib,The serum concentration of Naloxegol can be increased when it is combined with Vemurafenib.,increase,no risk
Naloxegol,Venetoclax,The serum concentration of Naloxegol can be increased when it is combined with Venetoclax.,increase,no risk
Naloxegol,Verapamil,The serum concentration of Naloxegol can be increased when it is combined with Verapamil.,increase,no risk
Naloxegol,Viloxazine,The metabolism of Naloxegol can be decreased when combined with Viloxazine.,decrease,no risk
Naloxegol,Voclosporin,The serum concentration of Naloxegol can be increased when it is combined with Voclosporin.,increase,no risk
Naloxegol,Vorapaxar,The serum concentration of Naloxegol can be increased when it is combined with Vorapaxar.,increase,no risk
Naloxegol,Voriconazole,The serum concentration of Naloxegol can be increased when it is combined with Voriconazole.,increase,no risk
Naloxegol,Voxilaprevir,The serum concentration of Naloxegol can be increased when it is combined with Voxilaprevir.,increase,no risk
Naloxegol,Zimelidine,The metabolism of Naloxegol can be decreased when combined with Zimelidine.,decrease,no risk
Naloxegol,Ziprasidone,The metabolism of Naloxegol can be decreased when combined with Ziprasidone.,decrease,no risk
Naloxegol,Zonisamide,The serum concentration of Naloxegol can be increased when it is combined with Zonisamide.,increase,no risk
Ceftolozane,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Gadodiamide,Gadodiamide may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Gadoteric acid,Ceftolozane may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ceftolozane,Gadoteridol,Gadoteridol may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Ganciclovir,Ganciclovir may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Gemcitabine,Gemcitabine may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Gentamicin,Ceftolozane may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ceftolozane,Gimeracil,Ceftolozane may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ceftolozane,Givosiran,Givosiran may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Glipizide,Glipizide may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Golodirsen,Ceftolozane may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ceftolozane,Goserelin,Goserelin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Guanethidine,Guanethidine may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Guanfacine,Guanfacine may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Haloperidol,Haloperidol may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Ceftolozane.,decrease,no risk
Ceftolozane,Hydralazine,Hydralazine may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ceftolozane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ceftolozane,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ceftolozane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ceftolozane,Hydromorphone,Hydromorphone may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Hydroxyethyl Starch,Ceftolozane may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ceftolozane,Kanamycin,Ceftolozane may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ceftolozane,Ketamine,Ketamine may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Ketazolam,Ketazolam may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Ketoprofen,Ketoprofen may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Ketorolac,Ketorolac may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Octinoxate,Ceftolozane may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ceftolozane,Olsalazine,Olsalazine may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Opium,Ceftolozane may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ceftolozane,Oseltamivir,Oseltamivir may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Oxacillin,Oxacillin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Oxaprozin,Oxaprozin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Oxazepam,Oxazepam may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ceftolozane is combined with Oxetacaine.,increase,risk
Ceftolozane,Oxybenzone,Oxybenzone may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ceftolozane is combined with Oxybuprocaine.,increase,risk
Ceftolozane,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Oxyquinoline,Ceftolozane may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ceftolozane,Quetiapine,Quetiapine may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Quinethazone,Quinethazone may increase the excretion rate of Ceftolozane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ceftolozane,Quinidine,Ceftolozane may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ceftolozane,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftolozane.,decrease,no risk
Ceftolozane,Vaborbactam,Ceftolozane may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ceftolozane,Valaciclovir,Valaciclovir may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Valbenazine,Ceftolozane may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ceftolozane,Valdecoxib,Valdecoxib may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Valganciclovir,Valganciclovir may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Vancomycin,Ceftolozane may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ceftolozane,Varenicline,Varenicline may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Venlafaxine,Venlafaxine may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Verapamil,Verapamil may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ceftolozane.,decrease,no risk
Ceftolozane,Vilanterol,Ceftolozane may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ceftolozane,Viloxazine,Ceftolozane may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ceftolozane,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Ceftolozane.,decrease,no risk
Ceftolozane,Vortioxetine,Ceftolozane may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ceftolozane,Warfarin,Ceftolozane may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ceftolozane,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Ceftolozane.,decrease,no risk
Ceftolozane,Zaleplon,Zaleplon may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Zanamivir,Zanamivir may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,decrease,no risk
Ceftolozane,Zonisamide,Zonisamide may increase the excretion rate of Ceftolozane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Blinatumomab,Galcanezumab,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Galcanezumab.,increase,risk
Blinatumomab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Blinatumomab.,increase,risk
Blinatumomab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Blinatumomab.,increase,risk
Blinatumomab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Blinatumomab.,increase,risk
Blinatumomab,Glofitamab,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Glofitamab.,increase,risk
Blinatumomab,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Blinatumomab.,increase,risk
Blinatumomab,Guselkumab,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Guselkumab.,increase,risk
Blinatumomab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Blinatumomab.,decrease,no risk
Blinatumomab,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Blinatumomab.,increase,risk
Blinatumomab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Blinatumomab.,decrease,no risk
Blinatumomab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Blinatumomab.,increase,risk
Blinatumomab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Blinatumomab.,decrease,no risk
Blinatumomab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Blinatumomab.,increase,risk
Blinatumomab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Human cytomegalovirus immune globulin.,increase,risk
Blinatumomab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Blinatumomab.,increase,risk
Blinatumomab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Human Rho(D) immune globulin.,increase,risk
Blinatumomab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Human varicella-zoster immune globulin.,increase,risk
Blinatumomab,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Blinatumomab.,increase,risk
Blinatumomab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Hydrocortisone acetate.,increase,risk
Blinatumomab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Hydrocortisone butyrate.,increase,risk
Blinatumomab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Hydrocortisone succinate.,increase,risk
Blinatumomab,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Blinatumomab.,increase,risk
Blinatumomab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Blinatumomab.,increase,risk
Blinatumomab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Blinatumomab.,increase,risk
Blinatumomab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Blinatumomab.,decrease,no risk
Blinatumomab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Blinatumomab.,decrease,no risk
Blinatumomab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Blinatumomab.,increase,risk
Blinatumomab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Blinatumomab.,increase,risk
Blinatumomab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Blinatumomab.,increase,no risk
Blinatumomab,Odesivimab,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Odesivimab.,increase,risk
Blinatumomab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Blinatumomab.,increase,risk
Blinatumomab,Olaparib,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Olaparib.,increase,risk
Blinatumomab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Blinatumomab.,increase,risk
Blinatumomab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Blinatumomab.,increase,risk
Blinatumomab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Blinatumomab.,increase,risk
Blinatumomab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Oxetacaine.,increase,risk
Blinatumomab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Oxybuprocaine.,increase,risk
Blinatumomab,Ozanimod,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Ozanimod.,increase,risk
Blinatumomab,Quinestrol,Quinestrol may increase the thrombogenic activities of Blinatumomab.,increase,no risk
Blinatumomab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Blinatumomab.,increase,risk
Blinatumomab,Upadacitinib,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Upadacitinib.,increase,risk
Blinatumomab,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Blinatumomab.,increase,risk
Blinatumomab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Blinatumomab.,increase,risk
Blinatumomab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Blinatumomab.,increase,risk
Blinatumomab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Blinatumomab.,decrease,no risk
Blinatumomab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Blinatumomab.,increase,risk
Blinatumomab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Blinatumomab.,decrease,no risk
Blinatumomab,Vilanterol,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Vilanterol.,increase,risk
Blinatumomab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Blinatumomab.,increase,risk
Blinatumomab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Blinatumomab.,increase,risk
Blinatumomab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Blinatumomab.,increase,risk
Blinatumomab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Blinatumomab.,increase,risk
Blinatumomab,Voclosporin,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Voclosporin.,increase,risk
Blinatumomab,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Blinatumomab.,increase,risk
Blinatumomab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Blinatumomab.,increase,risk
Blinatumomab,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Blinatumomab.,increase,risk
Blinatumomab,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Blinatumomab.,increase,risk
Blinatumomab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Blinatumomab.,increase,risk
Blinatumomab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Blinatumomab.,increase,risk
Ibrutinib,Bicalutamide,The metabolism of Ibrutinib can be decreased when combined with Bicalutamide.,decrease,no risk
Ibrutinib,Bifonazole,The metabolism of Ibrutinib can be decreased when combined with Bifonazole.,decrease,no risk
Ibrutinib,Bimekizumab,The metabolism of Ibrutinib can be increased when combined with Bimekizumab.,increase,no risk
Ibrutinib,Biperiden,The metabolism of Ibrutinib can be decreased when combined with Biperiden.,decrease,no risk
Ibrutinib,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Bivalirudin.,increase,risk
Ibrutinib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Ibrutinib.,increase,risk
Ibrutinib,Blinatumomab,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Ibrutinib.,increase,risk
Ibrutinib,Boceprevir,The metabolism of Ibrutinib can be decreased when combined with Boceprevir.,decrease,no risk
Ibrutinib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Ibrutinib.",decrease,no risk
Ibrutinib,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Ibrutinib.,increase,risk
Ibrutinib,Bosutinib,The metabolism of Ibrutinib can be decreased when combined with Bosutinib.,decrease,no risk
Ibrutinib,Brentuximab vedotin,The metabolism of Ibrutinib can be decreased when combined with Brentuximab vedotin.,decrease,no risk
Ibrutinib,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Brodalumab,The risk or severity of adverse effects can be increased when Ibrutinib is combined with Brodalumab.,increase,risk
Ibrutinib,Bromocriptine,The metabolism of Ibrutinib can be decreased when combined with Bromocriptine.,decrease,no risk
Ibrutinib,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Ibrutinib.,increase,risk
Ibrutinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ibrutinib is combined with Bupivacaine.,increase,risk
Ibrutinib,Buprenorphine,The metabolism of Ibrutinib can be decreased when combined with Buprenorphine.,decrease,no risk
Ibrutinib,Bupropion,The metabolism of Ibrutinib can be decreased when combined with Bupropion.,decrease,no risk
Ibrutinib,Buspirone,The metabolism of Ibrutinib can be decreased when combined with Buspirone.,decrease,no risk
Ibrutinib,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Ibrutinib.,increase,risk
Ibrutinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Ibrutinib is combined with Butacaine.,increase,risk
Ibrutinib,Butamben,The risk or severity of methemoglobinemia can be increased when Ibrutinib is combined with Butamben.,increase,risk
Ibrutinib,Galantamine,The metabolism of Ibrutinib can be decreased when combined with Galantamine.,decrease,no risk
Ibrutinib,Gefitinib,The metabolism of Ibrutinib can be decreased when combined with Gefitinib.,decrease,no risk
Ibrutinib,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ibrutinib.,increase,risk
Ibrutinib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ibrutinib.,increase,risk
Ibrutinib,Givosiran,The serum concentration of Ibrutinib can be increased when it is combined with Givosiran.,increase,no risk
Ibrutinib,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Ibrutinib.,increase,risk
Ibrutinib,Glofitamab,The serum concentration of Ibrutinib can be increased when it is combined with Glofitamab.,increase,no risk
Ibrutinib,Glyburide,The metabolism of Ibrutinib can be decreased when combined with Glyburide.,decrease,no risk
Ibrutinib,Glycerol phenylbutyrate,The metabolism of Ibrutinib can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Ibrutinib,Golimumab,The metabolism of Ibrutinib can be increased when combined with Golimumab.,increase,no risk
Ibrutinib,Guselkumab,The risk or severity of adverse effects can be increased when Ibrutinib is combined with Guselkumab.,increase,risk
Ibrutinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Ibrutinib.,decrease,no risk
Ibrutinib,Halofantrine,The metabolism of Ibrutinib can be decreased when combined with Halofantrine.,decrease,no risk
Ibrutinib,Haloperidol,The metabolism of Ibrutinib can be decreased when combined with Haloperidol.,decrease,no risk
Ibrutinib,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Heparin.,increase,risk
Ibrutinib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Ibrutinib.,decrease,no risk
Ibrutinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Ibrutinib.,decrease,no risk
Ibrutinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Ibrutinib.,increase,risk
Ibrutinib,Hydralazine,The metabolism of Ibrutinib can be decreased when combined with Hydralazine.,decrease,no risk
Ibrutinib,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Ibrutinib.,increase,risk
Ibrutinib,Hydrocortisone,The metabolism of Ibrutinib can be decreased when combined with Hydrocortisone.,decrease,no risk
Ibrutinib,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Ibrutinib is combined with Hydrocortisone acetate.,increase,risk
Ibrutinib,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Ibrutinib is combined with Hydrocortisone butyrate.,increase,risk
Ibrutinib,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Ibrutinib is combined with Hydrocortisone succinate.,increase,risk
Ibrutinib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Ibrutinib.,increase,risk
Ibrutinib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Ibrutinib.,increase,risk
Ibrutinib,Hydroxyprogesterone caproate,The metabolism of Ibrutinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Ibrutinib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Ibrutinib.,increase,risk
Ibrutinib,Hydroxyzine,The metabolism of Ibrutinib can be decreased when combined with Hydroxyzine.,decrease,no risk
Ibrutinib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Ibrutinib.,decrease,no risk
Ibrutinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Ibrutinib.,decrease,no risk
Ibrutinib,Ketazolam,The metabolism of Ibrutinib can be decreased when combined with Ketazolam.,decrease,no risk
Ibrutinib,Ketoconazole,The metabolism of Ibrutinib can be decreased when combined with Ketoconazole.,decrease,no risk
Ibrutinib,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Ibrutinib.,increase,risk
Ibrutinib,Ocrelizumab,The risk or severity of adverse effects can be increased when Ibrutinib is combined with Ocrelizumab.,increase,risk
Ibrutinib,Octreotide,The metabolism of Ibrutinib can be decreased when combined with Octreotide.,decrease,no risk
Ibrutinib,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Ibrutinib.,increase,risk
Ibrutinib,Olanzapine,The metabolism of Ibrutinib can be decreased when combined with Olanzapine.,decrease,no risk
Ibrutinib,Olaparib,The metabolism of Ibrutinib can be decreased when combined with Olaparib.,decrease,no risk
Ibrutinib,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Olutasidenib,The therapeutic efficacy of Ibrutinib can be decreased when used in combination with Olutasidenib.,decrease,no risk
Ibrutinib,Omaveloxolone,The serum concentration of Ibrutinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ibrutinib,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Ibrutinib.,increase,no risk
Ibrutinib,Omega-3-acid ethyl esters,Omega-3-acid ethyl esters may increase the antiplatelet activities of Ibrutinib.,increase,no risk
Ibrutinib,Omega-3-carboxylic acids,Omega-3-carboxylic acids may increase the antiplatelet activities of Ibrutinib.,increase,no risk
Ibrutinib,Ondansetron,The metabolism of Ibrutinib can be decreased when combined with Ondansetron.,decrease,no risk
Ibrutinib,Opium,The metabolism of Opium can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Oritavancin,The metabolism of Ibrutinib can be decreased when combined with Oritavancin.,decrease,no risk
Ibrutinib,Orphenadrine,The metabolism of Ibrutinib can be decreased when combined with Orphenadrine.,decrease,no risk
Ibrutinib,Osilodrostat,The metabolism of Ibrutinib can be decreased when combined with Osilodrostat.,decrease,no risk
Ibrutinib,Ospemifene,The metabolism of Ibrutinib can be decreased when combined with Ospemifene.,decrease,no risk
Ibrutinib,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Ibrutinib.,increase,risk
Ibrutinib,Oxamniquine,The metabolism of Ibrutinib can be decreased when combined with Oxamniquine.,decrease,no risk
Ibrutinib,Oxcarbazepine,The metabolism of Ibrutinib can be increased when combined with Oxcarbazepine.,increase,no risk
Ibrutinib,Oxetacaine,The metabolism of Ibrutinib can be decreased when combined with Oxetacaine.,decrease,no risk
Ibrutinib,Oxprenolol,The metabolism of Ibrutinib can be decreased when combined with Oxprenolol.,decrease,no risk
Ibrutinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ibrutinib is combined with Oxybuprocaine.,increase,risk
Ibrutinib,Oxybutynin,The metabolism of Ibrutinib can be decreased when combined with Oxybutynin.,decrease,no risk
Ibrutinib,Oxycodone,The metabolism of Ibrutinib can be decreased when combined with Oxycodone.,decrease,no risk
Ibrutinib,Oxymetholone,The metabolism of Ibrutinib can be decreased when combined with Oxymetholone.,decrease,no risk
Ibrutinib,Oxymorphone,The metabolism of Ibrutinib can be decreased when combined with Oxymorphone.,decrease,no risk
Ibrutinib,Ozanimod,The risk or severity of adverse effects can be increased when Ibrutinib is combined with Ozanimod.,increase,risk
Ibrutinib,Quetiapine,The metabolism of Ibrutinib can be decreased when combined with Quetiapine.,decrease,no risk
Ibrutinib,Quinidine,The metabolism of Ibrutinib can be decreased when combined with Quinidine.,decrease,no risk
Ibrutinib,Quinine,The metabolism of Ibrutinib can be decreased when combined with Quinine.,decrease,no risk
Ibrutinib,Quinupristin,The metabolism of Ibrutinib can be decreased when combined with Quinupristin.,decrease,no risk
Ibrutinib,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Ibrutinib.,increase,risk
Ibrutinib,Udenafil,The metabolism of Ibrutinib can be decreased when combined with Udenafil.,decrease,no risk
Ibrutinib,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Upadacitinib,The risk or severity of adverse effects can be increased when Ibrutinib is combined with Upadacitinib.,increase,risk
Ibrutinib,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Urokinase.,increase,risk
Ibrutinib,Vadadustat,The serum concentration of Ibrutinib can be increased when it is combined with Vadadustat.,increase,no risk
Ibrutinib,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Valproic acid,The metabolism of Ibrutinib can be decreased when combined with Valproic acid.,decrease,no risk
Ibrutinib,Vardenafil,The metabolism of Ibrutinib can be decreased when combined with Vardenafil.,decrease,no risk
Ibrutinib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Ibrutinib.,increase,risk
Ibrutinib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Ibrutinib.,decrease,no risk
Ibrutinib,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Ibrutinib.,increase,risk
Ibrutinib,Vemurafenib,The metabolism of Ibrutinib can be decreased when combined with Vemurafenib.,decrease,no risk
Ibrutinib,Venetoclax,The metabolism of Ibrutinib can be decreased when combined with Venetoclax.,decrease,no risk
Ibrutinib,Venlafaxine,The metabolism of Ibrutinib can be decreased when combined with Venlafaxine.,decrease,no risk
Ibrutinib,Verapamil,The metabolism of Ibrutinib can be decreased when combined with Verapamil.,decrease,no risk
Ibrutinib,Vernakalant,The metabolism of Ibrutinib can be decreased when combined with Vernakalant.,decrease,no risk
Ibrutinib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ibrutinib.,decrease,no risk
Ibrutinib,Vilanterol,The risk or severity of adverse effects can be increased when Ibrutinib is combined with Vilanterol.,increase,risk
Ibrutinib,Vilazodone,The metabolism of Ibrutinib can be decreased when combined with Vilazodone.,decrease,no risk
Ibrutinib,Viloxazine,The metabolism of Ibrutinib can be decreased when combined with Viloxazine.,decrease,no risk
Ibrutinib,Vinblastine,The metabolism of Ibrutinib can be decreased when combined with Vinblastine.,decrease,no risk
Ibrutinib,Vincristine,The metabolism of Vincristine can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Ibrutinib.,increase,risk
Ibrutinib,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ibrutinib.,increase,risk
Ibrutinib,Vitamin E,Vitamin E may increase the antiplatelet activities of Ibrutinib.,increase,no risk
Ibrutinib,Voclosporin,The risk or severity of adverse effects can be increased when Ibrutinib is combined with Voclosporin.,increase,risk
Ibrutinib,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Vorapaxar.,increase,risk
Ibrutinib,Voriconazole,The metabolism of Ibrutinib can be decreased when combined with Voriconazole.,decrease,no risk
Ibrutinib,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Ibrutinib.,increase,risk
Ibrutinib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Ibrutinib.,decrease,no risk
Ibrutinib,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Warfarin.,increase,risk
Ibrutinib,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Ximelagatran.,increase,risk
Ibrutinib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Ibrutinib.,increase,risk
Ibrutinib,Yohimbine,The metabolism of Ibrutinib can be decreased when combined with Yohimbine.,decrease,no risk
Ibrutinib,Zafirlukast,The metabolism of Ibrutinib can be decreased when combined with Zafirlukast.,decrease,no risk
Ibrutinib,Zaleplon,The metabolism of Ibrutinib can be decreased when combined with Zaleplon.,decrease,no risk
Ibrutinib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Ibrutinib.,increase,risk
Ibrutinib,Zimelidine,The metabolism of Ibrutinib can be decreased when combined with Zimelidine.,decrease,no risk
Ibrutinib,Ziprasidone,The metabolism of Ibrutinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ibrutinib,Zolpidem,The metabolism of Ibrutinib can be decreased when combined with Zolpidem.,decrease,no risk
Ibrutinib,Zonisamide,The metabolism of Ibrutinib can be decreased when combined with Zonisamide.,decrease,no risk
Ibrutinib,Zuclopenthixol,The metabolism of Ibrutinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Idelalisib,Budesonide,The metabolism of Idelalisib can be increased when combined with Budesonide.,increase,no risk
Idelalisib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Idelalisib is combined with Bupivacaine.,increase,risk
Idelalisib,Buprenorphine,The metabolism of Idelalisib can be decreased when combined with Buprenorphine.,decrease,no risk
Idelalisib,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Idelalisib.,increase,risk
Idelalisib,Butacaine,The risk or severity of methemoglobinemia can be increased when Idelalisib is combined with Butacaine.,increase,risk
Idelalisib,Butalbital,The metabolism of Idelalisib can be increased when combined with Butalbital.,increase,no risk
Idelalisib,Butamben,The risk or severity of methemoglobinemia can be increased when Idelalisib is combined with Butamben.,increase,risk
Idelalisib,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Gefitinib,Gefitinib may decrease the excretion rate of Idelalisib which could result in a higher serum level.,decrease,no risk
Idelalisib,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Idelalisib.,increase,risk
Idelalisib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Idelalisib.,increase,risk
Idelalisib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Idelalisib.,increase,no risk
Idelalisib,Gilteritinib,The metabolism of Idelalisib can be decreased when combined with Gilteritinib.,decrease,no risk
Idelalisib,Ginkgo biloba,The metabolism of Idelalisib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Idelalisib,Glasdegib,Glasdegib may decrease the excretion rate of Idelalisib which could result in a higher serum level.,decrease,no risk
Idelalisib,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Idelalisib.,increase,risk
Idelalisib,Glecaprevir,The metabolism of Idelalisib can be decreased when combined with Glecaprevir.,decrease,no risk
Idelalisib,Glofitamab,The serum concentration of Idelalisib can be increased when it is combined with Glofitamab.,increase,no risk
Idelalisib,Glyburide,The metabolism of Idelalisib can be decreased when combined with Glyburide.,decrease,no risk
Idelalisib,Glycerol phenylbutyrate,The metabolism of Idelalisib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Idelalisib,Golimumab,The metabolism of Idelalisib can be increased when combined with Golimumab.,increase,no risk
Idelalisib,Grapefruit,The serum concentration of Idelalisib can be increased when it is combined with Grapefruit.,increase,no risk
Idelalisib,Grazoprevir,Grazoprevir may decrease the excretion rate of Idelalisib which could result in a higher serum level.,decrease,no risk
Idelalisib,Griseofulvin,The metabolism of Idelalisib can be increased when combined with Griseofulvin.,increase,no risk
Idelalisib,Guselkumab,The risk or severity of adverse effects can be increased when Idelalisib is combined with Guselkumab.,increase,risk
Idelalisib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Idelalisib.,decrease,no risk
Idelalisib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Idelalisib.,increase,no risk
Idelalisib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Idelalisib.,decrease,no risk
Idelalisib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Idelalisib.,decrease,no risk
Idelalisib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Idelalisib.,increase,risk
Idelalisib,Hydralazine,The serum concentration of Idelalisib can be increased when it is combined with Hydralazine.,increase,no risk
Idelalisib,Hydrocortamate,The metabolism of Idelalisib can be increased when combined with Hydrocortamate.,increase,no risk
Idelalisib,Hydrocortisone,The metabolism of Idelalisib can be increased when combined with Hydrocortisone.,increase,no risk
Idelalisib,Hydrocortisone acetate,The metabolism of Idelalisib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Idelalisib,Hydrocortisone butyrate,The metabolism of Idelalisib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Idelalisib,Hydrocortisone succinate,The metabolism of Idelalisib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Idelalisib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Idelalisib.,increase,risk
Idelalisib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Idelalisib.,increase,risk
Idelalisib,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Idelalisib.,decrease,no risk
Idelalisib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Idelalisib.,decrease,no risk
Idelalisib,Ketazolam,The serum concentration of Idelalisib can be increased when it is combined with Ketazolam.,increase,no risk
Idelalisib,Ketoconazole,The metabolism of Idelalisib can be decreased when combined with Ketoconazole.,decrease,no risk
Idelalisib,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Idelalisib.,increase,risk
Idelalisib,Ocrelizumab,The risk or severity of adverse effects can be increased when Idelalisib is combined with Ocrelizumab.,increase,risk
Idelalisib,Octreotide,The serum concentration of Idelalisib can be increased when it is combined with Octreotide.,increase,no risk
Idelalisib,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Idelalisib.,increase,risk
Idelalisib,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Olaparib,The metabolism of Idelalisib can be decreased when combined with Olaparib.,decrease,no risk
Idelalisib,Olutasidenib,The metabolism of Idelalisib can be increased when combined with Olutasidenib.,increase,no risk
Idelalisib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Idelalisib.,increase,no risk
Idelalisib,Omaveloxolone,The serum concentration of Idelalisib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Idelalisib,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Idelalisib.,increase,no risk
Idelalisib,Oritavancin,The metabolism of Idelalisib can be increased when combined with Oritavancin.,increase,no risk
Idelalisib,Orphenadrine,The metabolism of Idelalisib can be decreased when combined with Orphenadrine.,decrease,no risk
Idelalisib,Osilodrostat,The metabolism of Idelalisib can be decreased when combined with Osilodrostat.,decrease,no risk
Idelalisib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Oteseconazole,The serum concentration of Idelalisib can be increased when it is combined with Oteseconazole.,increase,no risk
Idelalisib,Ouabain,The excretion of Ouabain can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Idelalisib.,increase,risk
Idelalisib,Oxcarbazepine,The metabolism of Idelalisib can be increased when combined with Oxcarbazepine.,increase,no risk
Idelalisib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Idelalisib is combined with Oxetacaine.,increase,risk
Idelalisib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Idelalisib is combined with Oxybuprocaine.,increase,risk
Idelalisib,Oxybutynin,The serum concentration of Idelalisib can be increased when it is combined with Oxybutynin.,increase,no risk
Idelalisib,Ozanimod,The risk or severity of adverse effects can be increased when Idelalisib is combined with Ozanimod.,increase,risk
Idelalisib,Quinidine,The metabolism of Idelalisib can be decreased when combined with Quinidine.,decrease,no risk
Idelalisib,Quinine,The metabolism of Idelalisib can be increased when combined with Quinine.,increase,no risk
Idelalisib,Quinupristin,The metabolism of Idelalisib can be decreased when combined with Quinupristin.,decrease,no risk
Idelalisib,Quizartinib,The serum concentration of Idelalisib can be increased when it is combined with Quizartinib.,increase,no risk
Idelalisib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Idelalisib.,increase,risk
Idelalisib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Idelalisib.,increase,no risk
Idelalisib,Umbralisib,The serum concentration of Idelalisib can be increased when it is combined with Umbralisib.,increase,no risk
Idelalisib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Idelalisib.,increase,no risk
Idelalisib,Upadacitinib,The risk or severity of adverse effects can be increased when Idelalisib is combined with Upadacitinib.,increase,risk
Idelalisib,Vadadustat,The serum concentration of Idelalisib can be increased when it is combined with Vadadustat.,increase,no risk
Idelalisib,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Idelalisib.,decrease,no risk
Idelalisib,Valproic acid,The serum concentration of Idelalisib can be increased when it is combined with Valproic acid.,increase,no risk
Idelalisib,Valsartan,The excretion of Valsartan can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Idelalisib.,increase,risk
Idelalisib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Idelalisib.,decrease,no risk
Idelalisib,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Idelalisib.,increase,risk
Idelalisib,Velpatasvir,Velpatasvir may decrease the excretion rate of Idelalisib which could result in a higher serum level.,decrease,no risk
Idelalisib,Vemurafenib,The serum concentration of Idelalisib can be increased when it is combined with Vemurafenib.,increase,no risk
Idelalisib,Venetoclax,The metabolism of Idelalisib can be decreased when combined with Venetoclax.,decrease,no risk
Idelalisib,Venlafaxine,Venlafaxine may increase the excretion rate of Idelalisib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Idelalisib,Verapamil,The metabolism of Idelalisib can be decreased when combined with Verapamil.,decrease,no risk
Idelalisib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Idelalisib.,decrease,no risk
Idelalisib,Vilanterol,The risk or severity of adverse effects can be increased when Idelalisib is combined with Vilanterol.,increase,risk
Idelalisib,Viloxazine,The metabolism of Idelalisib can be decreased when combined with Viloxazine.,decrease,no risk
Idelalisib,Vinblastine,The metabolism of Idelalisib can be increased when combined with Vinblastine.,increase,no risk
Idelalisib,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Idelalisib.,increase,risk
Idelalisib,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Idelalisib.,increase,risk
Idelalisib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Idelalisib.,increase,risk
Idelalisib,Vismodegib,Vismodegib may decrease the excretion rate of Idelalisib which could result in a higher serum level.,decrease,no risk
Idelalisib,Vitamin E,The metabolism of Idelalisib can be increased when combined with Vitamin E.,increase,no risk
Idelalisib,Voclosporin,The risk or severity of adverse effects can be increased when Idelalisib is combined with Voclosporin.,increase,risk
Idelalisib,Vorapaxar,The metabolism of Idelalisib can be decreased when combined with Vorapaxar.,decrease,no risk
Idelalisib,Voriconazole,The metabolism of Idelalisib can be decreased when combined with Voriconazole.,decrease,no risk
Idelalisib,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Idelalisib.,increase,risk
Idelalisib,Voxelotor,The serum concentration of Idelalisib can be increased when it is combined with Voxelotor.,increase,no risk
Idelalisib,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Idelalisib which could result in a higher serum level.,decrease,no risk
Idelalisib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Idelalisib.,increase,no risk
Idelalisib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Idelalisib.,increase,risk
Idelalisib,Zafirlukast,The serum concentration of Idelalisib can be increased when it is combined with Zafirlukast.,increase,no risk
Idelalisib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Idelalisib.,increase,no risk
Idelalisib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Idelalisib.,increase,risk
Idelalisib,Zimelidine,The metabolism of Idelalisib can be decreased when combined with Zimelidine.,decrease,no risk
Idelalisib,Ziprasidone,The metabolism of Idelalisib can be decreased when combined with Ziprasidone.,decrease,no risk
Idelalisib,Zonisamide,The serum concentration of Idelalisib can be increased when it is combined with Zonisamide.,increase,no risk
Idelalisib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Idelalisib.,decrease,no risk
Idelalisib,Zuclopenthixol,The metabolism of Idelalisib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Acipimox,Baclofen,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Acipimox.",increase,risk
Acipimox,Betamethasone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Acipimox.",increase,risk
Acipimox,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bezafibrate is combined with Acipimox.",increase,risk
Acipimox,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Acipimox.",increase,risk
Acipimox,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Acipimox.",increase,risk
Acipimox,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Gemfibrozil is combined with Acipimox.",increase,risk
Acipimox,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Acipimox.",increase,risk
Acipimox,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Acipimox is combined with Ubidecarenone.",increase,risk
Acipimox,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Acipimox.",increase,risk
Acipimox,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Acipimox.",increase,risk
Anthrax immune globulin human,Galcanezumab,The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Galcanezumab.,increase,risk
Anthrax immune globulin human,Gemcitabine,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Gemcitabine.,decrease,no risk
Anthrax immune globulin human,Gemtuzumab ozogamicin,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
Anthrax immune globulin human,Glatiramer,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Glatiramer.,decrease,no risk
Anthrax immune globulin human,Glofitamab,The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Glofitamab.,increase,risk
Anthrax immune globulin human,Golimumab,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Golimumab.,decrease,no risk
Anthrax immune globulin human,Guselkumab,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Guselkumab.,decrease,no risk
Anthrax immune globulin human,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Anthrax immune globulin human.,increase,risk
Anthrax immune globulin human,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Human cytomegalovirus immune globulin.,increase,risk
Anthrax immune globulin human,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Anthrax immune globulin human.,increase,risk
Anthrax immune globulin human,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Human Rho(D) immune globulin.,increase,risk
Anthrax immune globulin human,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Human varicella-zoster immune globulin.,increase,risk
Anthrax immune globulin human,Hydrocortisone,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Anthrax immune globulin human,Hydrocortisone acetate,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Anthrax immune globulin human,Hydrocortisone butyrate,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Anthrax immune globulin human,Hydrocortisone succinate,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Anthrax immune globulin human,Hydroxychloroquine,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Anthrax immune globulin human,Hydroxyurea,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Anthrax immune globulin human,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Anthrax immune globulin human.,increase,risk
Anthrax immune globulin human,Obinutuzumab,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Anthrax immune globulin human,Ocrelizumab,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Ocrelizumab.,decrease,no risk
Anthrax immune globulin human,Odesivimab,The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Odesivimab.,increase,risk
Anthrax immune globulin human,Ofatumumab,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Ofatumumab.,decrease,no risk
Anthrax immune globulin human,Olaparib,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Olaparib.,decrease,no risk
Anthrax immune globulin human,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Anthrax immune globulin human.,increase,risk
Anthrax immune globulin human,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Anthrax immune globulin human.,increase,risk
Anthrax immune globulin human,Oxaliplatin,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Oxaliplatin.,decrease,no risk
Anthrax immune globulin human,Ozanimod,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Ozanimod.,decrease,no risk
Anthrax immune globulin human,Quinestrol,Quinestrol may increase the thrombogenic activities of Anthrax immune globulin human.,increase,no risk
Factor IX Complex (Human),Bemiparin,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Bemiparin.,decrease,no risk
Factor IX Complex (Human),Betrixaban,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Betrixaban.,decrease,no risk
Factor IX Complex (Human),Bivalirudin,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Bivalirudin.,decrease,no risk
Factor IX Complex (Human),Heparin,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Heparin.,decrease,no risk
Factor IX Complex (Human),Hydrogen peroxide,Hydrogen peroxide may increase the thrombogenic activities of Factor IX Complex (Human).,increase,no risk
Factor IX Complex (Human),Urokinase,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Urokinase.,decrease,no risk
Factor IX Complex (Human),Vorapaxar,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Vorapaxar.,decrease,no risk
Factor IX Complex (Human),Warfarin,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Warfarin.,decrease,no risk
Factor IX Complex (Human),Ximelagatran,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Ximelagatran.,decrease,no risk
Atosiban,Olodaterol,The risk or severity of adverse effects can be increased when Olodaterol is combined with Atosiban.,increase,risk
Atosiban,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Atosiban.,increase,risk
Atosiban,Vilanterol,The risk or severity of adverse effects can be increased when Vilanterol is combined with Atosiban.,increase,risk
Avibactam,Benzoic acid,The excretion of Avibactam can be decreased when combined with Benzoic acid.,decrease,no risk
Avibactam,Benzylpenicillin,The excretion of Avibactam can be decreased when combined with Benzylpenicillin.,decrease,no risk
Avibactam,Bumetanide,The excretion of Avibactam can be decreased when combined with Bumetanide.,decrease,no risk
Avibactam,Ganciclovir,The excretion of Avibactam can be decreased when combined with Ganciclovir.,decrease,no risk
Avibactam,Gemfibrozil,The excretion of Avibactam can be decreased when combined with Gemfibrozil.,decrease,no risk
Avibactam,Guanidine,The excretion of Avibactam can be decreased when combined with Guanidine.,decrease,no risk
Avibactam,Ketoprofen,The excretion of Avibactam can be decreased when combined with Ketoprofen.,decrease,no risk
Avibactam,Ouabain,The excretion of Avibactam can be decreased when combined with Ouabain.,decrease,no risk
Avibactam,Oxytetracycline,The excretion of Avibactam can be decreased when combined with Oxytetracycline.,decrease,no risk
Avibactam,Quinidine,The excretion of Avibactam can be decreased when combined with Quinidine.,decrease,no risk
Avibactam,Vadadustat,The serum concentration of Avibactam can be increased when it is combined with Vadadustat.,increase,no risk
Avibactam,Valproic acid,The excretion of Avibactam can be decreased when combined with Valproic acid.,decrease,no risk
Avibactam,Zidovudine,The excretion of Avibactam can be decreased when combined with Zidovudine.,decrease,no risk
Cannabidiol,Benazepril,Cannabidiol may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Cannabidiol,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Bendroflumethiazide,Cannabidiol may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Cannabidiol,Benorilate,The risk or severity of hypertension can be increased when Cannabidiol is combined with Benorilate.,increase,risk
Cannabidiol,Benoxaprofen,The risk or severity of hypertension can be increased when Benoxaprofen is combined with Cannabidiol.,increase,risk
Cannabidiol,Benperidol,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benperidol.,increase,risk
Cannabidiol,Benzatropine,The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Cannabidiol.,increase,risk
Cannabidiol,Benzocaine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benzocaine.,increase,risk
Cannabidiol,Benzphetamine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benzphetamine.,increase,risk
Cannabidiol,Benzydamine,The risk or severity of hypertension can be increased when Cannabidiol is combined with Benzydamine.,increase,risk
Cannabidiol,Benzyl alcohol,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benzyl alcohol.,increase,risk
Cannabidiol,Bepridil,The metabolism of Bepridil can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Bethanidine,Cannabidiol may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Cannabidiol,Bexagliflozin,The metabolism of Bexagliflozin can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Bimekizumab,The metabolism of Cannabidiol can be increased when combined with Bimekizumab.,increase,no risk
Cannabidiol,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Biperiden,The risk or severity of Tachycardia and drowsiness can be increased when Biperiden is combined with Cannabidiol.,increase,risk
Cannabidiol,Bisoprolol,Cannabidiol may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Cannabidiol,Boceprevir,The metabolism of Cannabidiol can be decreased when combined with Boceprevir.,decrease,no risk
Cannabidiol,Borage oil,The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Borage oil.,decrease,no risk
Cannabidiol,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Bosentan,The metabolism of Cannabidiol can be increased when combined with Bosentan.,increase,no risk
Cannabidiol,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Botulinum toxin type A.,increase,risk
Cannabidiol,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Botulinum toxin type B.,increase,risk
Cannabidiol,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Bretylium,Cannabidiol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Cannabidiol,Brexanolone,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brexanolone.,increase,risk
Cannabidiol,Brexpiprazole,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brexpiprazole.,increase,risk
Cannabidiol,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Cannabidiol.,increase,no risk
Cannabidiol,Brivaracetam,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brivaracetam.,increase,risk
Cannabidiol,Bromazepam,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromazepam.,increase,risk
Cannabidiol,Bromocriptine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromocriptine.,increase,risk
Cannabidiol,Bromotheophylline,Cannabidiol may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cannabidiol,Bromperidol,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromperidol.,increase,risk
Cannabidiol,Brompheniramine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brompheniramine.,increase,risk
Cannabidiol,Buclizine,The risk or severity of Tachycardia and drowsiness can be increased when Buclizine is combined with Cannabidiol.,increase,risk
Cannabidiol,Bumadizone,The risk or severity of hypertension can be increased when Cannabidiol is combined with Bumadizone.,increase,risk
Cannabidiol,Bupivacaine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bupivacaine.,increase,risk
Cannabidiol,Buprenorphine,Cannabidiol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Cannabidiol,Bupropion,The serum concentration of Bupropion can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Buspirone,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Buspirone.,increase,risk
Cannabidiol,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Butabarbital,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butabarbital.,increase,risk
Cannabidiol,Butacaine,The risk or severity of methemoglobinemia can be increased when Cannabidiol is combined with Butacaine.,increase,risk
Cannabidiol,Butalbital,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butalbital.,increase,risk
Cannabidiol,Butamben,The risk or severity of methemoglobinemia can be increased when Cannabidiol is combined with Butamben.,increase,risk
Cannabidiol,Butaperazine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butaperazine.,increase,risk
Cannabidiol,Butobarbital,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butobarbital.,increase,risk
Cannabidiol,Butorphanol,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butorphanol.,increase,risk
Cannabidiol,Butriptyline,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butriptyline.,increase,risk
Cannabidiol,Butylscopolamine,The risk or severity of Tachycardia and drowsiness can be increased when Butylscopolamine is combined with Cannabidiol.,increase,risk
Cannabidiol,Gabapentin,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gabapentin.,increase,risk
Cannabidiol,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gabapentin enacarbil.,increase,risk
Cannabidiol,Galantamine,The metabolism of Galantamine can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gallamine triethiodide.,increase,risk
Cannabidiol,Gamolenic acid,The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Cannabidiol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Cannabidiol is combined with Ganaxolone.",increase,risk
Cannabidiol,Ganciclovir,The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Ganciclovir.,decrease,no risk
Cannabidiol,Gefitinib,Cannabidiol may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Cannabidiol,Gemfibrozil,The metabolism of Cannabidiol can be decreased when combined with Gemfibrozil.,decrease,no risk
Cannabidiol,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Cannabidiol.,increase,risk
Cannabidiol,Gestrinone,The metabolism of Gestrinone can be increased when combined with Cannabidiol.,increase,no risk
Cannabidiol,Gilteritinib,The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Gilteritinib.,decrease,no risk
Cannabidiol,Ginkgo biloba,The metabolism of Cannabidiol can be decreased when combined with Ginkgo biloba.,decrease,no risk
Cannabidiol,Glasdegib,Cannabidiol may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Cannabidiol,Glecaprevir,Cannabidiol may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Cannabidiol,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Glipizide,The metabolism of Glipizide can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Glofitamab,The serum concentration of Cannabidiol can be increased when it is combined with Glofitamab.,increase,no risk
Cannabidiol,Glutethimide,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Glutethimide.,increase,risk
Cannabidiol,Glyburide,Cannabidiol may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Cannabidiol,Glycopyrronium,The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Cannabidiol.,increase,risk
Cannabidiol,Golimumab,The metabolism of Cannabidiol can be increased when combined with Golimumab.,increase,no risk
Cannabidiol,Granisetron,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Granisetron.,increase,risk
Cannabidiol,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Guanadrel,Cannabidiol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Cannabidiol,Guanethidine,Cannabidiol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Cannabidiol,Guanfacine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Guanfacine.,increase,risk
Cannabidiol,Guanoxan,Cannabidiol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Cannabidiol,Halazepam,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Halazepam.,increase,risk
Cannabidiol,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Cannabidiol.,increase,risk
Cannabidiol,Halothane,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Halothane.,increase,risk
Cannabidiol,Hexafluronium,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hexafluronium.,increase,risk
Cannabidiol,Hexocyclium,The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with Cannabidiol.,increase,risk
Cannabidiol,Homatropine methylbromide,The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with Cannabidiol.,increase,risk
Cannabidiol,Hydralazine,Cannabidiol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Cannabidiol,Hydrochlorothiazide,Cannabidiol may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Cannabidiol,Hydrocodone,Cannabidiol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cannabidiol,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Hydroflumethiazide,Cannabidiol may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Cannabidiol,Hydromorphone,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hydromorphone.,increase,risk
Cannabidiol,Hydroxychloroquine,The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Cannabidiol,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Cannabidiol.,increase,no risk
Cannabidiol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cannabidiol.,increase,no risk
Cannabidiol,Hyoscyamine,The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Cannabidiol.,increase,risk
Cannabidiol,Ketamine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ketamine.,increase,risk
Cannabidiol,Ketazolam,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ketazolam.,increase,risk
Cannabidiol,Ketoconazole,The metabolism of Cannabidiol can be decreased when combined with Ketoconazole.,decrease,no risk
Cannabidiol,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Cannabidiol.,increase,risk
Cannabidiol,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Olanzapine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Olanzapine.,increase,risk
Cannabidiol,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cannabidiol is combined with Oliceridine.",increase,risk
Cannabidiol,Olmesartan,Cannabidiol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Cannabidiol,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Omaveloxolone,The serum concentration of Cannabidiol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cannabidiol,Ombitasvir,Cannabidiol may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Cannabidiol,Omeprazole,The metabolism of Cannabidiol can be decreased when combined with Omeprazole.,decrease,no risk
Cannabidiol,Ondansetron,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ondansetron.,increase,risk
Cannabidiol,Opium,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Opium.,increase,risk
Cannabidiol,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Cannabidiol.,increase,risk
Cannabidiol,Oritavancin,The metabolism of Cannabidiol can be decreased when combined with Oritavancin.,decrease,no risk
Cannabidiol,Orlistat,Orlistat can cause a decrease in the absorption of Cannabidiol resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Cannabidiol,Orphenadrine,Cannabidiol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Cannabidiol,Osilodrostat,The metabolism of Cannabidiol can be decreased when combined with Osilodrostat.,decrease,no risk
Cannabidiol,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Oxaliplatin,Cannabidiol may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Cannabidiol,Oxandrolone,The metabolism of Cannabidiol can be decreased when combined with Oxandrolone.,decrease,no risk
Cannabidiol,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Cannabidiol.,increase,risk
Cannabidiol,Oxazepam,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxazepam.,increase,risk
Cannabidiol,Oxcarbazepine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxcarbazepine.,increase,risk
Cannabidiol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cannabidiol is combined with Oxetacaine.,increase,risk
Cannabidiol,Oxitriptan,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxitriptan.,increase,risk
Cannabidiol,Oxprenolol,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxprenolol.,increase,risk
Cannabidiol,Oxtriphylline,Cannabidiol may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cannabidiol,Oxybuprocaine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxybuprocaine.,increase,risk
Cannabidiol,Oxybutynin,The risk or severity of Tachycardia and drowsiness can be increased when Oxybutynin is combined with Cannabidiol.,increase,risk
Cannabidiol,Oxycodone,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxycodone.,increase,risk
Cannabidiol,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Cannabidiol.,increase,risk
Cannabidiol,Oxymorphone,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxymorphone.,increase,risk
Cannabidiol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Cannabidiol.,increase,risk
Cannabidiol,Oxyphencyclimine,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with Cannabidiol.,increase,risk
Cannabidiol,Oxyphenonium,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Cannabidiol.,increase,risk
Cannabidiol,Ozanimod,Cannabidiol may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Cannabidiol,Quazepam,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quazepam.,increase,risk
Cannabidiol,Quetiapine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quetiapine.,increase,risk
Cannabidiol,Quinapril,Cannabidiol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Cannabidiol,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Quinine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quinine.,increase,risk
Cannabidiol,Quinupramine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quinupramine.,increase,risk
Cannabidiol,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Udenafil,The metabolism of Udenafil can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Ulipristal,The metabolism of Ulipristal can be increased when combined with Cannabidiol.,increase,no risk
Cannabidiol,Umeclidinium,The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Cannabidiol.,increase,risk
Cannabidiol,Urethane,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Urethane.,increase,risk
Cannabidiol,Vadadustat,The serum concentration of Cannabidiol can be increased when it is combined with Vadadustat.,increase,no risk
Cannabidiol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Valganciclovir,The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Valganciclovir.,decrease,no risk
Cannabidiol,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Valproate bismuth.,increase,risk
Cannabidiol,Valproic acid,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Valproic acid.,increase,risk
Cannabidiol,Valsartan,The metabolism of Cannabidiol can be decreased when combined with Valsartan.,decrease,no risk
Cannabidiol,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Vecuronium,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vecuronium.,increase,risk
Cannabidiol,Velpatasvir,Cannabidiol may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Cannabidiol,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Venlafaxine.,increase,risk
Cannabidiol,Verapamil,The metabolism of Cannabidiol can be decreased when combined with Verapamil.,decrease,no risk
Cannabidiol,Vericiguat,The metabolism of Vericiguat can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Vigabatrin,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vigabatrin.,increase,risk
Cannabidiol,Vilanterol,The risk or severity of hypertension can be increased when Cannabidiol is combined with Vilanterol.,increase,risk
Cannabidiol,Vilazodone,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vilazodone.,increase,risk
Cannabidiol,Viloxazine,The metabolism of Cannabidiol can be decreased when combined with Viloxazine.,decrease,no risk
Cannabidiol,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Voriconazole,The metabolism of Cannabidiol can be decreased when combined with Voriconazole.,decrease,no risk
Cannabidiol,Vortioxetine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vortioxetine.,increase,risk
Cannabidiol,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Voxilaprevir,Cannabidiol may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Cannabidiol,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Xamoterol,The risk or severity of hypertension can be increased when Cannabidiol is combined with Xamoterol.,increase,risk
Cannabidiol,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Cannabidiol.,increase,risk
Cannabidiol,Yohimbine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Yohimbine.,increase,risk
Cannabidiol,Zafirlukast,The metabolism of Cannabidiol can be decreased when combined with Zafirlukast.,decrease,no risk
Cannabidiol,Zaleplon,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zaleplon.,increase,risk
Cannabidiol,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Cannabidiol.,increase,no risk
Cannabidiol,Ziconotide,The risk or severity of CNS depression can be increased when Cannabidiol is combined with Ziconotide.,increase,risk
Cannabidiol,Zidovudine,Cannabidiol may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Cannabidiol,Zileuton,The metabolism of Zileuton can be decreased when combined with Cannabidiol.,decrease,no risk
Cannabidiol,Zimelidine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zimelidine.,increase,risk
Cannabidiol,Ziprasidone,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ziprasidone.,increase,risk
Cannabidiol,Zofenopril,Cannabidiol may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Cannabidiol,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Cannabidiol is combined with Zolmitriptan.,increase,risk
Cannabidiol,Zolpidem,Cannabidiol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Cannabidiol,Zonisamide,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zonisamide.,increase,risk
Cannabidiol,Zopiclone,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zopiclone.,increase,risk
Cannabidiol,Zotepine,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zotepine.,increase,risk
Cannabidiol,Zuclopenthixol,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zuclopenthixol.,increase,risk
Cannabidiol,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Cannabidiol.,increase,risk
Cefminox,Gabapentin enacarbil,Cefminox may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefminox,Gadobenic acid,Cefminox may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefminox,Gadodiamide,Cefminox may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefminox,Gadofosveset trisodium,Cefminox may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefminox,Gadopentetic acid,Cefminox may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefminox,Gadoteric acid,Cefminox may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefminox,Gadoteridol,Cefminox may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefminox,Ganciclovir,Cefminox may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cefminox,Gemcitabine,Cefminox may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefminox,Gemfibrozil,Cefminox may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cefminox,Gentamicin,Cefminox may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefminox,Gimeracil,Cefminox may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefminox,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Givosiran.,increase,risk
Cefminox,Glipizide,Cefminox may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefminox,Glycerol phenylbutyrate,Cefminox may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefminox,Golodirsen,Cefminox may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefminox,Goserelin,Cefminox may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefminox,Guanethidine,Cefminox may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefminox,Guanfacine,Cefminox may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefminox,Haloperidol,Cefminox may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefminox,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefminox.,decrease,no risk
Cefminox,Hydralazine,Cefminox may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefminox,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefminox.,increase,risk
Cefminox,Hydromorphone,Cefminox may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefminox,Hydroxocobalamin,Cefminox may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefminox,Hydroxyethyl Starch,Cefminox may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefminox,Kanamycin,Cefminox may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefminox,Ketamine,Cefminox may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefminox,Ketazolam,Cefminox may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefminox,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Cefminox.,increase,risk
Cefminox,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefminox.,increase,risk
Cefminox,Octinoxate,Cefminox may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefminox,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Olsalazine.,increase,risk
Cefminox,Opium,Cefminox may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefminox,Oseltamivir,Cefminox may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cefminox,Oxacillin,Cefminox may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefminox,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefminox.,increase,risk
Cefminox,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cefminox.,increase,risk
Cefminox,Oxazepam,Cefminox may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefminox,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefminox is combined with Oxetacaine.,increase,risk
Cefminox,Oxybenzone,Cefminox may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefminox,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefminox is combined with Oxybuprocaine.,increase,risk
Cefminox,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Cefminox.,increase,risk
Cefminox,Oxyquinoline,Cefminox may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefminox,Quetiapine,Cefminox may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefminox,Quinidine,Cefminox may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefminox,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefminox.,decrease,no risk
Cefminox,Vaborbactam,Cefminox may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cefminox,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Cefminox.,increase,risk
Cefminox,Valbenazine,Cefminox may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cefminox,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefminox.,increase,risk
Cefminox,Valganciclovir,Cefminox may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cefminox,Vancomycin,Cefminox may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cefminox,Varenicline,Cefminox may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cefminox,Venlafaxine,Cefminox may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cefminox,Verapamil,Cefminox may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cefminox,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefminox.,decrease,no risk
Cefminox,Vilanterol,Cefminox may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Cefminox,Viloxazine,Cefminox may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cefminox,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Cefminox.,decrease,no risk
Cefminox,Vortioxetine,Cefminox may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Cefminox,Warfarin,Cefminox may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Cefminox,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Cefminox.,decrease,no risk
Cefminox,Zaleplon,Cefminox may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Cefminox,Zanamivir,Cefminox may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cefminox,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefminox is combined with Zoledronic acid.,increase,risk
Cefminox,Zonisamide,Cefminox may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Ceritinib,Bimekizumab,The metabolism of Ceritinib can be increased when combined with Bimekizumab.,increase,no risk
Ceritinib,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Ceritinib.,increase,no risk
Ceritinib,Bisoprolol,Bisoprolol may increase the bradycardic activities of Ceritinib.,increase,no risk
Ceritinib,Boceprevir,The metabolism of Ceritinib can be decreased when combined with Boceprevir.,decrease,no risk
Ceritinib,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Bosentan,The metabolism of Ceritinib can be increased when combined with Bosentan.,increase,no risk
Ceritinib,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Bretylium,Bretylium may increase the bradycardic activities of Ceritinib.,increase,no risk
Ceritinib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Ceritinib.,decrease,no risk
Ceritinib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Ceritinib.,increase,risk
Ceritinib,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ceritinib.,increase,risk
Ceritinib,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Ceritinib.,increase,risk
Ceritinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ceritinib is combined with Bupivacaine.,increase,risk
Ceritinib,Buprenorphine,The metabolism of Ceritinib can be decreased when combined with Buprenorphine.,decrease,no risk
Ceritinib,Bupropion,The metabolism of Bupropion can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ceritinib.,increase,risk
Ceritinib,Busulfan,The metabolism of Busulfan can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Ceritinib is combined with Butacaine.,increase,risk
Ceritinib,Butalbital,The metabolism of Ceritinib can be increased when combined with Butalbital.,increase,no risk
Ceritinib,Butamben,The risk or severity of methemoglobinemia can be increased when Ceritinib is combined with Butamben.,increase,risk
Ceritinib,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Ceritinib.,increase,risk
Ceritinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Ceritinib.,increase,risk
Ceritinib,Galantamine,Galantamine may increase the bradycardic activities of Ceritinib.,increase,no risk
Ceritinib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Ceritinib.,increase,risk
Ceritinib,Gemcitabine,The serum concentration of Ceritinib can be increased when it is combined with Gemcitabine.,increase,no risk
Ceritinib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Ceritinib.,increase,risk
Ceritinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Ceritinib.,increase,no risk
Ceritinib,Gilteritinib,The metabolism of Ceritinib can be decreased when combined with Gilteritinib.,decrease,no risk
Ceritinib,Ginkgo biloba,The metabolism of Ceritinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ceritinib,Glasdegib,The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Glasdegib.,increase,risk
Ceritinib,Glecaprevir,The serum concentration of Ceritinib can be increased when it is combined with Glecaprevir.,increase,no risk
Ceritinib,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Ceritinib.,decrease,no risk
Ceritinib,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Ceritinib.,decrease,no risk
Ceritinib,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Ceritinib.,decrease,no risk
Ceritinib,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Ceritinib.,decrease,no risk
Ceritinib,Glofitamab,The serum concentration of Ceritinib can be increased when it is combined with Glofitamab.,increase,no risk
Ceritinib,Glyburide,The metabolism of Ceritinib can be decreased when combined with Glyburide.,decrease,no risk
Ceritinib,Glycerol phenylbutyrate,The metabolism of Ceritinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Ceritinib,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Ceritinib.,decrease,no risk
Ceritinib,Golimumab,The metabolism of Ceritinib can be increased when combined with Golimumab.,increase,no risk
Ceritinib,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ceritinib.,increase,risk
Ceritinib,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Ceritinib.,increase,risk
Ceritinib,Grapefruit,The serum concentration of Ceritinib can be increased when it is combined with Grapefruit.,increase,no risk
Ceritinib,Grazoprevir,The serum concentration of Ceritinib can be increased when it is combined with Grazoprevir.,increase,no risk
Ceritinib,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Grepafloxacin.,increase,risk
Ceritinib,Griseofulvin,The metabolism of Ceritinib can be increased when combined with Griseofulvin.,increase,no risk
Ceritinib,Guanfacine,Guanfacine may increase the bradycardic activities of Ceritinib.,increase,no risk
Ceritinib,Halofantrine,The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Halofantrine.,increase,risk
Ceritinib,Haloperidol,The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Haloperidol.,increase,risk
Ceritinib,Halothane,The metabolism of Halothane can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ceritinib.,increase,risk
Ceritinib,Hydralazine,The serum concentration of Ceritinib can be increased when it is combined with Hydralazine.,increase,no risk
Ceritinib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ceritinib.,increase,risk
Ceritinib,Hydrocortamate,The metabolism of Ceritinib can be increased when combined with Hydrocortamate.,increase,no risk
Ceritinib,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Ceritinib.,increase,risk
Ceritinib,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Ceritinib.,increase,risk
Ceritinib,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Ceritinib.,increase,risk
Ceritinib,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Ceritinib.,increase,risk
Ceritinib,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Ceritinib.,increase,risk
Ceritinib,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Ceritinib.,increase,risk
Ceritinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Hydroxyzine.,increase,risk
Ceritinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ceritinib.,increase,risk
Ceritinib,Ketamine,The metabolism of Ketamine can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Ketazolam,The serum concentration of Ceritinib can be increased when it is combined with Ketazolam.,increase,no risk
Ceritinib,Ketoconazole,The metabolism of Ceritinib can be decreased when combined with Ketoconazole.,decrease,no risk
Ceritinib,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Octreotide,Octreotide may increase the bradycardic activities of Ceritinib.,increase,no risk
Ceritinib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Ceritinib.,increase,risk
Ceritinib,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Ceritinib.,increase,risk
Ceritinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Olutasidenib,The metabolism of Ceritinib can be increased when combined with Olutasidenib.,increase,no risk
Ceritinib,Omadacycline,The serum concentration of Ceritinib can be increased when it is combined with Omadacycline.,increase,no risk
Ceritinib,Omaveloxolone,The serum concentration of Ceritinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ceritinib,Ombitasvir,The serum concentration of Ceritinib can be increased when it is combined with Ombitasvir.,increase,no risk
Ceritinib,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ceritinib.,increase,risk
Ceritinib,Oritavancin,The metabolism of Ceritinib can be increased when combined with Oritavancin.,increase,no risk
Ceritinib,Orphenadrine,The metabolism of Ceritinib can be decreased when combined with Orphenadrine.,decrease,no risk
Ceritinib,Osilodrostat,The metabolism of Ceritinib can be decreased when combined with Osilodrostat.,decrease,no risk
Ceritinib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ceritinib.,increase,risk
Ceritinib,Oxatomide,The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Oxatomide.,increase,risk
Ceritinib,Oxcarbazepine,The metabolism of Ceritinib can be increased when combined with Oxcarbazepine.,increase,no risk
Ceritinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ceritinib is combined with Oxetacaine.,increase,risk
Ceritinib,Oxprenolol,Oxprenolol may increase the bradycardic activities of Ceritinib.,increase,no risk
Ceritinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ceritinib is combined with Oxybuprocaine.,increase,risk
Ceritinib,Oxybutynin,The serum concentration of Ceritinib can be increased when it is combined with Oxybutynin.,increase,no risk
Ceritinib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ceritinib.,increase,risk
Ceritinib,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Ceritinib.,increase,risk
Ceritinib,Quinidine,The serum concentration of Ceritinib can be increased when it is combined with Quinidine.,increase,no risk
Ceritinib,Quinine,The serum concentration of Ceritinib can be increased when it is combined with Quinine.,increase,no risk
Ceritinib,Quinupristin,The metabolism of Ceritinib can be decreased when combined with Quinupristin.,decrease,no risk
Ceritinib,Quizartinib,The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Quizartinib.,increase,risk
Ceritinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ceritinib.,increase,no risk
Ceritinib,Umbralisib,The serum concentration of Ceritinib can be increased when it is combined with Umbralisib.,increase,no risk
Ceritinib,Umeclidinium,The serum concentration of Ceritinib can be increased when it is combined with Umeclidinium.,increase,no risk
Ceritinib,Vadadustat,The serum concentration of Ceritinib can be increased when it is combined with Vadadustat.,increase,no risk
Ceritinib,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Valproic acid,The serum concentration of Ceritinib can be increased when it is combined with Valproic acid.,increase,no risk
Ceritinib,Valsartan,The metabolism of Valsartan can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Ceritinib.,increase,risk
Ceritinib,Vandetanib,The serum concentration of Ceritinib can be increased when it is combined with Vandetanib.,increase,no risk
Ceritinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Velpatasvir,The serum concentration of Ceritinib can be increased when it is combined with Velpatasvir.,increase,no risk
Ceritinib,Vemurafenib,The serum concentration of Ceritinib can be increased when it is combined with Vemurafenib.,increase,no risk
Ceritinib,Venetoclax,The serum concentration of Ceritinib can be increased when it is combined with Venetoclax.,increase,no risk
Ceritinib,Verapamil,Verapamil may increase the bradycardic activities of Ceritinib.,increase,no risk
Ceritinib,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ceritinib.,increase,risk
Ceritinib,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Ceritinib.,increase,risk
Ceritinib,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Ceritinib.,decrease,no risk
Ceritinib,Viloxazine,The metabolism of Ceritinib can be decreased when combined with Viloxazine.,decrease,no risk
Ceritinib,Vinblastine,The metabolism of Ceritinib can be increased when combined with Vinblastine.,increase,no risk
Ceritinib,Vincristine,The metabolism of Vincristine can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Vindesine,The metabolism of Vindesine can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Vitamin E,The metabolism of Ceritinib can be increased when combined with Vitamin E.,increase,no risk
Ceritinib,Voclosporin,The serum concentration of Ceritinib can be increased when it is combined with Voclosporin.,increase,no risk
Ceritinib,Vorapaxar,The serum concentration of Ceritinib can be increased when it is combined with Vorapaxar.,increase,no risk
Ceritinib,Voriconazole,The metabolism of Ceritinib can be decreased when combined with Voriconazole.,decrease,no risk
Ceritinib,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ceritinib.,increase,risk
Ceritinib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Voxelotor,The serum concentration of Ceritinib can be increased when it is combined with Voxelotor.,increase,no risk
Ceritinib,Voxilaprevir,The serum concentration of Ceritinib can be increased when it is combined with Voxilaprevir.,increase,no risk
Ceritinib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Ceritinib.,increase,no risk
Ceritinib,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Zafirlukast,The serum concentration of Ceritinib can be increased when it is combined with Zafirlukast.,increase,no risk
Ceritinib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Zileuton,The metabolism of Zileuton can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Zimelidine,The metabolism of Ceritinib can be decreased when combined with Zimelidine.,decrease,no risk
Ceritinib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Ziprasidone.,increase,risk
Ceritinib,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Ceritinib.,decrease,no risk
Ceritinib,Zonisamide,Zonisamide may increase the bradycardic activities of Ceritinib.,increase,no risk
Ceritinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ceritinib.,decrease,no risk
Ciprofibrate,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofibrate is combined with Ubidecarenone.",increase,risk
Ciprofibrate,Ursodeoxycholic acid,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Ciprofibrate.,decrease,no risk
Ciprofibrate,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Ciprofibrate.",increase,risk
Ciprofibrate,Warfarin,The risk or severity of bleeding can be increased when Ciprofibrate is combined with Warfarin.,increase,risk
Ciprofibrate,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ciprofibrate.",increase,risk
Cobicistat,Buspirone,The metabolism of Buspirone can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Busulfan,The metabolism of Busulfan can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Galantamine,The metabolism of Galantamine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Cobicistat.,decrease,no risk
Cobicistat,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Glecaprevir,Cobicistat may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Cobicistat,Glofitamab,The serum concentration of Cobicistat can be increased when it is combined with Glofitamab.,increase,no risk
Cobicistat,Glyburide,The metabolism of Glyburide can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Golimumab,The metabolism of Cobicistat can be increased when combined with Golimumab.,increase,no risk
Cobicistat,Granisetron,The metabolism of Granisetron can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Cobicistat.,decrease,no risk
Cobicistat,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Ketamine,The metabolism of Ketamine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Ketoconazole,The serum concentration of Cobicistat can be increased when it is combined with Ketoconazole.,increase,no risk
Cobicistat,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Olaparib,The metabolism of Olaparib can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Ombitasvir,Cobicistat may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Cobicistat,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Opium,The metabolism of Opium can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Ouabain,The excretion of Ouabain can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Oxaliplatin,Cobicistat may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Cobicistat,Oxcarbazepine,The metabolism of Cobicistat can be increased when combined with Oxcarbazepine.,increase,no risk
Cobicistat,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Ozanimod,Cobicistat may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Cobicistat,Quazepam,The metabolism of Quazepam can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Quinidine,The metabolism of Quinidine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Quinine,The metabolism of Quinine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Udenafil,The metabolism of Udenafil can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Cobicistat.,decrease,no risk
Cobicistat,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vadadustat,The serum concentration of Cobicistat can be increased when it is combined with Vadadustat.,increase,no risk
Cobicistat,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Valsartan,The excretion of Valsartan can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Verapamil,The metabolism of Verapamil can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Viloxazine,The metabolism of Cobicistat can be decreased when combined with Viloxazine.,decrease,no risk
Cobicistat,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Vindesine,The metabolism of Vindesine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Voriconazole,The metabolism of Cobicistat can be decreased when combined with Voriconazole.,decrease,no risk
Cobicistat,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Cobicistat.,increase,no risk
Cobicistat,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zileuton,The metabolism of Zileuton can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zimelidine,The metabolism of Cobicistat can be decreased when combined with Zimelidine.,decrease,no risk
Cobicistat,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zotepine,The metabolism of Zotepine can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Cobicistat.,decrease,no risk
Cobicistat,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Cobicistat.,increase,no risk
Corifollitropin alfa,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gadodiamide,Gadodiamide may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gadoteric acid,Corifollitropin alfa may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gadoteridol,Gadoteridol may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Ganciclovir,Ganciclovir may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gemcitabine,Gemcitabine may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gentamicin,Corifollitropin alfa may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gimeracil,Corifollitropin alfa may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Givosiran,Givosiran may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Glipizide,Glipizide may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Golodirsen,Corifollitropin alfa may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Gonadorelin,The therapeutic efficacy of Corifollitropin alfa can be increased when used in combination with Gonadorelin.,increase,no risk
Corifollitropin alfa,Goserelin,The therapeutic efficacy of Corifollitropin alfa can be increased when used in combination with Goserelin.,increase,no risk
Corifollitropin alfa,Guanethidine,Guanethidine may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Guanfacine,Guanfacine may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Haloperidol,Haloperidol may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Histrelin,The therapeutic efficacy of Corifollitropin alfa can be increased when used in combination with Histrelin.,increase,no risk
Corifollitropin alfa,Hydralazine,Hydralazine may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Corifollitropin alfa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Corifollitropin alfa,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Corifollitropin alfa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Corifollitropin alfa,Hydromorphone,Hydromorphone may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Hydroxyethyl Starch,Corifollitropin alfa may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Kanamycin,Corifollitropin alfa may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Ketamine,Ketamine may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Ketazolam,Ketazolam may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Ketoprofen,Ketoprofen may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Ketorolac,Ketorolac may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Octinoxate,Corifollitropin alfa may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Olsalazine,Olsalazine may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Opium,Corifollitropin alfa may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Oseltamivir,Oseltamivir may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Oxacillin,Oxacillin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Oxaprozin,Oxaprozin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Oxazepam,Oxazepam may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Oxybenzone,Oxybenzone may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Oxyquinoline,Corifollitropin alfa may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Quetiapine,Quetiapine may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Quinethazone,Quinethazone may increase the excretion rate of Corifollitropin alfa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Corifollitropin alfa,Quinidine,Corifollitropin alfa may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Vaborbactam,Corifollitropin alfa may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Valaciclovir,Valaciclovir may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Valbenazine,Corifollitropin alfa may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Valdecoxib,Valdecoxib may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Valganciclovir,Valganciclovir may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Vancomycin,Corifollitropin alfa may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Varenicline,Varenicline may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Venlafaxine,Venlafaxine may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Verapamil,Verapamil may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Vilanterol,Corifollitropin alfa may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Viloxazine,Corifollitropin alfa may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Vortioxetine,Corifollitropin alfa may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Warfarin,Corifollitropin alfa may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Zaleplon,Zaleplon may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Zanamivir,Zanamivir may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,decrease,no risk
Corifollitropin alfa,Zonisamide,Zonisamide may increase the excretion rate of Corifollitropin alfa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Corticorelin ovine triflutate,Beclomethasone dipropionate,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Corticorelin ovine triflutate,Bemiparin,The risk or severity of hypotension and sinus node depression can be increased when Bemiparin is combined with Corticorelin ovine triflutate.,increase,risk
Corticorelin ovine triflutate,Betamethasone,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Betamethasone.,decrease,no risk
Corticorelin ovine triflutate,Betamethasone phosphate,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Betamethasone phosphate.,decrease,no risk
Corticorelin ovine triflutate,Budesonide,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Budesonide.,decrease,no risk
Corticorelin ovine triflutate,Heparin,The risk or severity of hypotension and sinus node depression can be increased when Heparin is combined with Corticorelin ovine triflutate.,increase,risk
Corticorelin ovine triflutate,Hydrocortisone,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Corticorelin ovine triflutate,Hydrocortisone acetate,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Corticorelin ovine triflutate,Hydrocortisone butyrate,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Corticorelin ovine triflutate,Hydrocortisone cypionate,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Corticorelin ovine triflutate,Hydrocortisone succinate,The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Tibolone,Galcanezumab,Tibolone may increase the thrombogenic activities of Galcanezumab.,increase,no risk
Tibolone,Gemtuzumab ozogamicin,Tibolone may increase the thrombogenic activities of Gemtuzumab ozogamicin.,increase,no risk
Tibolone,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Tibolone.,decrease,no risk
Tibolone,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Tibolone.,decrease,no risk
Tibolone,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Tibolone.,decrease,no risk
Tibolone,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Tibolone.,decrease,no risk
Tibolone,Glofitamab,Tibolone may increase the thrombogenic activities of Glofitamab.,increase,no risk
Tibolone,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Tibolone.,decrease,no risk
Tibolone,Golimumab,Tibolone may increase the thrombogenic activities of Golimumab.,increase,no risk
Tibolone,Guselkumab,Tibolone may increase the thrombogenic activities of Guselkumab.,increase,no risk
Tibolone,Heparin,Tibolone may increase the anticoagulant activities of Heparin.,increase,no risk
Tibolone,Hepatitis B immune globulin,Tibolone may increase the thrombogenic activities of Hepatitis B immune globulin.,increase,no risk
Tibolone,Human cytomegalovirus immune globulin,Tibolone may increase the thrombogenic activities of Human cytomegalovirus immune globulin.,increase,no risk
Tibolone,Human immunoglobulin G,Tibolone may increase the thrombogenic activities of Human immunoglobulin G.,increase,no risk
Tibolone,Human Rho(D) immune globulin,Tibolone may increase the thrombogenic activities of Human Rho(D) immune globulin.,increase,no risk
Tibolone,Human varicella-zoster immune globulin,Tibolone may increase the thrombogenic activities of Human varicella-zoster immune globulin.,increase,no risk
Tibolone,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Tibolone.,decrease,no risk
Tibolone,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Tibolone.,decrease,no risk
Tibolone,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Tibolone.,decrease,no risk
Tibolone,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Tibolone.,increase,no risk
Tibolone,Obiltoxaximab,Tibolone may increase the thrombogenic activities of Obiltoxaximab.,increase,no risk
Tibolone,Obinutuzumab,Tibolone may increase the thrombogenic activities of Obinutuzumab.,increase,no risk
Tibolone,Ocrelizumab,Tibolone may increase the thrombogenic activities of Ocrelizumab.,increase,no risk
Tibolone,Odesivimab,Tibolone may increase the thrombogenic activities of Odesivimab.,increase,no risk
Tibolone,Ofatumumab,Tibolone may increase the thrombogenic activities of Ofatumumab.,increase,no risk
Tibolone,Olaratumab,Tibolone may increase the thrombogenic activities of Olaratumab.,increase,no risk
Tibolone,Omalizumab,Tibolone may increase the thrombogenic activities of Omalizumab.,increase,no risk
Tibolone,Ombitasvir,The risk or severity of liver enzyme elevations can be increased when Tibolone is combined with Ombitasvir.,increase,risk
Tibolone,Ospemifene,The risk or severity of adverse effects can be increased when Tibolone is combined with Ospemifene.,increase,risk
Tibolone,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Tibolone.,increase,no risk
Tibolone,Ublituximab,Tibolone may increase the thrombogenic activities of Ublituximab.,increase,no risk
Tibolone,Urokinase,Tibolone may increase the anticoagulant activities of Urokinase.,increase,no risk
Tibolone,Ustekinumab,Tibolone may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Tibolone,Valdecoxib,Valdecoxib may increase the thrombogenic activities of Tibolone.,increase,no risk
Tibolone,Vedolizumab,Tibolone may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Tibolone,Vorapaxar,Tibolone may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Tibolone,Warfarin,Tibolone may increase the anticoagulant activities of Warfarin.,increase,no risk
Tibolone,Ximelagatran,Tibolone may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Tibolone,Zinc ascorbate,The serum concentration of Zinc ascorbate can be decreased when it is combined with Tibolone.,decrease,no risk
Sodium oxybate,Gabapentin,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Sodium oxybate.,increase,risk
Sodium oxybate,Ganaxolone,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Gepirone,Gepirone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Granisetron,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Guanfacine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Haloperidol,Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Sodium oxybate.,increase,risk
Sodium oxybate,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Hydrocodone,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Hydromorphone,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Sodium oxybate.,increase,risk
Sodium oxybate,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Olanzapine,Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Sodium oxybate is combined with Oliceridine.",increase,risk
Sodium oxybate,Ondansetron,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Opium,Opium may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Orphenadrine,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Oxazepam,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Oxcarbazepine,Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Oxitriptan,Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Oxprenolol,Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Oxybuprocaine,Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Oxycodone,Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Oxymorphone,Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Quazepam,Quazepam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Quetiapine,Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Quinine,Quinine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Quinupramine,Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Urethane,Urethane may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Valproic acid,The serum concentration of Sodium oxybate can be increased when it is combined with Valproic acid.,increase,no risk
Sodium oxybate,Vecuronium,Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Venlafaxine,Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Vigabatrin,Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Vilazodone,Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Viloxazine,Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Vortioxetine,Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Yohimbine,Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Zaleplon,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Sodium oxybate.,increase,risk
Sodium oxybate,Zimelidine,Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Ziprasidone,Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Zolmitriptan,Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Zolpidem,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Zonisamide,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Zopiclone,Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Zotepine,Zotepine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Zuclopenthixol,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Sodium oxybate,Zuranolone,Zuranolone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.,increase,no risk
Palbociclib,Bifonazole,The metabolism of Palbociclib can be decreased when combined with Bifonazole.,decrease,no risk
Palbociclib,Bimekizumab,The metabolism of Palbociclib can be increased when combined with Bimekizumab.,increase,no risk
Palbociclib,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Bismuth subnitrate,The absorption of Palbociclib can be decreased when combined with Bismuth subnitrate.,decrease,no risk
Palbociclib,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Palbociclib.,increase,risk
Palbociclib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Palbociclib.,increase,risk
Palbociclib,Blinatumomab,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Palbociclib.,increase,risk
Palbociclib,Boceprevir,The metabolism of Palbociclib can be decreased when combined with Boceprevir.,decrease,no risk
Palbociclib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Palbociclib.",decrease,no risk
Palbociclib,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Bosentan,The metabolism of Palbociclib can be increased when combined with Bosentan.,increase,no risk
Palbociclib,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Palbociclib.,decrease,no risk
Palbociclib,Brodalumab,The risk or severity of adverse effects can be increased when Palbociclib is combined with Brodalumab.,increase,risk
Palbociclib,Budesonide,The metabolism of Palbociclib can be increased when combined with Budesonide.,increase,no risk
Palbociclib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Palbociclib is combined with Bupivacaine.,increase,risk
Palbociclib,Buprenorphine,The metabolism of Palbociclib can be decreased when combined with Buprenorphine.,decrease,no risk
Palbociclib,Busulfan,The metabolism of Busulfan can be decreased when combined with Palbociclib.,decrease,no risk
Palbociclib,Butacaine,The risk or severity of methemoglobinemia can be increased when Palbociclib is combined with Butacaine.,increase,risk
Palbociclib,Butalbital,The metabolism of Palbociclib can be increased when combined with Butalbital.,increase,no risk
Palbociclib,Butamben,The risk or severity of methemoglobinemia can be increased when Palbociclib is combined with Butamben.,increase,risk
Palbociclib,Ganciclovir,The risk or severity of adverse effects can be increased when Palbociclib is combined with Ganciclovir.,increase,risk
Palbociclib,Gefitinib,Gefitinib may decrease the excretion rate of Palbociclib which could result in a higher serum level.,decrease,no risk
Palbociclib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Palbociclib.,increase,risk
Palbociclib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Gilteritinib,The metabolism of Palbociclib can be decreased when combined with Gilteritinib.,decrease,no risk
Palbociclib,Ginkgo biloba,The metabolism of Palbociclib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Palbociclib,Glasdegib,Palbociclib may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Palbociclib,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Palbociclib.,increase,risk
Palbociclib,Glecaprevir,The metabolism of Palbociclib can be decreased when combined with Glecaprevir.,decrease,no risk
Palbociclib,Glofitamab,The serum concentration of Palbociclib can be increased when it is combined with Glofitamab.,increase,no risk
Palbociclib,Glyburide,The metabolism of Palbociclib can be decreased when combined with Glyburide.,decrease,no risk
Palbociclib,Glycerol phenylbutyrate,The metabolism of Palbociclib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Palbociclib,Golimumab,The metabolism of Palbociclib can be increased when combined with Golimumab.,increase,no risk
Palbociclib,Grapefruit,The serum concentration of Palbociclib can be increased when it is combined with Grapefruit.,increase,no risk
Palbociclib,Grazoprevir,Grazoprevir may decrease the excretion rate of Palbociclib which could result in a higher serum level.,decrease,no risk
Palbociclib,Griseofulvin,The metabolism of Palbociclib can be increased when combined with Griseofulvin.,increase,no risk
Palbociclib,Guanfacine,The risk or severity of adverse effects can be increased when Palbociclib is combined with Guanfacine.,increase,risk
Palbociclib,Guselkumab,The risk or severity of adverse effects can be increased when Palbociclib is combined with Guselkumab.,increase,risk
Palbociclib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Palbociclib.,decrease,no risk
Palbociclib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Palbociclib.,increase,risk
Palbociclib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Palbociclib.,decrease,no risk
Palbociclib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Palbociclib.,decrease,no risk
Palbociclib,Histamine,The risk or severity of adverse effects can be increased when Palbociclib is combined with Histamine.,increase,risk
Palbociclib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Palbociclib.,increase,risk
Palbociclib,Hydralazine,The serum concentration of Palbociclib can be increased when it is combined with Hydralazine.,increase,no risk
Palbociclib,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Palbociclib.,increase,risk
Palbociclib,Hydrocortamate,The metabolism of Palbociclib can be increased when combined with Hydrocortamate.,increase,no risk
Palbociclib,Hydrocortisone,The metabolism of Palbociclib can be increased when combined with Hydrocortisone.,increase,no risk
Palbociclib,Hydrocortisone acetate,The metabolism of Palbociclib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Palbociclib,Hydrocortisone butyrate,The metabolism of Palbociclib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Palbociclib,Hydrocortisone succinate,The metabolism of Palbociclib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Palbociclib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Palbociclib.,increase,risk
Palbociclib,Hydrotalcite,The absorption of Palbociclib can be decreased when combined with Hydrotalcite.,decrease,no risk
Palbociclib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Palbociclib.,increase,risk
Palbociclib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Palbociclib.,increase,risk
Palbociclib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Palbociclib.,decrease,no risk
Palbociclib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Palbociclib.,decrease,no risk
Palbociclib,Ketazolam,The serum concentration of Palbociclib can be increased when it is combined with Ketazolam.,increase,no risk
Palbociclib,Ketoconazole,The metabolism of Palbociclib can be decreased when combined with Ketoconazole.,decrease,no risk
Palbociclib,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Palbociclib.,increase,risk
Palbociclib,Ocrelizumab,The risk or severity of adverse effects can be increased when Palbociclib is combined with Ocrelizumab.,increase,risk
Palbociclib,Octreotide,The serum concentration of Palbociclib can be increased when it is combined with Octreotide.,increase,no risk
Palbociclib,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Palbociclib.,increase,risk
Palbociclib,Olaparib,The metabolism of Olaparib can be decreased when combined with Palbociclib.,decrease,no risk
Palbociclib,Olutasidenib,The metabolism of Palbociclib can be increased when combined with Olutasidenib.,increase,no risk
Palbociclib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Omaveloxolone,The serum concentration of Palbociclib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Palbociclib,Ombitasvir,Palbociclib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Palbociclib,Omeprazole,The absorption of Palbociclib can be decreased when combined with Omeprazole.,decrease,no risk
Palbociclib,Oritavancin,The metabolism of Palbociclib can be increased when combined with Oritavancin.,increase,no risk
Palbociclib,Orphenadrine,The metabolism of Palbociclib can be decreased when combined with Orphenadrine.,decrease,no risk
Palbociclib,Osilodrostat,The metabolism of Palbociclib can be decreased when combined with Osilodrostat.,decrease,no risk
Palbociclib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Oteseconazole,The serum concentration of Palbociclib can be increased when it is combined with Oteseconazole.,increase,no risk
Palbociclib,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Palbociclib.,increase,risk
Palbociclib,Oxcarbazepine,The metabolism of Palbociclib can be increased when combined with Oxcarbazepine.,increase,no risk
Palbociclib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Palbociclib is combined with Oxetacaine.,increase,risk
Palbociclib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Palbociclib is combined with Oxybuprocaine.,increase,risk
Palbociclib,Oxybutynin,The serum concentration of Palbociclib can be increased when it is combined with Oxybutynin.,increase,no risk
Palbociclib,Ozanimod,Palbociclib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Palbociclib,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Quinine,The metabolism of Palbociclib can be increased when combined with Quinine.,increase,no risk
Palbociclib,Quinupristin,The metabolism of Palbociclib can be decreased when combined with Quinupristin.,decrease,no risk
Palbociclib,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Palbociclib.,increase,risk
Palbociclib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Upadacitinib,The risk or severity of adverse effects can be increased when Palbociclib is combined with Upadacitinib.,increase,risk
Palbociclib,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Palbociclib.,increase,risk
Palbociclib,Vadadustat,The serum concentration of Palbociclib can be increased when it is combined with Vadadustat.,increase,no risk
Palbociclib,Valproic acid,The serum concentration of Palbociclib can be increased when it is combined with Valproic acid.,increase,no risk
Palbociclib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Palbociclib.,decrease,no risk
Palbociclib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Palbociclib.,decrease,no risk
Palbociclib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Palbociclib.,increase,risk
Palbociclib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Palbociclib.,decrease,no risk
Palbociclib,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Palbociclib.,increase,risk
Palbociclib,Velpatasvir,Palbociclib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Palbociclib,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Venlafaxine,Venlafaxine may increase the excretion rate of Palbociclib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Palbociclib,Verapamil,The metabolism of Palbociclib can be decreased when combined with Verapamil.,decrease,no risk
Palbociclib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Palbociclib.,decrease,no risk
Palbociclib,Vilanterol,The risk or severity of adverse effects can be increased when Palbociclib is combined with Vilanterol.,increase,risk
Palbociclib,Viloxazine,The metabolism of Palbociclib can be decreased when combined with Viloxazine.,decrease,no risk
Palbociclib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Vincristine,The excretion of Vincristine can be decreased when combined with Palbociclib.,decrease,no risk
Palbociclib,Vindesine,The metabolism of Vindesine can be decreased when combined with Palbociclib.,decrease,no risk
Palbociclib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Palbociclib.,decrease,no risk
Palbociclib,Vismodegib,Vismodegib may decrease the excretion rate of Palbociclib which could result in a higher serum level.,decrease,no risk
Palbociclib,Vitamin E,The metabolism of Palbociclib can be increased when combined with Vitamin E.,increase,no risk
Palbociclib,Voclosporin,The risk or severity of adverse effects can be increased when Palbociclib is combined with Voclosporin.,increase,risk
Palbociclib,Vonoprazan,The absorption of Palbociclib can be decreased when combined with Vonoprazan.,decrease,no risk
Palbociclib,Vorapaxar,The metabolism of Palbociclib can be decreased when combined with Vorapaxar.,decrease,no risk
Palbociclib,Voriconazole,The metabolism of Palbociclib can be decreased when combined with Voriconazole.,decrease,no risk
Palbociclib,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Palbociclib.,increase,risk
Palbociclib,Voxelotor,The serum concentration of Palbociclib can be increased when it is combined with Voxelotor.,increase,no risk
Palbociclib,Voxilaprevir,Palbociclib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Palbociclib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Palbociclib.,increase,no risk
Palbociclib,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Palbociclib.,increase,risk
Palbociclib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Palbociclib.,increase,risk
Palbociclib,Zafirlukast,The serum concentration of Palbociclib can be increased when it is combined with Zafirlukast.,increase,no risk
Palbociclib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Palbociclib.,decrease,no risk
Palbociclib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Palbociclib.,increase,risk
Palbociclib,Zimelidine,The metabolism of Palbociclib can be decreased when combined with Zimelidine.,decrease,no risk
Palbociclib,Ziprasidone,The metabolism of Palbociclib can be decreased when combined with Ziprasidone.,decrease,no risk
Palbociclib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Palbociclib.,decrease,no risk
Palbociclib,Zuclopenthixol,The metabolism of Palbociclib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Edoxaban,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Bismuth subgallate,Edoxaban may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Edoxaban,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Edoxaban.,increase,risk
Edoxaban,Bisoprolol,The serum concentration of Edoxaban can be increased when it is combined with Bisoprolol.,increase,no risk
Edoxaban,Bisoxatin,Edoxaban may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Edoxaban,Bivalirudin,The risk or severity of bleeding can be increased when Edoxaban is combined with Bivalirudin.,increase,risk
Edoxaban,Bleomycin,Bleomycin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Blinatumomab,The risk or severity of bleeding can be increased when Edoxaban is combined with Blinatumomab.,increase,risk
Edoxaban,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Brivaracetam,Brivaracetam may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Bromazepam,Bromazepam may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Bromotheophylline,Bromotheophylline may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Edoxaban,Budesonide,Budesonide may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Edoxaban.,increase,risk
Edoxaban,Bumetanide,Bumetanide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Edoxaban,Bupropion,Bupropion may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Buspirone,Buspirone may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Busulfan,The risk or severity of bleeding can be increased when Edoxaban is combined with Busulfan.,increase,risk
Edoxaban,Butabarbital,Butabarbital may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Gadodiamide,Gadodiamide may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Gadoteric acid,Edoxaban may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Edoxaban,Gadoteridol,Gadoteridol may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Ganciclovir,Ganciclovir may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Edoxaban is combined with Gemtuzumab ozogamicin.,increase,risk
Edoxaban,Gentamicin,Edoxaban may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Edoxaban,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Edoxaban.,increase,risk
Edoxaban,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Gimeracil,Edoxaban may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Edoxaban,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Edoxaban.,increase,no risk
Edoxaban,Givosiran,Givosiran may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Glasdegib,The serum concentration of Edoxaban can be increased when it is combined with Glasdegib.,increase,no risk
Edoxaban,Glecaprevir,The serum concentration of Edoxaban can be increased when it is combined with Glecaprevir.,increase,no risk
Edoxaban,Glipizide,Glipizide may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Edoxaban.,increase,risk
Edoxaban,Golodirsen,Edoxaban may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Edoxaban,Goserelin,Goserelin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Guanethidine,Guanethidine may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Guanfacine,Guanfacine may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Haloperidol,Haloperidol may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Hemin,Hemin may increase the anticoagulant activities of Edoxaban.,increase,no risk
Edoxaban,Heparin,The risk or severity of bleeding can be increased when Edoxaban is combined with Heparin.,increase,risk
Edoxaban,Hydralazine,Hydralazine may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Edoxaban,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Edoxaban,Hydromorphone,Hydromorphone may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Hydroxyethyl Starch,Edoxaban may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Edoxaban,Hydroxyprogesterone caproate,The therapeutic efficacy of Edoxaban can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Edoxaban,Hydroxyurea,The risk or severity of bleeding can be increased when Edoxaban is combined with Hydroxyurea.,increase,risk
Edoxaban,Kanamycin,Edoxaban may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Edoxaban,Ketamine,Ketamine may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Ketazolam,Ketazolam may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Ketoconazole,The serum concentration of Edoxaban can be increased when it is combined with Ketoconazole.,increase,no risk
Edoxaban,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Edoxaban.,increase,risk
Edoxaban,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Edoxaban.,increase,risk
Edoxaban,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Edoxaban is combined with Obeticholic acid.,increase,risk
Edoxaban,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Edoxaban is combined with Obinutuzumab.,increase,risk
Edoxaban,Octinoxate,Edoxaban may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Edoxaban,Olaparib,The risk or severity of bleeding can be increased when Edoxaban is combined with Olaparib.,increase,risk
Edoxaban,Olive oil,The therapeutic efficacy of Edoxaban can be decreased when used in combination with Olive oil.,decrease,no risk
Edoxaban,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Edoxaban.,increase,risk
Edoxaban,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Edoxaban is combined with Omacetaxine mepesuccinate.,increase,risk
Edoxaban,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Edoxaban.,increase,no risk
Edoxaban,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Edoxaban.,increase,risk
Edoxaban,Omega-3-carboxylic acids,The therapeutic efficacy of Edoxaban can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Edoxaban,Opium,Edoxaban may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Edoxaban,Oseltamivir,Oseltamivir may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Oxacillin,Oxacillin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Edoxaban.,increase,risk
Edoxaban,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Edoxaban.,increase,risk
Edoxaban,Oxazepam,Oxazepam may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Oxybenzone,Oxybenzone may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Edoxaban.,increase,risk
Edoxaban,Oxyquinoline,Edoxaban may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Edoxaban,Quetiapine,Quetiapine may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Quinestrol,Quinestrol may decrease the anticoagulant activities of Edoxaban.,decrease,no risk
Edoxaban,Quinethazone,Quinethazone may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Edoxaban,Quinidine,The serum concentration of Edoxaban can be increased when it is combined with Quinidine.,increase,no risk
Edoxaban,Quinine,The serum concentration of Edoxaban can be increased when it is combined with Quinine.,increase,no risk
Edoxaban,Quizartinib,The serum concentration of Edoxaban can be increased when it is combined with Quizartinib.,increase,no risk
Edoxaban,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Ulipristal,The therapeutic efficacy of Edoxaban can be decreased when used in combination with Ulipristal.,decrease,no risk
Edoxaban,Umbralisib,The serum concentration of Edoxaban can be increased when it is combined with Umbralisib.,increase,no risk
Edoxaban,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Urokinase,The risk or severity of bleeding can be increased when Edoxaban is combined with Urokinase.,increase,risk
Edoxaban,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Edoxaban is combined with Ursodeoxycholic acid.,increase,risk
Edoxaban,Vaborbactam,Edoxaban may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Edoxaban,Valaciclovir,Valaciclovir may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Valbenazine,Edoxaban may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Edoxaban,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Edoxaban.,increase,risk
Edoxaban,Valganciclovir,Valganciclovir may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Vancomycin,Edoxaban may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Edoxaban,Vandetanib,The serum concentration of Edoxaban can be increased when it is combined with Vandetanib.,increase,no risk
Edoxaban,Vardenafil,The serum concentration of Edoxaban can be increased when it is combined with Vardenafil.,increase,no risk
Edoxaban,Varenicline,Varenicline may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Velpatasvir,The serum concentration of Edoxaban can be increased when it is combined with Velpatasvir.,increase,no risk
Edoxaban,Vemurafenib,The serum concentration of Edoxaban can be increased when it is combined with Vemurafenib.,increase,no risk
Edoxaban,Venetoclax,The serum concentration of Edoxaban can be increased when it is combined with Venetoclax.,increase,no risk
Edoxaban,Venlafaxine,The risk or severity of bleeding can be increased when Edoxaban is combined with Venlafaxine.,increase,risk
Edoxaban,Verapamil,The serum concentration of Edoxaban can be increased when it is combined with Verapamil.,increase,no risk
Edoxaban,Vilanterol,Edoxaban may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Edoxaban,Viloxazine,Edoxaban may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Edoxaban,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Vindesine,The risk or severity of bleeding can be increased when Edoxaban is combined with Vindesine.,increase,risk
Edoxaban,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Edoxaban.,increase,no risk
Edoxaban,Vinorelbine,The risk or severity of bleeding can be increased when Edoxaban is combined with Vinorelbine.,increase,risk
Edoxaban,Vitamin E,Vitamin E may increase the anticoagulant activities of Edoxaban.,increase,no risk
Edoxaban,Voclosporin,The serum concentration of Edoxaban can be increased when it is combined with Voclosporin.,increase,no risk
Edoxaban,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Edoxaban.,decrease,no risk
Edoxaban,Vorapaxar,The risk or severity of bleeding can be increased when Edoxaban is combined with Vorapaxar.,increase,risk
Edoxaban,Vorinostat,The risk or severity of bleeding can be increased when Edoxaban is combined with Vorinostat.,increase,risk
Edoxaban,Vortioxetine,Vortioxetine may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Voxilaprevir,The serum concentration of Edoxaban can be increased when it is combined with Voxilaprevir.,increase,no risk
Edoxaban,Warfarin,The risk or severity of bleeding can be increased when Edoxaban is combined with Warfarin.,increase,risk
Edoxaban,Ximelagatran,The risk or severity of bleeding can be increased when Edoxaban is combined with Ximelagatran.,increase,risk
Edoxaban,Zaleplon,Zaleplon may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Zanamivir,Zanamivir may decrease the excretion rate of Edoxaban which could result in a higher serum level.,decrease,no risk
Edoxaban,Zidovudine,The risk or severity of bleeding can be increased when Edoxaban is combined with Zidovudine.,increase,risk
Edoxaban,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Edoxaban.,increase,risk
Edoxaban,Zonisamide,The serum concentration of Edoxaban can be increased when it is combined with Zonisamide.,increase,no risk
Umeclidinium,Galantamine,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Galantamine.,decrease,no risk
Umeclidinium,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Umeclidinium.,increase,risk
Umeclidinium,Gefitinib,The metabolism of Umeclidinium can be decreased when combined with Gefitinib.,decrease,no risk
Umeclidinium,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Ginkgo biloba,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Umeclidinium,Givosiran,The serum concentration of Umeclidinium can be increased when it is combined with Givosiran.,increase,no risk
Umeclidinium,Glasdegib,The serum concentration of Umeclidinium can be increased when it is combined with Glasdegib.,increase,no risk
Umeclidinium,Glecaprevir,The serum concentration of Umeclidinium can be increased when it is combined with Glecaprevir.,increase,no risk
Umeclidinium,Glucagon,Umeclidinium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Umeclidinium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Umeclidinium.,decrease,no risk
Umeclidinium,Glycerol phenylbutyrate,The metabolism of Umeclidinium can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Umeclidinium,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Umeclidinium.,increase,risk
Umeclidinium,Golimumab,The metabolism of Umeclidinium can be increased when combined with Golimumab.,increase,no risk
Umeclidinium,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Umeclidinium.,increase,risk
Umeclidinium,Guanfacine,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Umeclidinium.,increase,risk
Umeclidinium,Halofantrine,The metabolism of Umeclidinium can be decreased when combined with Halofantrine.,decrease,no risk
Umeclidinium,Haloperidol,The serum concentration of Umeclidinium can be increased when it is combined with Haloperidol.,increase,no risk
Umeclidinium,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Umeclidinium.,increase,risk
Umeclidinium,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Umeclidinium.,increase,risk
Umeclidinium,Homatropine,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Homatropine.,increase,risk
Umeclidinium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Umeclidinium.,increase,risk
Umeclidinium,Huperzine A,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Huperzine A.,decrease,no risk
Umeclidinium,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Hydrocodone,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Hydrocodone.,increase,risk
Umeclidinium,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Hydromorphone,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Hydromorphone.,increase,risk
Umeclidinium,Hydroxychloroquine,The metabolism of Umeclidinium can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Umeclidinium,Hydroxyzine,The metabolism of Umeclidinium can be decreased when combined with Hydroxyzine.,decrease,no risk
Umeclidinium,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Umeclidinium.,increase,risk
Umeclidinium,Ketamine,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Ketamine.,decrease,no risk
Umeclidinium,Ketoconazole,The metabolism of Umeclidinium can be decreased when combined with Ketoconazole.,decrease,no risk
Umeclidinium,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Umeclidinium.,increase,risk
Umeclidinium,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Umeclidinium is combined with Oliceridine.",increase,risk
Umeclidinium,Olodaterol,The risk or severity of Tachycardia can be increased when Umeclidinium is combined with Olodaterol.,increase,risk
Umeclidinium,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Ondansetron,The metabolism of Umeclidinium can be decreased when combined with Ondansetron.,decrease,no risk
Umeclidinium,Opium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Opium.,increase,risk
Umeclidinium,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Umeclidinium.,increase,risk
Umeclidinium,Oritavancin,The metabolism of Umeclidinium can be decreased when combined with Oritavancin.,decrease,no risk
Umeclidinium,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Umeclidinium.,increase,risk
Umeclidinium,Osilodrostat,The metabolism of Umeclidinium can be decreased when combined with Osilodrostat.,decrease,no risk
Umeclidinium,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Ospemifene,The metabolism of Umeclidinium can be decreased when combined with Ospemifene.,decrease,no risk
Umeclidinium,Oxamniquine,The metabolism of Umeclidinium can be decreased when combined with Oxamniquine.,decrease,no risk
Umeclidinium,Oxprenolol,The metabolism of Umeclidinium can be decreased when combined with Oxprenolol.,decrease,no risk
Umeclidinium,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Umeclidinium.,increase,risk
Umeclidinium,Oxycodone,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Oxycodone.,increase,risk
Umeclidinium,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Umeclidinium.,increase,risk
Umeclidinium,Oxymorphone,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Oxymorphone.,increase,risk
Umeclidinium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Umeclidinium.,increase,risk
Umeclidinium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Umeclidinium.,decrease,no risk
Umeclidinium,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Umeclidinium.,increase,risk
Umeclidinium,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Umeclidinium.,increase,risk
Umeclidinium,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Umeclidinium.,increase,risk
Umeclidinium,Quinine,The metabolism of Umeclidinium can be decreased when combined with Quinine.,decrease,no risk
Umeclidinium,Quinupramine,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Quinupramine.,increase,risk
Umeclidinium,Quizartinib,The serum concentration of Umeclidinium can be increased when it is combined with Quizartinib.,increase,no risk
Umeclidinium,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Umbralisib,The serum concentration of Umeclidinium can be increased when it is combined with Umbralisib.,increase,no risk
Umeclidinium,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Umeclidinium.,decrease,no risk
Umeclidinium,Vandetanib,The serum concentration of Umeclidinium can be increased when it is combined with Vandetanib.,increase,no risk
Umeclidinium,Vardenafil,The serum concentration of Umeclidinium can be increased when it is combined with Vardenafil.,increase,no risk
Umeclidinium,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Umeclidinium.,increase,risk
Umeclidinium,Velpatasvir,The serum concentration of Umeclidinium can be increased when it is combined with Velpatasvir.,increase,no risk
Umeclidinium,Vemurafenib,The serum concentration of Umeclidinium can be increased when it is combined with Vemurafenib.,increase,no risk
Umeclidinium,Venetoclax,The serum concentration of Umeclidinium can be increased when it is combined with Venetoclax.,increase,no risk
Umeclidinium,Venlafaxine,The metabolism of Umeclidinium can be decreased when combined with Venlafaxine.,decrease,no risk
Umeclidinium,Verapamil,The serum concentration of Umeclidinium can be increased when it is combined with Verapamil.,increase,no risk
Umeclidinium,Vernakalant,The metabolism of Umeclidinium can be decreased when combined with Vernakalant.,decrease,no risk
Umeclidinium,Vilazodone,The metabolism of Umeclidinium can be decreased when combined with Vilazodone.,decrease,no risk
Umeclidinium,Viloxazine,The metabolism of Umeclidinium can be decreased when combined with Viloxazine.,decrease,no risk
Umeclidinium,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Umeclidinium.,increase,no risk
Umeclidinium,Vinorelbine,The metabolism of Umeclidinium can be decreased when combined with Vinorelbine.,decrease,no risk
Umeclidinium,Voclosporin,The serum concentration of Umeclidinium can be increased when it is combined with Voclosporin.,increase,no risk
Umeclidinium,Vorapaxar,The serum concentration of Umeclidinium can be increased when it is combined with Vorapaxar.,increase,no risk
Umeclidinium,Vortioxetine,The metabolism of Umeclidinium can be decreased when combined with Vortioxetine.,decrease,no risk
Umeclidinium,Voxilaprevir,The serum concentration of Umeclidinium can be increased when it is combined with Voxilaprevir.,increase,no risk
Umeclidinium,Xamoterol,The risk or severity of Tachycardia can be increased when Umeclidinium is combined with Xamoterol.,increase,risk
Umeclidinium,Xylometazoline,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Umeclidinium.,increase,risk
Umeclidinium,Yohimbine,The metabolism of Umeclidinium can be decreased when combined with Yohimbine.,decrease,no risk
Umeclidinium,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Umeclidinium.,increase,risk
Umeclidinium,Zolpidem,The metabolism of Umeclidinium can be decreased when combined with Zolpidem.,decrease,no risk
Umeclidinium,Zonisamide,The serum concentration of Umeclidinium can be increased when it is combined with Zonisamide.,increase,no risk
Umeclidinium,Zuclopenthixol,The metabolism of Umeclidinium can be decreased when combined with Zuclopenthixol.,decrease,no risk
Dinutuximab,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dinutuximab.,increase,risk
Dinutuximab,Bretylium,The risk or severity of adverse effects can be increased when Bretylium is combined with Dinutuximab.,increase,risk
Dinutuximab,Brodalumab,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Brodalumab.,increase,risk
Dinutuximab,Brolucizumab,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Brolucizumab.,increase,risk
Dinutuximab,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Dinutuximab.,increase,risk
Dinutuximab,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Dinutuximab.,increase,risk
Dinutuximab,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Dinutuximab.,increase,risk
Dinutuximab,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Dinutuximab is combined with Bupivacaine.,increase,risk
Dinutuximab,Burosumab,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Burosumab.,increase,risk
Dinutuximab,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Dinutuximab.,increase,risk
Dinutuximab,Butabarbital,Butabarbital may increase the hypotensive activities of Dinutuximab.,increase,no risk
Dinutuximab,Butacaine,The risk or severity of methemoglobinemia can be increased when Dinutuximab is combined with Butacaine.,increase,risk
Dinutuximab,Butalbital,Butalbital may increase the hypotensive activities of Dinutuximab.,increase,no risk
Dinutuximab,Butamben,The risk or severity of methemoglobinemia can be increased when Dinutuximab is combined with Butamben.,increase,risk
Dinutuximab,Galcanezumab,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Galcanezumab.,increase,risk
Dinutuximab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dinutuximab.,increase,risk
Dinutuximab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dinutuximab.,increase,risk
Dinutuximab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Dinutuximab.,increase,risk
Dinutuximab,Glofitamab,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Glofitamab.,increase,risk
Dinutuximab,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Dinutuximab.,increase,risk
Dinutuximab,Guanabenz,Dinutuximab may increase the hypotensive activities of Guanabenz.,increase,no risk
Dinutuximab,Guanadrel,Dinutuximab may increase the hypotensive activities of Guanadrel.,increase,no risk
Dinutuximab,Guanethidine,Dinutuximab may increase the hypotensive activities of Guanethidine.,increase,no risk
Dinutuximab,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Dinutuximab.,increase,risk
Dinutuximab,Guanoxan,Dinutuximab may increase the hypotensive activities of Guanoxan.,increase,no risk
Dinutuximab,Guselkumab,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Guselkumab.,increase,risk
Dinutuximab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Dinutuximab.,decrease,no risk
Dinutuximab,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Dinutuximab.,increase,risk
Dinutuximab,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Dinutuximab.,increase,risk
Dinutuximab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Dinutuximab.,decrease,no risk
Dinutuximab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Dinutuximab.,increase,risk
Dinutuximab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Dinutuximab.,decrease,no risk
Dinutuximab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Dinutuximab.,increase,risk
Dinutuximab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Human cytomegalovirus immune globulin.,increase,risk
Dinutuximab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dinutuximab.,increase,risk
Dinutuximab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Human Rho(D) immune globulin.,increase,risk
Dinutuximab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Human varicella-zoster immune globulin.,increase,risk
Dinutuximab,Hydralazine,The risk or severity of adverse effects can be increased when Hydralazine is combined with Dinutuximab.,increase,risk
Dinutuximab,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Dinutuximab.,increase,risk
Dinutuximab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Hydrocortisone acetate.,increase,risk
Dinutuximab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Hydrocortisone butyrate.,increase,risk
Dinutuximab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Hydrocortisone succinate.,increase,risk
Dinutuximab,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Dinutuximab.,increase,risk
Dinutuximab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Dinutuximab.,increase,risk
Dinutuximab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Dinutuximab.,increase,risk
Dinutuximab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dinutuximab.,decrease,no risk
Dinutuximab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Dinutuximab.,decrease,no risk
Dinutuximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Dinutuximab.,increase,risk
Dinutuximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Dinutuximab.,increase,risk
Dinutuximab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Dinutuximab.,increase,no risk
Dinutuximab,Odesivimab,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Odesivimab.,increase,risk
Dinutuximab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Dinutuximab.,increase,risk
Dinutuximab,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Dinutuximab.,increase,risk
Dinutuximab,Olaparib,The risk or severity of adverse effects can be increased when Olaparib is combined with Dinutuximab.,increase,risk
Dinutuximab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Dinutuximab.,increase,risk
Dinutuximab,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Dinutuximab.,increase,risk
Dinutuximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dinutuximab.,increase,risk
Dinutuximab,Opicapone,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Opicapone.,increase,risk
Dinutuximab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Dinutuximab.,increase,risk
Dinutuximab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dinutuximab is combined with Oxetacaine.,increase,risk
Dinutuximab,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Dinutuximab.,increase,risk
Dinutuximab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dinutuximab is combined with Oxybuprocaine.,increase,risk
Dinutuximab,Ozanimod,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Ozanimod.,increase,risk
Dinutuximab,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Dinutuximab.,increase,risk
Dinutuximab,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Dinutuximab.,increase,risk
Dinutuximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Dinutuximab.,increase,no risk
Dinutuximab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Dinutuximab.,increase,risk
Dinutuximab,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Dinutuximab.,increase,risk
Dinutuximab,Upadacitinib,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Upadacitinib.,increase,risk
Dinutuximab,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Dinutuximab.,increase,risk
Dinutuximab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Dinutuximab.,increase,risk
Dinutuximab,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Dinutuximab.,increase,risk
Dinutuximab,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Dinutuximab.,increase,risk
Dinutuximab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Dinutuximab.,increase,risk
Dinutuximab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Dinutuximab.,decrease,no risk
Dinutuximab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Dinutuximab.,increase,risk
Dinutuximab,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Dinutuximab.,increase,risk
Dinutuximab,Vericiguat,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Vericiguat.,increase,risk
Dinutuximab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dinutuximab.,decrease,no risk
Dinutuximab,Vilanterol,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Vilanterol.,increase,risk
Dinutuximab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Dinutuximab.,increase,risk
Dinutuximab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Dinutuximab.,increase,risk
Dinutuximab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Dinutuximab.,increase,risk
Dinutuximab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dinutuximab.,increase,risk
Dinutuximab,Voclosporin,The risk or severity of adverse effects can be increased when Dinutuximab is combined with Voclosporin.,increase,risk
Dinutuximab,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Dinutuximab.,increase,risk
Dinutuximab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Dinutuximab.,increase,risk
Dinutuximab,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Dinutuximab.,increase,risk
Dinutuximab,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Dinutuximab.,increase,risk
Dinutuximab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Dinutuximab.,increase,risk
Dinutuximab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Dinutuximab.,increase,risk
Dinutuximab,Zofenopril,Dinutuximab may increase the hypotensive activities of Zofenopril.,increase,no risk
Lenvatinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Lenvatinib.,increase,risk
Lenvatinib,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Lenvatinib.,decrease,no risk
Lenvatinib,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lenvatinib.,increase,risk
Lenvatinib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lenvatinib.,increase,risk
Lenvatinib,Gefitinib,Gefitinib may decrease the excretion rate of Lenvatinib which could result in a higher serum level.,decrease,no risk
Lenvatinib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Lenvatinib.,increase,no risk
Lenvatinib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Lenvatinib.,increase,risk
Lenvatinib,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Lenvatinib.,increase,no risk
Lenvatinib,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Lenvatinib.,increase,risk
Lenvatinib,Gilteritinib,The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Gilteritinib.,increase,risk
Lenvatinib,Glasdegib,The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Glasdegib.,increase,risk
Lenvatinib,Glecaprevir,Glecaprevir may decrease the excretion rate of Lenvatinib which could result in a higher serum level.,decrease,no risk
Lenvatinib,Glimepiride,Lenvatinib may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Lenvatinib,Glipizide,Lenvatinib may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Lenvatinib,Glyburide,Lenvatinib may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Lenvatinib,Glycyrrhizic acid,Lenvatinib may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Lenvatinib,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lenvatinib.,increase,risk
Lenvatinib,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Lenvatinib.,increase,risk
Lenvatinib,Grazoprevir,Grazoprevir may decrease the excretion rate of Lenvatinib which could result in a higher serum level.,decrease,no risk
Lenvatinib,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Grepafloxacin.,increase,risk
Lenvatinib,Halofantrine,The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Halofantrine.,increase,risk
Lenvatinib,Haloperidol,The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Haloperidol.,increase,risk
Lenvatinib,Histamine,The serum concentration of Histamine can be increased when it is combined with Lenvatinib.,increase,no risk
Lenvatinib,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Lenvatinib.,increase,risk
Lenvatinib,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Lenvatinib.,decrease,no risk
Lenvatinib,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Lenvatinib.,decrease,no risk
Lenvatinib,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Lenvatinib.,increase,risk
Lenvatinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Hydroxyzine.,increase,risk
Lenvatinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lenvatinib.,increase,risk
Nintedanib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Nintedanib.,increase,no risk
Nintedanib,Gemfibrozil,The metabolism of Nintedanib can be decreased when combined with Gemfibrozil.,decrease,no risk
Nintedanib,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Ginkgo biloba,The metabolism of Nintedanib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Nintedanib,Glasdegib,The serum concentration of Nintedanib can be increased when it is combined with Glasdegib.,increase,no risk
Nintedanib,Glecaprevir,The serum concentration of Nintedanib can be increased when it is combined with Glecaprevir.,increase,no risk
Nintedanib,Glofitamab,The serum concentration of Nintedanib can be increased when it is combined with Glofitamab.,increase,no risk
Nintedanib,Glyburide,The metabolism of Nintedanib can be decreased when combined with Glyburide.,decrease,no risk
Nintedanib,Glycerol phenylbutyrate,The metabolism of Nintedanib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Nintedanib,Golimumab,The metabolism of Nintedanib can be increased when combined with Golimumab.,increase,no risk
Nintedanib,Grapefruit,The metabolism of Nintedanib can be decreased when combined with Grapefruit.,decrease,no risk
Nintedanib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Nintedanib.,increase,no risk
Nintedanib,Griseofulvin,The metabolism of Nintedanib can be increased when combined with Griseofulvin.,increase,no risk
Nintedanib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Nintedanib.,increase,no risk
Nintedanib,Heparin,The risk or severity of bleeding can be increased when Nintedanib is combined with Heparin.,increase,risk
Nintedanib,Hydralazine,The metabolism of Nintedanib can be decreased when combined with Hydralazine.,decrease,no risk
Nintedanib,Hydrocortamate,The metabolism of Nintedanib can be increased when combined with Hydrocortamate.,increase,no risk
Nintedanib,Hydrocortisone,The metabolism of Nintedanib can be increased when combined with Hydrocortisone.,increase,no risk
Nintedanib,Hydrocortisone acetate,The metabolism of Nintedanib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Nintedanib,Hydrocortisone butyrate,The metabolism of Nintedanib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Nintedanib,Hydrocortisone succinate,The metabolism of Nintedanib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Nintedanib,Ketazolam,The metabolism of Nintedanib can be decreased when combined with Ketazolam.,decrease,no risk
Nintedanib,Ketoconazole,The serum concentration of Nintedanib can be increased when it is combined with Ketoconazole.,increase,no risk
Nintedanib,Octreotide,The metabolism of Nintedanib can be decreased when combined with Octreotide.,decrease,no risk
Nintedanib,Olaparib,The metabolism of Olaparib can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Olutasidenib,The metabolism of Nintedanib can be increased when combined with Olutasidenib.,increase,no risk
Nintedanib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Nintedanib.,increase,no risk
Nintedanib,Omaveloxolone,The serum concentration of Nintedanib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Nintedanib,Ombitasvir,The metabolism of Nintedanib can be decreased when combined with Ombitasvir.,decrease,no risk
Nintedanib,Oritavancin,The metabolism of Nintedanib can be increased when combined with Oritavancin.,increase,no risk
Nintedanib,Orphenadrine,The metabolism of Nintedanib can be decreased when combined with Orphenadrine.,decrease,no risk
Nintedanib,Osilodrostat,The metabolism of Nintedanib can be decreased when combined with Osilodrostat.,decrease,no risk
Nintedanib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Oxcarbazepine,The metabolism of Nintedanib can be increased when combined with Oxcarbazepine.,increase,no risk
Nintedanib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nintedanib is combined with Oxetacaine.,increase,risk
Nintedanib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nintedanib is combined with Oxybuprocaine.,increase,risk
Nintedanib,Oxybutynin,The metabolism of Nintedanib can be decreased when combined with Oxybutynin.,decrease,no risk
Nintedanib,Quinidine,The metabolism of Quinidine can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Quinine,The serum concentration of Nintedanib can be increased when it is combined with Quinine.,increase,no risk
Nintedanib,Quinupristin,The metabolism of Nintedanib can be decreased when combined with Quinupristin.,decrease,no risk
Nintedanib,Quizartinib,The serum concentration of Nintedanib can be increased when it is combined with Quizartinib.,increase,no risk
Nintedanib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Nintedanib.,increase,no risk
Nintedanib,Umbralisib,The serum concentration of Nintedanib can be increased when it is combined with Umbralisib.,increase,no risk
Nintedanib,Umeclidinium,The serum concentration of Nintedanib can be increased when it is combined with Umeclidinium.,increase,no risk
Nintedanib,Urokinase,The risk or severity of bleeding can be increased when Nintedanib is combined with Urokinase.,increase,risk
Nintedanib,Vadadustat,The serum concentration of Nintedanib can be increased when it is combined with Vadadustat.,increase,no risk
Nintedanib,Valproic acid,The metabolism of Nintedanib can be decreased when combined with Valproic acid.,decrease,no risk
Nintedanib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Vardenafil,The serum concentration of Nintedanib can be increased when it is combined with Vardenafil.,increase,no risk
Nintedanib,Velpatasvir,The serum concentration of Nintedanib can be increased when it is combined with Velpatasvir.,increase,no risk
Nintedanib,Vemurafenib,The serum concentration of Nintedanib can be increased when it is combined with Vemurafenib.,increase,no risk
Nintedanib,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Verapamil,The metabolism of Nintedanib can be decreased when combined with Verapamil.,decrease,no risk
Nintedanib,Viloxazine,The metabolism of Nintedanib can be decreased when combined with Viloxazine.,decrease,no risk
Nintedanib,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Vincristine,The metabolism of Vincristine can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Vindesine,The metabolism of Vindesine can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Vitamin E,The metabolism of Nintedanib can be increased when combined with Vitamin E.,increase,no risk
Nintedanib,Voclosporin,The serum concentration of Nintedanib can be increased when it is combined with Voclosporin.,increase,no risk
Nintedanib,Vorapaxar,The risk or severity of bleeding can be increased when Nintedanib is combined with Vorapaxar.,increase,risk
Nintedanib,Voriconazole,The serum concentration of Nintedanib can be increased when it is combined with Voriconazole.,increase,no risk
Nintedanib,Voxilaprevir,The serum concentration of Nintedanib can be increased when it is combined with Voxilaprevir.,increase,no risk
Nintedanib,Warfarin,The risk or severity of bleeding can be increased when Nintedanib is combined with Warfarin.,increase,risk
Nintedanib,Ximelagatran,The risk or severity of bleeding can be increased when Nintedanib is combined with Ximelagatran.,increase,risk
Nintedanib,Zafirlukast,The metabolism of Nintedanib can be decreased when combined with Zafirlukast.,decrease,no risk
Nintedanib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Nintedanib.,decrease,no risk
Nintedanib,Zidovudine,The metabolism of Nintedanib can be increased when combined with Zidovudine.,increase,no risk
Nintedanib,Zimelidine,The metabolism of Nintedanib can be decreased when combined with Zimelidine.,decrease,no risk
Nintedanib,Ziprasidone,The metabolism of Nintedanib can be decreased when combined with Ziprasidone.,decrease,no risk
Nintedanib,Zonisamide,The serum concentration of Nintedanib can be increased when it is combined with Zonisamide.,increase,no risk
Nintedanib,Zuclopenthixol,The metabolism of Nintedanib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Olodaterol,Bisoprolol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Bisoprolol.,decrease,no risk
Olodaterol,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Olodaterol.,increase,risk
Olodaterol,Bosentan,The metabolism of Olodaterol can be increased when combined with Bosentan.,increase,no risk
Olodaterol,Bosutinib,The metabolism of Olodaterol can be decreased when combined with Bosutinib.,decrease,no risk
Olodaterol,Bretylium,Olodaterol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Olodaterol,Brexpiprazole,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Olodaterol,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Olodaterol.,decrease,no risk
Olodaterol,Brivaracetam,The metabolism of Olodaterol can be decreased when combined with Brivaracetam.,decrease,no risk
Olodaterol,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Olodaterol.,increase,no risk
Olodaterol,Bromotheophylline,Bromotheophylline may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Olodaterol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Olodaterol.,increase,risk
Olodaterol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Olodaterol.,increase,risk
Olodaterol,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Olodaterol.,increase,risk
Olodaterol,Bumadizone,The risk or severity of hypertension can be increased when Olodaterol is combined with Bumadizone.,increase,risk
Olodaterol,Bumetanide,The risk or severity of hypokalemia can be increased when Olodaterol is combined with Bumetanide.,increase,risk
Olodaterol,Buprenorphine,The metabolism of Olodaterol can be decreased when combined with Buprenorphine.,decrease,no risk
Olodaterol,Bupropion,The metabolism of Olodaterol can be decreased when combined with Bupropion.,decrease,no risk
Olodaterol,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Olodaterol.,increase,risk
Olodaterol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Olodaterol.,increase,risk
Olodaterol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Olodaterol.,increase,risk
Olodaterol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Olodaterol is combined with Butylscopolamine.,increase,risk
Olodaterol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Gadobenic acid.,increase,risk
Olodaterol,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Olodaterol.,increase,risk
Olodaterol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Olodaterol.,increase,risk
Olodaterol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Olodaterol.,increase,risk
Olodaterol,Gemfibrozil,The metabolism of Olodaterol can be decreased when combined with Gemfibrozil.,decrease,no risk
Olodaterol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Gemifloxacin.,increase,risk
Olodaterol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Olodaterol.,increase,risk
Olodaterol,Gilteritinib,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Gilteritinib.,increase,risk
Olodaterol,Ginkgo biloba,The metabolism of Olodaterol can be decreased when combined with Ginkgo biloba.,decrease,no risk
Olodaterol,Glasdegib,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Glasdegib.,increase,risk
Olodaterol,Gliclazide,The metabolism of Olodaterol can be decreased when combined with Gliclazide.,decrease,no risk
Olodaterol,Glimepiride,The metabolism of Olodaterol can be decreased when combined with Glimepiride.,decrease,no risk
Olodaterol,Glipizide,The metabolism of Olodaterol can be decreased when combined with Glipizide.,decrease,no risk
Olodaterol,Gliquidone,The metabolism of Olodaterol can be decreased when combined with Gliquidone.,decrease,no risk
Olodaterol,Glofitamab,The serum concentration of Olodaterol can be increased when it is combined with Glofitamab.,increase,no risk
Olodaterol,Glyburide,The metabolism of Olodaterol can be decreased when combined with Glyburide.,decrease,no risk
Olodaterol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Olodaterol.,increase,risk
Olodaterol,Golimumab,The metabolism of Olodaterol can be increased when combined with Golimumab.,increase,no risk
Olodaterol,Goserelin,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Goserelin.,increase,risk
Olodaterol,Granisetron,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Granisetron.,increase,risk
Olodaterol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Grepafloxacin.,increase,risk
Olodaterol,Guanabenz,Olodaterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Olodaterol,Guanadrel,Olodaterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Olodaterol,Guanethidine,Olodaterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Olodaterol,Guanfacine,Olodaterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Olodaterol,Guanoxan,Olodaterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Olodaterol,Halofantrine,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Halofantrine.,increase,risk
Olodaterol,Haloperidol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Haloperidol.,increase,risk
Olodaterol,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Olodaterol.,increase,risk
Olodaterol,Hexocyclium,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Olodaterol.,increase,risk
Olodaterol,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Olodaterol.,increase,risk
Olodaterol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Olodaterol.,increase,risk
Olodaterol,Hydralazine,Olodaterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Olodaterol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Olodaterol is combined with Hydrochlorothiazide.,increase,risk
Olodaterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Olodaterol.,increase,risk
Olodaterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Olodaterol.,increase,risk
Olodaterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Olodaterol.,increase,risk
Olodaterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Olodaterol.,increase,risk
Olodaterol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Olodaterol.,increase,risk
Olodaterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Olodaterol is combined with Hydroflumethiazide.,increase,risk
Olodaterol,Hydromorphone,The metabolism of Olodaterol can be decreased when combined with Hydromorphone.,decrease,no risk
Olodaterol,Hydroxychloroquine,The metabolism of Olodaterol can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Olodaterol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Hydroxyzine.,increase,risk
Olodaterol,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Olodaterol.,increase,risk
Olodaterol,Ketamine,The metabolism of Olodaterol can be decreased when combined with Ketamine.,decrease,no risk
Olodaterol,Ketoconazole,The metabolism of Olodaterol can be decreased when combined with Ketoconazole.,decrease,no risk
Olodaterol,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Olodaterol.,increase,risk
Olodaterol,Ketorolac,The metabolism of Olodaterol can be decreased when combined with Ketorolac.,decrease,no risk
Olodaterol,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Olodaterol.,increase,risk
Olodaterol,Ofloxacin,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Ofloxacin.,increase,risk
Olodaterol,Olanzapine,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Olanzapine.,decrease,no risk
Olodaterol,Olmesartan,Olodaterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Olodaterol,Omaveloxolone,The serum concentration of Olodaterol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Olodaterol,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Olodaterol.,decrease,no risk
Olodaterol,Ondansetron,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Ondansetron.,increase,risk
Olodaterol,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Olodaterol.,increase,risk
Olodaterol,Oritavancin,The metabolism of Olodaterol can be decreased when combined with Oritavancin.,decrease,no risk
Olodaterol,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Olodaterol.,increase,risk
Olodaterol,Ospemifene,The metabolism of Olodaterol can be decreased when combined with Ospemifene.,decrease,no risk
Olodaterol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Olodaterol.,increase,risk
Olodaterol,Oxandrolone,The metabolism of Olodaterol can be decreased when combined with Oxandrolone.,decrease,no risk
Olodaterol,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Olodaterol.,increase,risk
Olodaterol,Oxatomide,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Oxatomide.,increase,risk
Olodaterol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Olodaterol.,decrease,no risk
Olodaterol,Oxtriphylline,Oxtriphylline may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Olodaterol,Oxybutynin,The metabolism of Olodaterol can be decreased when combined with Oxybutynin.,decrease,no risk
Olodaterol,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Olodaterol.,increase,risk
Olodaterol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Olodaterol.,increase,risk
Olodaterol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Olodaterol.,increase,risk
Olodaterol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Olodaterol.,increase,risk
Olodaterol,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Olodaterol.,increase,risk
Olodaterol,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Olodaterol.,decrease,no risk
Olodaterol,Quetiapine,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Quetiapine.,decrease,no risk
Olodaterol,Quinapril,Olodaterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Olodaterol,Quinethazone,Olodaterol may increase the hypokalemic activities of Quinethazone.,increase,no risk
Olodaterol,Quinidine,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Quinidine.,decrease,no risk
Olodaterol,Quinine,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Quinine.,increase,risk
Olodaterol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Olodaterol.,increase,risk
Olodaterol,Quizartinib,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Quizartinib.,increase,risk
Idebenone,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Gadodiamide,Gadodiamide may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Gadoteric acid,Idebenone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Idebenone,Gadoteridol,Gadoteridol may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Ganciclovir,Ganciclovir may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Gemcitabine,Gemcitabine may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Gentamicin,Idebenone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Idebenone,Gimeracil,Idebenone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Idebenone,Givosiran,Givosiran may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Glipizide,Glipizide may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Golodirsen,Idebenone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Idebenone,Goserelin,Goserelin may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Guanethidine,Guanethidine may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Guanfacine,Guanfacine may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Haloperidol,Haloperidol may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Hydralazine,Hydralazine may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Idebenone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Idebenone,Hydromorphone,Hydromorphone may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Hydroxyethyl Starch,Idebenone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Idebenone,Kanamycin,Idebenone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Idebenone,Ketamine,Ketamine may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Ketazolam,Ketazolam may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Ketoprofen,Ketoprofen may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Ketorolac,Ketorolac may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Octinoxate,Idebenone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Idebenone,Olsalazine,Olsalazine may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Opium,Idebenone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Idebenone,Oseltamivir,Oseltamivir may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Oxacillin,Oxacillin may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Oxaprozin,Oxaprozin may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Oxazepam,Oxazepam may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Oxybenzone,Oxybenzone may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Oxyquinoline,Idebenone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Idebenone,Quetiapine,Quetiapine may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Quinethazone,Quinethazone may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Idebenone,Quinidine,Idebenone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Idebenone,Vaborbactam,Idebenone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Idebenone,Valaciclovir,Valaciclovir may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Valbenazine,Idebenone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Idebenone,Valdecoxib,Valdecoxib may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Valganciclovir,Valganciclovir may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Vancomycin,Idebenone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Idebenone,Varenicline,Varenicline may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Venlafaxine,Venlafaxine may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Verapamil,Verapamil may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Vilanterol,Idebenone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Idebenone,Viloxazine,Idebenone may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Idebenone,Vortioxetine,Vortioxetine may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Warfarin,Idebenone may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Idebenone,Zaleplon,Zaleplon may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Zanamivir,Zanamivir may decrease the excretion rate of Idebenone which could result in a higher serum level.,decrease,no risk
Idebenone,Zonisamide,Zonisamide may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ivabradine,Gadobenic acid,Ivabradine may increase the QTc-prolonging activities of Gadobenic acid.,increase,no risk
Ivabradine,Galantamine,Galantamine may increase the bradycardic activities of Ivabradine.,increase,no risk
Ivabradine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Ivabradine.,increase,risk
Ivabradine,Gemifloxacin,Ivabradine may increase the QTc-prolonging activities of Gemifloxacin.,increase,no risk
Ivabradine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Ivabradine.,increase,risk
Ivabradine,Gilteritinib,Ivabradine may increase the QTc-prolonging activities of Gilteritinib.,increase,no risk
Ivabradine,Glasdegib,The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Glasdegib.,increase,risk
Ivabradine,Glofitamab,The serum concentration of Ivabradine can be increased when it is combined with Glofitamab.,increase,no risk
Ivabradine,Goserelin,Ivabradine may increase the QTc-prolonging activities of Goserelin.,increase,no risk
Ivabradine,Granisetron,Ivabradine may increase the QTc-prolonging activities of Granisetron.,increase,no risk
Ivabradine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Ivabradine.,increase,risk
Ivabradine,Guanfacine,Guanfacine may increase the bradycardic activities of Ivabradine.,increase,no risk
Ivabradine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Ivabradine.,increase,risk
Ivabradine,Haloperidol,The metabolism of Ivabradine can be decreased when combined with Haloperidol.,decrease,no risk
Ivabradine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ivabradine.,increase,risk
Ivabradine,Hydrochlorothiazide,The risk or severity of Cardiac Arrhythmia can be increased when Hydrochlorothiazide is combined with Ivabradine.,increase,risk
Ivabradine,Hydroflumethiazide,The risk or severity of Cardiac Arrhythmia can be increased when Hydroflumethiazide is combined with Ivabradine.,increase,risk
Ivabradine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Ivabradine.,increase,risk
Ivabradine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Hydroxyzine.,increase,risk
Ivabradine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ivabradine.,increase,risk
Ivabradine,Ketoconazole,The metabolism of Ivabradine can be decreased when combined with Ketoconazole.,decrease,no risk
Ivabradine,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Ivabradine.,increase,no risk
Ivabradine,Ofloxacin,Ivabradine may increase the QTc-prolonging activities of Ofloxacin.,increase,no risk
Ivabradine,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Ivabradine.,increase,risk
Ivabradine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Ivabradine.,increase,risk
Ivabradine,Olutasidenib,The therapeutic efficacy of Ivabradine can be decreased when used in combination with Olutasidenib.,decrease,no risk
Ivabradine,Omaveloxolone,The serum concentration of Ivabradine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ivabradine,Ondansetron,Ivabradine may increase the QTc-prolonging activities of Ondansetron.,increase,no risk
Ivabradine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Ivabradine.,increase,risk
Ivabradine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ivabradine.,increase,risk
Ivabradine,Oxatomide,Ivabradine may increase the QTc-prolonging activities of Oxatomide.,increase,no risk
Ivabradine,Oxprenolol,Oxprenolol may increase the bradycardic activities of Ivabradine.,increase,no risk
Ivabradine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ivabradine.,increase,risk
Ivabradine,Quetiapine,Ivabradine may increase the QTc-prolonging activities of Quetiapine.,increase,no risk
Ivabradine,Quinethazone,The risk or severity of Cardiac Arrhythmia can be increased when Quinethazone is combined with Ivabradine.,increase,risk
Ivabradine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Ivabradine.,increase,risk
Ivabradine,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Ivabradine.,increase,risk
Ivabradine,Quizartinib,The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Quizartinib.,increase,risk
Ivabradine,Vadadustat,The serum concentration of Ivabradine can be increased when it is combined with Vadadustat.,increase,no risk
Ivabradine,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Ivabradine.,increase,risk
Ivabradine,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Ivabradine.,increase,risk
Ivabradine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ivabradine.,increase,risk
Ivabradine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Ivabradine.,increase,risk
Ivabradine,Venetoclax,The metabolism of Ivabradine can be decreased when combined with Venetoclax.,decrease,no risk
Ivabradine,Verapamil,The metabolism of Ivabradine can be decreased when combined with Verapamil.,decrease,no risk
Ivabradine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ivabradine.,increase,risk
Ivabradine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Ivabradine.,increase,risk
Ivabradine,Viloxazine,The metabolism of Ivabradine can be decreased when combined with Viloxazine.,decrease,no risk
Ivabradine,Voriconazole,The risk or severity of QTc prolongation and torsade de pointes can be increased when Voriconazole is combined with Ivabradine.,increase,risk
Ivabradine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ivabradine.,increase,risk
Ivabradine,Zimelidine,The metabolism of Ivabradine can be decreased when combined with Zimelidine.,decrease,no risk
Ivabradine,Ziprasidone,The metabolism of Ivabradine can be decreased when combined with Ziprasidone.,decrease,no risk
Ivabradine,Zonisamide,Zonisamide may increase the bradycardic activities of Ivabradine.,increase,no risk
Ivabradine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Ivabradine.,increase,risk
Benzydamine,Bismuth subgallate,Benzydamine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Benzydamine,Bisoprolol,Benzydamine may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Benzydamine,Bisoxatin,Benzydamine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Benzydamine,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Bivalirudin.,increase,risk
Benzydamine,Bleomycin,Benzydamine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Benzydamine,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Benzydamine.,decrease,no risk
Benzydamine,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Benzydamine.,decrease,no risk
Benzydamine,Brexpiprazole,The risk or severity of hypertension can be increased when Benzydamine is combined with Brexpiprazole.,increase,risk
Benzydamine,Brivaracetam,Benzydamine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Benzydamine,Bromazepam,Benzydamine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Benzydamine,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Benzydamine.,increase,risk
Benzydamine,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Benzydamine.,increase,risk
Benzydamine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Benzydamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Benzydamine,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Benzydamine.,increase,risk
Benzydamine,Bufexamac,The risk or severity of adverse effects can be increased when Benzydamine is combined with Bufexamac.,increase,risk
Benzydamine,Bumadizone,The risk or severity of adverse effects can be increased when Benzydamine is combined with Bumadizone.,increase,risk
Benzydamine,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Benzydamine.,decrease,no risk
Benzydamine,Bupropion,Benzydamine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Benzydamine,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Benzydamine.,increase,risk
Benzydamine,Butabarbital,Benzydamine may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Benzydamine,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Benzydamine.,increase,risk
Tetracaine,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Tetracaine.,increase,risk
Tetracaine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Tetracaine.,increase,risk
Tetracaine,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Tetracaine.,increase,risk
Tetracaine,Bromperidol,The risk or severity of CNS depression can be increased when Tetracaine is combined with Bromperidol.,increase,risk
Tetracaine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Tetracaine.,increase,risk
Tetracaine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Tetracaine.,increase,risk
Tetracaine,Buprenorphine,Tetracaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Tetracaine,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Tetracaine.,increase,risk
Tetracaine,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Tetracaine.,increase,risk
Tetracaine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Tetracaine.,increase,risk
Tetracaine,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Tetracaine.,increase,risk
Tetracaine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Tetracaine.,increase,risk
Tetracaine,Butacaine,The risk or severity of methemoglobinemia can be increased when Tetracaine is combined with Butacaine.,increase,risk
Tetracaine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Tetracaine.,increase,risk
Tetracaine,Butamben,The risk or severity of methemoglobinemia can be increased when Tetracaine is combined with Butamben.,increase,risk
Tetracaine,Butaperazine,The risk or severity of CNS depression can be increased when Tetracaine is combined with Butaperazine.,increase,risk
Tetracaine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Tetracaine.,increase,risk
Tetracaine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Tetracaine.,increase,risk
Tetracaine,Butriptyline,The risk or severity of CNS depression can be increased when Butriptyline is combined with Tetracaine.,increase,risk
Tetracaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Tetracaine.,increase,risk
Tetracaine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Tetracaine.,increase,risk
Tetracaine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Tetracaine.,increase,risk
Tetracaine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tetracaine is combined with Ganaxolone.",increase,risk
Tetracaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Tetracaine.,increase,risk
Tetracaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Tetracaine.,increase,risk
Tetracaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Tetracaine.,increase,risk
Tetracaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Tetracaine.,increase,risk
Tetracaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Tetracaine.,increase,risk
Tetracaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Tetracaine.,increase,risk
Tetracaine,Gepirone,The risk or severity of CNS depression can be increased when Tetracaine is combined with Gepirone.,increase,risk
Tetracaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Tetracaine.,increase,risk
Tetracaine,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Tetracaine.,increase,risk
Tetracaine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Tetracaine.,increase,risk
Tetracaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Tetracaine.,increase,risk
Tetracaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Tetracaine.,increase,risk
Tetracaine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Tetracaine.,increase,risk
Tetracaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Tetracaine.,increase,risk
Tetracaine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Tetracaine.,increase,risk
Tetracaine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Tetracaine.,increase,risk
Tetracaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Tetracaine.,increase,risk
Tetracaine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tetracaine.,increase,risk
Tetracaine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Tetracaine.,increase,risk
Tetracaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Tetracaine.,increase,risk
Tetracaine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Tetracaine.,increase,risk
Tetracaine,Hyaluronidase,Hyaluronidase can cause an increase in the absorption of Tetracaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Tetracaine,Hyaluronidase (human recombinant),Hyaluronidase (human recombinant) can cause an increase in the absorption of Tetracaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Tetracaine,Hyaluronidase (ovine),Hyaluronidase (ovine) can cause an increase in the absorption of Tetracaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Tetracaine,Hydrocodone,Tetracaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tetracaine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Tetracaine.,increase,risk
Tetracaine,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Tetracaine.,increase,risk
Tetracaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Tetracaine.,increase,risk
Tetracaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Tetracaine.,increase,risk
Tetracaine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tetracaine.,increase,no risk
Tetracaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Tetracaine.,increase,risk
Tetracaine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Tetracaine.,increase,risk
Tetracaine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Tetracaine.,increase,risk
Tetracaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Tetracaine.,increase,risk
Tetracaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Tetracaine.,increase,risk
Tetracaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Tetracaine.,increase,risk
Tetracaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Tetracaine.,increase,risk
Tetracaine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Tetracaine.,increase,risk
Tetracaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Tetracaine.,increase,risk
Tetracaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Tetracaine.,increase,risk
Tetracaine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tetracaine is combined with Oliceridine.",increase,risk
Tetracaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Tetracaine.,increase,risk
Tetracaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Tetracaine.,increase,risk
Tetracaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Tetracaine.,increase,risk
Tetracaine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Tetracaine.,increase,risk
Tetracaine,Opium,The risk or severity of CNS depression can be increased when Tetracaine is combined with Opium.,increase,risk
Tetracaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Tetracaine.,increase,risk
Tetracaine,Orphenadrine,Tetracaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tetracaine,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Tetracaine.,increase,risk
Tetracaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Tetracaine.,increase,risk
Tetracaine,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Tetracaine.,increase,risk
Tetracaine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Tetracaine.,increase,risk
Tetracaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Tetracaine.,increase,risk
Tetracaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tetracaine is combined with Oxetacaine.,increase,risk
Tetracaine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Tetracaine.,increase,risk
Tetracaine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Tetracaine.,increase,risk
Tetracaine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Tetracaine.,increase,risk
Tetracaine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Tetracaine.,increase,risk
Tetracaine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Tetracaine.,increase,risk
Tetracaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Tetracaine.,increase,risk
Tetracaine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Tetracaine.,increase,risk
Tetracaine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Tetracaine.,increase,risk
Tetracaine,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Tetracaine.,increase,risk
Tetracaine,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Tetracaine.,increase,risk
Tetracaine,Quinupramine,The risk or severity of CNS depression can be increased when Tetracaine is combined with Quinupramine.,increase,risk
Tetracaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Tetracaine.,increase,risk
Tetracaine,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Tetracaine.,increase,risk
Tetracaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Tetracaine.,increase,risk
Tetracaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Tetracaine.,increase,risk
Tetracaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Tetracaine.,increase,risk
Tetracaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Tetracaine.,increase,risk
Tetracaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Tetracaine.,increase,risk
Tetracaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Tetracaine.,increase,risk
Tetracaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Tetracaine.,increase,risk
Tetracaine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Tetracaine.,increase,risk
Tetracaine,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Tetracaine.,increase,risk
Tetracaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Tetracaine.,increase,risk
Tetracaine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Tetracaine.,increase,risk
Tetracaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Tetracaine.,increase,risk
Tetracaine,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Tetracaine.,increase,risk
Tetracaine,Viloxazine,The risk or severity of CNS depression can be increased when Tetracaine is combined with Viloxazine.,increase,risk
Tetracaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Tetracaine.,increase,risk
Tetracaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Tetracaine.,increase,risk
Tetracaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Tetracaine.,increase,risk
Tetracaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Tetracaine.,increase,risk
Tetracaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Tetracaine.,increase,risk
Tetracaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Tetracaine.,increase,risk
Tetracaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Tetracaine.,increase,risk
Tetracaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Tetracaine.,increase,risk
Tetracaine,Vortioxetine,The risk or severity of CNS depression can be increased when Vortioxetine is combined with Tetracaine.,increase,risk
Tetracaine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Tetracaine.,increase,risk
Tetracaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Tetracaine.,increase,risk
Tetracaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Tetracaine.,increase,risk
Tetracaine,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Tetracaine.,increase,risk
Tetracaine,Zimelidine,The risk or severity of adverse effects can be increased when Tetracaine is combined with Zimelidine.,increase,risk
Tetracaine,Ziprasidone,The risk or severity of adverse effects can be increased when Tetracaine is combined with Ziprasidone.,increase,risk
Tetracaine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Tetracaine.,increase,risk
Tetracaine,Zolpidem,Tetracaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tetracaine,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Tetracaine.,increase,risk
Tetracaine,Zopiclone,The risk or severity of adverse effects can be increased when Tetracaine is combined with Zopiclone.,increase,risk
Tetracaine,Zotepine,The risk or severity of CNS depression can be increased when Tetracaine is combined with Zotepine.,increase,risk
Tetracaine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Tetracaine.,increase,risk
Tetracaine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tetracaine.,increase,risk
Potassium alum,Obeticholic acid,Potassium alum can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Potassium alum,Olmesartan,Potassium alum may increase the hyperkalemic activities of Olmesartan.,increase,no risk
Potassium alum,Ox bile extract,The serum concentration of Ox bile extract can be decreased when it is combined with Potassium alum.,decrease,no risk
Potassium alum,Oxaprozin,Potassium alum may increase the hyperkalemic activities of Oxaprozin.,increase,no risk
Potassium alum,Oxprenolol,Potassium alum may increase the hyperkalemic activities of Oxprenolol.,increase,no risk
Potassium alum,Oxyphenbutazone,Potassium alum may increase the hyperkalemic activities of Oxyphenbutazone.,increase,no risk
Potassium alum,Quinapril,The risk or severity of hyperkalemia can be increased when Potassium alum is combined with Quinapril.,increase,risk
Potassium alum,Ursodeoxycholic acid,Potassium alum can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Potassium alum,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Potassium alum.,decrease,no risk
Potassium alum,Valdecoxib,Potassium alum may increase the hyperkalemic activities of Valdecoxib.,increase,no risk
Potassium alum,Valsartan,Potassium alum may increase the hyperkalemic activities of Valsartan.,increase,no risk
Potassium alum,Zofenopril,The risk or severity of hyperkalemia can be increased when Potassium alum is combined with Zofenopril.,increase,risk
Potassium alum,Zonisamide,Potassium alum may increase the hyperkalemic activities of Zonisamide.,increase,no risk
Trimebutine,Benorilate,The risk or severity of hyperkalemia can be increased when Trimebutine is combined with Benorilate.,increase,risk
Trimebutine,Benoxaprofen,The risk or severity of hyperkalemia can be increased when Benoxaprofen is combined with Trimebutine.,increase,risk
Trimebutine,Benserazide,Trimebutine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Trimebutine,Benzatropine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Trimebutine.,increase,risk
Trimebutine,Benzhydrocodone,The risk or severity of adverse effects can be increased when Trimebutine is combined with Benzhydrocodone.,increase,risk
Trimebutine,Benznidazole,Trimebutine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Trimebutine,Benzphetamine,The risk or severity of Tachycardia can be increased when Benzphetamine is combined with Trimebutine.,increase,risk
Trimebutine,Benzthiazide,Benzthiazide may increase the excretion rate of Trimebutine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trimebutine,Benzydamine,The risk or severity of hyperkalemia can be increased when Benzydamine is combined with Trimebutine.,increase,risk
Trimebutine,Bepotastine,Bepotastine may decrease the excretion rate of Trimebutine which could result in a higher serum level.,decrease,no risk
Trimebutine,Bepridil,Bepridil may increase the arrhythmogenic activities of Trimebutine.,increase,no risk
Trimebutine,Beractant,Beractant may increase the bradycardic activities of Trimebutine.,increase,no risk
Trimebutine,Berotralstat,The metabolism of Trimebutine can be decreased when combined with Berotralstat.,decrease,no risk
Trimebutine,Betaine,The therapeutic efficacy of Trimebutine can be decreased when used in combination with Betaine.,decrease,no risk
Trimebutine,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Trimebutine.,increase,no risk
Trimebutine,Bethanidine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Trimebutine.,increase,risk
Trimebutine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Bexagliflozin.,increase,risk
Trimebutine,Bicisate,Trimebutine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Trimebutine,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Trimebutine.,increase,no risk
Trimebutine,Bilastine,The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Bilastine.,increase,risk
Trimebutine,Bioallethrin,Trimebutine may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Trimebutine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Trimebutine.,increase,risk
Trimebutine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Trimebutine.,decrease,no risk
Trimebutine,Bismuth subgallate,Trimebutine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Trimebutine,Bisoprolol,The therapeutic efficacy of Trimebutine can be increased when used in combination with Bisoprolol.,increase,no risk
Trimebutine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Trimebutine.,decrease,no risk
Trimebutine,Bleomycin,Bleomycin may decrease the excretion rate of Trimebutine which could result in a higher serum level.,decrease,no risk
Trimebutine,Boceprevir,The serum concentration of Trimebutine can be increased when it is combined with Boceprevir.,increase,no risk
Trimebutine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Trimebutine.,increase,risk
Trimebutine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Trimebutine is combined with Botulinum toxin type A.,increase,risk
Trimebutine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Trimebutine is combined with Botulinum toxin type B.,increase,risk
Trimebutine,Bretylium,Bretylium may increase the arrhythmogenic activities of Trimebutine.,increase,no risk
Trimebutine,Brexpiprazole,The risk or severity of hypotension can be increased when Brexpiprazole is combined with Trimebutine.,increase,risk
Trimebutine,Brivaracetam,Brivaracetam may decrease the excretion rate of Trimebutine which could result in a higher serum level.,decrease,no risk
Trimebutine,Bromazepam,Bromazepam may decrease the excretion rate of Trimebutine which could result in a higher serum level.,decrease,no risk
Trimebutine,Bromocriptine,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Bromocriptine.,increase,risk
Trimebutine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Trimebutine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trimebutine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Trimebutine.,increase,risk
Trimebutine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Trimebutine.,increase,risk
Trimebutine,Budesonide,Budesonide may decrease the excretion rate of Trimebutine which could result in a higher serum level.,decrease,no risk
Trimebutine,Bumadizone,The risk or severity of hyperkalemia can be increased when Trimebutine is combined with Bumadizone.,increase,risk
Trimebutine,Bumetanide,Bumetanide may increase the excretion rate of Trimebutine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trimebutine,Buprenorphine,The risk or severity of adverse effects can be increased when Trimebutine is combined with Buprenorphine.,increase,risk
Trimebutine,Bupropion,Bupropion may decrease the excretion rate of Trimebutine which could result in a higher serum level.,decrease,no risk
Trimebutine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Trimebutine.,increase,risk
Trimebutine,Buspirone,Buspirone may decrease the excretion rate of Trimebutine which could result in a higher serum level.,decrease,no risk
Trimebutine,Butabarbital,The metabolism of Trimebutine can be increased when combined with Butabarbital.,increase,no risk
Trimebutine,Butalbital,The metabolism of Trimebutine can be increased when combined with Butalbital.,increase,no risk
Trimebutine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Trimebutine.,increase,risk
Trimebutine,Butorphanol,The risk or severity of adverse effects can be increased when Trimebutine is combined with Butorphanol.,increase,risk
Trimebutine,Butriptyline,The risk or severity of adverse effects can be increased when Trimebutine is combined with Butriptyline.,increase,risk
Trimebutine,Butylscopolamine,The risk or severity of adverse effects can be increased when Trimebutine is combined with Butylscopolamine.,increase,risk
Pinaverium,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Gadobenic acid.,increase,risk
Pinaverium,Galantamine,Galantamine may increase the bradycardic activities of Pinaverium.,increase,no risk
Pinaverium,Gallamine triethiodide,Pinaverium may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Pinaverium,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Pinaverium.,increase,risk
Pinaverium,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Gemifloxacin.,increase,risk
Pinaverium,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Pinaverium.,increase,risk
Pinaverium,Gilteritinib,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Gilteritinib.,increase,risk
Pinaverium,Glasdegib,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Glasdegib.,increase,risk
Pinaverium,Gliclazide,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Gliclazide.,increase,risk
Pinaverium,Glimepiride,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Glimepiride.,increase,risk
Pinaverium,Glipizide,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Glipizide.,increase,risk
Pinaverium,Gliquidone,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Gliquidone.,increase,risk
Pinaverium,Glofitamab,The serum concentration of Pinaverium can be increased when it is combined with Glofitamab.,increase,no risk
Pinaverium,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Pinaverium.,decrease,no risk
Pinaverium,Glyburide,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Glyburide.,increase,risk
Pinaverium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Pinaverium.,decrease,no risk
Pinaverium,Glymidine,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Glymidine.,increase,risk
Pinaverium,Goserelin,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Goserelin.,increase,risk
Pinaverium,Granisetron,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Granisetron.,increase,risk
Pinaverium,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Grepafloxacin.,increase,risk
Pinaverium,Guanfacine,Guanfacine may increase the bradycardic activities of Pinaverium.,increase,no risk
Pinaverium,Halofantrine,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Halofantrine.,increase,risk
Pinaverium,Haloperidol,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Haloperidol.,increase,risk
Pinaverium,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Pinaverium.,increase,risk
Pinaverium,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Pinaverium.,increase,risk
Pinaverium,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Pinaverium.,increase,risk
Pinaverium,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Pinaverium.,increase,risk
Pinaverium,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Pinaverium.,increase,risk
Pinaverium,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Hydroxyzine.,increase,risk
Pinaverium,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Pinaverium.,increase,no risk
Tixocortol,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Tixocortol.,increase,risk
Tixocortol,Bexagliflozin,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Bexagliflozin.,increase,risk
Tixocortol,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Tixocortol.,increase,risk
Tixocortol,Bicisate,Tixocortol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Tixocortol,Bimekizumab,The risk or severity of adverse effects can be increased when Tixocortol is combined with Bimekizumab.,increase,risk
Tixocortol,Bismuth subgallate,Tixocortol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Tixocortol,Bisoprolol,Bisoprolol may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Bisoxatin,Tixocortol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Tixocortol,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Tixocortol.,increase,risk
Tixocortol,Blinatumomab,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Tixocortol.,increase,risk
Tixocortol,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Tixocortol.",decrease,no risk
Tixocortol,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Tixocortol.,increase,risk
Tixocortol,Bosutinib,The risk or severity of adverse effects can be increased when Bosutinib is combined with Tixocortol.,increase,risk
Tixocortol,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Tixocortol.,increase,risk
Tixocortol,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tixocortol.,increase,risk
Tixocortol,Brivaracetam,Brivaracetam may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Brodalumab,The risk or severity of adverse effects can be increased when Tixocortol is combined with Brodalumab.,increase,risk
Tixocortol,Bromazepam,Bromazepam may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Bromocriptine,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Bromocriptine.,increase,risk
Tixocortol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Tixocortol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tixocortol,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Tixocortol.,increase,risk
Tixocortol,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Tixocortol is combined with Bumadizone.,increase,risk
Tixocortol,Bumetanide,Bumetanide may increase the excretion rate of Tixocortol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tixocortol,Bupropion,Bupropion may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Buspirone,Buspirone may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Tixocortol.,increase,risk
Tixocortol,Butabarbital,Butabarbital may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Gadodiamide,Gadodiamide may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Gadoteric acid,Tixocortol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tixocortol,Gadoteridol,Gadoteridol may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Ganciclovir,Ganciclovir may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Gatifloxacin,The risk or severity of tendinopathy can be increased when Tixocortol is combined with Gatifloxacin.,increase,risk
Tixocortol,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Tixocortol.,increase,risk
Tixocortol,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Gemifloxacin,The risk or severity of tendinopathy can be increased when Tixocortol is combined with Gemifloxacin.,increase,risk
Tixocortol,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tixocortol.,increase,risk
Tixocortol,Gentamicin,Tixocortol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Tixocortol,Gestrinone,The serum concentration of Tixocortol can be increased when it is combined with Gestrinone.,increase,no risk
Tixocortol,Gimeracil,Tixocortol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tixocortol,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Givosiran,Givosiran may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Tixocortol.,increase,risk
Tixocortol,Gliclazide,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Gliclazide.,increase,risk
Tixocortol,Glimepiride,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Glimepiride.,increase,risk
Tixocortol,Glipizide,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Glipizide.,increase,risk
Tixocortol,Gliquidone,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Gliquidone.,increase,risk
Tixocortol,Glyburide,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Glyburide.,increase,risk
Tixocortol,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Tixocortol is combined with Glycol salicylate.,increase,risk
Tixocortol,Glymidine,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Glymidine.,increase,risk
Tixocortol,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Tixocortol.,increase,risk
Tixocortol,Golodirsen,Tixocortol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tixocortol,Goserelin,Goserelin may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Grepafloxacin,The risk or severity of tendinopathy can be increased when Tixocortol is combined with Grepafloxacin.,increase,risk
Tixocortol,Guanethidine,Guanethidine may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Guanfacine,Guanfacine may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Guselkumab,The risk or severity of adverse effects can be increased when Tixocortol is combined with Guselkumab.,increase,risk
Tixocortol,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Haloperidol,Haloperidol may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Tixocortol.,increase,risk
Tixocortol,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Hydralazine,Hydralazine may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Tixocortol is combined with Hydrochlorothiazide.,increase,risk
Tixocortol,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Tixocortol is combined with Hydrocortisone acetate.,increase,risk
Tixocortol,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Tixocortol is combined with Hydrocortisone butyrate.,increase,risk
Tixocortol,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Tixocortol is combined with Hydrocortisone succinate.,increase,risk
Tixocortol,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Tixocortol is combined with Hydroflumethiazide.,increase,risk
Tixocortol,Hydromorphone,Hydromorphone may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Tixocortol.,increase,risk
Tixocortol,Hydroxyethyl Starch,Tixocortol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tixocortol,Hydroxyprogesterone caproate,The serum concentration of Tixocortol can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Tixocortol,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Tixocortol.,increase,risk
Tixocortol,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Kanamycin,Tixocortol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Tixocortol,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Ketazolam,Ketazolam may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Tixocortol is combined with Ketoprofen.,increase,risk
Tixocortol,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Tixocortol is combined with Ketorolac.,increase,risk
Tixocortol,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Tixocortol.,increase,risk
Tixocortol,Ocrelizumab,The risk or severity of adverse effects can be increased when Tixocortol is combined with Ocrelizumab.,increase,risk
Tixocortol,Octinoxate,Tixocortol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Tixocortol,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Tixocortol.,increase,risk
Tixocortol,Ofloxacin,The risk or severity of tendinopathy can be increased when Tixocortol is combined with Ofloxacin.,increase,risk
Tixocortol,Olaparib,The risk or severity of adverse effects can be increased when Olaparib is combined with Tixocortol.,increase,risk
Tixocortol,Olodaterol,The risk or severity of hypokalemia can be increased when Tixocortol is combined with Olodaterol.,increase,risk
Tixocortol,Olsalazine,Olsalazine may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Opium,Tixocortol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Tixocortol,Orciprenaline,The risk or severity of hypokalemia can be increased when Tixocortol is combined with Orciprenaline.,increase,risk
Tixocortol,Oseltamivir,Oseltamivir may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Oxacillin,Oxacillin may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Tixocortol.,increase,risk
Tixocortol,Oxandrolone,The risk or severity of fluid retention can be increased when Tixocortol is combined with Oxandrolone.,increase,risk
Tixocortol,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Tixocortol is combined with Oxaprozin.,increase,risk
Tixocortol,Oxazepam,Oxazepam may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Oxybenzone,Oxybenzone may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Oxymetazoline,The absorption of Tixocortol can be decreased when combined with Oxymetazoline.,decrease,no risk
Tixocortol,Oxymetholone,The risk or severity of fluid retention can be increased when Tixocortol is combined with Oxymetholone.,increase,risk
Tixocortol,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Tixocortol is combined with Oxyphenbutazone.,increase,risk
Tixocortol,Oxyquinoline,Tixocortol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Tixocortol,Ozanimod,The risk or severity of adverse effects can be increased when Tixocortol is combined with Ozanimod.,increase,risk
Tixocortol,Quetiapine,Quetiapine may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Quinethazone,Tixocortol may increase the hypokalemic activities of Quinethazone.,increase,no risk
Tixocortol,Quinidine,Tixocortol may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tixocortol,Quinine,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Quinine.,increase,risk
Tixocortol,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Tixocortol.,increase,risk
Tixocortol,Ulipristal,The serum concentration of Tixocortol can be increased when it is combined with Ulipristal.,increase,no risk
Tixocortol,Upadacitinib,The risk or severity of adverse effects can be increased when Tixocortol is combined with Upadacitinib.,increase,risk
Tixocortol,Vaborbactam,Tixocortol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Tixocortol,Valaciclovir,Valaciclovir may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Valbenazine,Tixocortol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Tixocortol,Valdecoxib,The risk or severity of gastrointestinal irritation can be increased when Tixocortol is combined with Valdecoxib.,increase,risk
Tixocortol,Valganciclovir,Valganciclovir may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Vancomycin,Tixocortol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Tixocortol,Varenicline,Varenicline may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Tixocortol.,increase,risk
Tixocortol,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Vecuronium,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Tixocortol.,increase,risk
Tixocortol,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Tixocortol.,increase,risk
Tixocortol,Venlafaxine,Venlafaxine may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Verapamil,Verapamil may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Vilanterol,The risk or severity of adverse effects can be increased when Vilanterol is combined with Tixocortol.,increase,risk
Tixocortol,Vildagliptin,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Vildagliptin.,increase,risk
Tixocortol,Viloxazine,Tixocortol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Tixocortol,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Tixocortol.,increase,risk
Tixocortol,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Tixocortol.,increase,risk
Tixocortol,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Tixocortol.,increase,risk
Tixocortol,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Tixocortol.,increase,risk
Tixocortol,Vitamin D,The therapeutic efficacy of Vitamin D can be decreased when used in combination with Tixocortol.,decrease,no risk
Tixocortol,Voclosporin,The risk or severity of adverse effects can be increased when Tixocortol is combined with Voclosporin.,increase,risk
Tixocortol,Voriconazole,The serum concentration of Tixocortol can be increased when it is combined with Voriconazole.,increase,no risk
Tixocortol,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Tixocortol.,increase,risk
Tixocortol,Vortioxetine,Vortioxetine may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Warfarin,Tixocortol may increase the anticoagulant activities of Warfarin.,increase,no risk
Tixocortol,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Tixocortol.,increase,risk
Tixocortol,Zaleplon,Zaleplon may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Zanamivir,Zanamivir may decrease the excretion rate of Tixocortol which could result in a higher serum level.,decrease,no risk
Tixocortol,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Tixocortol.,increase,risk
Tixocortol,Zonisamide,Zonisamide may increase the excretion rate of Tixocortol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlortetracycline,Benzocaine,The risk or severity of methemoglobinemia can be increased when Chlortetracycline is combined with Benzocaine.,increase,risk
Chlortetracycline,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Chlortetracycline is combined with Benzyl alcohol.,increase,risk
Chlortetracycline,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Chlortetracycline is combined with Bupivacaine.,increase,risk
Chlortetracycline,Butacaine,The risk or severity of methemoglobinemia can be increased when Chlortetracycline is combined with Butacaine.,increase,risk
Chlortetracycline,Butamben,The risk or severity of methemoglobinemia can be increased when Chlortetracycline is combined with Butamben.,increase,risk
Chlortetracycline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Chlortetracycline is combined with Oxetacaine.,increase,risk
Chlortetracycline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Chlortetracycline is combined with Oxybuprocaine.,increase,risk
Chlortetracycline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Chlortetracycline.,decrease,no risk
Difluocortolone,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Difluocortolone.,increase,risk
Difluocortolone,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Difluocortolone.,decrease,no risk
Difluocortolone,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Difluocortolone.,increase,risk
Difluocortolone,Bacitracin,Bacitracin may decrease the excretion rate of Difluocortolone which could result in a higher serum level.,decrease,no risk
Difluocortolone,Baclofen,Baclofen may decrease the excretion rate of Difluocortolone which could result in a higher serum level.,decrease,no risk
Difluocortolone,Balsalazide,The risk or severity of gastrointestinal irritation can be increased when Difluocortolone is combined with Balsalazide.,increase,risk
Difluocortolone,Baricitinib,The risk or severity of adverse effects can be increased when Difluocortolone is combined with Baricitinib.,increase,risk
Difluocortolone,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Difluocortolone.,increase,risk
Difluocortolone,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Difluocortolone.,increase,risk
Difluocortolone,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Difluocortolone.,increase,risk
Difluocortolone,Belatacept,The risk or severity of adverse effects can be increased when Belatacept is combined with Difluocortolone.,increase,risk
Difluocortolone,Belimumab,The risk or severity of adverse effects can be increased when Belimumab is combined with Difluocortolone.,increase,risk
Difluocortolone,Belinostat,The risk or severity of adverse effects can be increased when Belinostat is combined with Difluocortolone.,increase,risk
Difluocortolone,Belumosudil,The risk or severity of adverse effects can be increased when Difluocortolone is combined with Belumosudil.,increase,risk
Difluocortolone,Bendamustine,The risk or severity of adverse effects can be increased when Bendamustine is combined with Difluocortolone.,increase,risk
Difluocortolone,Bendroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Difluocortolone is combined with Bendroflumethiazide.,increase,risk
Difluocortolone,Benorilate,The risk or severity of gastrointestinal irritation can be increased when Difluocortolone is combined with Benorilate.,increase,risk
Difluocortolone,Benoxaprofen,The risk or severity of gastrointestinal irritation can be increased when Difluocortolone is combined with Benoxaprofen.,increase,risk
Difluocortolone,Benserazide,Difluocortolone may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Difluocortolone,Benzatropine,Benzatropine may decrease the excretion rate of Difluocortolone which could result in a higher serum level.,decrease,no risk
Difluocortolone,Benznidazole,Difluocortolone may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Difluocortolone,Benzoic acid,The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Difluocortolone.,decrease,no risk
Difluocortolone,Benzthiazide,The risk or severity of electrolyte imbalance can be increased when Difluocortolone is combined with Benzthiazide.,increase,risk
Difluocortolone,Benzydamine,The risk or severity of gastrointestinal irritation can be increased when Difluocortolone is combined with Benzydamine.,increase,risk
Difluocortolone,Bepotastine,Bepotastine may decrease the excretion rate of Difluocortolone which could result in a higher serum level.,decrease,no risk
Difluocortolone,Berotralstat,The metabolism of Difluocortolone can be decreased when combined with Berotralstat.,decrease,no risk
Difluocortolone,Betaine,The therapeutic efficacy of Betaine can be decreased when used in combination with Difluocortolone.,decrease,no risk
Difluocortolone,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Difluocortolone.,increase,risk
Difluocortolone,Bexagliflozin,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Bexagliflozin.,increase,risk
Difluocortolone,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Difluocortolone.,increase,risk
Difluocortolone,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Difluocortolone.,increase,no risk
Difluocortolone,Bicisate,Difluocortolone may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Difluocortolone,Bimekizumab,The risk or severity of adverse effects can be increased when Difluocortolone is combined with Bimekizumab.,increase,risk
Difluocortolone,Bismuth subgallate,Difluocortolone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Difluocortolone,Bisoprolol,Bisoprolol may decrease the excretion rate of Difluocortolone which could result in a higher serum level.,decrease,no risk
Difluocortolone,Bisoxatin,Difluocortolone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Difluocortolone,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Difluocortolone.,increase,risk
Difluocortolone,Blinatumomab,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Difluocortolone.,increase,risk
Difluocortolone,Boceprevir,The metabolism of Difluocortolone can be decreased when combined with Boceprevir.,decrease,no risk
Difluocortolone,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Difluocortolone.",decrease,no risk
Difluocortolone,Bortezomib,The metabolism of Bortezomib can be increased when combined with Difluocortolone.,increase,no risk
Difluocortolone,Bosutinib,The metabolism of Bosutinib can be increased when combined with Difluocortolone.,increase,no risk
Difluocortolone,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Difluocortolone.,increase,risk
Difluocortolone,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Difluocortolone.,increase,no risk
Difluocortolone,Brigatinib,The metabolism of Brigatinib can be increased when combined with Difluocortolone.,increase,no risk
Difluocortolone,Brivaracetam,Brivaracetam may decrease the excretion rate of Difluocortolone which could result in a higher serum level.,decrease,no risk
Difluocortolone,Brodalumab,The risk or severity of adverse effects can be increased when Difluocortolone is combined with Brodalumab.,increase,risk
Difluocortolone,Bromazepam,Bromazepam may decrease the excretion rate of Difluocortolone which could result in a higher serum level.,decrease,no risk
Difluocortolone,Bromocriptine,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Bromocriptine.,increase,risk
Difluocortolone,Bromotheophylline,Bromotheophylline may increase the excretion rate of Difluocortolone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Difluocortolone,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Difluocortolone.,increase,risk
Difluocortolone,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Difluocortolone is combined with Bumadizone.,increase,risk
Difluocortolone,Bumetanide,The risk or severity of hypokalemia can be increased when Difluocortolone is combined with Bumetanide.,increase,risk
Difluocortolone,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Difluocortolone.,increase,no risk
Difluocortolone,Bupropion,Bupropion may decrease the excretion rate of Difluocortolone which could result in a higher serum level.,decrease,no risk
Difluocortolone,Buspirone,The metabolism of Buspirone can be increased when combined with Difluocortolone.,increase,no risk
Difluocortolone,Busulfan,The metabolism of Busulfan can be increased when combined with Difluocortolone.,increase,no risk
Difluocortolone,Butabarbital,Butabarbital may decrease the excretion rate of Difluocortolone which could result in a higher serum level.,decrease,no risk
Quinagolide,Benperidol,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Benperidol.,decrease,no risk
Quinagolide,Brexpiprazole,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Quinagolide,Bromocriptine,The risk or severity of adverse effects can be decreased when Bromocriptine is combined with Quinagolide.,decrease,risk
Quinagolide,Bromperidol,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Bromperidol.,decrease,no risk
Quinagolide,Buspirone,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Buspirone.,decrease,no risk
Quinagolide,Butaperazine,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Butaperazine.,decrease,no risk
Quinagolide,Haloperidol,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Haloperidol.,decrease,no risk
Quinagolide,Olanzapine,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Olanzapine.,decrease,no risk
Quinagolide,Quetiapine,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Quetiapine.,decrease,no risk
Quinagolide,Yohimbine,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Yohimbine.,decrease,no risk
Quinagolide,Ziprasidone,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Quinagolide,Zotepine,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Zotepine.,decrease,no risk
Quinagolide,Zuclopenthixol,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Somatrem,Olanzapine,The metabolism of Olanzapine can be increased when combined with Somatrem.,increase,no risk
Somatrem,Ondansetron,The metabolism of Ondansetron can be increased when combined with Somatrem.,increase,no risk
Somatrem,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Somatrem.,increase,no risk
Somatrem,Quinine,Somatrem may decrease the hypoglycemic activities of Quinine.,decrease,no risk
Somatrem,Verapamil,The metabolism of Verapamil can be increased when combined with Somatrem.,increase,no risk
Somatrem,Vildagliptin,Somatrem may decrease the hypoglycemic activities of Vildagliptin.,decrease,no risk
Somatrem,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Somatrem.,increase,no risk
Somatrem,Warfarin,The metabolism of Warfarin can be increased when combined with Somatrem.,increase,no risk
Somatrem,Zileuton,The metabolism of Zileuton can be increased when combined with Somatrem.,increase,no risk
Somatrem,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Somatrem.,increase,no risk
Somatrem,Zolpidem,The metabolism of Zolpidem can be increased when combined with Somatrem.,increase,no risk
Somatrem,Zotepine,The metabolism of Zotepine can be increased when combined with Somatrem.,increase,no risk
Somatostatin,Olaparib,The metabolism of Olaparib can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Quinidine,The metabolism of Quinidine can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Somatostatin.,increase,no risk
Somatostatin,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Vincristine,The metabolism of Vincristine can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Vindesine,The metabolism of Vindesine can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Somatostatin.,increase,no risk
Somatostatin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Somatostatin.,increase,no risk
Somatostatin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Somatostatin.,decrease,no risk
Somatostatin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Somatostatin.,decrease,no risk
"Thyroid, porcine",Gefitinib,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Gefitinib.",decrease,no risk
"Thyroid, porcine",Gilteritinib,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Gilteritinib.",decrease,no risk
"Thyroid, porcine",Gliclazide,"Thyroid, porcine may decrease the hypoglycemic activities of Gliclazide.",decrease,no risk
"Thyroid, porcine",Glimepiride,"Thyroid, porcine may decrease the hypoglycemic activities of Glimepiride.",decrease,no risk
"Thyroid, porcine",Glipizide,"Thyroid, porcine may decrease the hypoglycemic activities of Glipizide.",decrease,no risk
"Thyroid, porcine",Gliquidone,"Thyroid, porcine may decrease the hypoglycemic activities of Gliquidone.",decrease,no risk
"Thyroid, porcine",Glyburide,"Thyroid, porcine may decrease the hypoglycemic activities of Glyburide.",decrease,no risk
"Thyroid, porcine",Glymidine,"Thyroid, porcine may decrease the hypoglycemic activities of Glymidine.",decrease,no risk
"Thyroid, porcine",Olsalazine,"The therapeutic efficacy of Thyroid, porcine can be increased when used in combination with Olsalazine.",increase,no risk
"Thyroid, porcine",Orciprenaline,"The risk or severity of adverse effects can be increased when Orciprenaline is combined with Thyroid, porcine.",increase,risk
"Thyroid, porcine",Osimertinib,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Osimertinib.",decrease,no risk
"Thyroid, porcine",Oxprenolol,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Oxprenolol.",decrease,no risk
"Thyroid, porcine",Oxtriphylline,"Thyroid, porcine may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.",increase,no risk
"Thyroid, porcine",Oxymetazoline,"The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Thyroid, porcine.",increase,risk
"Thyroid, porcine",Quinestrol,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Quinestrol.",decrease,no risk
"Thyroid, porcine",Quinine,"Thyroid, porcine may decrease the hypoglycemic activities of Quinine.",decrease,no risk
"Thyroid, porcine",Quinupramine,"The risk or severity of Cardiac Arrhythmia can be increased when Thyroid, porcine is combined with Quinupramine.",increase,risk
"Thyroid, porcine",Quizartinib,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Quizartinib.",decrease,no risk
"Thyroid, porcine",Vandetanib,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Vandetanib.",decrease,no risk
"Thyroid, porcine",Vasopressin,"Thyroid, porcine may increase the vasoconstricting activities of Vasopressin.",increase,no risk
"Thyroid, porcine",Vemurafenib,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Vemurafenib.",decrease,no risk
"Thyroid, porcine",Vildagliptin,"Thyroid, porcine may decrease the hypoglycemic activities of Vildagliptin.",decrease,no risk
"Thyroid, porcine",Warfarin,"The risk or severity of bleeding can be increased when Thyroid, porcine is combined with Warfarin.",increase,risk
"Thyroid, porcine",Xylometazoline,"Thyroid, porcine may increase the vasoconstricting activities of Xylometazoline.",increase,no risk
"Thyroid, porcine",Zanubrutinib,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Zanubrutinib.",decrease,no risk
"Thyroid, porcine",Zimelidine,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Zimelidine.",decrease,no risk
